Editorial Panel

Editors

Professor Alfio Ferlito, MD

University of Udine School of Medicine
Professor Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP

Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013.
He graduated in medicine at the University of Bologna in 1968. He completed his residence programme in otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997.
Since 2009 he is the Coordinator of the International Head Neck Scientific Group (www.IHNSG.com).

Professor Ferlito has collaborated in writing articles, editorials, commentaries, consensus statements, letters to the editor, special issues, book chapters and books with 642 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), Surgical Pathology of Laryngeal Neoplasms (Chapman and Hall, London, 1996) and Diseases of the Larynx (Arnold, London, 2000), and co-authored two books entitled Granulomas and Neoplasms of the Larynx together with Professor Imrich Friedmann (Churchill Livingstone, Edinburgh, 1988) and Surgery for Cancer of the Larynx and Related Structures together with Dr. Carl E. Silver (Saunders, Philadelphia, 1996). He is editor with Dr. Marvin P. Fried of the third edition of a two-volume book entitled The Larynx (Plural Publishing, San Diego, 2009) and with Drs. K. Thomas Robbins and Carl E. Silver of the book entitled Neck Dissection - Management of Regional Disease in Head and Neck Cancer (Plural Publishing, San Diego, 2010). He is Editor of four issues of ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery. Professor Ferlito has been author or co-author of 648 referred publications in 67 medical journals and 54 chapters in various books.
Professor Ferlito has been awarded ad hominem fellowship from the Royal College of Surgeons of Edinburgh and ad eundem fellowship from the Royal College of Surgeons of England, Glasgow, Ireland and Dental Surgery of the Royal College of Surgeons of England. He is a fellow or a member of the American College of Surgeons, the Royal College of Pathologists, the Royal Society of Medicine of London, the American Otological Society, the American Laryngological Association, the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum, the American Laryngological Rhinological and Otological Association, the American Society for Head and Neck Surgery, the Society of Head and Neck Surgeons, the American Broncho-Esophagological Association, the American Rhinologic Society, the Association for Research in Otolaryngology, the American Academy of Otolaryngology-Head and Neck Surgery, the International Broncho-Esophagological Society, the Oto-Rhino-Laryngological Society of Japan, the Japan Laryngological Association, the American Association for the Advancement of Science, the Hungarian Association of Otorhinolaryngologists (Honorary), the Slovenian Association of Otorhinolaryngologists, the Slovak Society of Otolaryngology-Head and Neck Surgery (Honorary), the Spanish Society of Otorhinolaryngology-Head and Neck Surgery (Honorary), the Israeli Society of Head and Neck Surgery and Oncology, the Hong Kong College of Otolaryngologists, the New York Academy of Sciences, the Laryngeal Cancer Association, Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, the American Society for Clinical Pathology, the College of American Pathologists, the International Academy of Pathology, the International Academy of Oral Oncology and the Interventional Oncology Society.

Professor Ferlito has been honored with several distinctions from professional ENT Societies including two Presidential Citations from the American Laryngological Association for his contributions made to the field of laryngology and the association. He has been appointed as the International Liaison for Corresponding Fellows of the American Laryngological Association. He is also a Fellowship External Examiner in Otorhinolaryngology at the Royal College of Surgeons in Ireland.

He has been invited as visiting professor at the Departments of Otolaryngology of the Universities of Ljubljiana, Valencia, Zagreb, Yale, Pittsburgh, Amsterdam, San Francisco, Hong Kong, Seoul and Tokyo, at the House Ear Institute of Los Angeles, at the Memorial Sloan-Kettering Cancer Center and Montefiore Medical Center of New York. He collaborated as a member of the World Health Organization’s Committee on Histological Typing of Tumours of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association’s Committee on the Classification of Laryngeal Cancer. He was consultant to Yale University.

Professor Ferlito has delivered prestigious lectures all over the world. In 2006 he gave the 2nd Morrison Lecture in San Francisco and the 19th Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research. One of his chief interests is the promotion of international cooperation in head and neck surgery, oncology and cancer research.
Journal articles


1) Ferlito A
Sul papilloma intraduttale del capezzolo nella mammella maschile
Riv Anat Patol Oncol 35, 339-344, 1969.

2) Ferlito A
Sul carcinoma adenoide-cistico della mammella maschile
Riv Anat Patol Oncol 35, 441-445, 1969.

3) Ferlito A, Mainini F, Natali R
Cisti epidermoidali multiple in mastopatia fibrocistica e fibroadenoma intracanalicolare
Riv Anat Patol Oncol 36, 106-118, 1970.

4) Rinaldi G, Ferlito A, Campos E
Su una rara osservazione di epitelioma basocellulare palpebrale in un giovane
Ann Ottal 96, 171-180, 1970.

5) Ferlito A, Spanio M
Sul carcinoma adenoide-cistico del corpo dell'utero
Clin Ostet Ginec 72, 271-281, 1970.

6) Babighian G, Ferlito A
Poliblastomatosi primaria multipla: su un caso di associa zione linfosarcoma-cancro (linfosarcomatosi di Kundrat in associazione con carcinoma del labbro inferiore, carcinoma spinocellulare corneificante della laringe, carcinoma bronchiale)
Riv Anat Patol Oncol 36, 360-371, 1970.

7) Ferlito A, Babighian G
Caso inconsueto di fibrolipoma del seno piriforme. Considerazioni e spunti critici su un'osservazione personale
Minerva Med Giul 61, 5884-5887, 1970.

8) Muratti G, Bianchi C, Ferlito A
L'osteoma della lingua. Osservazione di un caso
Arch Ital Otol 81, 304-310, 1970.

9) Ferlito A
Su un caso di tumore misto maligno laryngo-ipofaringo-esofageo. Considerazioni cliniche ed anatomopatologiche
Chir Ital 22, 127-144, 1970.

10) Ferlito A
Considerazioni sulla patogenesi del cosiddetto colesteatoma dell'orecchio medio
Otorinolaringol Ital 39, 185-201, 1970.
11) Delaini A, Ferlito A
Il ganglioneuroma perifaringeo. Contributo casistico e considerazioni anatomoistopatologiche
Ann Laringol 70, 455-468, 1971.

12) Di Bonito L, Ferlito A
Considerazioni cliniche e di patologia su di una osservazione di tofo laringeo
Clinica ORL 23, 94-99, 1971.

13) Babighian G, Ferlito A
Su di un caso di cisti laringee branchiogene. Proposta d'inquadramento e d'interpretazione istogenetica su basi istopatologiche
Ann Laringol 71, 227-238, 1972.

14) Sala O, Ferlito A
Ricerche istopatologiche sull'otite media purulenta cronica: deduzioni cliniche
Ann Laringol 71, 373-380, 1972.

15) Sala O, Ferlito A
Mucus hypersecretion in chronic otitis media
Minerva Otorinolaringol 22, 211-215, 1972.

16) Ferlito A, Di Bonito L, Silvestri F
A propos du lipome bronchique. Considérations et suggestions critiques à l'aide de trois observations
Poumoun Coeur 28, 435-440, 1972.

17) Ferlito A, Babighian G
Pseudosarcoma dell'epiglottide con diffusione metastatica allo scheletro
Morgagni 5, 85-94, 1972.

18) Ferlito A
Il cosiddetto "colesteatoma" dell'orecchio medio ed il granuloma colesterinico: considerazioni istopatologiche e cliniche
Atti LX Congr Naz Soc Ital Otorinolaringol Patol Cerv Facc, Rimini, 1-17, 1972.

19) Ferlito A
Sull'adenocarcinoma delle ghiandole ceruminose del condotto uditivo esterno
Ann Laringol 71, 485-493, 1972.

20) Ferlito A
Studio istopatologico ed istochimico della mucosa dell'orecchio medio nella otite media purulenta cronica (indagine su 31 pazienti operati di timpanoplastica)
Nuovo Arch Ital Otol 1, 22-75, 1973.*
21) Giarelli L, Ferlito A, Purini A
Une entité pathologique rare: la stéatonécrose de l'épicarde (à propos d'une observation)
Poumon Coeur 29, 197-201, 1973.

22) Ferlito A
Considerazioni su alcuni quadri istologici ed istochimici dell'otite media cronica
Boll Aud Fon 22, 111-120, 1973.

23) Ferlito A
Ricerche istologiche ed istochimiche sul comportamento delle strutture ossee dell'orecchio medio nella otite media purulenta cronica
Nuovo Arch Ital Otol 1, 149-180, 1973.*

24) Sala O, Ferlito A
Considerazioni sulla dissociazione tra quadro istopatologico e sintomi clinici nelle flogosi otitiche acute
Ann Laringol 72, 369-376, 1973.

25) Ferlito A
Le "cholestéatome" de l'oreille moyenne et le granulome à cholestérol: considérations histopathologiques et cliniques
Ann Otolaryngol Chir Cervicofac 90, 697-710, 1973.

26) Sala O, Ferlito A
Istopatologia della mucosa dell'orecchio medio nelle otiti croniche. In: Dissertationes De Aurium Partis Mediae Morbis. XX Conventus Societas Otorhinolaringologica Latina, Roma, 411-424, 1974.

27) Ferlito A, Di Bonito L
I.F. 0.607 Adenoid cystic carcinoma of the male breast: report of a case
Am Surg 40, 72-76, 1974.

28) Ferlito A
I.F. 1.513 Oat cell carcinoma of the larynx
Ann Otol Rhinol Laryngol 83, 254-256, 1974.*

29) Ferlito A
L'épithelioma a cellules géantes du sein
Arch Anat Pathol 22, 99-104, 1974.

30) Ferlito A, Di Bonito L
A propos d'une observation de laryngo-oesophagite ulcéro-nécrotique chez un malade atteint de leucose aiguè (considérations étiopathogéniques)
Ann Otolaryngol Chir Cervicofac 91, 199-209, 1974.
31) Ferlito A
I.F. 1.012 Pathology of chronic suppurative otitis media. A histological and histochemical study
ORL J Otorhinolaryngol Relat Spec 36, 257-274, 1974.*

32) Ferlito A
I.F. 1.513 Oat cell carcinoma of the larynx
Ann Otol Rhinol Laryngol 83, 834, 1974. (Letter to the Editor).

33) Ferlito A
I.F. 0.967 Primary aspergillosis of the larynx
J Laryngol Otol 88, 1257-1263, 1974.

34) Ferlito A
Chronic suppurative otitis media - mucosal and bone changes in the middle ear: a histopathological and histochemical study
Proc X World Congr Otorhinolaryngol, Venice, 1973. Excerpta Medica, Amsterdam, 368-371, 1974.

35) Sala O, Ferlito A
L'otomastoidite ghiandolare cistica. Interpretazione patogenetica
Ann Laringol 73, 75-96, 1974.

36) Melato M, Ferlito A
I.F. 1.012 Heterotopic gastric mucosa of the tongue and the oesophagus
ORL J Otorhinolaryngol Relat Spec 37, 244-254, 1975.*

37) Ferlito A, Frugoni P
I.F. 0.967 Rhabdomyoma purum of the larynx
J Laryngol Otol 89, 1131-1141, 1975.*

38) Ferlito A
Proposition de classification des processus inflammatoires non spécifiques et spécifiques, aigus et chroniques, de l'oreille moyenne et de leurs séquelles
Rev Laryngol Otol Rhinol 96, 473-501, 1975.

39) Sala O, Babighian G, Ferlito A
Trapianti ed impianti nella moderna chirurgia della sordità
Chir Triv 15, 211-218, 1975.

40) Pesavento G, Ferlito A
I.F. 0.967 Benign mixed tumour of heterotopic salivary gland tissue in upper neck. Report of a case with a review of the literature on heterotopic salivary gland tissue
J Laryngol Otol 90, 577-584, 1976.

41) Frugoni P, Ferlito A
I.F. 0.967 Pleomorphic rhabdomyosarcoma of the larynx. A case report and review of the literature
J Laryngol Otol 90, 687-698, 1976.
42) Sala O, Ferlito A
I.F. 1.161 Morphological observations of immunobiology of laryngeal cancer. Evaluation of the defensive activity of immunocompetent cells present in tumour stroma
Acta Otolaryngol 81, 353-363, 1976.

43) Ferlito A
I.F. 0.967 Primary anaplastic giant cell adenocarcinoma of the larynx
J Laryngol Otol 90, 1053-1060, 1976.

44) Ferlito A, Antonutto G, Silvestri F
I.F. 1.012 Histological appearances and nuclear DNA content of verrucous squamous cell carcinoma of the larynx
ORL J Otorhinolaryngol Relat Spec 38, 65-85, 1976.**

45) Giarelli L, Ferlito A
I.F. 4.155 Bilateral breast metastases from oat-cell lung carcinoma in a man treated with diethylstilbestrol for prostatic adenocarcinoma
J Am Geriatr Soc 24, 511-515, 1976.

46) Ferlito A
A pathological and clinical study of adenosquamous carcinoma of the larynx. Report of four cases and review of the literature
Acta Otorhinolaryngol Belg 30, 379-389, 1976.

47) Ferlito A, Di Bonito L
I.F. 1.012 Primary cancer of the larynx associated with primary lung cancer. Report of 21 cases, 14 with autopsy findings and 7 biopsies
ORL J Otorhinolaryngol Relat Spec 38, 230-245, 1976.

48) Ferlito A
Simultaneous malignant pleomorphic fibrous histiocytoma and squamous cell carcinoma "in situ" of the larynx
Acta Otorhinolaryngol Belg 30, 390-397, 1976.

49) Sala O, Ferlito A
Oncotipo, grado istologico di malignità, reazione citostromale: loro importanza nella prognosi e nella terapia del cancro della laringe
Chir Triv 16, 834-836, 1976.

50) Ferlito A
I.F. 0.967 Primary lymphoepithelial carcinoma of the hypopharynx
J Laryngol Otol 91, 361-367, 1977.

51) Ferlito A
Istologia patologica delle otiti medie croniche
Rad Med 69, 239, 1977.

52) Ferlito A
I.F. 2.696 Carcinoma "in situ" of the larynx. An unsatisfactory diagnosis
Clin Otolaryngol 2, 292, 1977. (Letter to the Editor).
53) Ferlito A, Fiore Donati L
I.F. 0.967 "Malignant lymphoepithelial lesions" (undifferentiated ductal carcinomas of the parotid gland). Three case reports and review of the literature
J Laryngol Otol 91, 869-885, 1977.

54) Ferlito A
I.F. 1.704 Primary pleomorphic liposarcoma of the larynx
J Otolaryngol 7, 161-166, 1978.

55) Ferlito A
I.F. 0.967 Primary malignant haemangiopericytoma of the larynx: a case report with autopsy
J Laryngol Otol 92, 511-519, 1978.

56) Ferlito A
I.F. 1.012 Bilateral synchronous trabecular adenocarcinoma of the parotid gland
ORL J Otorhinolaryngol Relat Spec 40, 120-126, 1978.

57) Ferlito A
I.F. 4.155 Primary oat-cell carcinoma of the larynx following supraglottic laryngectomy for squamous-cell carcinoma
J Am Geriatr Soc 26, 278-283, 1978.

58) Ferlito A
I.F. 0.967 Primary Ewing's sarcoma of the maxilla: a clinicopathological study of four cases
J Laryngol Otol 92, 1007-1024, 1978.*

59) Ferlito A
I.F. 6.537 Histiocytic tumors of the larynx. A clinicopathological study with review of the literature
Cancer 42, 611-622, 1978.

60) Ferlito A, Friedmann I
I.F. 1.012 Leishmaniasis of the oral mucous membrane
ORL J Otorhinolaryngol Relat Spec 40, 193-198, 1978.

61) Ferlito A
I.F. 0.967 Histopathogenesis of tympanosclerosis
J Laryngol Otol 93, 25-37, 1979.* **

62) Ferlito A, Polidoro F
I.F. 0.967 Biological and prognostic implications of the morphologic aspects of immune reaction in lymph nodes draining head and neck cancers. (A review)
J Laryngol Otol 93, 153-175. 1979.
63) Pesavento G, Ferlito A, Recher G
I.F. 0.967 Benign solitary schwannoma of the cervical vagus nerve. A case report with a review of the literature
J Laryngol Otol 93, 307-316, 1979.

64) Ferlito A, Micheau C
I.F. 1.012 Infantile olfactory neuroblastoma. A clinicopathological study with review of the literature
ORL J Otorhinolaryngol Relat Spec 41, 40-50, 1979.

65) Ferlito A Recher G, Fosser V
I.F. 0.967 Lennert's lymphoma (lympho-epithelioid cellular lymphoma)
J Laryngol Otol 93, 909-921, 1979.* ***

66) Ferlito A, Recher G, Tomazzoli L
I.F. 0.967 Radiation-induced fibrosarcoma of the mandible following treatment for bilateral retinoblastoma
J Laryngol Otol 93, 1015-1020, 1979.

67) Ferlito A, Recher G, Polidoro F, Rossi M
I.F. 0.967 Malignant pleomorphic fibrous histiocytoma of the larynx. (Further observations)
J Laryngol Otol 93, 1021-1029, 1979.

68) Ferlito A, Recher G, Polidoro F
I.F. 0.967 Nasal metastasis from primary cancer of the kidney
J Laryngol Otol 93, 1115-1119, 1979.

69) Giarelli L, Silvestri F, Ferlito A, Brollo A, Clocchiati L
I.F. 2.696 Observations on the epidemiology of oesophageal carcinoma in the province of Trieste
Clin Otolaryngol 5, 13-21, 1980.

70) Rossi M, Ferlito A, Polidoro F
I.F. 0.967 Maternal rubella and hearing impairment in children. (Considerations on 66 cases)
J Laryngol Otol 94, 281-289, 1980.

71) Ferlito A
I.F. 3.267 Acinic cell carcinoma of minor salivary glands
Histopathology 4, 331-343, 1980.

72) Ferlito A, Polidoro F
I.F. 1.012 Simultaneous primary oat cell carcinoma (apudoma) and squamous cell carcinoma of the hypopharynx
ORL J Otorhinolaryngol Relat Spec 42, 146-157, 1980.

73) Ferlito A, Pederzini A, Polidoro F, Rossi M
I.F. 0.967 Therapeutic prospects in cancer of the larynx. (Multidisciplinary approach to the treatment of the cancer patient)
J Laryngol Otol 94, 405-410, 1980.
74) Ferlito A, Polidoro F, Recher G
I.F. 2.442 Extramedullary plasmacytoma of the parotid gland
Laryngoscope 90, 486-493, 1980.°

75) Ferlito A, Gale N
I.F. 1.012 Parotid involvement by Lennert's lymphoma
ORL J Otorhinolaryngol Relat Spec 42, 249-257, 1980.

76) Lim DJ, Friedmann I,Carpenter AM, Ishii T, Kawamoto K, Tos M, Zechner G, Ferlito A
I.F. 1.513 Anatomy, cell biology, and pathology. Report of research conference on recent advances in otitis media with effusion
Ann Otol Rhinol Laryngol 89 (Suppl 69), 13-14, 1980.

77) Ferlito A, Recher G
I.F. 6.537 Ackerman's tumor (verrucous carcinoma) of the larynx. A clinicopathologic study of 77 cases
Cancer 46, 1617-1630, 1980.**

78) Ferlito A, Cattai N
I.F. 0.967 The so-called "benign lymphoepithelial lesions" (part I - explanation of the term and of its synonymous and related terms)
J Laryngol Otol 94, 1189-1197, 1980.

79) Ferlito A, Cattai N
I.F. 0.967 The so-called "benign lymphoepithelial lesion" (part II -clinical and pathological considerations with regard to evolution)
J Laryngol Otol 94, 1283-1301, 1980.

80) Pesavento G, Ferlito A, Recher G
I.F. 2.894 Primary clear cell carcinoma of the larynx
J Clin Pathol 33, 1160-1164, 1980.

81) Ferlito A, Nicolai P, Gale N
Intramuscular haemangioma of the middle scalene muscle
Acta Otorhinolaryngol Belg 34, 345-349, 1980.

82) Ferlito A
I.F. 3.295 Double primary synchronous and metachronous cancer of the larynx and hypopharynx with dissimilar histology. Five case reports and review of the literature
Arch Otorhinolaryngol 229, 107-119, 1980.

83) Ferlito A, Nicolai P
Laryngeal cancer in pregnancy
Acta Otorhinolaryngol Belg 34, 706-709, 1980.

84) Ferlito A, Polidoro F, Rossi M
I.F. 0.967 Pathological basis and clinical aspects of treatment policy in carcinoma in situ of the larynx
J Laryngol Otol 95, 141-154, 1981.
85) Ferlito A, Gale N, Hvala A, Masera A
I.F. 0.967 Synovial sarcoma of the soft palate in a child. A light and electron microscopic study
J Laryngol Otol 95, 197-204, 1981.

86) Ferlito A, Carbone A, Volpe R
I.F. 1.012 Diagnosis and assessment of non-Hodgkin's malignant lymphomas of the larynx
ORL J Otorhinolaryngol Relat Spec 43, 61-78, 1981.°° °°°

87) Ferlito A, Caruso G, Nicolai P, Recher G, Silvestri F
I.F. 1.012 Primary small cell ("oat cell") carcinoma of the larynx and hypopharynx. A clinico-pathological study of 8 cases with a review of the literature
ORL J Otorhinolaryngol Relat Spec 43, 204-222, 1981.

88) Ferlito A, Gale N, Hvala A
I.F. 0.967 Laryngeal salivary duct carcinoma. A light and electron microscopic study
J Laryngol Otol 95, 731-738, 1981.

89) Ferlito A, Recher G, Polidoro F, Bordin S
I.F. 0.967 Solitary trichoepithelioma and epithelioma adenoides cysticum of Brooke involving the external auditory meatus
J Laryngol Otol 95, 835-841, 1981.

90) Friedmann I, Ferlito A
I.F. 0.967 Primary eosinophilic granuloma of the larynx
J Laryngol Otol 95, 1249-1254, 1981.

91) Ferlito A, Recher G, Bottin R
I.F. 1.012 Mucoepidermoid carcinoma of the larynx. A clinicopathological study of 11 cases with review of the literature
ORL J Otorhinolaryngol Relat Spec 43, 280-299, 1981.

92) Ferlito A, Recher G
I.F. 3.295 Oncocytic lesions of the larynx
Arch Otorhinolaryngol 232, 107-115, 1981.

93) Ferlito A, Recher G, Calzavara M, Bonino M
I.F. 1.046 Malignant ameloblastoma of the mandible
Am J Otolaryngol 3, 57-60, 1982.

94) Ferlito A, Carbone A, Volpe R, Recher G
I.F. 0.967 Late occurrence of IgD myeloma in plasmacytoma of nasal cavity, cervical lymph node and larynx
J Laryngol Otol 96, 759-766, 1982.

95) Pesavento G, Ferlito A
I.F. 0.967 Haemangiopericytoma of the larynx. A clinico-pathological study with review of the literature
J Laryngol Otol 96, 1065-1073, 1982.

96) Ferlito A
El denominado colesteatoma aural. Revisión
An Otorrinolaringol Ibero Am 9, 431-460, 1982.

97) Ferlito A, Barion U, Nicolai P
I.F. 3.295 Myositis ossificans of the head and neck. Review of the literature and report of a case
Arch Otorhinolaryngol 237, 103-113, 1983.

98) Ferlito A, Recher G, Bordin S
I.F. 2.444 Involvement of the temporal bone in hyperlipidemic xanthomatosis
Otolaryngol Head Neck Surg 91, 100-104, 1983.

99) Gnepp DR, Ferlito A, Hyams V
I.F. 6.537 Primary anaplastic small cell (oat cell) carcinoma of the larynx. Review of the literature and report of 18 cases
Cancer 51, 1731-1745, 1983.

100) Ferlito A, Caruso G
I.F. 1.012 Biological behaviour of laryngeal adenoid cystic carcinoma. Therapeutic considerations
ORL J Otorhinolaryngol Relat Spec 45, 245-256, 1983.°

101) Ferlito A, Nicolai P, Recher G, Narne S
I.F. 2.442 Primary laryngeal malignant fibrous histiocytoma: review of the literature and report of seven cases
Laryngoscope 93, 1351-1358, 1983.

102) Ferlito A, Nicolai P, Barion U
Critical comments on laryngeal fibrosarcoma
Acta Otorhinolaryngol Belg 37, 918-925,1983.

103) Ferlito A, Caruso G
I.F. 1.012 Secondary malignant melanoma of the larynx. Report of 2 cases and review of 79 laryngeal secondary cancers
ORL J Otorhinolaryngol Relat Spec 46, 117-133, 1984.

104) Ferlito A, Doglioni C, Bontempini L, Arrigoni A
I.F. 1.012 Metachronous coexistence of laryngeal pseudolymphoma and squamous cell carcinoma. An unreported case
ORL J Otorhinolaryngol Relat Spec 46, 202-209, 1984.

105) Pesavento G, Ferlito A
Management of squamous cell carcinoma of the pyriform sinus
Acta Otorhinolaryngol Belg 38, 156-163,1984.

106) Ferlito A, Pesavento G, Recher G, Nicolai P, Narne S, Polidoro F
I.F. 2.471 Assessment and treatment of neurogenic and non-neurogenic tumors of the parapharyngeal space
Head Neck Surg 7, 32-43,1984.

107) Ferlito A, Nicolai P, Montaguti A, Cecchetto A, Pennelli N
I.F. 1.046 Chondrosarcoma of the larynx: review of the literature and report of three cases
Am J Otolaryngol 5, 350-359, 1984.

108) Ferlito A, Nicolai P, Caruso G
I.F. 1.513 Angiosarcoma of the larynx. Case report
Ann Otol Rhinol Laryngol 94, 93-95, 1985.

109) Ferlito A, Friedmann I, Recher G
I.F. 1.012 Primary giant cell carcinoma of the larynx. A clinico-pathological study of four cases
ORL J Otorhinolaryngol Relat Spec 47, 105-112, 1985.

110) Ferlito A, Caruso G
I.F. 1.012 Angiolymphoid hyperplasia with eosinophilia of the external ear (Kimura's disease)
ORL J Otorhinolaryngol Relat Spec 47, 139-144, 1985.

111) Ferlito A, Recher G
I.F. 1.012 Chondrometaplasia of the larynx
ORL J Otorhinolaryngol Relat Spec 47, 174-177, 1985.

112) Ferlito A, Recher G, Caruso G
I.F. 1.046 Primary combined small cell carcinoma of the larynx
Am J Otolaryngol 6, 302-308, 1985.#

113) Ferlito A
Vocal cord polyp with stromal atypia. A pseudosarcomatous lesion
Acta Otorhinolaryngol Belg 39, 955-960, 1985.

114) Ferlito A
I.F. 1.513 Diagnosis and treatment of verrucous squamous cell carcinoma of the larynx: a critical review
Ann Otol Rhinol Laryngol 94, 575-579, 1985.

115) Ferlito A, Recher G, Visonà A
I.F. 0.967 Laryngeal cancer metastatic to lymph nodes with lymphocytic leukaemia
J Laryngol Otol 100, 233-237, 1986.

116) Ferlito A, Recher G
I.F. 1.513 Laryngeal involvement by mycosis fungoides
Ann Otol Rhinol Laryngol 95, 275-277,1986.

117) Ferlito A, Pesavento G, Visonà A, Recher G, Meli S, Bevilacqua P
I.F. 1.012 Leishmaniasis donovani presenting as an isolated lesion of the larynx
ORL J Otorhinolaryngol Relat Spec 48, 243-248, 1986.




118) Ferlito A, Pesavento G, Recher G, Caruso G, Dal Fior S, Montaguti A, Carraro R, Narne S, Pennelli N
I.F. 1.387 Long-term survival in response to combined chemotherapy and radiotherapy in laryngeal small cell carcinoma
Auris Nasus Larynx 13, 113-123, 1986.

119) Ferlito A
I.F. 1.513 Diagnosis and treatment of small cell carcinoma of the larynx: a critical review
Ann Otol Rhinol Laryngol 95, 590-600,1986.

120) Ferlito A, Friedmann I, Recher G
I.F. 0.967 Squamous cell carcinoma of the larynx with osteoclast-like giant cells
J Laryngol Otol 101, 393-398, 1987.

121) Ferlito A, Pesavento G, Meli S, Recher G, Visonà A
I.F. 0.967 Metastasis to the larynx revealing a renal cell carcinoma
J Laryngol Otol 101, 843-850, 1987.

122) Ferlito A
I.F. 1.513 Malignant laryngeal epithelial tumors and lymph node involvement: therapeutic and prognostic considerations
Ann Otol Rhinol Laryngol 96, 542-548, 1987.

123) Ferlito A, Giarelli L, Silvestri F
I.F. 0.967 Intratracheal thyroid
J Laryngol Otol 102, 95-96, 1988.

124) Ferlito A, Caruso G, Recher G
I.F. 3.295 Secondary laryngeal tumors. Report of seven cases with review of the literature
Arch Otolaryngol Head Neck Surg 114, 635-639, 1988.° °°

125) Ferlito A, Friedmann I, Goldman NC
I.F. 1.012 Primary carcinoid tumour of the larynx
ORL J Otorhinolaryngol Relat Spec 50, 129-149, 1988.°°

126) Ferlito A, Pesavento G, Recher G, Mingrino S, Visonà A, Fiore DL, Macchi C
I.F. 0.967 Intracranial pneumocephalus (secondary to frontoethmoidal osteoma)
J Laryngol Otol 103, 634-637, 1989.

127) Ferlito A, Friedmann I
I.F. 1.513 Review of neuroendocrine carcinomas of the larynx
Ann Otol Rhinol Laryngol 98, 780-790, 1989.§

128) Ferlito A, Friedmann I
I.F. 1.012 Poorly-differentiated laryngeal malignancies
ORL J Otorhinolaryngol Relat Spec 52, 63-64, 1990.



129) Ferlito A, Barnes L, Myers EN
I.F. 1.513 Neck dissection for laryngeal adenoid cystic carcinoma: is it indicated?
Ann Otol Rhinol Laryngol 99, 277-280, 1990.§

130) Ferlito A
Pathology of malignant tumors of the larynx
In: Inouye T, Fukuda H, Sato T, Hinohara T (eds), Recent Advances in Bronchoesophagology, Proc 6th World Congr Bronchoesophagol, Tokyo, 1989. Excerpta Medica, Amsterdam, 57-61, 1990.

131) Ferlito A
I.F. 1.012 Laryngeal fibrosarcoma: an over-diagnosed tumor
ORL J Otorhinolaryngol Relat Spec 52, 194-195, 1990.

132) Nicolai P, Ferlito A, Sasaki CT, Kirchner JA
I.F. 1.513 Laryngeal chondrosarcoma: incidence, pathology, biological behavior, and treatment
Ann Otol Rhinol Laryngol 99, 515-523, 1990.

133) Doglioni C, Ferlito A, Chiamenti C, Viale G, Rosai J
I.F. 1.012 Laryngeal carcinoma showing multidirectional epithelial neuroendocrine and sarcomatous differentiation
ORL J Otorhinolaryngol Relat Spec 52, 316-326, 1990.

134) Ferlito A
Precancerous lesions in the larynx: Diagnostic and therapeutic problems
Proc XIV World Congr Otorhinolaryngol Head Neck Surg, Madrid, 1989. Kugler & Ghedini Publ, Amsterdam, 2315-2318, 1990.

135) Ferlito A, Caruso G
I.F. 1.012 Endolaryngeal synovial sarcoma. An update on diagnosis and treatment
ORL J Otorhinolaryngol Relat Spec 53, 116-119, 1991.

136) Recher G, Pesavento G, Cristoferi V, Ferlito A
I.F. 1.513 Italian experience of voice restoration after laryngectomy with tracheoesophageal puncture
Ann Otol Rhinol Laryngol 100, 206-210, 1991.

137) Ferlito A, Baldan M, Andretta M, Blandamura S, Pesavento G, Piazza M
I.F. 1.012 Implantation of parotid pleomorphic adenoma in the upper neck
ORL J Otorhinolaryngol Relat Spec 53, 165-176, 1991.

138) Ferlito A, Rosai J
I.F. 1.012 Terminology and classification of neuroendocrine neoplasms of the larynx
ORL J Otorhinolaryngol Relat Spec 53, 185-187,1991.

139) Ferlito A, Friedmann I
I.F. 1.012 Contribution of immunohistochemistry in the diagnosis of neuroendocrine neoplasms of the larynx
ORL J Otorhinolaryngol Relat Spec 53, 235-244, 1991.

140) Silvestri F, Bussani R, Stanta G, Cosatti C, Ferlito A
I.F. 1.012 Supraglottic versus glottic laryngeal cancer:epidemiological and pathological aspects
ORL J Otorhinolaryngol Relat Spec 54, 43-48, 1992.§

141) Ferlito A, Andretta M, Baldan M, Candiani F
I.F. 0.967 Non-occupational recurrent bilateral pneumoparotitis in an adolescent
J Laryngol Otol 106, 558-560, 1992.

142) Ferlito A
Advanced laryngeal cancer
In: Johnson JT, Didolkar MS (eds), Third International Conference on Head and Neck Cancer. San Francisco, 1992. Elsevier, Amsterdam, 257-258, 1993.

143) Ferlito A
I.F. 0.967 A review of the definition, terminology and pathology of aural cholesteatoma
J Laryngol Otol 107, 483-488, 1993. Review

144) Ferlito A
I.F. 1.513 The World Health Organization's revised classification of tumours of the larynx, hypopharynx and trachea
Ann Otol Rhinol Laryngol 102, 666-669, 1993.

145) Ferlito A, Barnes L, Wenig BM
I.F. 1.513 Identification, classification, treatment, and prognosis of laryngeal paraganglioma. Review of the literature and eight new cases
Ann Otol Rhinol Laryngol 103, 525-536, 1994.¤  

146) Ferlito A
I.F. 1.161 The natural history of early vocal cord cancer
Acta Otolaryngol 115, 345-347, 1995.

147) Ferlito A, Milroy CM, Wenig BM, Barnes L, Silver CE
I.F. 1.513 Laryngeal paraganglioma versus atypical carcinoid tumor
Ann Otol Rhinol Laryngol 104, 78-83, 1995.

148) Ferlito A, Barnes L, Wenig BM
I.F. 1.513 Identification, classification, treatment, and prognosis of laryngeal paraganglioma. Review of the literature and eight new cases
Ann Otol Rhinol Laryngol 104, 84-85, 1995. (Letter to the Editor).

149) Devaney KO, Ferlito A, Silver CE
I.F. 1.513 Cartilaginous tumors of the larynx
Ann Otol Rhinol Laryngol 104, 251-255, 1995.

150) Milroy CM, Ferlito A
I.F. 1.513 Immunohistochemical markers in the diagnosis of neuroendocrine neoplasms of the head and neck
Ann Otol Rhinol Laryngol 104, 413-418, 1995.
151) Ferlito A, Rinaldo A, Devaney KO
I.F. 1.513 Malignant laryngeal tumors: phenotypic evaluation and clinical implications
Ann Otol Rhinol Laryngol 104, 587-589, 1995.

152) Ferlito A, Harrison DFN, Bailey BJ, DeSanto LW
I.F. 1.513 Are clinical classifications for laryngeal cancer satisfactory?
Ann Otol Rhinol Laryngol 104, 741-747, 1995.

153) Ferlito A, Devaney KO
I.F. 1.513 Developmental lesions of the head and neck: terminology and biological behavior
Ann Otol Rhinol Laryngol 104, 913-918, 1995.

154) Barnes L, Ferlito A, Altavilla G, MacMillan C, Rinaldo A, Doglioni C
I.F. 1.513 Basaloid squamous cell carcinoma of the head and neck: clinicopathological features and differential diagnosis
Ann Otol Rhinol Laryngol 105, 75-82, 1996.

155) Ferlito A, Carbone A, DeSanto LW, Barnes L, Rinaldo A, D’Angelo L, Devaney KO
I.F. 1.513 “Early” cancer of the larynx: the concept as defined by clinicians, pathologists, and biologists
Ann Otol Rhinol Laryngol 105, 245-250, 1996. 

156) Da Mosto MC, Marchiori C, Rinaldo A, Ferlito A
I.F. 1.513 Laryngeal pleomorphic rhabdomyosarcoma. A critical review of the literature
Ann Otol Rhinol Laryngol 105, 289-294, 1996.

157) Ferlito A, Devaney KO, Rinaldo A, Milroy CM, Carbone A
I.F. 1.513 Mucosal adenoid squamous cell carcinoma of the head and neck
Ann Otol Rhinol Laryngol 105, 409-413, 1996.

158) Rinaldo A, Marchiori C, Faggionato L, Saffiotti U, Ferlito A
I.F. 1.546 The association of cancers of the larynx with cancers of the lung
Eur Arch Otorhinolaryngol 253, 256-259, 1996.

159) Carbone A, Gaidano G, Gloghini A, Tirelli U, Rinaldo A, Ferlito A
I.F. 1.513 Morphologic patterns and molecular pathways of AIDS-related head and neck and other systemic lymphomas
Ann Otol Rhinol Laryngol 105, 495-499, 1996.

160) Horny H-P, Ferlito A, Carbone A
I.F. 1.513 Laryngeal lymphoma derived from mucosa-associated lymphoid tissue
Ann Otol Rhinol Laryngol 105, 577-583, 1996.





161) Ferlito A
Problems with the definition, terminology and staging of early invasive laryngeal cancer
In: Shah JP, Johnson JT (eds), Fourth International Conference on Head and Neck Cancer. Toronto, 274-276, 1996.

162) Carbone A, Weiss LM, Gloghini A, Ferlito A
I.F. 1.513 Hodgkin’s disease. Old and recent clinical concepts
Ann Otol Rhinol Laryngol 105, 751-758, 1996.

163) Ferlito A, Devaney KO, Rinaldo A
I.F. 1.513 Squamous neoplastic component in unconventional squamous cell carcinomas of the larynx
Ann Otol Rhinol Laryngol 105, 926-932, 1996.

164) Ferlito A, Devaney KO, Rinaldo A, Milroy CM, Wenig BM, Iurato S, McCabe BF
I.F. 1.513 Ear cholesteatoma versus cholesterol granuloma
Ann Otol Rhinol Laryngol 106, 79-85, 1997.

165) Devaney KO, Ferlito A
I.F. 1.513 Yolk sac tumors (endodermal sinus tumors) of the extracranial head and neck regions
Ann Otol Rhinol Laryngol 106, 254-260, 1997.

166) Vasef MA, Ferlito A, Weiss LM
I.F. 1.513 Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus
Ann Otol Rhinol Laryngol 106, 348-356, 1997. ¤

167) Barnes L, Ferlito A, Wenig BM
I.F. 0.967 Laryngeal paragangliomas. A review and report of a single case
J Laryngol Otol 111, 197-198, 1997. (Letter to the Editor).

168) Ferlito A, Weiss LM, Rinaldo A, Carbone A, Devaney KO, MacMillan C, Barnes L
I.F. 1.513 Lymphoepithelial carcinoma of the larynx, hypopharynx, and trachea
Ann Otol Rhinol Laryngol 106, 437-444, 1997.

169) Devaney KO, Putzi MJ, Ferlito A, Rinaldo A
I.F. 1.513 Head and neck Langerhans cell histiocytosis
Ann Otol Rhinol Laryngol 106, 526-532, 1997.

170) Frankel SS, Wenig BM, Ferlito A
I.F. 1.513 Human immunodeficiency virus-1 infection of the lymphoid tissues of Waldeyer’s ring
Ann Otol Rhinol Laryngol 106, 611-618, 1997.

171) Ferlito A, Olofsson J, Rinaldo A
I.F. 1.513 Barrier between the supraglottis and the glottis: myth or reality?
Ann Otol Rhinol Laryngol 106, 716-719, 1997.


172) Milroy CM, Ferlito A, Devaney KO, Rinaldo A
I.F. 1.513 Role of DNA measurements of head and neck tumors
Ann Otol Rhinol Laryngol 106, 801-804, 1997.

173) Ferlito A, Rinaldo A, Devaney KO
I.F. 1.513 Syndrome of inappropriate antidiuretic hormone secretion associated with head and neck cancers: review of the literature
Ann Otol Rhinol Laryngol 106, 878-883, 1997.

174) Devaney KO, Hunter BC, Ferlito A, Rinaldo A
I.F. 1.513 Pretreatment pathologic prognostic factors in head and neck squamous cell carcinoma
Ann Otol Rhinol Laryngol 106, 983-988, 1997.

175) Ferlito A, Altavilla G, Rinaldo A, Doglioni C
I.F. 1.513 Basaloid squamous cell carcinoma of the larynx and hypopharynx
Ann Otol Rhinol Laryngol 106, 1024-1035, 1997.

176) Ferlito A, Rinaldo A, Devaney KO, Hunter BC
I.F. 1.513 Synchronous and metachronous multiple primary laryngeal malignancies
Ann Otol Rhinol Laryngol 107, 181–186, 1998.

177) Rinaldo A, Fisher C, Mannarà GM, Ferlito A
I.F. 1.513 Hamartoma of the larynx: a critical review of the literature
Ann Otol Rhinol Laryngol 107, 264-267, 1998.

178) Ferlito A, Rinaldo A, Mannarà GM
I.F. 0.967 Is primary radiotherapy an appropriate option for the treatment of verrucous carcinoma of the head and neck?
J Laryngol Otol 112, 132-139, 1998. Review

179) Devaney KO, Ferlito A, Hunter BC, Devaney SL, Rinaldo A
I.F. 1.513 Wegener's granulomatosis of the head and neck
Ann Otol Rhinol Laryngol 107, 439-445, 1998.

180) Nicolai P, Caruso G, Redaelli de Zinis LO, Devaney KO, Rinaldo A, Berlucchi M, Ferlito A
I.F. 1.513 Regional and distant metastases in laryngeal and hypopharyngeal sarcomas
Ann Otol Rhinol Laryngol 107, 540-546, 1998.

181) Ferlito A, Rinaldo A
I.F. 0.967 Level I dissection for laryngeal and hypopharyngeal cancer: is it indicated?
J Laryngol Otol 112, 438-440, 1998. Review

182) Devaney KO, Ferlito A, Rinaldo A
I.F. 1.513 Giant cell tumor of the larynx
Ann Otol Rhinol Laryngol 107, 729-732, 1998.

183) Ferlito A, Rinaldo A, Devaney KO, Devaney SL, Milroy CM
I.F. 0.967 Impact of phenotype on treatment and prognosis of laryngeal malignancies
J Laryngol Otol 112, 710-714, 1998. Review
184) Hunter BC, Devaney KO, Ferlito A, Rinaldo A
I.F. 1.513 Alveolar soft part sarcoma of the head and neck region
Ann Otol Rhinol Laryngol 107, 810-814, 1998.

185) Ferlito A, Barnes L, Rinaldo A, Gnepp DR, Milroy CM
I.F. 0.967 A review of neuroendocrine neoplasms of the larynx: update on diagnosis and treatment
J Laryngol Otol 112, 827-834, 1998. Review

186) Ferlito A, Rinaldo A
I.F. 0.967 Selective lateral neck dissection for laryngeal cancer in the clinically negative neck: is it justified?
J Laryngol Otol 112, 921-924, 1998. Review

187) Ferlito A, Devaney SL, Carbone A, Maio M, Devaney KO, Rinaldo A, Friedmann I
I.F. 1.513 Pregnancy and malignant neoplasms of the head and neck
Ann Otol Rhinol Laryngol 107, 991-998, 1998.

188) Ferlito A, Rinaldo A
I.F. 0.967 Selective lateral neck dissection for laryngeal cancer with limited metastatic disease: is it indicated?
J Laryngol Otol 112, 1031-1033, 1998.

189) Dei Tos A, Dal Cin P, Sciot R, Furlanetto A, Da Mosto MC, Giannini C, Rinaldo A, Ferlito A
I.F. 1.513 Synovial sarcoma of the larynx and hypopharynx
Ann Otol Rhinol Laryngol 107, 1080-1085, 1998.

190) Carbone A, Gaidano G, Gloghini A, Ferlito A, Rinaldo A, Stein H
I.F. 1.513 AIDS-related plasmablastic lymphomas of the oral cavity and jaws. A diagnostic dilemma
Ann Otol Rhinol Laryngol 108, 95-99, 1999.

191) Tami TA, Ferlito A, Rinaldo A, Lee KC, Singh B
I.F. 1.513 Laryngeal pathology in the acquired immunodeficiency syndrome: diagnostic and therapeutic dilemmas
Ann Otol Rhinol Laryngol 108, 214-220, 1999.

192) Ferlito A, Devaney KO, Rinaldo A, Putzi MJ
I.F. 1.513 Papillary squamous cell carcinoma versus verrucous squamous cell carcinoma of the head and neck
Ann Otol Rhinol Laryngol 108, 318-322, 1999.

193) Vidal RW, Devaney K, Ferlito A, Rinaldo A, Carbone A
I.F. 1.513 Sinonasal malignant lymphomas: a distinct clinicopathological category
Ann Otol Rhinol Laryngol 108, 411-419, 1999.

194) Ferlito A, Bertino G, Rinaldo A, Mannarà GM, Devaney KO
I.F. 0.967 A review of heterotopia and associated salivary gland neoplasms of the head and neck
J Laryngol Otol 113, 299-303, 1999. Review
195) Altavilla A, Mannarà GM, Rinaldo A, Ferlito A
I.F. 1.012 Basaloid squamous cell carcinoma of oral cavity and oropharynx
ORL J Otorhinolaryngol Relat Spec 61, 169-173, 1999.

196) Ferlito A, Rinaldo A, Marioni G
I.F. 1.305 Laryngeal malignant neoplasms in children and adolescents
Int J Pediatr Otorhinolaryngol 49, 1-14, 1999. Review

197) Ferlito A, Rinaldo A, Devaney KO, Carbone A
I.F. 0.967 Management of the clinically negative cervical lymph nodes in patients with non-conventional squamous carcinoma of the larynx
J Laryngol Otol 113, 619-623, 1999. Review

198) Boccato P, Mannarà GM, Rinaldo A, La Rosa F, Ferlito A
I.F. 1.012 Kimura's disease of the intraparotid lymph nodes: fine needle aspiration biopsy findings
ORL J Otorhinolaryngol Relat Spec 61, 227-231, 1999.

199) Carbone A, Passannante A, Gloghini A, Devaney KO, Rinaldo A, Ferlito A
I.F. 1.513 Review of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) of head and neck
Ann Otol Rhinol Laryngol 108, 1095-1104, 1999.

200) Mannarà GM, Boccato P, Rinaldo A, La Rosa F, Ferlito A
I.F. 1.012 Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease) diagnosed by fine needle aspiration biopsy
ORL J Otorhinolaryngol Relat Spec 61, 367-371, 1999.

201) Ferlito A, Devaney KO, Rinaldo A, Devaney SL, Carbone A
I.F. 1.513 Micrometastases: have they an impact on prognosis?
Ann Otol Rhinol Laryngol 108, 1185-1189, 1999.

202) Rinaldo A, Sacilotto C, Mannarà GM, Florio F, Ferlito A
I.F. 1.704 Wegener's granulomatosis presenting with otological manifestations
J Otolaryngol 28, 347-350, 1999.

203) Mannarà GM, Sacilotto C, Frattasio A, Pedace E, Di Loreto C, Ferlito A
I.F. 0.967 Bilateral secondary syphilis of the tonsil
J Laryngol Otol 113, 1125-1128, 1999.

204) Ferlito A, Rinaldo A
I.F. 1.513 Paraneoplastic syndromes in patients with laryngeal and hypopharyngeal cancers
Ann Otol Rhinol Laryngol 109, 109-117, 2000.

205) Boccato P, Mannarà GM, La Rosa F, Rinaldo A, Ferlito A
I.F. 1.513 Hyalinizing trabecular adenoma of the thyroid diagnosed by fine-needle aspiration biopsy
Ann Otol Rhinol Laryngol 109, 235-238, 2000.


206) Ferlito A, Doglioni C, Rinaldo A, Devaney KO
I.F. 1.012 What is the earliest non-invasive malignant lesion of the larynx?
ORL J Otorhinolaryngol Relat Spec 62, 57-59, 2000. Editorial

207) Ferlito A, Rinaldo A
I.F. 1.012 False negative conventional histology of lymph nodes in patients with head and neck cancer
ORL J Otorhinolaryngol Relat Spec 62, 112-114, 2000.

208) Ferlito A, Rinaldo A
I.F. 1.546 The pathology and management of subglottic cancer
Eur Arch Otorhinolaryngol 257, 168-173, 2000.

209) Devaney SL, Ferlito A, Rinaldo A, Devaney KO
I.F. 1.161 Pathologic detection of occult metastases in regional lymph nodes in patients with head and neck cancer
Acta Otolaryngol 120, 344-349, 2000.

210) Devaney SL, Ferlito A, Rinaldo A, Devaney KO
I.F. 1.012 The pathology of neck dissection in cancer of the larynx
ORL J Otorhinolaryngol Relat Spec 62, 204-211, 2000.

211) Ferlito A, Som PM, Rinaldo A, Mondin V
I.F. 1.012 Classification and terminology of neck dissections
ORL J Otorhinolaryngol Relat Spec 62, 212-216, 2000.

212) Ferlito A, Silver CE, Rinaldo A, Smith RV
I.F. 1.012 Surgical treatment of the neck in cancer of the larynx
ORL J Otorhinolaryngol Relat Spec 62, 217-225, 2000.

213) Ferlito A, Silver CE, Howard DJ, Laccourreye O, Rinaldo A, Owen R
I.F. 1.161 The role of partial laryngeal resection in current management of laryngeal cancer: a collective review
Acta Otolaryngol 120, 456-465, 2000.

214) Carbone A, Canzonieri V, Gloghini A, Rinaldo A, Gaidano G, Ferlito A
I.F. 1.513 Burkitt’s lymphoma. Historical background and recent insights into classification and pathogenesis
Ann Otol Rhinol Laryngol 109, 693-702, 2000.

215) Rinaldo A, Ferlito A
I.F. 1.546 The pathology and clinical features of “glue ear”: a review
Eur Arch Otorhinolaryngol 257, 300-303, 2000.

216) Ferlito A, Rinaldo A
I.F. 1.546 A comment on misuse of the term “early” laryngeal cancer
Eur Arch Otorhinolaryngol 257, 347-348, 2000. (Letter to the Editors).




217) Politi M, Costa F, Robiony M, Rinaldo A, Ferlito A
I.F. 1.161 Review of segmental and marginal resection of the mandible in patients with oral cancer
Acta Otolaryngol 120, 569-579, 2000.

218) Rinaldo A, Howard DJ, Ferlito A
I.F. 1.161 Laryngeal chondrosarcoma: A 24-year experience at The Royal National Throat, Nose and Ear Hospital
Acta Otolaryngol 120, 680-688, 2000.

219) Ferlito A, Rinaldo A
I.F. 1.012 Controversies in the treatment for N0 neck in laryngeal cancer: neck dissection, no surgery, or sentinel lymph node biopsy?
ORL J Otorhinolaryngol Relat Spec 62, 287-289, 2000. Editorial

220) Ferlito A, Mannarà GM, Rinaldo A, Politi M, Robiony M, Costa F
I.F. 1.161 Is extended selective supraomohyoid neck dissection indicated for treatment of oral cancer with clinically negative neck?
Acta Otolaryngol 120, 792-795, 2000.

221) Carbone A, Gloghini A, Ferlito A
I.F. 1.513 Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis vs low-grade B-cell lymphoma of MALT-type
Ann Otol Rhinol Laryngol 109, 1170-1175, 2000.

222) Ferlito A, Devaney KO, Devaney SL, Rinaldo A
I.F. 1.012 What is the incidence of occult metastasis in patients with stage N0 cancers of the head and neck?
ORL J Otorhinolaryngol Relat Spec 63, 1-5, 2001. Editorial

223) Ferlito A, Devaney KO, Rinaldo A
I.F. 2.442 Is it time to develop an “ultrastaging system” for use in patients with head and neck malignancies?
Laryngoscope 111, 185-186, 2001. Commentary

224) Bertino G, Bellomo A, Ferrero FE, Ferlito A
I.F. 1.381 Acoustic analysis of voice quality after cordectomy with or without reconstruction
J Voice 15, 131-140, 2001.

225) Ferlito A, Silver CE, Pelizzo MR, Rinaldo A, Toniato A, Owen RP
I.F. 1.012 Surgical management of the neck in thyroid cancer
ORL J Otorhinolaryngol Relat Spec 63, 63-65, 2001. Editorial

226) Ferlito A, Shaha AR, Rinaldo A, Mondin V
I.F. 1.012 Management of the clinically negative cervical lymph nodes in patients with malignant neoplasms of the parotid gland
ORL J Otorhinolaryngol Relat Spec 63, 123-126, 2001. Editorial


227) Ferlito A, Boccato P, Shaha AR, Carbone A, Noyek AM, Doglioni C, Bradley PJ, Rinaldo A
I.F. 1.161 The art of diagnosis in head and neck tumors
Acta Otolaryngol 121, 324-328, 2001.

228) Ferlito A, Shaha AR, Buckley JG, Rinaldo A
I.F. 1.161 Selective neck dissection for hypopharyngeal cancer in the clinically negative neck: should it be bilateral?
Acta Otolaryngol 121, 329-335, 2001.

229) Pelizzo MR, Merante Boschin I, Toniato A, Bernante P, Piotto A, Rinaldo A,
Ferlito A
I.F. 1.161 The sentinel node procedure with Patent Blue V dye in the surgical treatment of papillary thyroid carcinoma
Acta Otolaryngol 121, 421-424, 2001.

230) Ferlito A, Rinaldo A, Buckley JG, Mondin V
I.F. 1.012 General considerations on distant metastases from head and neck cancer
ORL J Otorhinolaryngol Relat Spec 63, 189-191, 2001.

231) Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V
I.F. 1.012 Incidence and sites of distant metastases from head and neck cancer
ORL J Otorhinolaryngol Relat Spec 63, 202-207, 2001.

232) Ferlito A, Buckley JG, Rinaldo A, Mondin V
I.F. 1.012 Screening tests to evaluate distant metastases in head and neck cancer
ORL J Otorhinolaryngol Relat Spec 63, 208-211, 2001.

233) Shaha AR, Ferlito A, Rinaldo A
I.F. 1.012 Distant metastases from thyroid and parathyroid cancer
ORL J Otorhinolaryngol Relat Spec 63, 243-249, 2001.

234) Buckley JG, Ferlito A, Shaha AR, Rinaldo A
I.F. 1.012 The treatment of distant metastases in head and neck cancer - present and future
ORL J Otorhinolaryngol Relat Spec 63, 259-264, 2001.

235) Ferlito A, Buckley JG, Shaha AR, Silver CE, Rinaldo A, Kowalski L
I.F. 1.161 The role of neck dissection in the treatment of supraglottic laryngeal cancer
Acta Otolaryngol 121, 448-453, 2001. Guest Editorial

236) Ferlito A, Buckley JG, Shaha AR, Rinaldo A
I.F. 1.161 Rationale for selective neck dissection in tumors of the upper aerodigestive tract
Acta Otolaryngol 121, 548-555, 2001. Guest Editorial

237) Ferlito A, Shaha AR, Buckley JG, Caruso G, Rinaldo A
I.F. 1.161 Metastatic cervical lymph nodes from urogenital tract carcinoma: a diagnostic and therapeutic challenge
Acta Otolaryngol 121, 556-564, 2001. Guest Editorial

238) Ferlito A, Gavilán J, Buckley JG, Shaha AR, Miodonski AJ, Rinaldo A
I.F. 2.471 Functional neck dissection: fact and fiction
Head Neck 23, 804-808, 2001. Review

239) Ferlito A, Partridge M, Brennan J, Hamakawa H
I.F. 1.161 Lymph node micrometastases in head and neck cancer: a review
Acta Otolaryngol 121, 660-665, 2001. Review

240) Ferlito A, Shaha AR, Rinaldo A
I.F. 1.161 Paraneoplastic syndromes in neuroendocrine neoplasms of the head and neck: have they an impact on prognosis?
Acta Otolaryngol 121, 756-758, 2001. Guest Editorial

241) dos Santos CR, Gonçalves Filho J, Magrin J, Johnson LFP, Ferlito A, Kowalski LP
I.F. 1.513 Involvement of level I neck lymph nodes in advanced squamous carcinoma of the larynx
Ann Otol Rhinol Laryngol 110, 982-984, 2001.

242) Ferlito A, Shaha AR, Rinaldo A
I.F. 1.161 Surgical management of head and neck cancer: The next decade
Acta Otolaryngol 121, 772-776, 2001. Guest Editorial

243) Ferlito A, Buckley JG, Ossoff RH, Rinaldo A, Weir N
I.F. 1.161 The future of laryngology
Acta Otolaryngol 121, 859-867, 2001.

244) Ferlito A, Shaha AR, Gavilán J, Buckley JG, Rinaldo A, Herranz J, Suárez C
I.F. 1.161 Is radiotherapy recommended after supraglottic laryngectomy?
Acta Otolaryngol 121, 877-880, 2001.

245) Carbone A, Dolcetti R, Shaha AR, Gloghini A, Molinari R, Rinaldo A, Boiocchi M, Wei WI, Ferlito A
I.F. 1.161 What's new in the biology and treatment of undifferentiated carcinoma of nasopharyngeal type?
Acta Otolaryngol 121, 884-895, 2001. Review

246) Ferlito A, Shaha AR, Rinaldo A
I.F. 1.161 Evolution in the philosophy of neck dissection
Acta Otolaryngol 121, 963-966, 2001.

247) Rinaldo A, Shaha AR, Patel SG, Ferlito A
I.F. 1.161 Primary mucosal melanoma of the nasal cavity and paranasal sinuses
Acta Otolaryngol 121, 979-982, 2001.

248) Ferlito A, Shaha AR, Rinaldo A
I.F. 4.636 The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx
Oral Oncol 38, 3-5, 2002. Review



249) Wong RJ, Rinaldo A, Ferlito A, Shah JP
I.F. 1.161 Occult cervical metastasis in head and neck cancer and its impact on therapy
Acta Otolaryngol 122, 107-114, 2002.

250) Ferlito A, Buckley JG, Shaha AR, Rinaldo A
I.F. 1.161 Contemporary important considerations in diagnosis and treatment of head and neck cancer
Acta Otolaryngol 122, 115-120, 2002.

251) Ferlito A, Shaha AR, Rinaldo A
I.F. 1.161 Surgical management of recurrent tumor in the neck
Acta Otolaryngol 122, 121-126, 2002.

252) Rinaldo A, Ferlito A, Shaha AR, Wei WI, Lund VJ
I.F. 1.161 Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications
Acta Otolaryngol 122, 215-221, 2002. Review

253) Ferlito A, Silver CE, Rinaldo A, Kim H, Shaha AR
I.F. 1.161 Parastomal recurrence: A therapeutic challenge
Acta Otolaryngol 122, 222-229, 2002. Review

254) Ferlito A, Silver CE, Shaha AR, Rinaldo A
I.F. 1.161 Management of N3 neck
Acta Otolaryngol 122, 230-233, 2002.

255) Ferlito A, Robbins KT, Shaha AR, Pellitteri PK, Kowalski LP, Gavilán J, Silver CE, Rinaldo A, Medina JE, Pitman KT, Byers RM
I.F. 1.161 Current considerations in neck dissection
Acta Otolaryngol 122, 323-329, 2002. Review

256) Shaha AR, Ferlito A, Rinaldo A
I.F. 1.161 Thyroid cancer: a unique human neoplasm
Acta Otolaryngol 122, 343-347, 2002. Guest Editorial

257) Ferlito A, Shaha AR, Rinaldo A
I.F. 1.012 Neuroendocrine neoplasms of the larynx: diagnosis, treatment and prognosis
ORL J Otorhinolaryngol Relat Spec 64, 108-113, 2002.

258) Ferlito A, Shaha AR, Lefebvre J-L, Silver CE, Rinaldo A
I.F. 1.161 Organ and voice preservation in advanced laryngeal cancer
Acta Otolaryngol 122, 438-442, 2002.

259) Rinaldo A, Ferlito A, Shaha AR, Wei WI
I.F. 1.161 Is elective neck treatment indicated in patients with squamous cell carcinoma of the maxillary sinus?
Acta Otolaryngol 122, 443-447, 2002. Review


260) Rao SR, Shaha AR, Singh B, Rinaldo A, Ferlito A
I.F. 1.161 Management of cancer of the parathyroid
Acta Otolaryngol 122, 448-452, 2002. Review

261) Gavilán J, Ferlito A, Silver CE, Shaha AR, Martín L, Rinaldo A
I.F. 1.161 Status of carotid resection in head and neck cancer
Acta Otolaryngol 122, 453-455, 2002. Review

262) Ferlito A, Shaha AR, Rinaldo A
I.F. 1.161 Prognostic value of the Delphian lymph node metastasis from laryngeal and hypopharyngeal cancer
Acta Otolaryngol 122, 456-457, 2002. Review

263) Ferlito A, Kowalski LP, Silver CE, Shaha AR, Rinaldo A, Byers RM
I.F. 1.161 The use and misuse of level IA dissection for head and neck cancer
Acta Otolaryngol 122, 553-555, 2002.

264) Ferlito A, Shaha AR, Rinaldo A
I.F. 1.161 Retropharyngeal lymph node metastasis from cancer of the head and neck
Acta Otolaryngol 122, 556-560, 2002. Guest Editorial

265) Ferlito A
I.F. 3.295 Classification and terminology of neck dissection
Arch Otolaryngol Head Neck Surg 128, 747-748, 2002. Commentary

266) Bradley PJ, Ferlito A, Brandwein MS, Benninger MS, Rinaldo A
I.F. 1.161 Anthrax: what should the otolaryngologist know?
Acta Otolaryngol 122, 580-585, 2002. Guest Editorial

267) Ferlito A, Silver CE, Zeitels SM, Rinaldo A
I.F. 1.161 Evolution of laryngeal cancer surgery
Acta Otolaryngol 122, 665-672, 2002. Review

268) Ferlito A, Pellitteri PK, Robbins KT, Shaha AR, Kowalski LP, Silver CE, Anniko M, Rinaldo A, Medina JE, Bradley PJ, Byers RM
I.F. 1.161 Management of the neck in cancer of major salivary glands, thyroid and parathyroid glands
Acta Otolaryngol 122, 673-678, 2002. Review

269) Ferlito A, Rinaldo A, Devaney KO, MacLennan K, Myers JN, Petruzzelli GJ, Shaha AR, Genden EM, Johnson JT, de Carvalho MB, Myers EN
I.F. 4.636 Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes
Oral Oncol 38, 747-751, 2002. Review

270) Brandwein MS, Ferlito A, Bradley PJ, Hille JJ, Rinaldo A
I.F. 1.161 Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes
Acta Otolaryngol 122, 758-764, 2002. Guest Editorial

271) León X, Ferlito A, Myer CM III, Saffiotti U, Shaha AR, Bradley PJ, Brandwein MS, Anniko M, Elluru RG, Rinaldo A
I.F. 1.161 Second primary tumors in head and neck cancer patients
Acta Otolaryngol 122, 765-778, 2002.

272) Rinaldo A, Shaha AR, Wei WI, Silver CE, Ferlito A
I.F. 1.161 Microvascular free flaps: a major advance in head and neck reconstruction
Acta Otolaryngol 122, 779-784, 2002. Review

273) Ferlito A, Shaha AR, Rinaldo A, Pellitteri PK, Mondin V, Byers RM
I.F. 1.161 “Skip metastases” from head and neck cancers
Acta Otolaryngol 122, 788-791, 2002. Guest Editorial

274) Ferlito A, Kowalski LP, Byers RM, Pellitteri PK, Bradley PJ, Rinaldo A, Silver CE, Wei WI, Shaha AR, Medina JE
I.F. 1.161 Is the standard radical neck dissection no longer standard?
Acta Otolaryngol 122, 792-795, 2002. Guest Editorial

275) Rucci L, Ferlito A, Bradley PJ, Romagnoli P, Rinaldo A, Anniko M
I.F. 1.161 Can embryology influence clinicians concerning the “best therapy” for glottic cancer?
Acta Otolaryngol 122, 796-798, 2002. Guest Editorial

276) Rinaldo A, Mondin V, Ferlito A
I.F. 1.012 Immediate facial nerve palsy following stapedectomy
ORL J Otorhinolaryngol Relat Spec 64, 355-357, 2002.

277) Ferlito A, Robbins KT, Medina JE, Shaha AR, Som PM, Rinaldo A
I.F. 1.161 Is it time to eliminate confusion regarding cervical lymph node levels according to the scheme originated at the Memorial Sloan-Kettering Cancer Center?
Acta Otolaryngol 122, 805-807, 2002. Guest Editorial

278) Medina JE, Ferlito A, Brandwein MS, Fisher SR, Pellitteri PK, Shaha AR, Pitman KT, Robbins KT, Rinaldo A, Silver CE, Byers RM, O’Brien CJ
I.F. 1.161 Current management of cutaneous malignant melanoma of the head and neck
Acta Otolaryngol 122, 900-906, 2002. Review

279) Pellitteri PK, Ferlito A, Bradley PJ, Shaha AR, Rinaldo A
I.F. 4.636 Management of sarcomas of the head and neck in adults
Oral Oncol 39, 2-12, 2003. Review

280) Ferlito A, Rogers SN, Shaha AR, Bradley PJ, Rinaldo A
I.F. 1.161 Quality of life in head and neck cancer
Acta Otolaryngol 123, 5-7, 2003. Editorial

281) Rodrigo JP, Suárez C, Ferlito A, Devaney KO, Petruzzelli GJ, Rinaldo A
I.F. 1.161 Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma
Acta Otolaryngol 123, 100-105, 2003. Review
282) Harrison LB, Ferlito A, Shaha AR, Bradley PJ, Genden EM, Rinaldo A
I.F. 4.636 Current philosophy on the management of cancer of the base of tongue
Oral Oncol 39, 101-105, 2003. Review

283) Genden EM, Ferlito A, Bradley PJ, Rinaldo A, Scully C
I.F. 4.636 Neck disease and distant metastases
Oral Oncol 39, 207-212, 2003. Review

284) MacLennan K, Jose J, Ferlito A, Devaney KO, Robbins KT, Moor J, Rinaldo A
I.F.1.161 Cervical soft tissue metastases in head and neck cancer
Acta Otolaryngol 123, 336-339, 2003. Guest Editorial

285) Bradley PJ, Ferlito A, Lowe J, Devaney KO, Wei WI, Rinaldo A
I.F.1.161 A head and neck cancer patient dies! Why perform an autopsy: for the relatives, for the clinicians or for the pathologists?
Acta Otolaryngol 123, 348-354, 2003. Review

286) Kowalski LP, Rinaldo A, Robbins KT, Pellitteri PK, Shaha AR, Weber RS, Ferlito A
I.F. 1.161 Stomal recurrence: pathophysiology, treatment and prevention
Acta Otolaryngol 123, 421-432, 2003. Review

287) Genden EM, Ferlito A, Scully C, Shaha AR, Higgins K, Rinaldo A
I.F. 4.636 Current management of tonsillar cancer
Oral Oncol 39, 337-342, 2003. Review

288) Pitman KT, Ferlito A, Devaney KO, Shaha AR, Rinaldo A
I.F. 4.636 Sentinel lymph node biopsy in head and neck cancer
Oral Oncol 39, 343-349, 2003. Review

289) Ferlito A, Rinaldo A, Robbins KT, Leemans CR, Shah JP, Shaha AR, Andersen PE, Kowalski LP, Pellitteri PK, Clayman GL, Rogers SN, Medina JE, Byers RM
I.F. 4.636 Changing concepts in the surgical management of the cervical node metastasis
Oral Oncol 39, 429-435, 2003. Review

290) Medina JE, Ferlito A, Pellitteri PK, Shaha AR, Khafif A, Devaney KO, Fisher SR, O’Brien CJ, Byers RM, Robbins KT, Pitman KT, Rinaldo A
I.F. 2.886 Current management of mucosal melanoma of the head and neck
J Surg Oncol 83, 116-122, 2003. Review

291) Rinaldo A, Brandwein MS, Devaney KO, Ferlito A
I.F. 1.161 AIDS-related otological lesions
Acta Otolaryngol 123, 672-674, 2003. Editorial

292) Ferlito A, Devaney KO, Anniko M, Arnold W, Rinaldo A
I.F.1.161 Otological Wegener’s granulomatosis at the time of initial presentation: a potential diagnostic dilemma
Acta Otolaryngol 123, 675-677, 2003. Editorial




293) Devaney KO, Ferlito A, Rinaldo A
I.F. 1.161 Epithelial tumors of the middle ear - Are middle ear carcinoids really distinct from middle ear adenomas?
Acta Otolaryngol 123, 678-682, 2003. Review

294) Ferlito A, Arnold W, Rinaldo A, Niedermeyer HP, Bozorg Grayeli A, Devaney KO, McKenna MJ, Anniko M, Pulec JL, McCabe BF, van den Broek P, Shea JJ Jr
I.F. 1.161 Viruses and otosclerosis: Chance association or true causal link?
Acta Otolaryngol 123, 741-746, 2003. Editorial

295) Devaney KO, Ferlito A, Rinaldo A
I.F. 1.161 Endodermal sinus tumor (yolk sac tumor) of the temporal bone: an exotic disease for otorhinolaryngologists and head and neck surgeons
Acta Otolaryngol 123, 747-748, 2003. Editorial

296) Ferlito A, Paparella MM, Rinaldo A, Schachern PA, Cureoglu S
I.F. 1.161 The entity known as chronic silent (subclinical) otitis media: a common lesion and a forgotten diagnosis
Acta Otolaryngol 123, 749-751, 2003. Editorial

297) Ferlito A, Rinaldo A
I.F. 1.012 Small cell neuroendocrine carcinoma of the larynx: a preventable and frustrating disease with a highly aggressive lethal behavior
ORL J Otorhinolaryngol Relat Spec 65, 131-133, 2003. Editorial

298) Genden EM, Ferlito A, Shaha AR, Talmi YP, Robbins KT, Rhys-Evans PH, Rinaldo A
I.F. 1.161 Complications of neck dissection
Acta Otolaryngol 123, 795-801, 2003. Review

299) Genden EM, Ferlito A, Shaha AR, Rinaldo A
I.F. 4.636 Management of cancer of the retromolar trigone
Oral Oncol 39, 633-637, 2003. Review

300) Rinaldo A, Ferlito A, Pellitteri PK, Robbins KT, Shaha AR, Bradley PJ, Kowalski LP, Wei WI
I.F. 1.161 Management of malignant submandibular gland tumors
Acta Otolaryngol 123, 896-904, 2003. Review

301) Ferlito A, Rinaldo A, Rhys-Evans PH
I.F. 2.442 Contemporary clinical commentary: esthesioneuroblastoma: an update on management of the neck
Laryngoscope 113, 1935-1938, 2003.

302) Ferlito A, Rinaldo A, Shaha AR, Bradley PJ
I.F. 1.161 Percutaneous tracheotomy
Acta Otolaryngol 123, 1008-1012, 2003. Editorial




303) Devaney KO, Ferlito A, Rinaldo A
I.F. 1.161 Endolymphatic sac tumor (low-grade papillary adenocarcinoma) of the temporal bone
Acta Otolaryngol 123, 1022-1026, 2003. Review

304) Rinaldo A, Shaha AR, Pellitteri PK, Bradley PJ, Ferlito A
I.F. 4.636 Management of malignant sublingual salivary gland tumors
Oral Oncol 40, 2-5, 2004. Review

305) Ferlito A, Devaney KO, Rinaldo A
I.F. 1.161 Primary extracranial meningioma in the vicinity of the temporal bone: a benign lesion which is rarely recognized clinically
Acta Otolaryngol 124, 5-7, 2004. Editorial

306) Rucci L, Bocciolini C, Franchi A, Ferlito A, Casucci A
I.F. 1.161 EGFR and p53 expression in anterior and posterior commissure T1-T2 glottic cancer
Acta Otolaryngol 124, 102-106, 2004.

307) Genden EM, Rinaldo A, Shaha AR, Bradley PJ, Rhys-Evans PH, Ferlito A
I.F. 1.161 Pharyngocutaneous fistula following laryngectomy
Acta Otolaryngol 124, 117-120, 2004. Editorial

308) Ferlito A, Devaney KO, Rinaldo A
I.F. 1.161 Association between Schneiderian papilloma of the temporal bone and carcinoma: a critical review of the literature
Acta Otolaryngol 124, 121-123, 2004. Review

309) Devaney KO, Ferlito A, Rinaldo A
I.F. 4.636 The language of surgical pathology - a precis for the head and neck surgeon
Oral Oncol 40, 233-235, 2004. Editorial Review

310) Rinaldo A, Ferlito A, Devaney KO
I.F. 4.636 Can the surgeon consistently differentiate intraoperatively benign from malignant lymph nodes?
Oral Oncol 40, 361-363, 2004. Editorial Review

311) Rinaldo A, Ferlito A, Myssiorek D, Devaney KO
I.F. 4.636 Which paragangliomas of the head and neck have a higher rate of malignancy?
Oral Oncol 40, 458-460, 2004. Editorial Review

312) Rinaldo A, Devaney KO, Ferlito A
I.F. 1.161 Verrucous carcinoma of the ear: an uncommon and difficult lesion
Acta Otolaryngol 124, 228-230, 2004. Editorial

313) Rogers SN, Ferlito A, Pellitteri PK, Shaha AR, Rinaldo A
I.F. 1.161 Quality of life following neck dissections
Acta Otolaryngol 124, 231-236, 2004. Review


314) Bradley PJ, Ferlito A, Devaney KO, Rinaldo A
I.F. 1.161 Crohn’s disease manifesting in the head and neck
Acta Otolaryngol 124, 237-241, 2004. Review

315) Devaney KO, Rinaldo A, Zeitels SM, Bradley PJ, Ferlito A
I.F. 1.012 Laryngeal dysplasia and other epithelial changes on endoscopic biopsy: what does it all mean to the individual patient?
ORL J Otorhinolaryngol Relat Spec 66, 1-4, 2004. Editorial

316) Rinaldo A, Devaney KO, Ferlito A
I.F. 1.012 Immunohistochemical studies in the identification of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck
ORL J Otorhinolaryngol Relat Spec 66, 38-41, 2004. Review

317) Rinaldo A, Ferlito A, Kowalski LP, Quer M, Suárez C, León X, Robbins KT
I.F. 0.967 Is dissection of level V necessary in patients with T2-T4N0 supraglottic cancer?
J Laryngol Otol 118, 175-178, 2004. Editorial

318) Pellitteri PK, Rinaldo A, Myssiorek D, Jackson CG, Bradley PJ, Devaney KO, Shaha AR, Netterville JL, Manni JJ, Ferlito A
I.F. 4.636 Paragangliomas of the head and neck
Oral Oncol 40, 563-575, 2004. Review

319) Rinaldo A, Robbins KT, Ferlito A
I.F. 1.012 The importance of distinguishing between sublevel IA and IB in neck dissection
ORL J Otorhinolaryngol Relat Spec 66, 53-55, 2004. Editorial

320) Rinaldo A, Bradley PJ, Ferlito A
I.F. 0.967 Tularemia in otolaryngology: a forgotten but not gone disease and a possible sign of bio-terrorism
J Laryngol Otol 118, 257-259, 2004. Editorial

321) Cohen EG, Shaha AR, Rinaldo A, Devaney KO, Ferlito A
I.F. 1.161 Medullary thyroid carcinoma
Acta Otolaryngol 124, 544-557, 2004. Review

322) Rinaldo A, Devaney KO, Ferlito A
I.F. 1.161 Immunohistochemical studies in support of a diagnosis of small cell neuroendocrine carcinoma of the larynx
Acta Otolaryngol 124, 638-641, 2004.

323) Soga J, Ferlito A, Rinaldo A
I.F. 4.636 Endocrinocarcinomas (carcinoids and their variants) of the larynx: a comparative consideration with those of other sites
Oral Oncol 40, 668-672, 2004. Review



324) Ferlito A, Robbins KT , Rinaldo A
I.F. 0.967 Neck dissection: historical perspective
J Laryngol Otol 118, 403-405, 2004. Editorial

325) León X, Rinaldo A, Saffiotti U, Ferlito A
I.F. 1.161 Laryngeal cancer in nonsmoking and nondrinking patients
Acta Otolaryngol 124, 664-669, 2004 . Editorial

326) Ferlito A, Rinaldo A
I.F. 2.442 Osvaldo Suárez: often-forgotten father of functional neck dissection (in the non-Spanish-speaking literature)
Laryngoscope 114, 1177-1178, 2004.

327) Rinaldo A, Ferlito A, Devaney KO
I.F. 1.012 Salivary gland choristoma of the middle ear. A review
ORL J Otorhinolaryngol Relat Spec 66, 141-147, 2004. Review

328) Suárez C, Rodrigo JP, Ferlito A, Devaney KO, Rinaldo A
I.F. 4.636 Merkel cell carcinoma of the head and neck
Oral Oncol 40, 773-779, 2004.

329) Rinaldo A, Ferlito A
I.F. 1.161 Open supraglottic laryngectomy
Acta Otolaryngol 124, 768-771, 2004.

330) Rinaldo A, Robbins KT, Ferlito A
I.F. 0.967 Is it useful to divide level VA of the neck into two sections?
J Laryngol Otol 118, 587-588, 2004. Editorial

331) Rinaldo A, Ferlito A, Healy GB
I.F. 1.161 Cancer of the larynx in children and adolescents: a neoplastic lesion with a different etiology
Acta Otolaryngol 124, 992-994, 2004. Editorial

332) Myssiorek D, Rinaldo A, Barnes L, Ferlito A
I.F. 1.161 Laryngeal paraganglioma: an updated critical review
Acta Otolaryngol 124, 995-999, 2004. Review

333) Talmi YP, Rinaldo A, Robbins KT, Ferlito A
I.F. 1.012 Why promote an educational process for separating level II into level IIA and level IIB in neck dissection?
ORL J Otorhinolaryngol Relat Spec 66, 229-232, 2004. Editorial

334) Ferlito A, Devaney KO, Robbins KT, Rinaldo A
I.F. 4.636 Recommendations for studies on detection of neck disease
Oral Oncol 40, 967-970, 2004. Editorial

335) Genden EM, Rinaldo A, Suárez C, Wei WI, Bradley PJ, Ferlito A
I.F. 4.636 Complications of free flap transfers for head and neck reconstruction following cancer resection
Oral Oncol 40, 979-984, 2004. Review
336) Rucci L, Romagnoli P, Casucci A, Ferlito A
I.F. 4.636 Embryological study of the glottic site and clinical implications
Oral Oncol 40, 1017-1025, 2004.

337) Cureoglu S, Tulunay O, Ferlito A, Schachern PA, Paparella MM, Rinaldo A
I.F. 1.161 Otologic manifestations of metastatic tumors to the temporal bone
Acta Otolaryngol 124, 1117-1123, 2004. Review

338) Ferlito A, Bradley PJ, Rinaldo A
I.F. 0.967 What is the treatment of choice for T1 squamous cell carcinoma of the larynx?
J Laryngol Otol 118, 747-749, 2004. Editorial

339) Robbins KT, Ferlito A, Suárez C, Brizel DM, Bradley PJ, Pellitteri PK, Clayman GL, Kowalski LP, Genden EM, Rinaldo A
I.F. 4.767 Is there a role for selective neck dissection after chemoradiation for head and neck cancer?
J Am Coll Surg 199, 913-916, 2004. Editorial

340) Rinaldo A, Ferlito A, Suárez C, Kowalski LP
I.F. 1.161 Nodal disease in temporal bone squamous carcinoma
Acta Otolaryngol 125, 5-8, 2005. Review

341) Cureoglu S, Schachern PA, Rinaldo A, Tsuprun V, Ferlito A, Paparella MM
I.F. 1.161 Round window membrane and labyrinthine pathological changes: an overview
Acta Otolaryngol 125, 9-15, 2005. Review

342) Rinaldo A, Ferlito A, Cureoglu S, Devaney KO, Schachern PA, Paparella MM
I.F. 1.161 Cholesterol granuloma of the temporal bone: a pathologic designation or a clinical diagnosis?
Acta Otolaryngol 125, 86-90, 2005. Editorial

343) Devaney KO, Rinaldo A, Ferlito A
I.F. 1.161 Teratoma of the middle ear. A real entity or a non-entity?
Acta Otolaryngol 125, 122-124, 2005. Review

344) Rinaldo A, Devaney KO, Ferlito A
I.F. 1.161 Merkel cell carcinoma of the auricle
Acta Otolaryngol 125, 125-129, 2005. Review

345) Ferlito A, Rinaldo A
I.F. 4.636 Errare humanum est, in errore perseverare stultum: this is true also for neck dissection
Oral Oncol 41, 132-134, 2005.

346) Rodrigo JP, Suárez C, Rinaldo A, Devaney KO, Carbone A, Barnes L, Heffner DK, Ferlito A
I.F. 4.636 Idiopathic midline destructive disease: fact or fiction
Oral Oncol 41, 340-348, 2005. Review


347) Genden EM, Rinaldo A, Shaha AR, Clayman GL, Werner JA, Suárez C, Ferlito A
I.F. 0.967 Treatment considerations for head and neck cancer in the elderly
J Laryngol Otol 119, 169-174, 2005. Review

348) Mondin V, Rinaldo A, Ferlito A
I.F. 1.046 Management of nasal bone fractures
Am J Otolaryngol 26, 181-185, 2005. Review

349) Devaney KO, Boschman CR, Willard SC, Ferlito A, Rinaldo A
I.F. 36.418 Tumours of the external ear and temporal bone
Lancet Oncol 6, 411-420, 2005. Review

350) Devaney KO, Rinaldo A, Ferlito A
I.F. 4.636 Vocal process granuloma of the larynx - Recognition, differential diagnosis and treatment
Oral Oncol 41, 666-669, 2005. Review

351) Genden EM, Rinaldo A, Jacobson A, Shaha AR, Suárez C, Lowry J, Urquhart AC, Werner JA, Gullane PJ, Ferlito A
I.F. 4.636 Management of mandibular invasion: when is a marginal mandibulectomy appropriate?
Oral Oncol 41, 776-782, 2005. Review

352) Ferlito A, Rinaldo A
I.F. 4.636 The spectrum of endocrinocarcinomas of the larynx
Oral Oncol 41, 878-883, 2005. Review

353) Ferlito A, Rinaldo A
I.F. 1.046 Neck dissection: historical and current concepts
Am J Otolaryngol 26, 289-295, 2005. Editorial

354) Rinaldo A, Mondin V, Suárez C, Genden EM, Ferlito A
I.F. 4.636 Grisel’s syndrome in head and neck practice
Oral Oncol 41, 966-970, 2005. Review

355) Rodrigo JP, Ferlito A, Suárez C, Shaha AR, Silver CE, Devaney KO, Bradley PJ, Bocker JM, McLaren KM, Grénman R, Rinaldo A.
I.F. 2.471 New molecular diagnostic methods in head and neck cancer
Head Neck 27, 995-1003, 2005. Review

356) Mondin V, Rinaldo A, Shaha AR, Cureoglu S, Devaney KO, Suárez C, Ferlito A
I.F. 1.161 Malignant melanoma of the auricle
Acta Otolaryngol 125, 1140-1144, 2005. Review

357) Ferlito A, Rinaldo A, Silver CE, Gourin CG, Shah JP, Clayman GL, Kowalski LP, Shaha AR, Robbins KT, Suárez C, Leemans CR, Ambrosch P, Medina JE, Weber RS, Genden EM, Pellitteri PK, Werner JA, Myers EN
I.F. 4.636 Elective and therapeutic selective neck dissection
Oral Oncol 42, 14-25, 2006. Review



358) Wei WI, Ferlito A, Rinaldo A, Gourin CG, Lowry J, Ho WK, Leemans CR, Shaha AR, Suárez C, Clayman GL, Robbins KT, Bradley PJ, Silver CE
I.F. 4.636 Management of the N0 neck - Reference or preference
Oral Oncol 42, 115-122, 2006. Review

359) Ferlito A, Rinaldo A, Robbins KT, Silver CE
I.F. 0.967 Neck dissection: past, present, and future?
J Laryngol Otol 120, 87-92, 2006. Review (•)

360) Pellitteri PK, Ferlito A, Rinaldo A, Shah JP, Weber RS, Lowry J, Medina JE, Gourin CG, Robbins KT, Suárez C, Shaha AR, Genden EM, Leemans CR, Lefebvre JL, Kowalski LP, Wei WI
I.F. 2.471 Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?
Head Neck 28, 166-175, 2006. Review

361) Elsheikh MN, Ferlito A, Rinaldo A, Shaha AR, Khafif A, Coskun HH, Kowalski LP, Medina JE
I.F. 4.767 Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck?
J Am Coll Surg 202, 320-323, 2006. Review

362) Ferlito A, Silver CE, Shaha AR, Rinaldo A
I.F. 1.046 The head and neck surgeon as oncologist
Am J Otolaryngol 27, 73-75, 2006. Editorial

363) Ferlito A, Devaney KO, Rinaldo A
I.F. 1.161 Primary carcinoid tumor of the middle ear - a potentially metastasizing tumor
Acta Otolaryngol 126, 228-231, 2006. Review

364) Genden EM, Rinaldo A, Bradley PJ, Lowry J, Suárez C, Shaha AR, Scully C, Ferlito A
I.F. 1.387 Referral guidelines for suspected cancer of the head and neck
Auris Nasus Larynx 33, 1-5, 2006.

365) Rinaldo A, Elsheikh MN, Ferlito A, Chone CT, Coskun HH, Köybaşioğlu A, Esclamado RM, Corlette TH, TalmiYP
I.F. 4.767 Prospective studies of neck dissection specimens support preservation of sublevel IIB for laryngeal squamous carcinoma with clinically negative neck.
J Am Coll Surg 202, 967-970, 2006. Review

366) Elsheikh MN, Ferlito A, Rinaldo A, Shaha AR, Khafif A, Coskun HH, Kowalski LP, Medina JE
I.F. 4.767 Level IV neck dissection in laryngeal carcinoma
J Am Coll Surg 203, 136-137, 2006. (Letter to the Editor).


367) Elsheikh MN, Rinaldo A, Hamakawa H, Mahfouz ME, Rodrigo JP, Brennan J, Devaney KO, Grandis JR, Ferlito A
I.F. 2.471 Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma
Head Neck 28, 842-849, 2006. Review

368) Cureoglu S, Schachern PA, Ferlito A, Rinaldo A, Tsuprun V, Paparella MM
I.F. 1.046 Otosclerosis: etiopathogenesis and histopathology
Am J Otolaryngol 27, 334-340, 2006. Review

369) Ferlito A, Devaney KO, Rinaldo A
I.F. 4.636 Neuroendocrine neoplasms of the larynx: advances in identification, understanding and management
Oral Oncol 42, 770-788, 2006. Review

370) Bradley PJ, Rinaldo A, Suárez C, Shaha AR, Leemans CR, Langendijk JA, Patel SG, Ferlito A
I.F. 1.546 Primary treatment of the anterior vocal commissure squamous carcinoma
Eur Arch Otorhinolaryngol 263, 879-888, 2006. Review

371) Bradley PJ, Ferlito A, Suárez C, Werner JA, Genden EM, Shaha AR, Leemans CR, Langendijk JA, Rinaldo A
I.F. 1.546 Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinoma
Eur Arch Otorhinolaryngol 263, 889-894, 2006. Review

372) Ferlito A, Rinaldo A, Silver CE, Shah JP, Suárez C, Medina JE, Kowalski LP, Johnson JT, Strome M, Rodrigo JP, Werner JA, Takes RP, Towpik E, Robbins KT, Leemans CR, Herranz J, Gavilán J, Shaha AR, Wei WI
I.F. 1.387 Neck dissection: then and now
Auris Nasus Larynx 33, 365-374, 2006. Review (••)

373) Rodrigo JP, Rinaldo A, Devaney KO, Shaha AR, Ferlito A
I.F. 2.471 Molecular diagnostic methods in the diagnosis and follow-up of well-differentiated thyroid carcinoma
Head Neck 28, 1032-1039, 2006. Review

374) Suárez C, Rodrigo JP, Ferlito A, Cabanillas R, Shaha AR, Rinaldo A.
I.F. 4.636 Tumours of familial origin in the head and neck
Oral Oncol 42, 965-978, 2006. Review (•••)

375) Devaney KO, Rinaldo A, Rodrigo JP, Ferlito A
I.F. 2.471 Sentinel node biopsy and head and neck tumors – Where do we stand today?
Head Neck 28, 1122-1131, 2006. Review

376) Ferlito A, Silver CE, Suárez C, Rinaldo A
I.F. 1.546 Preliminary multi-institutional prospective pathologic and molecular studies support preservation of sublevel IIB and level IV for laryngeal squamous carcinoma with clinically negative neck
Eur Arch Otorhinolaryngol 264, 111-114, 2007. Review
377) Ferlito A, Elsheikh MN, Manni JJ, Rinaldo A
I.F. 1.546 Paraneoplastic syndromes in patients with primary head and neck cancer
Eur Arch Otorhinolaryngol 264, 211-222, 2007. Review (••••)

378) Ferlito A, Silver CE, Rinaldo A
I.F. 4.767 Neck dissection in the new era
J Am Coll Surg 204, 466-468, 2007.

379) Cabanillas R, Rodrigo JP, Ferlito A, Rinaldo A, Fresno MF, Aguilar C, Alvarez ME, Suárez C
I.F. 4.636 Is there an epidemiological link between Human Papillomavirus DNA and basaloid squamous cell carcinoma of the pharynx?
Oral Oncol 43, 327-332, 2007. Review

380) Folz BJ, Ferlito A, Silver CE, Olofsson J, Bradley PJ, Bieñ S, Towpik E, Weir N, Rinaldo A
I.F. 1.546 Neck dissection in the nineteenth century
Eur Arch Otorhinolaryngol 264, 455-460, 2007. Editorial

381) Ferlito A, Johnson JT, Rinaldo A, Pratt LW, Fagan JJ, Weir N, Suárez C, Folz BJ, Bieñ S, Towpik E, Leemans CR, Bradley PJ, Kowalski LP, Herranz J, Gavilán J, Olofsson J
I.F. 2.442 European surgeons were the first to perform neck dissection
Laryngoscope 117, 797-802, 2007.

382) Genden EM, Ferlito A, Silver CE, Jacobson AS, Werner JA, Suárez C, Leemans CR, Bradley PJ, Rinaldo A
I.F. 4.636 Evolution of the management of laryngeal cancer
Oral Oncol 43, 431-439, 2007. Review

383) Folz BJ, Ferlito A, Weir N, Pratt LW, Rinaldo A, Werner JA
I.F. 0.967 A historical review of head and neck cancer in celebrities
J Laryngol Otol 121, 511-520, 2007. Review

384) Ferlito A, Rinaldo A
I.F. 1.513 Paraneoplastic syndromes in patients with cancer of the larynx and hypopharynx
Ann Otol Rhinol Laryngol 116, 502-513, 2007.

385) Devaney KO, Rinaldo A, Ferlito A
I.F. 1.046 Micrometastases in cervical lymph nodes from patients with squamous carcinoma of the head and neck - Should they be actively sought?Maybe.
Am J Otolaryngol 28, 271-274, 2007.

386) Sanabria A, Carvalho AL, Silver CE, Rinaldo A, Shaha AR, Kowalski LP, Ferlito A
I.F. 2.886 Routine drainage after thyroid surgery – A meta-analysis
J Surg Oncol 96, 273-280, 2007. Review

387) Pellitteri PK, Ferlito A, Fagan JJ, Suárez C, Devaney KO, Rinaldo A
I.F. 4.636 Mesenchymal chondrosarcoma of the head and neck
Oral Oncol 43, 970-975, 2007. Review
388) Sanabria A, Carvalho AL, Andrade VP, Rodrigo JP, Vartanian JG, Rinaldo A, Ikeda MK, Devaney KO, Magrin J, Soares FA, Ferlito A, Kowalski LP
I.F. 2.471 Is galectin-3 a good method for the detection of malignancy in patients with thyroid nodules and a cytologic diagnosis of “follicular neoplasm”? A critical appraisal of the evidence.
Head Neck 29, 1046-1054, 2007. Review

389) Silver CE, Rinaldo A, Ferlito A
I.F. 2.442 Crile’s neck dissection
Laryngoscope 117, 1974-1977, 2007.

390) Jose J, Ferlito A, Rodrigo JP, Devaney KO, Rinaldo A, MacLennan K
I.F. 0.967 Soft tissue deposits from head and neck cancer: an under-recognised prognostic factor?
J Laryngol Otol 121, 1115-1117, 2007. Editorial

391) Johnson JT, Ferlito A, Fagan JJ, Bradley PJ, Rinaldo A
I.F. 0.967 Role of limited parotidectomy in management of pleomorphic adenoma
J Laryngol Otol 121, 1126-1128, 2007. Review

392) de Bree R, Rinaldo A, Genden EM, Suárez C, Rodrigo JP, Fagan JJ, Kowalski LP,
Ferlito A, Leemans CR
I.F. 1.546 Modern reconstruction techniques for oral and pharyngeal defects after tumor resection
Eur Arch Otorhinolaryngol 265, 1-9, 2008. Review

393) Genden EM, Ferlito A, Rinaldo A, Silver CE, Fagan JJ, Suárez C, Langendijk JA, Lefebvre JL, Bradley PJ, Leemans CR, Chen AY, Jose J, Wolf GT
I.F. 2.471 Recent changes in the treatment of patients with advanced laryngeal cancer
Head Neck 30, 103-110, 2008. Review

394) Folz BJ, Silver CE, Rinaldo A, Fagan JJ, Pratt LW, Weir N, Seitz D, Ferlito A
I.F. 4.636 An outline of the history of head and neck oncology
Oral Oncol 44, 2-9, 2008. Review

395) Mondin V, Ferlito A, Muzzi E, Silver CE, Fagan JJ, Devaney KO, Rinaldo A
I.F. 1.387 Thyroglossal duct cyst: personal experience and literature review
Auris Nasus Larynx 35, 11-25, 2008. Review

396) Suárez C, Ferlito A, Lund VJ, Silver CE, Fagan JJ, Rodrigo JP, Llorente JL, Cantù G, Politi M, Wei WI, Rinaldo A
I.F. 2.471 Management of the orbit in malignant sinonasal tumors
Head Neck 30, 242-250, 2008. Review

397) Elsheikh MN, Rinaldo A, Ferlito A, Fagan JJ, Suárez C, Lowry J, Paleri V, Khafif A, Olofsson J
I.F. 4.636 Elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: is dissection of sublevel IIB necessary?
Oral Oncol 44, 216-219, 2008. Review

398) Bień S, Rinaldo A, Silver CE, Fagan JJ, Pratt LW, Tarnowska C, Towpik E, Weir N, Folz BJ, Ferlito A
I.F. 2.442 History of voice rehabilitation following laryngectomy
Laryngoscope 118, 453-458, 2008. Review

399) Ferlito A, Rinaldo A
I.F. 2.471 Primary and secondary small cell neuroendocrine carcinoma of the larynx: a review
Head Neck 30, 518-524, 2008. Review

400) Takes RP, Rinaldo A, Rodrigo JP, Devaney KO, Fagan JJ, Ferlito A
I.F. 2.471 Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer?
Head Neck 30, 525-538, 2008. Review

401) Ferlito A, Silver CE, Rinaldo A
I.F. 2.442 Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma
Laryngoscope 118, 676-679, 2008. Review

402) Rodrigo JP, Suárez C, Silver CE, Rinaldo A, Ambrosch P, Fagan JJ, Genden EM, Ferlito A
I.F. 2.471 Transoral laser surgery for supraglottic cancer
Head Neck 30, 658-666, 2008. Review

403) Kim S, Grandis JR, Rinaldo A, Takes RP, Ferlito A
I.F. 2.471 Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer
Head Neck 30, 667-674, 2008. Review

404) Muzzi E, Rinaldo A, Ferlito A
I.F. 1.046 Ménière’s disease: diagnostic instrumental support
Am J Otolaryngol 29, 188-194, 2008. Review

405) Ferlito A, Silver CE, Rinaldo A
I.F. 1.546 Neck dissection: present, and future?
Eur Arch Otorhinolaryngol 265, 621-626, 2008. Review

406) Hamakawa H, Nakashiro K, Sumida T, Shintani S, Myers JN, Takes RP, Rinaldo A, Ferlito A
I.F. 2.471 Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer
Head Neck 30, 800-809, 2008. Review

407) Myssiorek D, Ferlito A, Silver CE, Rodrigo JP, Baysal BE, Fagan JJ, Suárez C, Rinaldo A
I.F. 4.636 Screening for familial paragangliomas
Oral Oncol 44, 532-537, 2008. Review


408) Robbins KT, Shaha AR, Medina JE, Califano J, Wolf GT, Ferlito A, Som PM, Day T
I.F. 3.295 Consensus statement on the classification and terminology of neck dissection
Arch Otolaryngol Head Neck Surg 134, 536-538, 2008.

409) Devaney KO, Rinaldo A, Ferlito A, Silver CE, Fagan JJ, Bradley PJ, Suárez C
I.F. 0.967 Squamous carcinoma arising in a branchial cleft cyst: have you ever treated one? Will you?
J Laryngol Otol 122, 547-550, 2008. Review

410) Carbone A, Ferlito A, Devaney KO, Rinaldo A
I.F. 2.886 Ultrasound-guided core-needle biopsy: is it effective in the diagnosis of suspicious malignant lymphomas presenting in the head and neck?
J Surg Oncol 98, 4-5, 2008. Editorial

411) Ferlito A, Rinaldo A, Devaney KO, Nakashiro K, Hamakawa H
I.F. 1.546 Detection of lymph node micrometastases in patients with squamous carcinoma of the head and neck
Eur Arch Otorhinolaryngol 265, 1147-1153, 2008. Review

412) Pratt LW, Ferlito A, Rinaldo A
I.F. 2.442 Tracheotomy: historical review
Laryngoscope 118, 1597-1606, 2008. Review

413) Ferlito A, Rinaldo A
I.F. 2.442 Is radical neck dissection a current option for neck disease?
Laryngoscope 118, 1717-1718, 2008. Editorial

414) Ferlito A, Rinaldo A, Silver CE, Robbins KT, Medina JE, Rodrigo JP, Shaha AR, Takes RP, Bradley PJ
I.F. 4.767 Neck dissection for laryngeal cancer
J Am Coll Surg 207, 587-593, 2008. Review

415) Ferlito A, Rinaldo A
I.F. 1.546 The future of TNM staging system in laryngeal cancer: time for a debate?
Eur Arch Otorhinolaryngol 265, 1441-1443, 2008. Editorial

416) Rinaldo A, Ferlito A, Silver CE
I.F. 1.546 Early history of neck dissection
Eur Arch Otorhinolaryngol 265, 1535-1538, 2008. Review

417) Ferlito A, Rinaldo A, Silver CE, Shaha AR, Fliss DM, Rodrigo JP, Elsheikh MN, Khafif A
I.F. 1.387 Paratracheal node dissection for well-differentiated cancer of the thyroid: indications, technique and results
Auris Nasus Larynx 35, 463-468, 2008. Review

418) Rinaldo A, Ferlito A, Bradley PJ
Decision making in the management of the neck in head and neck squamous cell carcinoma
J ENT Masterclass 1, 88-92, 2008.

419) Ferlito A, Rinaldo A, Devaney KO
I.F. 1.546 Authors’ response to the comments by Eckel on the editorial “The future of the TNM staging system in laryngeal cancer: time for a debate?”
Eur Arch Otorhinolaryngol 266, 153-154, 2009. Letter to the Editor

420) Ferlito A, Rinaldo A, Devaney KO
I.F. 1.546 Authors’ response to Shah’s letter concerning the editorial “The future of the TNM staging system in laryngeal cancer: time for a debate?”
Eur Arch Otorhinolaryngol 266, 157-158, 2009. Letter to the Editor

421) Ferlito A, Silver CE, Rinaldo A
I.F. 1.260 Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies
Br J Oral Maxillofac Surg 47, 5-9, 2009. Review

422) Ferlito A, Robbins KT, Silver CE, Hasegawa Y, Rinaldo A
I.F. 1.387 Classification of neck dissections:an evolving system
Auris Nasus Larynx 36, 127-134, 2009. Review

423) Carbone A, Gloghini A, Rinaldo A, Devaney KO, Tubbs R, Ferlito A
I.F. 2.471 True identity by immunohistochemistry and molecular morphology of undifferentiated malignancies of the head and neck
Head Neck 31, 949-961, 2009. Review

424) Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A
I.F. 1.546 Current trends in initial management of laryngeal cancer: the declining use of open surgery
Eur Arch Otorhinolaryngol 266, 1333-1352, 2009. Review

425) Toro C, Rinaldo A, Silver CE, Politi M, Ferlito A
I.F. 1.387 Paraneoplastic syndromes in patients with nasopharyngeal cancer
Auris Nasus Larynx 36, 513-520, 2009. Review

426) Haigentz M Jr, Silver CE, Corry J, Genden EM, Takes RP, Rinaldo A, Ferlito A
I.F. 1.546 Current trends in initial management of oropharyngeal cancer: the declining use of open surgery
Eur Arch Otorhinolaryngol 266, 1845-1855, 2009. Review

427) Ferlito A, Silver CE, Bradford CR, Rinaldo A
I.F. 2.471 Neuroendocrine neoplasms of the larynx: an overview
Head Neck 31, 1634-1646, 2009. Review

428) Haigentz M Jr, Silver CE, Rinaldo A, Ferlito A
I.F. 1.546 Definitive chemotherapy: a new frontier in the fight against laryngeal cancer
Eur Arch Otorhinolaryngol 267, 1-4, 2010. Editorial

429) Toro C, Rinaldo A, Silver CE, Politi M, Ferlito A
I.F. 4.636 Paraneoplastic syndromes in patients with oral cancer
Oral Oncol 46, 14-18, 2010. Review


430) Devaney KO, Rinaldo A, Ferlito A
I.F. 1.546 Pathologic diagnosis in head and neck practice: how fast is fast enough?
Eur Arch Otorhinolaryngol 267, 167-169, 2010. Editorial

431) Folz BJ, Rinaldo A, Silver CE, Ferlito A
I.F. 1.546 The history of horizontal glottectomy
Eur Arch Otorhinolaryngol 267, 255-259, 2010.

432) Ferlito A, Corry J, Silver CE, Shaha AR, Robbins KT, Rinaldo A
I.F. 2.471 Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence
Head Neck 32, 253-261, 2010. Review

433) Ferlito A, Takes RP, Rinaldo A, Devaney KO
I.F. 1.546 Which is the single most important factor in deciding the management and determining the prognosis of head and neck cancer?
Eur Arch Otorhinolaryngol 267, 325-326, 2010. Editorial

434) Strojan P, Ferlito A, Wu C-F, Rinaldo A
I.F. 1.546 Intraarterial chemotherapy: a valid option in the treatment of verrucous carcinoma?
Eur Arch Otorhinolaryngol 267, 835-837, 2010. Editorial

435) Civantos FJ, Stoeckli SJ, Takes RP, Woolgar JA, de Bree R, Paleri V, Devaney KO, Rinaldo A, Silver CE, Mondin V, Werner JA, Ferlito A
I.F. 1.546 What is the role of sentinel lymph node biopsy in the management of oral cancer in 2010?
Eur Arch Otorhinolaryngol 267, 839-844, 2010. Editorial

436) Mahfouz ME, Rodrigo JP, Takes RP, Elsheikh MN, Rinaldo A, Brakenhoff RH, Ferlito A
I.F. 1.546 Current potential and limitations of molecular diagnostic methods in head and neck cancer
Eur Arch Otorhinolaryngol 267, 851-860, 2010. Review

437) Haigentz M Jr, Silver CE, Hartl DM, Takes RP, Rodrigo JP, Robbins KT, Rinaldo A, Ferlito A
I.F. 3.475 Chemotherapy regimens and treatment protocols for laryngeal cancer
Expert Opin Pharmacother 11, 1305-1316, 2010. Review

438) Khafif A, Ferlito A, Takes RP, Robbins KT
I.F. 1.546 Is it necessary to perform radical neck dissection as a salvage procedure for persistent or recurrent neck disease after chemoradiotherapy in patients with nasopharyngeal cancer?
Eur Arch Otorhinolaryngol 267, 997-999, 2010. Editorial

439) Genden EM, Ferlito A, Silver CE, Takes RP, Suárez C, Owen RP, Haigentz M Jr, Stoeckli SJ, Shaha AR, Rapidis AD, Rodrigo JP, Rinaldo A
I.F. 1.546 Contemporary management of cancer of the oral cavity
Eur Arch Otorhinolaryngol 267, 1001-1017, 2010. Review

440) Iyer NG, Shaha AR, Silver CE, Devaney KO, Rinaldo A, Pellitteri PK, Ferlito A
I.F. 1.546 Thyroid incidentaloma - to treat or not to treat
Eur Arch Otorhinolaryngol 267, 1019-1026, 2010. Review

441) Devaney KO, Ferlito A, Rinaldo A
I.F. 1.546 Neuroendocrine carcinomas of the larynx: what do the different histologic types really mean?
Eur Arch Otorhinolaryngol 267, 1323-1325, 2010. Editorial

442) Langendijk JA, Ferlito A, Takes RP, Rodrigo JP, Suárez C, Strojan P, Haigentz M Jr, Rinaldo A
I.F. 4.636 Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck
Oral Oncol 46, 577-585, 2010. Review

443) Iyer NG, Shaha AR, Ferlito A, Robbins KT, Medina JE, Silver CE, Rinaldo A, Takes RP, Suárez C, Rodrigo JP, Bradley PJ, Werner JA
I.F. 2.886 Delphian node metastasis in head and neck cancers - Oracle or myth?
J Surg Oncol 102, 354-358, 2010. Review

444) Mondin V, Ferlito A, Devaney KO, Woolgar JA, Rinaldo A
I.F. 1.546 A survey of metastatic central nervous system tumors to cervical lymph nodes
Eur Arch Otorhinolaryngol 267,1657-1666, 2010. Review

445) Zanation AM, Ferlito A, Rinaldo A, Gore MR, Lund VJ, McKinney KA, Suárez C, Takes RP, Devaiah AK
I.F. 1.546 When, how and why to treat the neck in patients with esthesioneuroblastoma: a review
Eur Arch Otorhinolaryngol 267, 1667–1671, 2010. Review

446) Paleri V, Wight RG, Silver CE, Haigentz M Jr, Takes RP, Bradley PJ, Rinaldo A, Sanabria A, Bień S, Ferlito A
I.F. 4.636 Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice
Oral Oncol 46, 712-719, 2010. Review

447) Suárez C, Rodrigo JP, Rinaldo A, Langendijk JA, Shaha AR, Ferlito A
I.F. 1.546 Current treatment options for recurrent nasopharyngeal cancer
Eur Arch Otorhinolaryngol 267, 1811-1824, 2010. Review

448) Owen RP, Chou KJ, Silver CE, Beilin Y, Tang JJ, Yanagisawa R, Rinaldo A, Shaha AR, Ferlito A
I.F. 1.546 Thyroid and parathyroid surgery in pregnancy
Eur Arch Otorhinolaryngol 267, 1825-1835, 2010. Review

449) Takes RP, Rinaldo A, Silver CE, Piccirillo JF, Haigentz M Jr, Suárez C, Vander Poorten V, Hermans R, Rodrigo JP, Devaney KO, Ferlito A
I.F. 2.471 Future of the TNM classification and staging system in head and neck cancer
Head Neck 32, 1693-1711, 2010. Review

450) Woolgar JA, Ferlito A, Takes RP, Rodrigo JP, Silver CE, Devaney KO, Rinaldo A
I.F. 1.546 The sudden presentation and progression of overt cervical metastases following treatment of head and neck cancers
Eur Arch Otorhinolaryngol 268, 1-4, 2011. Editorial

451) Woolgar JA, Lewis JS Jr, Devaney KO, Rinaldo A, Coskun HH, Takes RP, Hartl DM, Ereño Zárate C, Zbären P, Ferlito A
I.F. 1.546 Basaloid squamous cell carcinoma of the upper aerodigestive tract – a single squamous cell carcinoma subtype or two distinct entities hiding under one histologic pattern?
Eur Arch Otorhinolaryngol 268, 161-164, 2011. Editorial

452) Owen RP, Silver CE, Pellitteri PK, Shaha AR, Devaney KO, Werner JA, Rinaldo A, Ferlito A
I.F. 2.471 Parathyroid carcinoma: a review
Head Neck 33, 429-436, 2011. Review

453) Ferlito A, Robbins KT, Shah JP, Medina JE, Silver CE, Al-Tamimi S, Fagan JJ, Paleri V, Takes RP, Bradford CR, Devaney KO, Stoeckli SJ, Weber RS, Bradley PJ, Suárez C, Leemans CR, Coskun HH, Pitman KT, Shaha AR, de Bree R, Hartl DM, Haigentz M Jr, Rodrigo JP, Hamoir M, Khafif A, Langendijk JA, Owen RP, Sanabria A, Strojan P, Vander Poorten V, Werner JA, Bień S, Woolgar JA, Zbären P, Betka J, Folz BJ, Genden EM, Talmi YP, Strome M, Herranz González Botas J, Olofsson J, Kowalski LP, Holmes JD, Hisa Y, Rinaldo A
I.F. 2.471 Proposal for a rational classification of neck dissections
Head Neck 33, 445-450, 2011. Editorial

454) Torrente MC, Rodrigo JP, Haigentz M Jr, Dikkers FG, Rinaldo A, Takes RP, Olofsson J, Ferlito A
I.F. 2.471 Human papillomavirus infections in laryngeal cancer
Head Neck 33, 581-586, 2011. Review

455) Devaney KO, Ferlito A, Rinaldo A, El-Naggar AK, Barnes L
I.F. 1.546 Verrucous carcinoma (carcinoma cuniculatum) of the head and neck: what do we know now that we didn’t know a decade ago?
Eur Arch Otorhinolaryngol 268, 477-480, 2011. Editorial

456) Papaspyrou G, Ferlito A, Silver CE, Werner JA, Genden EM, Sesterhenn AM
I.F. 3.117 Extra-cervical approaches to endoscopic thyroid surgery
Surg Endosc 25, 995-1003, 2011. Review

457) Woolgar JA, Ferlito A, Devaney KO, Rinaldo A, Barnes L
I.F. 1.546 How trustworthy is a diagnosis in head and neck surgical pathology? A consideration of diagnostic discrepancies (errors)
Eur Arch Otorhinolaryngol 268, 643-651, 2011. Editorial

458) Takes RP, Robbins KT, Woolgar JA, Rinaldo A, Silver CE, Olofsson I, Ferlito A
I.F. 2.471 Questionable necessity to remove the submandibular gland in neck dissection
Head Neck 33, 743-745, 2011. Review

459) Medina JE, Ferlito A, Robbins KT, Silver CE, Rodrigo JP, de Bree R, Rinaldo A, Elsheikh MN, Weber RS, Werner JA
I.F. 2.471 Central compartment dissection in laryngeal cancer
Head Neck 33, 746-752, 2011. Review

460) Papaspyrou G, Werner JA, Roeßler M, Devaney KO, Rinaldo A, Ferlito A
I.F. 1.046 Adult rhabdomyoma in the parapharyngeal space - report of 2 cases and review of the literature
Am J Otolaryngol 32, 240-246, 2011. Review

461) Papaspyrou G, Hoch S, Rinaldo A, Rodrigo JP, Takes RP, van Herpen C, Werner JA, Ferlito A
I.F. 2.471 Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review
Head Neck 33, 905-911, 2011. Review

462) de Bree R, Leemans CR, Silver CE, Robbins KT, Rodrigo JP, Rinaldo A, Takes RP, Shaha AR, Medina JE, Suárez C, Ferlito A
I.F. 2.471 Paratracheal lymph node dissection in cancer of the larynx, hypopharynx and cervical esophagus: the need for guidelines
Head Neck 33, 912-916, 2011. Review

463) Lewis JS Jr, Ferlito A, Gnepp DR, Rinaldo A, Devaney KO, Silver CE, Travis WD
I.F. 2.442 Terminology and classification of neuroendocrine neoplasms of the larynx
Laryngoscope 121, 1187-1193, 2011. Review

464) Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A
I.F. 2.471 Aggressive variants of papillary thyroid carcinoma
Head Neck 33, 1052-1059, 2011. Review

465) Bradley PJ, Ferlito A, Silver CE, Takes RP, Woolgar JA, Strojan P, Suárez C, Coskun HH, Zbären P, Rinaldo A
I.F. 2.471 Neck treatment and shoulder morbidity: still a challenge
Head Neck 33, 1060-1067, 2011. Review

466) Rodrigo JP, Shah JP, Silver CE, Medina JE, Takes RP, Robbins KT, Rinaldo A, Werner JA, Ferlito A
I.F. 2.471 Management of the clinically negative neck in early-stage head and neck cancers after transoral resection
Head Neck 33, 1210-1219, 2011. Review

467) Folz BJ, Silver CE, Rinaldo A, Ferlito A
I.F. 1.546 Themistocles Gluck: biographic remarks emphasising his contributions to laryngectomy
Eur Arch Otorhinolaryngol 268, 1175-1179, 2011. Review

468) Ferlito A, Lewis JS Jr, Rinaldo A
I.F. 1.546 The evolving management of laryngeal neuroendocrine carcinomas
Eur Arch Otorhinolaryngol 268, 1247-1248, 2011. Editorial


469) Hartl DM, Ferlito A, Silver CE, Takes RP, Stoeckli SJ, Suárez C, Rodrigo JP, Sesterhenn AM, Snyderman CH, Terris DJ, Genden EM, Rinaldo A
I.F. 1.546 Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directions
Eur Arch Otorhinolaryngol 268, 1249-1257, 2011. Review

470) Robbins KT, Ferlito A, Silver CE, Takes RP, Strojan P, Snyderman CH, de Bree R, Haigentz M Jr, Langendijk JA, Rinaldo A, Shaha AR, Hanna EY, Werner JA, Suárez C
I.F. 2.471 Contemporary management of sinonasal cancer
Head Neck 33, 1352-1365, 2011. Review

471) da Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Dominguez Valentin M, Woolgar JA, Bradford CR, Rodrigo JP, Rinaldo A, Hier MP, Kowalski LP
I.F. 4.636 Advances and applications of oral cancer basic research
Oral Oncol 47, 783-791, 2011. Review

472) Coskun HH, Ferlito A, Medina JE, Robbins KT, Rodrigo JP, Strojan P, Suárez C, Takes RP, Woolgar JA, Shaha AR, de Bree R, Rinaldo A, Silver CE
I.F. 2.471 Retropharyngeal lymph node metastases in head and neck malignancies
Head Neck 33, 1520-1529, 2011. Review

473) Hartl DM, Ferlito A, Brasnu DF, Langendijk JA, Rinaldo A, Silver CE, Wolf GT
I.F. 2.471 Evidence-based review of treatment options for patients with glottic cancer
Head Neck 33, 1638-1648, 2011. Review

474) Talmi YP, Ferlito A, Takes RP, Strojan P, Langendijk JA, Shaha AR, Rinaldo A
I.F. 2.471 Lymph node metastasis in nasal vestibule cancer: a review
Head Neck 33, 1783-1788, 2011. Review

475) O’Hara J, Ferlito A, Takes RP, Rinaldo A, Strojan P, Shaha AR, Rodrigo JP, Paleri V
I.F. 2.471 Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland – A review of current recommendations
Head Neck 33, 1789-1795, 2011. Review

476) Strojan P, Ferlito A, Langendijk JA, Silver CE
I.F. 2.471 Indications for radiotherapy after neck dissection
Head Neck 34, 113-119, 2012. Review

477) Takes RP, Strojan P, Silver CE, Bradley PJ, Haigentz M Jr, Wolf GT, Shaha AR, Hartl DM, Olofsson J, Langendijk JA, Rinaldo A, Ferlito A
I.F. 2.471 Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery
Head Neck 34, 270-281, 2012. Review

478) Vander Poorten V, Bradley PJ, Takes RP, Rinaldo A, Woolgar JA, Ferlito A
I.F. 2.471 Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology
Head Neck 34, 429-440, 2012. Review

479) Albirmawy OA, Elsheikh MN, Silver CE, Rinaldo A, Ferlito A
I.F. 2.442 Impact of primary neopharyngoplasty on acoustic characteristics of alaryngeal tracheoesophageal voice
Laryngoscope 122, 299-306, 2012. Review

480) Haigentz M Jr, Corry J, Strojan P, Ferlito A
I.F. 36.418 Easing acceleration of head and neck chemoradiotherapy
Lancet Oncol 13, 113-115, 2012. Comment

481) Hamoir M, Ferlito A, Schmitz S, Hanin F-X, Thariat J, Weynand B, Machiels J-P, Grégoire V, Robbins KT, Silver CE, Strojan P, Rinaldo A, Corry J, Takes RP
I.F. 4.636 The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease
Oral Oncol 48, 203-210, 2012. Review

482) Kusafuka K, Ferlito A, Lewis JS Jr, Woolgar JA, Rinaldo A, Slootweg PJ, Gnepp DR, Devaney KO, Travis WD, Barnes L
I.F. 4.636 Large cell neuroendocrine carcinoma of the head and neck
Oral Oncol 48, 211-215, 2012. Review

483) Strojan, Ferlito A, Lund VJ, Kennedy DW, Silver CE, Rinaldo A, Barnes L
I.F. 4.636 Sinonasal inverted papilloma associated with malignancy: the role of human papillomavirus infection and its implications for radiotherapy
Oral Oncol 48, 216-218, 2012. Review

484) Sanabria A, Kowalski LP, Bradley PJ, Hartl DM, Bradford CR, de Bree R, Rinaldo A, Ferlito A
I.F. 2.471 Sternocleidomastoid muscle flap in preventing Frey’s syndrome after parotidectomy: a systematic review
Head Neck 34, 589-598, 2012. Review

485) Rodrigo JP, García-Pedrero JM, Suárez C, Takes RP, Thompson LDR, Slootweg PJ, Woolgar JA, Westra WH, Brakenhoff RH, Rinaldo A, Devaney KO, Williams MD, Gnepp DR, Ferlito A
I.F. 1.546 Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: a systematic review
Eur Arch Otorhinolaryngol 269, 1073-1083, 2012. Review

486) Gonçalves Agra IM, Ferlito A, Takes RP, Silver CE, Olsen KD, Stoeckli SJ, Strojan P, Rodrigo JP, Gonçalves Filho J, Genden EM, Haigentz M Jr, Khafif A, Weber RS, Zbären P, Suárez C, Hartl DM, Rinaldo A, Kim KH, Kowalski LP
I.F. 2.471 Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy
Head Neck 34, 727-735, 2012. Review

487) Madorin C, Owen RP, Fraser WD, Pellitteri PK, Radbill B, Rinaldo A, Seethala RR, Shaha AR, Silver CE, Suh MY, Weinstein B, Ferlito A
I.F. 1.546 The surgical management of renal hyperparathyroidism
Eur Arch Otorhinolaryngol 269, 1565-1576, 2012. Review

488) Genden EM, O’Malley BW Jr, Weinstein GS, Stucken CL, Selber JC, Rinaldo A, Hockstein NG, Ozer E, Mallet Y, Satava RM, Moore EJ, Silver CE, Ferlito A
I.F. 2.471 Transoral robotic surgery for upper aerodigestive tract tumors: the current state of the art
Head Neck 34, 886-893, 2012. Review

489) Suárez C, Rodrigo JP, Silver CE, Hartl DM, Takes RP, Rinaldo A, Strojan P, Ferlito A
I.F. 2.471 Laser surgery for early to moderately advanced glottic, supraglottic and hypopharyngeal cancers
Head Neck 34, 1028-1035, 2012. Review

490) Fernandez-Miranda JC, Gardner PA, Snyderman CH, Devaney KO, Strojan P, Suárez C, Genden EM, Rinaldo A, Ferlito A
I.F. 2.471 Craniopharyngioma: a pathological, clinical, and surgical review
Head Neck 34, 1036-1044, 2012. Review

491) Lund VJ, Chisholm EJ, Takes RP, Suárez C, Mendenhall WM, Rinaldo A, Llorente JL, Terhaard CHJ, Rodrigo JP, Maughan E, Ferlito A
I.F. 2.471 Evidence for treatment strategies in sinonasal adenocarcinoma
Head Neck 34, 1168-1178, 2012. Review

492) Pellitteri PK, Takes RP, Lewis JS Jr, Devaney KO, Harlor EJ, Strojan P, Rodrigo JP, Suárez C, Rinaldo A, Medina JE, Woolgar JA, Ferlito A
I.F. 2.471 Merkel cell carcinoma of the head and neck
Head Neck 34, 1346-1354, 2012. Review

493) Takes RP, Rinaldo A, Silver CE, Haigentz M Jr, Woolgar JA, Triantafyllou A, Mondin V, Paccagnella D, de Bree R, Shaha AR, Hartl DM, Ferlito A
I.F. 4.636 Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects
Oral Oncol 48, 775-779, 2012. Review

494) de Bree R, Haigentz M Jr, Silver CE, Paccagnella D, Hamoir M, Hartl DM, Machiels JP, Paleri V, Rinaldo A, Shaha AR, Takes RP, Leemans CR, Ferlito A
I.F. 4.636 Distant metastases from head and neck squamous cell carcinoma. Part II. Diagnosis
Oral Oncol 48, 780-786, 2012. Review

495) Haigentz M Jr, Hartl DM, Silver CE, Langendijk JA, Strojan P, Paleri V, de Bree R, Machiels JP, Hamoir M, Rinaldo A, Paccagnella D, Shaha AR, Takes RP, Ferlito A
I.F. 4.636 Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment
Oral Oncol 48, 787-793, 2012. Review

496) Mendenhall WM, Ferlito A, Takes RP, Bradford CR, Corry J, Fagan JJ, Rinaldo A, Strojan P, Rodrigo JP
I.F. 4.636 Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion
Oral Oncol 48, 918-922, 2012. Review

497) Mendenhall WM, Ferlito A, Takes RP, Bradford CR, Corry J, Fagan JJ, Rinaldo A, Strojan P, Rodrigo JP
I.F. 4.636 Response to comments by Panizza et al. on article “Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion”
Oral Oncol 48, e37, 2012. Letter to the Editor

498) Haigentz M Jr, Cohen EEW, Wolf GT, Strojan P, Eisbruch A, Ferlito A
I.F. 4.636 The future of induction chemotherapy for head and neck squamous cell carcinoma
Oral Oncol 48, 1065-1067, 2012. Editorial

499) Ferlito A, Devaney KO, Woolgar JA, Slootweg PJ, Paleri V, Takes RP, Strojan P, Bradley PJ, Rinaldo A
I.F. 2.471 Squamous epithelial changes of the larynx: diagnosis and therapy
Head Neck 34, 1810-1816, 2012. Review

500) Strojan P, Ferlito A, Medina JE, Woolgar JA, Rinaldo A, Robbins KT, Fagan JJ, Mendenhall WM, Paleri V, Silver CE, Olsen KD, Corry J, Suárez C, Rodrigo JP, Langendijk JA, Devaney KO, Kowalski LP, Hartl DM, Haigentz M Jr, Werner JA, Pellitteri PK, de Bree R, Wolf GT, Takes RP, Genden EM, Hinni ML, Mondin V, Shaha AR, Barnes L
I.F. 2.471 Response to comments by Straetmans et al. on article “Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches”
Head Neck 34, 1820-1821, 2012. Letter to the Editor

501) Devaney KO, LaFeir DJ, Triantafyllou A, Mendenhall WM, Woolgar JA, Rinaldo A, Ferlito A
I.F. 1.546 Inflammatory myofibroblastic tumors of the head and neck: evaluation of clinicopathologic and prognostic features
Eur Arch Otorhinolaryngol 269, 2461-2465, 2012. Review

502) Strojan P, Ferlito A, Medina JE, Woolgar JA, Rinaldo A, Robbins KT, Fagan JJ, Mendenhall WM, Paleri V, Silver CE, Olsen KD, Corry J, Suárez C, Rodrigo JP, Langendijk JA, Devaney KO, Kowalski LP, Hartl DM, Haigentz M Jr, Werner JA, Pellitteri PK, de Bree R, Wolf GT, Takes RP, Genden EM, Hinni ML, Mondin V, Shaha AR, Barnes L
I.F. 2.471 Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches
Head Neck 35, 123-132, 2013. Review

503) Zbären P, Vander Poorten V, Witt RL, Woolgar JA, Shaha AR, Triantafyllou A, Takes RP, Rinaldo A, Ferlito A
I.F. 2.141 Pleomorphic adenoma of the parotid: formal parotidectomy or limited surgery?
Am J Surg 205, 109-118, 2013. Review

504) Hamoir M, Silver CE, Schmitz S, Takes RP, Rinaldo A, Rodrigo JP, Robbins KT, Pitman KT, Medina JE, Ferlito A
I.F. 1.546 Radical neck dissection: is it still indicated?
Eur Arch Otorhinolaryngol 270, 1-4, 2013. Editorial

505) Slootweg PJ, Ferlito A, Cardesa A, Thompson LDR, Hunt JL, Strojan P, Takes RP, Triantafyllou A, Woolgar JA, Rinaldo A, Devaney KO, Barnes L
I.F. 1.546 Sinonasal tumors: a clinicopathologic update of selected tumors
Eur Arch Otorhinolaryngol 270, 5-20, 2013. Review

506) Strojan P, Ferlito A, Langendijk JA, Corry J, Woolgar JA, Rinaldo A, Silver CE, Paleri V, Fagan JJ, Pellitteri PK, Haigentz M Jr, Suárez C, Robbins KT, Rodrigo JP, Olsen KD, Hinni ML, Werner JA, Mondin V, Kowalski LP, Devaney KO, de Bree R, Takes RP, Wolf GT, Shaha AR, Genden EM, Barnes L
I.F. 2.471 Contemporary management of lymph node metastases from an unknown primary to the neck: II. A review of therapeutic options
Head Neck 35, 286-293, 2013. Review

507) Strojan P, Haigentz M Jr, Bradford CR, Hartl DM, Wolf GT, Langendijk JA, Rinaldo A, Eisbruch A, Mendenhall WM, Forastiere AA, Takes RP, Ferlito A
I.F. 4.636 Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma
Oral Oncol 49, 283-286, 2013. Editorial

508) Khafif A, Medina JE, Robbins KT, Silver CE, Weber RS, Rinaldo A, Owen RP, Shaha AR, Ferlito A
I.F. 2.471 Level V in therapeutic neck dissections for papillary thyroid carcinoma
Head Neck 35, 605-607, 2013. Review

509) Ferlito A, Thompson LDR, Cardesa A, Gnepp DR, Devaney KO, Rodrigo JP, Hunt JL, Rinaldo A, Takes RP
I.F. 1.546 The importance of histological types for treatment and prognosis in laryngeal cancer
Eur Arch Otorhinolaryngol 270, 401-403, 2013. Editorial

510) Genden EM, Sambur IM, de Almeida JR, Posner M, Rinaldo A, Rodrigo JP, Strojan P, Takes RP, Ferlito A
I.F. 1.546 Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know
Eur Arch Otorhinolaryngol 270, 405-416, 2013. Review

511) Coca-Pelaz A, Rodrigo JP, Paccagnella D, Takes RP, Rinaldo A, Silver CE, Woolgar JA, Hinni ML, Ferlito A
I.F. 1.546 Reflux and aerodigestive tract diseases
Eur Arch Otorhinolaryngol 270, 417-423, 2013. Review

512) Robbins KT, Ferlito A, Shah JP, Hamoir M, Takes RP, Strojan P, Khafif A, Silver CE, Rinaldo A, Medina JE
I.F. 1.546 The evolving role of selective neck dissection for head and neck squamous cell carcinoma
Eur Arch Otorhinolaryngol 270, 1195-1202, 2013. Review






513) Digonnet A, Hamoir M, Andry G, Haigentz M Jr, Takes RP, Silver CE, Hartl DM, Strojan P, Rinaldo A, de Bree R, Dietz A, Grégoire V, Paleri V, Langendijk JA, Vander Poorten V, Hinni ML, Rodrigo JP, Suárez C, Mendenhall WM, Werner JA, Genden EM, Ferlito A
I.F. 1.546 Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma
Eur Arch Otorhinolaryngol 270, 1569-1580, 2013. Review

514) Woolgar JA, Triantafyllou A, Lewis JS Jr, Hunt JL, Williams MD, Takes RP, Thompson LDR, Slootweg PJ, Devaney KO, Ferlito A
I.F. 1.546 Prognostic biological features in neck dissection specimens
Eur Arch Otorhinolaryngol 270, 1581-1592, 2013. Review

515) Owen RP, Silver CE, Shaha AR, Pellitteri PK, Ferlito A
I.F. 1.546 Minimally invasive parathyroid surgery
Eur Arch Otorhinolaryngol 270, 1171-1173, 2013. Editorial

516) Woolgar JA, Triantafyllou A, Ferlito A, Devaney KO, Lewis JS Jr, Rinaldo A, Slootweg PJ, Barnes L
I.F. 2.471 Intraosseous carcinoma of the jaws: a clinicopathologic review. Part I: metastatic and salivary-type carcinomas
Head Neck 35, 895-901, 2013. Review

517) Woolgar JA, Triantafyllou A, Ferlito A, Devaney KO, Lewis JS Jr, Rinaldo A, Slootweg PJ, Barnes L
I.F. 2.471 Intraosseous carcinoma of the jaws: a clinicopathologic review. Part II: odontogenic carcinomas
Head Neck 35, 902-905, 2013. Review

518) Woolgar JA, Triantafyllou A, Ferlito A, Devaney KO, Lewis JS Jr, Rinaldo A, Slootweg PJ, Barnes L
I.F. 2.471 Intraosseous carcinoma of the jaws: a clinicopathologic review. Part III: primary intraosseous squamous cell carcinoma
Head Neck 35, 906-909, 2013. Review

519) Ferlito A, Takes RP, Silver CE, Strojan P, Haigentz M Jr, Robbins KT, Genden EM, Hartl DM, Shaha AR, Rinaldo A, Suárez C, Olsen KD
I.F. 1.546 The changing role of surgery in the current era of head and neck oncology
Eur Arch Otorhinolaryngol 270, 1971-1973, 2013. Editorial

520) Digonnet A, Hamoir M, Andry G, Vander Poorten V, Haigentz M Jr, Langendijk JA, de Bree R, Hinni ML, Mendenhall WM, Paleri V, Rinaldo A, Werner JA, Takes RP, Ferlito A
I.F. 1.546 Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma
Eur Arch Otorhinolaryngol 270, 1981-1989, 2013. Review

521) Coca-Pelaz A, Paccagnella D, Rodrigo JP, Rinaldo A, Takes RP, Ferlito A
I.F. 0.210 Diagnosis and treatment of gastroesophageal reflux disease
J Gastroint Dig Syst S3, e001, 2013. Editorial


522) Sanabria A, Ramirez AT, Kowalski LP, Silver CE, Shaha AR, Owen RP, Suárez C, Khafif A, Rinaldo A, Ferlito A
I.F. 1.546 Neuromonitoring in thyroidectomy: a meta-analysis of effectiveness from randomized controlled trials
Eur Arch Otorhinolaryngol 270, 2175-2189, 2013. Review

523) Suárez C, Rodrigo JP, Bödeker CC, Llorente JL, Silver CE, Jansen JC, Takes RP, Strojan P, Pellitteri PK, Rinaldo A, Mendenhall WM, Ferlito A
I.F. 2.471 Jugular and vagal paragangliomas: a systematic study on management with surgery and radiotherapy
Head Neck 35, 1195-1204, 2013. Review

524) Sanabria A, Silver CE, Suárez C, Shaha AR, Khafif A, Owen RP, Rinaldo A, Ferlito A
I.F. 1.546 Neuromonitoring of the laryngeal nerves in thyroid surgery: a critical appraisal of the literature
Eur Arch Otorhinolaryngol 270, 2383-2395, 2013. Review

525) Hinni ML, Ferlito A, Brandwein-Gensler MS, Takes RP, Silver CE, Westra WH, Seethala RR, Rodrigo JP, Corry J, Bradford CR, Hunt JL, Strojan P, Devaney KO, Gnepp DR, Hartl DM, Kowalski LP, Rinaldo A, Barnes L
I.F. 2.471 Surgical margins in head and neck cancer: a contemporary review
Head Neck 35, 1362-1370, 2013. Review

526) Shaha AR, Ferlito A, Owen RP, Silver CE, Rodrigo JP, Haigentz M Jr, Mendenhall WM, Rinaldo A, Smallridge RC
I.F. 1.546 Airway issues in anaplastic thyroid carcinoma
Eur Arch Otorhinolaryngol 270, 2579-2583, 2013. Editorial

527) Zbären P, de Bree R, Takes RP, Rinaldo A, Ferlito A
I.F. 1.546 Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?
Eur Arch Otorhinolaryngol 270, 2787-2791, 2013. Editorial

528) Hartl DM, Brasnu DF, Shah JP, Hinni ML, Takes RP, Olsen KD, Kowalski LP, Rodrigo JP, Strojan P, Wolf GT, Rinaldo A, Suárez C, Mendenhall WM, Paleri V, Forastiere AA, Werner JA, Ferlito A
I.F. 1.546 Is open surgery for head and neck cancers truly declining?
Eur Arch Otorhinolaryngol 270, 2793-2802, 2013. Review

529) Suárez C, Rodrigo JP, Robbins KT, Paleri V, Silver CE, Rinaldo A, Medina JE, Hamoir M, Sanabria A, Mondin V, Takes RP, Ferlito A
I.F. 1.546 Superselective neck dissection: rationale, indications, and results
Eur Arch Otorhinolaryngol 270, 2815-2821, 2013. Review

530) Coca-Pelaz A, Rodrigo JP, Takes RP, Silver CE, Paccagnella D, Rinaldo A, Hinni ML, Ferlito A
I.F. 2.471 Relationship between reflux and laryngeal cancer
Head Neck 35, 1814-1818, 2013. Review



531) Bacchetti S, Pasqual EM, Rinaldo A, Ferlito A
I.F. 0.210 Current advances in diagnosis of hepatic metastases from neuroendocrine carcinomas
J Gastrointest Dig Syst S2, e001, 2013. Review

532) Ferlito A, Devaney KO, Hunt JL, Rinaldo A
I.F. 1.546 Is the clinical course of laryngeal typical carcinoid tumor indolent?
Eur Arch Otorhinolaryngol 271, 1-2, 2014. Editorial

533) Suárez C, Rodrigo JP, Mendenhall WM, Hamoir M, Silver CE, Grégoire V, Strojan P, Neumann HPH, Obholzer R, Offergeld C, Langendijk JA, Rinaldo A, Ferlito A
I.F. 1.546 Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy
Eur Arch Otorhinolaryngol 271, 23-34, 2014. Review

534) Owen RP, Lee JS, Silver CE, Bäck L, Beitler JJ, Rinaldo A, O'Malley BW Jr, Haigentz M Jr, Ferlito A
I.F. 1.546 Radiofrequency ablation in advanced head and neck cancer
Eur Arch Otorhinolaryngol 271, 207-210, 2014. Editorial

535) Hunt JL, Barnes L, Lewis JS Jr, Mahfouz ME, Slootweg PJ, Thompson LDR, Cardesa A, Devaney KO, Gnepp DR, Westra WH, Rodrigo JP, Woolgar JA, Rinaldo A, Triantafyllou A, Takes RP, Ferlito A
I.F. 1.546 Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications
Eur Arch Otorhinolaryngol 271, 211-223, 2014. Review

536) Ferlito A, Haigentz M Jr, Bradley PJ, Suárez C, Strojan P, Wolf GT, Olsen KD, Mendenhall WM, Mondin V, Rodrigo JP, Bödeker CC, Hamoir M, Hartl DM, Hunt JL, Devaney KO, Thompson LDR, Rinaldo A, Takes RP
I.F. 1.546 Causes of death of patients with laryngeal cancer
Eur Arch Otorhinolaryngol 271, 425-434, 2014. Review

537) Paleri V, Roe JWG, Strojan P, Corry J, Grégoire V, Hamoir M, Eisbruch A, Mendenhall WM, Silver CE, Rinaldo A, Takes RP, Ferlito A
I.F. 2.471 Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review
Head Neck 36, 431-443, 2014. Review

538) Vander Poorten V, Hunt JL, Bradley PJ, Haigentz M Jr, Rinaldo A, Mendenhall WM, Suárez C, Silver CE, Takes RP, Ferlito A
I.F. 2.471 Recent trends in the management of minor salivary gland carcinoma
Head Neck 36, 444-455, 2014. Review

539) Teymoortash A, Silver CE, Rinaldo A, Cardesa A, Folz BJ, Ferlito A
I.F. 1.546 Verrucous carcinoma: a retrospective diagnosis in three historic patients
Eur Arch Otorhinolaryngol 271, 631-633, 2014. Editorial




540) Triantafyllou A, Hunt JL, Devaney KO, Ferlito A
I.F. 1.546 A perspective of comparative salivary and breast pathology. Part I. Microstructural aspects, adaptations and cellular events
Eur Arch Otorhinolaryngol 271, 647-663, 2014. Review

541) Kupferman ME, Kubik MW, Bradford CR, Civantos FJ, Devaney KO, Medina JE, Rinaldo A, Stoeckli SJ, Takes RP, Ferlito A
I.F. 1.046 The role of sentinel lymph node biopsy for thin cutaneous melanomas of the head and neck
Am J Otolaryngol 35, 226-232, 2014. Review

542) Woolgar JA, Triantafyllou A, Thompson LDR, Hunt JL, Lewis JS Jr, Williams MD, Cardesa A, Rinaldo A, Barnes L, Slootweg PJ, Devaney KO, Gnepp DR, Westra WH, Ferlito A
I.F. 1.546 Double reporting and second opinion in head and neck pathology
Eur Arch Otorhinolaryngol 271, 847-854, 2014. Editorial

543) Lacko M, Braakhuis B, Sturgis EM, Boedeker CC, Suárez C, Rinaldo A, Ferlito A, Takes RP
I.F. 5.554 Genetic susceptibility to head and neck squamous cell carcinoma
Int J Radiat Oncol Biol Phys 89, 38-48, 2014. Review

544) Takes RP, Ferlito A, Silver CE, Rinaldo A, Medina JE, Robbins KT, Rodrigo JP, Hamoir M, Suárez C, Zbären P, Mondin V, Shaha AR, Mendenhall WM, Strojan P
I.F. 1.546 The controversy in the management of the N0 neck for squamous cell carcinoma of the maxillary sinus
Eur Arch Otorhinolaryngol 271, 899-904, 2014. Review

545) Sanabria A, Kowalski LP, Shaha AR, Silver CE, Werner JA, Mandapathil M, Takes RP, Strojan P, Rinaldo A, Ferlito A
I.F. 1.546 Salvage surgery for head and neck cancer: a plea for better definitions
Eur Arch Otorhinolaryngol 271, 1347-1350, 2014. Editorial

546) Fernandez-Miranda JC, Gardner PA, Snyderman CH, Devaney KO, Mendenhall WM, Suárez C, Rinaldo A, Ferlito A
I.F. 2.471 Clival chordomas: a pathological, surgical, and radiotherapeutic review
Head Neck 36, 892-906, 2014. Review

547) Boedeker CC, Hensen EF, Neumann HPH, Maier W, van Nederveen FH, Suárez C, Kunst HP, Rodrigo JP, Takes RP, Pellitteri PK, Rinaldo A, Ferlito A
I.F. 2.471 Genetics of hereditary head and neck paragangliomas
Head Neck 36, 907-916, 2014. Review

548) Mandapathil M, Roessler M, Werner JA, Silver CE, Rinaldo A, Ferlito A
I.F. 1.546 Salvage surgery for head and neck squamous cell carcinoma
Eur Arch Otorhinolaryngol 271, 1845-1850, 2014. Editorial

549) Ferlito A, Strojan P, Lewis JS Jr, Perez-Ordoñez B, Rinaldo A
I.F. 1.546 Large cell neuroendocrine carcinoma of the head and neck: a distinct clinicopathologic entity
Eur Arch Otorhinolaryngol 271, 2093-2095, 2014. Editorial
550) Lewis JS Jr, Westra WH, Thompson LDR, Barnes L, Cardesa A, Hunt JL, Williams MD, Slootweg PJ, Triantafyllou A, Woolgar JA, Devaney KO, Rinaldo A, Ferlito A
The sinonasal tract – Another potential "hot spot" for carcinomas with transcriptionally-active human papillomavirus
Head Neck Pathol 8, 241-249, 2014. Review

551) Mendenhall WM, Mancuso AA, Strojan P, Beitler JJ, Suárez C, Lee T-F, Langendijk JA, Corry J, Eisbruch A, Rinaldo A, Ferlito A
I.F. 2.471 Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancer
Head Neck 36, 1363-1367, 2014. Review

552) Paleri V, Drinnan M, van den Brekel MWM, Hinni ML, Bradley PJ, Wolf GT, de Bree R, Fagan JJ, Hamoir M, Strojan P, Rodrigo JP, Olsen KD, Pellitteri PK, Shaha AR, Genden EM, Silver CE, Suárez C, Takes RP, Rinaldo A, Ferlito A
I.F. 2.442 Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review
Laryngoscope 124, 1848-1853, 2014. Review

553) Teymoortash A, Halmos GB, Silver CE, Strojan P, Haigentz M Jr, Rinaldo A, Ferlito A
I.F. 1.546 On the need for comprehensive assessment of impact of comorbidity in elderly patients with head and neck cancer
Eur Arch Otorhinolaryngol 271, 2597-2600, 2014. Editorial

554) Coca-Pelaz A, Rodrigo JP, Triantafyllou A, Hunt JL, Fernández-Miranda JC, Strojan P, de Bree R, Rinaldo A, Takes RP, Ferlito A
I.F. 1.546 Chondrosarcomas of the head and neck
Eur Arch Otorhinolaryngol 271, 2601-2609, 2014. Review

555) de Bree E, Zoras O, Hunt JL, Takes RP, Suárez C, Mendenhall WM, Hinni ML, Rodrigo JP, Shaha AR, Rinaldo A, Ferlito A, de Bree R
I.F. 2.471 Desmoid tumors of the head and neck: a therapeutic challenge
Head Neck 36, 1517-1526, 2014. Review

556) Mendenhall WM, Strojan P, Silver CE, Owen RP, Rinaldo A, Shaha AR, Eisbruch A, Takes RP, Ferlito A
I.F. 1.546 When is radiation therapy in head and neck squamous cell carcinoma not indicated?
Eur Arch Otorhinolaryngol 271, 2849-2850, 2014. Editorial

557) Strojan P, Beitler JJ, Silver CE, Mendenhall WM, Shaha AR, Rinaldo A, Takes RP, Ferlito A
I.F. 1.546 When is re-irradiation in head and neck squamous cell carcinoma not indicated?
Eur Arch Otorhinolaryngol 271, 3107-3109, 2014. Editorial



558) Sanabria A, Silver CE, Olsen KD, Medina JE, Hamoir M, Paleri V, Mondin V, Rinaldo A, Rodrigo JP, Suárez C, Bödeker CC, Hinni ML, Kowalski LP, Teymoortash A, Werner JA, Takes RP, Ferlito A
I.F. 1.546 Is elective neck dissection indicated during salvage surgery for head and neck squamous cell carcinoma?
Eur Arch Otorhinolaryngol 271, 3111-3119, 2014. Review

559) Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, Lee AWM, Haigentz M Jr, Beitler JJ, de Bree R, Takes RP, Paleri V, Kelly CG, Genden EM, Bradford CR, Harrison LB, Rinaldo A, Ferlito A
I.F. 2.471 Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate
Head Neck 37, 134-150, 2015. Review

560) Rodrigo JP, Kowalski LP, Silver CE, de Bree R, Rinaldo A, Shaha AR, Strojan P, Elsheikh MN, Haigentz M Jr, Sanabria A, Coskun HH, Takes RP, Ferlito A
I.F. 1.546 When is reoperative surgery not indicated for recurrent head and neck squamous cell carcinoma?
Eur Arch Otorhinolaryngol 272, 259-262, 2015. Editorial

561) Saba NF, Haigentz M Jr, Vermorken JB, Strojan P, Bossi P, Rinaldo A, Takes RP, Ferlito A
I.F. 4.636 Prevention of head and neck squamous cell carcinoma: removing the “chemo” from “chemoprevention”
Oral Oncol 51, 112-118, 2015. Review

562) Suárez C, Takes RP, Silver CE, Rodrigo JP, Strojan P, Woolgar JA, Haigentz M Jr, Coskun HH, de Bree R, Owen RP, Elsheikh MN, Shaha AR, Rinaldo A, Ferlito A
I.F. 1.546 When is surgical therapy for head and neck malignant epithelial tumors not indicated?
Eur Arch Otorhinolaryngol 272, 513-516, 2015. Editorial

563) Haigentz M Jr, Vermorken JB, Forastiere AA, Corry J, Beitler JJ, Strojan P, Hartl DM, Rodrigo JP, Bradford CR, Rinaldo A, Takes RP, Mendenhall WM, Shaha AR, Wolf GT, Ferlito A
I.F. 1.546 When is chemotherapy in head and neck squamous cell carcinoma not indicated?
Eur Arch Otorhinolaryngol 272, 781-787, 2015. Editorial

564) Coca-Pelaz A, Rodrigo JP, Triantafyllou A, Hunt JL, Rinaldo A, Strojan P, Haigentz M Jr, Mendenhall WM, Takes RP, Vander Poorten V, Ferlito A
I.F. 1.546 Salivary mucoepidermoid carcinoma revisited
Eur Arch Otorhinolaryngol 272, 799-819, 2015. Review

565) Paleri V, Drinnan M, van den Brekel MWM, Takes RP, Rinaldo A, Ferlito A
I.F. 2.442 In response to Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review
Laryngoscope 125, E156, 2015. Letter to the Editor


566) Bäck LJJ, Mäkitie AA, O'Malley Jr. BW, Owen RP, Rinaldo A, Silver CE, Ferlito A
I.F. 1.546 When is radiofrequency ablation not indicated in head and neck squamous cell carcinoma management?
Eur Arch Otorhinolaryngol 272, 1045-1046, 2015. Editorial

567) de Bree E, Karatzanis A, Hunt JL, Strojan P, Rinaldo A, Takes RP, Ferlito A, de Bree R
I.F. 1.546 Lipomatous tumours of the head and neck: a spectrum of biological behaviour
Eur Arch Otorhinolaryngol 272, 1061-1077, 2015. Review

568) Ferlito A, Coca-Pelaz A, Rodrigo JP, Triantafyllou A, Devaney KO, Hunt JL, Perez-Ordoñez B, Slootweg PJ, Bell D, Bishop JA, Rinaldo A
I.F. 1.046 New tumor phenotypes reported in the larynx in the last decades: a critique
Am J Otolaryngol 36, 494-497, 2015. Consensus Statement

569) Coskun HH, Medina JE, Robbins KT, Silver CE, Strojan P, Teymoortash A, Pellitteri PK, Rodrigo JP, Stoeckli SJ, Shaha AR, Suárez C, Hartl DM, de Bree R, Takes RP, Hamoir M, Pitman KT, Rinaldo A, Ferlito A
I.F. 2.471 Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma
Head Neck 37, 915-926, 2015. Review

570) Weinstein GS, O'Malley Jr. BW, Rinaldo A, Silver CE, Werner JA, Ferlito A
I.F. 1.546 Understanding contraindications for transoral robotic surgery (TORS) for oropharyngeal cancer
Eur Arch Otorhinolaryngol 272, 1551-1552, 2015. Editorial

571) Mamelle E, Borget I, Leboulleux S, Mirghani H, Suárez C, Pellitteri PK, Shaha AR, Hamoir M, Robbins KT, Khafif A, Rodrigo JP, Silver CE, Rinaldo A, Ferlito A, Hartl DM
I.F. 1.546 Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review
Eur Arch Otorhinolaryngol 272, 1577-1586, 2015. Review

572) Coca-Pelaz A, Rodrigo JP, Bradley PJ, Vander Poorten V, Triantafyllou A, Hunt JL, Strojan P, Rinaldo A, Haigentz M Jr, Takes RP, Mondin V, Teymoortash A, Thompson LDR, Ferlito A
I.F. 4.636 Adenoid cystic carcinoma of the head and neck – Update
Oral Oncol 51, 652-661, 2015. Review

573) Mendenhall WM, Takes RP, Shah JP, Bradley PJ, Beitler JJ, Strojan P, Suárez C, Rodrigo JP, Saba NF, Rinaldo A, Werner JA, Ferlito A
I.F. 1.546 Current treatment of T1N0 squamous cell carcinoma of the glottic larynx
Eur Arch Otorhinolaryngol 272, 1821–1824, 2015. Editorial




574) Gleber-Netto FO, Braakhuis BJM, Triantafyllou A, Takes RP, Kelner N, Rodrigo JP, Strojan P, Vander Poorten V, Rapidis AD, Rinaldo A, Brakenhoff RH, Ferlito A, Kowalski LP
I.F. 4.636 Molecular events in relapsed oral squamous cell carcinoma: recurrence vs secondary primary tumor
Oral Oncol 51, 738-744, 2015. Review

575) Mendenhall WM, Strojan P, Eisbruch A, Smee R, Rinaldo A, Ferlito A
I.F. 1.546 When is definitive radiotherapy the preferred treatment for head and neck squamous cell carcinoma?
Eur Arch Otorhinolaryngol 272, 2583-2586, 2015. Editorial

576) Triantafyllou A, Thompson LDR, Devaney KO, Bell D, Hunt JL, Rinaldo A, Vander Poorten V, Ferlito A
Functional histology of salivary gland pleomorphic adenoma: an appraisal
Head Neck Pathol 9, 387-404, 2015. Review

577) Suárez C, Fernández-Alvarez V, Neumann HPH, Boedeker CC, Offergeld C, Rinaldo A, Strojan P, Ferlito A
I.F. 1.546 Modern trends in the management of head and neck paragangliomas
Eur Arch Otorhinolaryngol 272, 3595-3599, 2015. Editorial

578) de Bree R, Takes RP, Castelijns JA, Medina JE, Stoeckli SJ, Mancuso AA, Hunt JL, Rodrigo JP, Triantafyllou A, Teymoortash A, Civantos FJ, Rinaldo A, Pitman KT, Hamoir M, Robbins KT, Silver CE, Hoekstra OS, Ferlito A
I.F. 2.471 Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma
Head Neck 37, 1829-1839, 2015. Review

579) Bishop JA, Thompson LDR, Cardesa A, Barnes L, Lewis JS Jr, Triantafyllou A, Hellquist HB, Stenman G, Hunt JL, Williams MD, Slootweg PJ, Devaney KO, Gnepp DR, Wenig BM, Rinaldo A, Ferlito A
A rhabdomyoblastic differentiation in head and neck malignancies other than rhabdomyosarcoma
Head Neck Pathol 9, 507-518, 2015. Review

580) Bossi P, Saba NF, Vermorken JB, Strojan P, Pala L, de Bree R, Rodrigo JP, López F, Hanna EY, Haigentz M Jr, Takes RP, Slootweg PJ, Silver CE, Rinaldo A, Ferlito A.
I.F. 8.122 The role of systemic therapy in the management of sinonasal cancer: a critical review
Cancer Treat Rev 41, 836-843, 2015. Review

581) Takes RP, Wierzbicka M, D'Souza G, Jackowska J, Silver CE, Rodrigo JP, Dikkers FG, Olsen KD, Rinaldo A, Brakenhoff RH, Ferlito A
I.F. 4.636 HPV vaccination to prevent oropharyngeal carcinoma: what can be learned from anogenital vaccination programs?
Oral Oncol 51, 1057-1060, 2015. Review


582) Rapidis AD, Dijkstra PU, Roodenburg JLN, Rodrigo JP, Rinaldo A, Strojan P, Takes RP, Ferlito A
I.F. 2.696 Trismus in patients with head and neck cancer. Etiopathogenesis, diagnosis and management
Clin Otolaryngol 40, 516-526, 2015. Review

583) Hoch S, Katabi N, Daniel H, Franke N, Wiegand S, Zimmerman AP, Mandapathil M, Ferlito A, Teymoortash A
I.F. 2.471 Prognostic value of level IV metastases from head and neck squamous cell carcinoma
Head Neck 38, 140-146, 2016. Review

584) López F, Rodrigo JP, Cardesa A, Triantafyllou A, Devaney KO, Mendenhall WM, Haigentz M Jr, Strojan P, Pellitteri PK, Bradford CR, Shaha AR, Hunt JL, de Bree R, Takes RP, Rinaldo A, Ferlito A
I.F. 2.471 Update on primary head and neck mucosal melanoma
Head Neck 38, 147-155, 2016. Review

585) Giefing M, Wierzbicka M, Szyfter K, Brenner JC, Braakhuis BJ, Brakenhoff RH, Bradford CR, Sorensen JA, Rinaldo A, Rodrigo JP, Takes RP, Ferlito A
I.F. 7.191 Moving towards personalized therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data
Eur J Cancer 55, 147-157, 2016. Review

586) Wierzbicka M, Bartochowska A, Strnad V, Strojan P, Mendenhall WM, Harrison LB, Rinaldo A, Sahai P, Wiegand S, Ferlito A
I.F. 1.546 The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck
Eur Arch Otorhinolaryngol 273, 269-276, 2016. Review

587) Ferlito A, Rinaldo A, Bishop JA, Hunt JL, Vander Poorten V, Williams MD, Triantafyllou A, Devaney KO, Gnepp DR, Kusafuka K, Halmos GB, Westra WH, Takes RP, Thompson LDR
I.F. 1.546 Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance
Eur Arch Otorhinolaryngol 273, 533-536, 2016. Review

588) Szyfter K, Wierzbicka M, Hunt JL, Rinaldo A, Rodrigo JP, Takes RP, Ferlito A
I.F. 1.546 Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma
Eur Arch Otorhinolaryngol 273, 537-545, 2016. Review

589) Hellquist HB, Skálová A, Barnes L, Cardesa A, Thompson LDR, Triantafyllou A, Williams MD, Devaney KO, Gnepp DR, Bishop JA, Wenig BM, Suárez C, Rodrigo JP, Coca-Pelaz A, Strojan P, Shah JP, Hamoir M, Bradley PJ, Silver CE, Slootweg PJ, Vander Poorten V, Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Eloy JA, Takes RP, Rinaldo A, Ferlito A
I.F. 3.085 Cervical lymph node metastasis in high-grade transformation of head and neck adenoid cystic carcinoma: a collective international review
Adv Ther 33, 357-368 2016. Review
590) Teymoortash A, Ferlito A, Halmos GB
I.F. 0.893 Treatment in elderly patients with head and neck cancer: a challenging dilemma
HNO 64, 217-220, 2016. Review

591) Coca-Pelaz A, Barnes L, Rinaldo A, Cardesa A, Shah JP, Rodrigo JP, Suárez C, Eloy JA, Bishop JA, Devaney KO, Thompson LDR, Wenig BM, Strojan P, Hamoir M, Bradley PJ, Gnepp DR, Silver CE, Slootweg PJ, Triantafyllou A, Vander Poorten Vincent, Williams MD, Skálová A, Hellquist HB, Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Takes RP, Ferlito A
I.F. 3.085 Cervical lymph node metastasis in adenoid cystic carcinoma of the larynx: a collective international review
Adv Ther 33, 553-579, 2016. Review

592) Bell D, Hanna EY, Weber RS, DeMonte F, Triantafyllou A, Lewis JS Jr, Cardesa A, Slootweg PJ, Stenman G, Gnepp DR, Devaney KO, Rodrigo JP, Rinaldo A, Wenig BM, Westra WH, Bishop JA, Hellquist HB, Hunt JL, Kusafuka K, Perez-Ordoñez B, Williams MD, Takes RP, Ferlito A
I.F. 2.471 Neuroendocrine neoplasms of the sinonasal region
Head Neck 38 (Suppl 1), E2259-2266, 2016. Review

593) López F, Rodrigo JP, Silver CE, Haigentz M Jr, Bishop JA, Strojan P, Hartl DM, Bradley PJ, Mendenhall WM, Suárez C, Takes RP, Hamoir M, Robbins KT, Shaha AR, Werner JA, Rinaldo A, Ferlito A
I.F. 2.471 Cervical lymph node metastasis from remote primary tumor sites
Head Neck 38 (Suppl 1), E2374-2385, 2016. Review

594) Suárez C, Barnes L, Silver CE, Rodrigo JP, Shah JP, Triantafyllou A, Rinaldo A, Cardesa A, Pitman KT, Kowalski LP, Robbins KT, Hellquist HB, Medina JE, de Bree R, Takes RP, Coca-Pelaz A, Bradley PJ, Gnepp DR, Teymoortash A, Strojan P, Mendenhall WM, Eloy JA, Bishop JA, Devaney KO, Thompson LDR, Hamoir M, Slootweg PJ, Vander Poorten V, Williams MD, Wenig BM, Skálová A, Ferlito A
I.F. 1.387 Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx:a collective international review
Auris Nasus Larynx 43, 477-484, 2016. Review

595) Coca-Pelaz A, Triantafyllou A, Devaney KO, Rinaldo A, Takes RP, Ferlito A
I.F. 1.046 Collision tumors of the larynx: a critical review
Am J Otolaryngol 37, 365-368, 2016. Review

596) Nixon IJ, Simo R, Newbold K, Rinaldo A, Suárez C, Kowalski LP, Silver CE, Shah JP, Ferlito A
I.F. 7.557 Management of invasive differentiated thyroid cancer
Thyroid 26, 1156-1166, 2016. Review




597) Triantafyllou A, Williams MD, Angelos P, Shah JP, Westra WH, Hunt JL, Devaney KO, Rinaldo A, Slootweg PJ, Gnepp DR, Silver C, Ferlito A
I.F. 1.546 Incidental findings of thyroid tissue in cervical lymph nodes: old controversy not yet resolved?
Eur Arch Otorhinolaryngol 273, 2867-2875, 2016. Review

598) Samuels SE, Eisbruch A, Beitler JJ, Corry J, Bradford CR, Saba NF, van den Brekel MWM, Smee R, Strojan P, Suárez C, Mendenhall WM, Takes RP, Rodrigo JP, Haigentz M Jr, Rapidis A, Rinaldo A, Ferlito A
I.F. 1.546 Management of locally advanced HPV related oropharyngeal squamous cell carcinoma: where are we?
Eur Arch Otorhinolaryngol 273, 2877-2894, 2016. Review

599) Coca-Pelaz A, Devaney KO, Rodrigo JP, Halmos GB, Strojan P, Mendenhall WM, Eisbruch A, Smee R, Kusafuka K, Rinaldo, Ferlito A
I.F. 1.546 Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation?
Eur Arch Otorhinolaryngol 273, 2925-2930, 2016. Review

600) Nixon IJ, Suárez C, Simo R, Sanabria A, Angelos P, Rinaldo A, Rodrigo JP, Kowalski LP, Hartl DM, Hinni ML, Shah JP, Ferlito A
I.F. 3.688 The impact of family history on non-medullary thyroid cancer
Eur J Surg Oncol 42, 1455-1463, 2016. Review

601) Kirschbaum A, Teymoortash A, Suárez C, Shah JP, Silver CE, Nixon IJ, Rinaldo A, Kowalski LP, Robbins KT, Ferlito A
I.F. 1.387 Treatment of large tracheal defects after resection: Laryngotracheal release and tracheal replacement
Auris Nasus Larynx 43, 602-608, 2016. Review

602) Vander Poorten V, Triantafyllou A, Thompson LDR, Bishop J, Hauben E, Hunt JL, Skalova A, Stenman G, Takes RP, Gnepp DR, Hellquist HB, Wenig B, Bell D, Rinaldo A, Ferlito A
I.F. 1.546 Salivary acinic cell carcinoma: reappraisal and update
Eur Arch Otorhinolaryngol 273, 3511-3531, 2016. Review

603) Robbins KT, Bradford CR, Rodrigo JP, Suárez C, de Bree R, Kowalski LP, Rinaldo A, Silver CE, Lund VJ, Nibu K, Ferlito A
I.F. 2.444 Removing the taboo on the surgical violation (cut-through) of cancer
JAMA Otolaryngol Head Neck Surg 142, 1010-1013, 2016. Review

604) Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M Jr, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, Lee AWM, Harrison LB, Bradford CR, Smee R, Silver CE, Rinaldo A, Ferlito A
I.F. 2.471 Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: a systematic review
Head Neck 38 (Suppl 1), E2151-E2158, 2016. Review

605) López F, Devaney KO, Hanna EY, Rinaldo A, Ferlito A
I.F. 2.471 Metastases to nasal cavity and paranasal sinuses
Head Neck 38, 1847-1854, 2016. Review
606) Bishop JA, Devaney KO, Barnes L, Slootweg PJ, Cardesa A, Gnepp DR, Williams MD, Triantafyllou A, de Bree R, Robbins KT, Coca-Pelaz A, Vander Poorten V, Suárez C, Shah JP, Bradley PJ, Kowalski LP, Silver CE, Rodrigo JP, Pitman KT, Teymoortash A, Eloy JA, Takes RP, Hamoir M, Medina JE, Mendenhall WM, Strojan P, Hellquist HB, Skálová A, Rinaldo A, Ferlito A
I.F. 0.967 Cervical lymph node metastasis in adenoid cystic carcinoma of the sinonasal tract, nasopharynx, lacrimal glands, and external auditory canal: a collective international review
J Laryngol Otol 130, 1093-1097, 2016. Review

607) Sanabria A, Chaves ALF, Kowalski LP, Wolf GT, Saba NF, Forastiere AA, Beitler JJ, Nibu KI, Bradford CR, Suárez C, Rodrigo JP, Strojan P, Rinaldo A, de Bree R, Haigentz M Jr, Takes RP, Ferlito A
I.F. 1.387 Organ preservation with chemoradiation in advanced laryngeal cancer: the problem of generalizing results from randomized controlled trials
Auris Nasus Larynx 44, 18-25, 2017. Review

608) Silver CE, Bradley PJ, Barnes L, de Bree R, Hamoir M, Medina JE, Strojan P, Mendenhall WM, Kowalski LP, Vander Poorten Vincent, Eloy JA, Robbins KT, Triantafyllou A, Teymoortash A, Rinaldo A, Pitman KT, Ferlito A
I.F. 0.967 Cervical lymph node metastasis in adenoid cystic carcinoma of the major salivary glands
J Laryngol Otol 131, 96-105, 2017. Review

609) López F, Triantafyllou A, Snyderman CH, Hunt JL, Suárez C, Lund VJ, Strojan P, Saba NF, Nixon IJ, Devaney KO, Alobid I, Bernal-Sprekelsen M, Hanna EY, Rinaldo A, Ferlito A
I.F. 2.471 Nasal juvenile angiofibroma: current perspectives with emphasis on management
Head Neck 39, 1033-1045, 2017. Review

610) López F, Williams MD, Skálová A, Hellquist HB, Suárez C, Nixon IJ, Rodrigo JP, Cardesa A, Strojan P, Quer M, Hunt JL, Rinaldo A, Ferlito A
I.F. 3.085 How phenotype guides the treatment of the most common malignant
salivary neoplasms of the larynx?
Adv Ther 34, 813-825, 2017. Review

611) Hartl DM, Morel D, Saavedra E, Massard C, Rinaldo A, Saba NF, Ferlito A, Soria JC
I.F. 3.085 Oto-rhino-laryngologic toxicities of new drugs in oncology: a review
Adv Ther 34, 866-894, 2017. Review

612) Hunt JL, Ferlito A, Hellquist HB, Rinaldo A, Skalova A, Slootweg PJ, Willems S, Cardesa A
I.F. 2.358 Differential diagnosis in neuroendocrine neoplasms of the larynx
Adv Anat Pathol 24, 161-168, 2017. Review

613) Hellquist HB, French CA, Bishop JA, Coca-Pelaz A, Propst EJ, Correia AP, Ngan B-Y, Grant R, Cipriani NA, Vokes D, Henrique R, Pardal F, Vizcaino JR, Rinaldo A, Ferlito A
I.F. 3.267 NUT midline carcinoma of the larynx: a collective international series
Histopathology 70, 861-868, 2017. Review
614) Nixon IJ, Coca-Pelaz A, Kaleva AI, Triantafyllou A, Angelos P, Owen RP, Rinaldo A, Shaha AR, Silver CE, Ferlito A
I.F. 3.655 Metastasis to the thyroid gland – A critical review
Ann Surg Oncol 24, 1533-1539, 2017. Review

615) Saba NF, Mody MD, Tan ES, Gill HS, Rinaldo A, Takes RP, Strojan P, Hartl DM, Vermorken JB, Haigentz M Jr., Ferlito A
I.F. 4.495 Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); a new perspective in the era of immunotherapy
Crit Rev Oncol Hematol 115, 50-58, 2017. Review

616) López F, Williams MD, Cardesa A, Hunt JL, Strojan P, Rinaldo A, Nixon IJ, Rodrigo JP, Saba NF, Mendenhall WM, Quer M, Suárez C, Ferlito A
I.F. 1.546 How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?
Eur Arch Otorhinolaryngol 274, 2709-2726, 2017. Review

617) Skalova A, Gnepp DR, Lewis JS Jr., Hunt JL, Bishop JA, Hellquist HB, Rinaldo A, Vander Poorten V, Ferlito A
I.F. 5.878 Newly described entities in salivary gland pathology
Am J Surg Pathol 41, e33-e47, 2017. Review

618) Strojan P, Hutcheson K, Eisbruch A, Beitler JJ, Langendijk JA, Lee AWM, Corry J, Mendenhall WM, Smee R, Rinaldo A, Ferlito A
I.F. 8.122 Treatment of late sequelae after radiotherapy for head and neck cancer
Cancer Treat Rev 59, 79- 92, 2017. Review

619) Quer M, Vander Poorten V, Takes RP, Silver CE, Bödeker CC, de Bree R, Rinaldo A, Sanabria A, Shaha AR, Pujol A, Zbären P, Ferlito A
I.F. 1.546 Surgical options in benign parotid tumors: a proposal for classification
Eur Arch Otorhinolaryngol 274, 3825-3836, 2017. Review

620) de Bree R, Wolf GT, de Keizer B, Nixon IJ, Hartl DM, Forastiere AA, Haigentz M Jr, Rinaldo A, Rodrigo JP, Saba NF, Suárez C, Vermorken JB, Ferlito A
I.F. 2.471 Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: from physical examination to modern imaging techniques and beyond
Head Neck 39, 2329-2349, 2017. Review

621) Olsen KD, Quer M, de Bree R, Vander Poorten V,Rinaldo A, Ferlito A
I.F. 1.546 Deep lobe parotidectomy – Why, when, and how?
Eur Arch Otorhinolaryngol 274, 4073-4078, 2017. Editorial

622) López F, Lund VJ, Suárez C, Snyderman CH, Saba NF, Robbins KT, Vander Poorten V, Strojan P, Mendenhall WM, Rinaldo A, Ferlito A
I.F. 3.085 The impact of histologic phenotype in the treatment of sinonasal cancer
Adv Ther 34, 2181-2198, 2017.



623) Shaha AR, Silver CE, Angelos P, Nixon IJ, Rodrigo JP, Sanabria A, Vander Poorten V, Williams MD, Rinaldo A, Ferlito A
I.F. 3.688 The central compartment - Center of controversy, confusion, and concern in management of differentiated thyroid cancer
Eur J Surg Oncol 43, 1981-1984, 2017.

624) Skálová A, Stenman G, Simpson RHW, Hellquist HB, Slouka D, Svoboda T, Bishop JA, Hunt JL, Nibu K-I, Rinaldo A, Vander Poorten V, Devaney KO, Steiner P, Ferlito A
I.F. 5.878 The role of molecular testing in the differential diagnosis of salivary gland carcinomas
Am J Surg Pathol 42, e11-e27, 2018.

625) Coca-Pelaz A, Takes RP, Hutcheson K, Saba NF, Haigentz Jr. M, Bradford CR, de Bree R, Strojan P, Lund VJ, Mendenhall WM, Nixon IJ, Quer M, Rinaldo A, Ferlito A
I.F. 3.085 Head and neck cancer: a review of the impact of treatment delay on outcome
Adv Ther 35, 153-160, 2018. Review

626) de Bree R, Senft A, Coca-Pelaz A, Kowalski LP, López F, Mendenhall WM, Quer M, Rinaldo A, Shaha AR, Strojan P, Takes RP, Silver CE, Leemans CR, Ferlito A
I.F. 3.085 Detection of distant metastases in head and neck cancer: changing landscape
Adv Ther 35, 161-172, 2018.

627) Angelos P, Hartl DM, Shah JP, Nixon IJ, Owen RP, Rinaldo A, Rodrigo JP, Shaha AR, Silver CE, Suárez C, Ferlito A
I.F. 3.688 Ethical issues in non-intervention trials for thyroid cancer
Eur J Surg Oncol 44, 316-320, 2018. Review

628) Sanabria A, Kowalski LP, Shah JP, Nixon IJ, Angelos P, Williams MD, Rinaldo A, Ferlito A
I.F. 2.471 Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis
Head Neck 40, 855-866, 2018. Review

629) Rodrigo JP, Grilli G, Shah JP, Medina JE, Robbins KT, Takes RP, Hamoir M, Kowalski LP, Suárez C, López F, Quer M, Bödeker CC, de Bree R, Coskun HH, Rinaldo A, Silver CE, Ferlito A
I.F. 3.688 Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: systematic review
Eur J Surg Oncol 44, 395-403, 2018. Review

630) Cardesa A, Nadal A, Alos L, Lloreta-Rull J, Ferlito A
Sebaceous differentiation in squamous cell carcinoma of the larynx: case report with review and discussion of the literature
Head Neck Pathol 12, 118-122, 2018.


631) Haigentz Jr. M, Suárez C, Strojan P, Rodrigo JP, Rinaldo A, Bradford CR, Corry J, Takes RP, Alfio Ferlito
I.F. 3.085 Understanding interactions of smoking on prognosis of HPV-associated oropharyngeal cancers
Adv Ther 35, 255-260, 2018. Commentary

632) Civantos FJ, Karakullukcu B, Biel M, Silver CE, Rinaldo A, Saba NF, Takes RP, Vander Poorten V, Ferlito A
I.F. 3.085 A review of photodynamic therapy for neoplasms of the head and neck
Adv Ther 35, 324-340, 2018.

633) Talmi YP, Takes RP, Alon EE, Nixon IJ, López F, de Bree R, Rodrigo JP, Shaha AR, Halmos GB, Rinaldo A, Ferlito A
I.F. 2.471 Prognostic value of lymph node ratio in head and neck squamous cell carcinoma
Head Neck 40, 1082-1090, 2018. Review

634) Bäck L, Aro K, Tapiovaara L, Vikatmaa P, de Bree R, Fernández-Álvarez V, Kowalski LP, Nixon IJ, Rinaldo A, Rodrigo JP, Robbins KT, Silver CE, Snyderman CH, Suárez C, Takes RP, Ferlito A
I.F. 2.471 Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma – a review of the literature
Head Neck 40, 1305-1320, 2018. Review

635) D'Cruz A, Vaish R, Vaidya A, Nixon IJ, Williams MD, Vander Poorten V, López F, Angelos P, Shaha AR, Khafif A, Skálová A, Rinaldo A, Hunt JL, Ferlito A
I.F. 1.546 Molecular markers in well-differentiated thyroid cancer
Eur Arch Otorhinolaryngol 275, 1375-1384, 2018.

636) Hellquist HB, Hunt JL, Cardesa A, Skalova A, Slootweg PJ, Rinaldo A, Ferlito A
I.F. 2.936 Role of ancillary techniques in profiling unclassified laryngeal malignancies
Virchows Arch 472, 705-715, 2018.

637) Vander Poorten V, Triantafyllou A, Skalova A, Stenman G, Bishop JA, Hauben E, Hunt JL, Hellquist HB, Feys S, de Bree R, Mäkitie A, Quer M, Strojan P, Guntinas-Lichius O, Rinaldo, Ferlito A
I.F. 1.546 Polymorphous adenocarcinoma of the salivary glands: reappraisal and update
Eur Arch Otorhinolaryngol 275, 1681-1695, 2018.

638) Mendenhall WM, Suárez C, Skálová A, Strojan P, Triantafyllou A, Devaney KO, Rinaldo A, Williams MD, Ferlito A
I.F. 3.085 Current treatment of endolymphatic sac tumor of the temporal bone
Adv Ther 35, 887-898, 2018. Review

639) Fernández-Álvarez V, López F, Suárez C, Strojan P, Eisbruch A, Silver CE, Mendenhall WM, Langendijk JA, Rinaldo A, Lee AWM, Beitler JJ, Smee R, Álvarez J, Ferlito A
I.F. 2.459 Radiation induced carotid artery lesions
Strahlenther Onkol 194, 699-710, 2018. Review
640) López F, Hunt JL, Nixon IJ, Rinaldo A, Williams MD, Cardesa A, Ferlito A
I.F. 0.967 How phenotype guides management of the neuroendocrine carcinomas of the larynx?
J Laryngol Otol 132, 568-574, 2018. Review

641) Kwon D, Genden EM, de Bree R, Rodrigo JP, Rinaldo A, Sanabria A, Rapidis AD, Takes RP, Ferlito A
I.F. 1.387 Overcoming wound complications in head and neck salvage surgery
Auris Nasus Larynx 45, 1135-1142, 2018.

642) Hamoir M, Schmitz S, Suárez C, Strojan P, Hutcheson KA, Rodrigo JP, Mendenhall WM, Simo R, Saba NF, D'Cruz AK, Haigentz Jr. M, Bradford CR, Genden EM, Rinaldo A, Ferlito A
I.F. 5.326 The current role of salvage surgery in recurrent head and neck squamous
cell carcinoma
Cancers (Basel) 10, E267, 2018.

643) Ferguson MS, Lund VJ, Howard D, Hellquist HB, Petruzzelli GJ, Snyderman CH, Strojan P, Suárez C, Rinaldo A, López F, Ferlito A
Management of sinonasal and skull base non-mesenchymal chondrosarcoma, a narrative review
Rhinology Online 1, 94-103, 2018.

644) Nixon IJ, Angelos P, Shaha AR, Rinaldo A, Williams MD, Ferlito A
I.F. 2.471 Image-guided chemical and thermal ablations for thyroid disease: review of efficacy and complications
Head Neck 40, 2013-2115, 2018.

645) Gonçalves Filho J, Zafereo ME, Ahmad FI, Nixon IJ, Shaha AR, Vander Poorten V, Sanabria A, Khafif A, Robbins KT, Kamani D, Randolph GW, Coca-Pelaz A, Simo R, Rinaldo A, Angelos P, Ferlito A, Kowalski LP
I.F. 3.688 Decision making for the central compartment in differentiated thyroid
cancer
Eur J Surg Oncol 44, 1671-1678, 2018.

646) Zbären P, Triantafyllou T, Devaney KO, Vander Poorten V, Hellquist H, Rinaldo A, Ferlito A
I.F. 1.546 Preoperative diagnostic of parotid gland neoplasms: fine-needle aspiration
cytology or core needle biopsy?
Eur Arch Otorhinolaryngol 275, 2609-2613, 2018. Editorial

647) Guntinas-Lichius O, Silver CE, Thielker G, Bernal-Sprekelsen M, Bradford CR, de Bree R, Kowalski LP, Olsen KD, Quer M, Rinaldo A, Rodrigo JR, Sanabria A, Shaha AR, Takes RP, Vander Poorten V, Zbären P, Ferlito A
I.F. 1.546 Management of the facial nerve in parotid cancer: preservation or resection and reconstruction
Eur Arch Otorhinolaryngol 275, 2615-2626, 2018. Review



648) Andreasen S, Bishop JA, Hellquist H, Hunt J, Kiss K, Rinaldo A, Skálová A, Willems S, Williams M, Ferlito A
I.F. 2.936 Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features and prognosis of a recently described entity
Virchows Arch 473, 615-626, 2018.

649) Suárez C, Fernández-Alvarez V, Hamoir M, Mendenhall WM, Strojan P, Quer M,
Silver CE, Rodrigo JP, Rinaldo A, Ferlito A
I.F. 3.702 Carotid blowout syndrome: modern trends in management
Cancer Manag Res 10, 5617-5628, 2018.

650) Beitler JJ, Ridge JA, Vermorken JB, Bradford CR, Strojan P, Saba NF, Suárez C, Rodrigo JP, Rinaldo A, Chen AY, Ferlito A
I.F.5.554 T4 laryngeal cancer with good function: should we be reluctant to treat it without surgery?
Int J Radiat Oncol Biol Phys 102, 1400-1403, 2018. Editorial

651) Mendenhall WM, Suárez C, Genden EM, de Bree R, Strojan P, Langendijk JA, Mäkitie AA, Smee R, Eisbruch A, Lee AWM, Rinaldo A, Ferlito A
I.F.3.424 Parameters associated with mandibular osteoradionecrosis
Am J Clin Oncol 2018 Jan 22. [Epub ahead of print].

652) Coskun HH, Mendenhall WM, Rinaldo A, Rodrigo JP, Suárez C, Strojan P, López F, Mondin V, Saba NF, Shaha AR, Smee R, Takes RP, Ferlito A
I.F. 2.471 Prognosis of subglottic carcinoma: is it really worse?
Head Neck 2018 Jun 26. [Epub ahead of print].

653) Robbins KT, Triantafyllou A, Suárez C, López F, Hunt JL, Strojan P, Williams MD, Braakhuis BJM, de Bree R, Hinni ML, Kowalski LP, Rinaldo A, Rodrigo JP, Vander Poorten V, Nixon IJ, Takes RP, Silver CE, Ferlito A
I.F. 1.387 Surgical margins in head and neck cancer: intra- and postoperative
considerations
Auris Nasus Larynx 2018 Aug 29. [Epub ahead of print].

654) Szyfter K, Napierala M, Florek E, Braakhuis BJM, Takes RP, Rodrigo JP, Rinaldo A, Silver CE, Ferlito A
I.F. 7.360 Molecular and health effects in the upper respiratory tract associated with tobacco use other than cigarettes
Int J Cancer 2018 Sep 5. [Epub ahead of print].

655) Saba NF, Mendenhall WM, Hutcheson K, Suárez C, Wolf GT, Ferlito A
I.F. 6.537 Salvage surgery for SCCHN in the era of immunotherapy; is it time to clarify our guidelines?
Cancer 2018 Oct 5. [Epub ahead of print]. Editorial

656) Triantafyllou A, Devaney KO, Hunt JL, Rinaldo A, Ferlito A
I.F. 1.466 Structural biology of intraepithelial neuroendocrine cells in the larynx:
literature review
Pathol Res Pract Oct 24. [Epub ahead of print].

657) López F, Suárez C, Vander Poorten V, Mäkitie A, Nixon IJ, Strojan P, Hanna EY, Rodrigo JP, de Bree R, Quer M, Takes RP, Bradford CR, Shaha AR, Sanabria A, Rinaldo A, Ferlito A
I.F. 2.471 Contemporary management of primary parapharyngeal space tumors
Head Neck. In press

658) Simo R, Nixon IJ, Vander Poorten V, Quer M, Shaha AR, Lopez F, Sanabria A,
Angelos P, Rinaldo A, Ferlito A
I.F. 1.546 Surgical management of intrathoracic goitres
Eur Arch Otorhinolaryngol. In press

659) Cabeçadas J, Martinez D, Andreasen S, Mikkelsen LH, Molina-Urra R, Hall D,
Strojan P, Hellquist H, Bandello F, Rinaldo A, Cardesa A, Ferlito A
I.F. 2.936 Lymphomas of the head and neck region: an update
Virchows Arch. In press

660) Hunt J, Barnes L, Triantafyllou A, Gnepp DR, Devaney KO, Stenman G, Halmos GB, Bishop JA, Skálová A, Willems SM, Hellquist H, Rinaldo A, Ferlito A
I.F. 2.358 Well-differentiated neuroendocrine carcinoma of the larynx: confusion of
terminology and uncertainty of early studies
Adv Anat Pathol. In press

661) Triantafyllou A, Mikkelsen LH, Gnepp DR, Andreasen S, Hunt JL, Devaney KO,
Vander Poorten V, Rinaldo A, Willems SM, Ferlito A
I.F. 0.657 Salivary myoepithelial cells: an addendum
Ultrastructural Pathology. In press

662) Coca-Pelaz A, Halmos GB, Strojan P, de Bree R, Bossi P, Bradford CR, Rinaldo A, Vander Poorten V, Sanabria A, Takes RP, Ferlito A
The role of age in treatment-related adverse events in head and neck cancer patients
Submitted

663) Bossi P, Alfieri S, Strojan P, Takes RP, López F, Mäkitie A, Saba NF, Rodrigo JP, Bradford CR, Suárez C, Zafereo M, Forastiere AA, Vermorken JB, Quer M, Sanabria A, Simo R, de Bree R, Rinaldo A, Ferlito A
Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: a literature review
Submitted

664) Rodrigo JP, García-Velasco F, Ambrosch P, Vander Poorten V, Suárez C, Coca-Pelaz A, Strojan P, Hutcheson K, Folz BJ, Bernal-Sprekelsen M, Rinaldo A, Silver CE, Ferlito A
Transoral laser microsurgery for glottic cancer in the elderly: efficacy and safety
Submitted



665) de Bree R, Takes RP, Shah JP, Hamoir M, Kowalski LP, Robbins KT, Rodrigo JP, Sanabria A, Medina JE, Rinaldo A, Shaha AR, Silver CE, Suárez C, Bernal-Sprekelsen M, Ferlito A
Elective neck dissection in oral squamous cell carcinoma: past, present and future
Submitted

666) Sanabria A, Kowalski LP, Nixon IJ, Angelos P, Shaha AR, Owen RP, Suárez C, Rinaldo A, Ferlito A
Neuromonitoring in thyroidectomy: results and methodological assessment of systematic reviews and meta-analyses
Submitted

667) Mendenhall WM, Strojan P, Beitler JJ, Langendijk JA, Suárez C, Lee AW, Rinaldo
A, Rodrigo JP, Smee R, Eisbruch A, Harrison LB, Corry J, Ferlito A
Radiotherapy for parapharyngeal space tumors
Submitted

668) Sanabria A, Kowalski LP, Nixon IJ, Guntinas-Lichius O, Coca-Pelaz A, Hamoir M, Rodrigo JP, Silver CE, Quer M, Paleri V, Suárez C, Simo R, Takes RP, Angelos P, Rinaldo A, Ferlito A
A bibliometric analysis of an interdisciplinary group production. The experience of the International Head and Neck Scientific Group
Submitted

Emmanuel ANDRES

Professor of Internal Medicine Head of the Department of Internal Medicine University of Strasbourg France
In 1996, Dr Andrès received his MD degree in Internal Medicine, at the University of Strasbourg, France. He worked as an associated professor in the University Hospital of Strasbourg, France. In 1998 he worked as PhD in Molecular Biology in the Laboratory of Professor Hoffmann (2011, Nobel Prize of Medicine) in the field of cationic antimicrobial peptides and pathogens - host relations. In 2002, he was nominated Professor at the University of Strasbourg, France. He also was in the head of an Internal Medicine Department (of 62 beads) in the University hospital of Strasbourg, France. He was awarded the French Society of Haematology, price for research in the field of anaemia related to cobalamin or folate deficiencies in 2004. Achievements include development of research in: all type of anaemia, neutropenia and thrombocytopenia, particularly drug-induced neutropenia and agranulocytosis or thrombocytopenia; haematopoietic growth factors; and cobalamin deficiencies. He also conducts several studies on inflammatory or immune disorders. His recent works also include research and development on human sounds analysis, electronic stethoscope, e-auscultation, and e-medicine. In that function he was recruited as advisor to several pharmaceutical and telemedicine companies or start-up.
immunity; host-pathogens relation; immune cytopenias; systemic immune and inflammatory diseases; chronic pathologies, telemedicine, drug-induced side effects, vitamin deficiency

Alexander Birbrair, PhD

Professor Department of Pathology Federal University of Minas Gerais Belo Horizonte, MG, Brazil
EDUCATION
(2016 – present), Professor, Department of Pathology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
(2014 – 2016), Posdoc, Albert Einstein College of Medicine, Bronx, NY, USA, Field of Study: Stem cell biology, Advisor: Paul S. Frenette, MD.
(2010 – 2014), PhD., Neuroscience Program, Wake Forest School of Medicine, Winston-Salem, NC, USA, Field of Study: Stem cell biology, Advisor: Osvaldo Delbono, PhD., MD.
(2009 – 2010), Research Scholar, Wake Forest School of Medicine, Winston-Salem, NC, USA, Field of Study: Muscle biology, Advisor: Osvaldo Delbono, PhD, MD.
(2005 - 2009) BS., Biomedical Science, Universidade Estadual de Santa Cruz, UESC, Ilheus, Brazil, Field of Study: Genetics of microorganisms, Advisors: Rachel Passos Rezende, Ph.D. and Joao Carlos Teixeira Dias, PhD.
HONORS AND AWARDS
2017. Won the prestigious Instituto Serrapilheira Grant 2017-Call
2017. Elected Affiliated Member of the Brazilian Academy of Sciences
2015. Recipient of Gordon A. Melson Outstanding Doctoral Student Award for 2015
2014. Winner of 3-minute thesis (3MT) oral competition (2014 Fourteenth Annual Wake Forest University Graduate Student & Postdoc Research Day)
2014. Editor's choice in Journal of Gerontology Biological Sciences Volume 69 Issue 12 December 2014 for the manuscript “Human Slow Troponin T (TNNT1) Pre-mRNA Alternative Splicing is An Indicator of Skeletal Muscle Response to Resistance Exercise in Older Adults.” by Zhang T, Choi SJ, Wang ZM, Birbrair A, Messi ML, Jin J-P, Marsh AP, Nicklas B, and Delbono O.
2013. Awarded with the Glenn/AFAR Scholarship for Research in the Biology of Aging
2012. Wake Forest University Graduate and Postdoctoral Students Research Day (Troponin T nuclear localization and its role in skeletal muscle aging) (12th annual competition) (First place) (Co-author)
2008. “Metagenome of soil contaminated with petroleum.” Scholarship from : Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB), Brazil.
2006. “Best poster (Genetic diversity between isolates of Chromobacterium violaceum) presented in the area of biological sciences during the XII Seminário de Iniciação Científica da Universidade Estadual de Santa Cruz – UESC, Ilhéus – Bahia.”

PROFESSIONAL MEMEBERSHIPS
(1) American Heart Association (AHA): 2012 - present
(2) Western NC Chapter of the Society for Neuroscience: 2011 – present
(3) International Society for Stem Cell Research: 2013 - present
(1) Costa MA, Paiva AE, Andreotti JP, Cardoso MV, Cardoso CD, Mintz A, Birbrair A. (2018) Pericytes constrict blood vessels after myocardial ischemia. J Mol Cell Cardiol. In press. PMID: 29371134.
(2) Andreotti JP, Lousado L, Magno LAV, Birbrair A. (2017) Hypothalamic Neurons Take Center Stage in the Neural Stem Cell Niche. Cell Stem Cell. 21(3):293-294. PMID: 28886362.
(3) Guerra DAP, Paiva AE, Sena IFG, Azevedo PO, Batista ML Jr, Mintz A, Birbrair A. (2017) Adipocytes role in the bone marrow niche. Cytometry A. In press. PMID: 29236351.
(4) Azevedo PO, Sena IFG, Andreotti JP, Carvalho-Tavares J, Alves-Filho JC, Cunha TM, Cunha FQ, Mintz A, Birbrair A. (2017) Pericytes modulate myelination in the central nervous system. J Cell Physiol. In press. PMID: 29215724.
(5) Birbrair A. (2017) Stem Cell Microenvironments and Beyond. Adv Exp Med Biol. 1041:1-3. PMID: 29204825.
(6) Santos GSP, Prazeres PHDM, Mintz A, Birbrair A. (2017) Role of pericytes in the retina. Eye (Lond). In press. PMID: 29125148.
(7) Prazeres PHDM, Almeida VM, Lousado L, Andreotti JP, Paiva AE, Santos GSP, Azevedo PO, Souto L, Almeida GG, Filev R, Mintz A, Gonçalves R, Birbrair A. (2017) Macrophages Generate Pericytes in the Developing Brain. Cell Mol Neurobiol. In press. PMID: 28894964.
(8) Sena IFG, Prazeres PHDM, Santos GSP, Borges IT, Azevedo PO, Andreotti JP, Almeida VM, Paiva AE, Guerra DAP, Lousado L, Souto L, Mintz A, Birbrair A. (2017) LepR+ cells dispute hegemony with Gli1+ cells in bone marrow fibrosis. Cell Cycle. In press. PMID: 28976809.
(9) Paiva AE, Lousado L, Almeida VM, Andreotti JP, Santos GSP, Azevedo PO, Sena IFG, Prazeres PHDM, Borges IT, Azevedo V, Mintz A, Birbrair A. (2017) Endothelial cells as precursors for osteoblasts in the metastatic prostate cancer bone. Neoplasia. 19(11):928-931. PMID: 28957694.
(10) Lousado L, Prazeres PHDM, Andreotti JP, Paiva AE, Azevedo PO, Santos GSP, Filev R, Mintz A, Birbrair A. (2017) Schwann cell precursors as a source for adrenal gland chromaffin cells. Cell Death and Disease. 8(10):e3072. PMID: 28981120.
(11) Almeida VM, Paiva AE, Sena IFG, Mintz A, Magno LAV, Birbrair A. (2017) Pericytes make spinal cord breathless after injury. Neuroscientist. In press. PMID: 29283016.
(12) Azevedo PO, Lousado L, Paiva AE, Andreotti JP, Santos GSP, Sena IFG, Prazeres PHDM, Filev R, Mintz A, Birbrair A. (2017) Endothelial cells maintain neural stem cells quiescent in their niche. Neuroscience. 363:62-65. PMID: 28893649.
(13) Coatti GC, Frangini M, Valadares MC, Gomes JP, Lima NO, Cavaçana N, Assoni AF, Pelatti MV, Birbrair A, de Lima ACP, Singer JM, Rocha FMM, Da Silva GL, Mantovani MS, Macedo-Souza LI, Ferrari MFR, Zatz M. (2017) Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient. Stem Cell Reviews and Reports. 13:686-698. PMID: 28710685.
(14) Sena IFG, Prazeres PHDM, Santos GSP, Borges IT, Azevedo PO, Andreotti JP, Almeida VM, Paiva AE, Guerra DAP, Lousado L, Souto L, Mintz A, Birbrair A. (2017) Identity of Gli1+ cells in the bone marrow. Exp Hematol. 54:12-16. PMID: 28690072.
(15) Borges I, Sena I, Azevedo P, Andreotti J, Almeida V, Paiva A, Santos G, Guerra D, Prazeres P, Mesquita LL, Silva LSB, Leonel C, Mintz A, Birbrair A. (2017) Lung as a Niche for Hematopoietic Progenitors. Stem Cell Reviews and Reports. 13: 567-574. PMID: 28669077.
(16) Birbrair A, Borges IDT, Gilson Sena IF, Almeida GG, da Silva Meirelles L, Gonçalves R, Mintz A, Delbono O. (2017) How Plastic Are Pericytes? Stem Cells Dev. 26(14):1013-1019. PMID: 28490256.
(17) Dias Moura Prazeres PH, Sena IFG, Borges IDT, de Azevedo PO, Andreotti JP, de Paiva AE, de Almeida VM, de Paula Guerra DA, Pinheiro Dos Santos GS, Mintz A, Delbono O, Birbrair A. (2017) Pericytes are heterogeneous in their origin within the same tissue. Dev Biol. 427(1):6-11. PMID: 28479340.
(18) Pereira LX, Viana CTR, Orellano LAA, Almeida SA, Vasconcelos AC, Goes AM, Birbrair A, Andrade SP, Campos PP. (2017) Synthetic matrix of polyether-polyurethane as a biological platform for pancreatic regeneration. Life Sciences. 176:67-74. PMID: 28336399.
(19) Asada N, Kunisaki Y, Pierce H, Wang Z, Fernandez NF, Birbrair A, Ma'ayan A, Frenette PS. (2017) Differential cytokine contributions of perivascular haematopoietic stem cell niches. Nature Cell Biology. 19(3):214-223. PMID: 28218906.
(20) Birbrair A, Sattiraju A, Zhu D, Zulato G, Batista I, Nguyen VT, Messi ML, Solingapuram Sai KK, Marini FC, Delbono O, Mintz A. (2017) Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas. Stem Cells Translational Medicine. 6(2):471-481. PMID: 28191774.
(21) Birbrair A. (2016) Learn new languages to get ahead. Nature Biotechnology. 34:1073-1074. PMID: 27727214.
(22) Birbrair A and Frenette PS. (2016). Niche heterogeneity in the bone marrow. Annals of the New York Academy of Sciences. 1370(1):82-96. PMID: 27015419.
(23) Zhang T, Pereyra AS, Wang ZM, Birbrair A, Reisz JA, Files DC, Purcell L, Feng X, Messi ML, Feng H, Chalovich J, Jin JP, Furdui C, Delbono O. (2016) Calpain inhibition rescues troponin T3 fragmentation, increases Cav1.1 , and enhances skeletal muscle force in aging sedentary mice. Aging Cell. 15(3):488-98. PMID: 26892246.
(24) Khan JA, Mendelson A, Kunisaki Y, Birbrair A, Kou Y, Arnal A, Pinho S, Ciero P, Nakahara F, Ma’ayan A, Bergman A, Merad M and Frenette PS. (2015) Identification of a portal vessel-associated fetal liver hematopoietic stem cell niche. Science. 351:176-180. PMID: 26634440.
(25) Birbrair A and Delbono O. (2015). Pericytes are Essential for Skeletal Muscle Formation. Stem Cell Reviews and Reports. 11(4):547-8. PMID: 25896402.
(26) Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A and Delbono O. (2015). Pericytes at the intersection between tissue regeneration and pathology. Clinical Science. 128(2): 81–93. PMID: 25236972.
(27) Zhang T, Birbrair A, Wang ZM, Messi ML, Marsh AP, Leng I, Nicklas BJ, Delbono O. (2015). Improved knee extensor strength with resistance training associates with muscle specific miRNAs in older adults. Exp Gerontol. 62:7-13. PMID: 25560803.
(28) Birbrair A, Zhang T, Files DC, Mannava S, Smith T, Wang ZM, Messi ML, Mintz A, Delbono O. (2014). Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther. 5(6):122. PMID: 25376879.
(29) Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A and Delbono O. (2014). Pericytes: Multitasking Cells in the Regeneration of Injured, Diseased, and Aged Skeletal Muscle. Frontiers in Aging Neuroscience. 6:245. PMID: 25278877.
(30) Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A and Delbono O. (2014). Type-2 Pericytes Participate in Normal and Tumoral Angiogenesis. Am J Physiol Cell Physiol. 307 (1): C25-C38. PMID: 24788248
(31) Zhang T, Choi SJ, Wang ZM, Birbrair A, Messi ML, Jin J-P, Marsh AP, Nicklas B, and Delbono O. (2014). Human Slow Troponin T (TNNT1) Pre-mRNA Alternative Splicing is An Indicator of Skeletal Muscle Response to Resistance Exercise in Older Adults. J Gerontol A Biol Sci Med Sci. 69(12):1437-47. PMID: 24368775.
(32) Birbrair A, T Zhang, ZM Wang, ML Messi, A Mintz and O Delbono. (2013). Type-1 Pericytes Participate in Fibrous Tissue Deposition in Aged Skeletal Muscle. Am J Physiol Cell Physiol. 305 (11): C1098-C1113. PMID: 24067916.
(33) Birbrair A, T Zhang, ZM Wang, ML Messi, GN Enikolopov, A Mintz and O Delbono. (2013). Role of Pericytes in Skeletal Muscle Regeneration and Fat Accumulation. Stem Cells Dev. 22 (16): 2298-314. PMID: 23517218.
(34) Zhang, T, Birbrair, A, and Delbono, O. (2013). Nonmyofilament-Associated Troponin T3 Nuclear and Nucleolar Localization Sequence and Leucine Zipper Domain Mediate Muscle Cell Apoptosis. Cytoskeleton (Hoboken). 70(3):134-47. PMID: 23378072.
(35) Birbrair A, T Zhang, ZM Wang, ML Messi, GN Enikolopov, A Mintz and O Delbono. (2013). Skeletal muscle neural progenitor cells exhibit properties of NG2-glia. Exp Cell Res 319:45–63. PMID: 22999866.
(36) Birbrair A, T Zhang, ZM Wang, ML Messi, GN Enikolopov, A Mintz and O Delbono. (2013). Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res 10:67-84. PMID: 23128780.
(37) Zhang T, Birbrair A, ZM Wang, J Taylor, ML Messi and O Delbono. (2013). Troponin T nuclear localization and its role in aging skeletal muscle. Age (Dordr). 35(2):353-70. PMID: 22189912.
(38) Birbrair A, ZM Wang, ML Messi, GN Enikolopov and O Delbono. (2011). Nestin-GFP transgene reveals neural precursor cells in adult skeletal muscle. PLoS One 6:e16816. PMID: 21304812.
BOOKS
Birbrair A. (2017). Stem Cell Microenvironments and Beyond. 1. ed. Springer Nature. Print ISBN: 978-3-319-69193-0. DOI: https://doi.org/10.1007/978-3-319-69194-7

Guneet Sarai, MD

Sound Physicians of Richmond Brain Oncology Research And Hematology University of Hopkins and University of Maryland USA
Medical Education
07/2000 - 12/2005
Government Medical College Chandigarh, India.

Residency
07/2010 -06/2013
Medstar Good Samaritan Hospital, Baltimore, Maryland
Affiliated with The Johns Hopkins University School of Medicine, Internal Medicine.

Work Experience
5/2017 to current
Sound Physicians of Richmond, Adult Hospitalist , currently contracted with Bon Secor hospitals .
8/2013 to 5/2017
Bon Secours St Mary’s Hospital, Richmond VA, Adult hospital Medicine physician
Expertise in adult inpatient care. Admit, round and discharge wide variety of patients including ICU and CCU level of care. Ventilation management. Certified in LVAD inpatient care as team with advanced heart failure specialists.
07/2010 to 7/2013
Medstar Good Samaritan Hospital, Internal Medicine Resident
Academic community hospital affiliated with The Johns Hopkins University School of Medicine. Rotated at the world-famous John Hopkins University Hospital for Critical Cardiac Care Unit, Rheumatology and Neurology rotations. Involved in extensive teaching of medical students and presenting lectures and conducting grand rounds.
02/2012
John Hopkins University: Neuro oncology clinics, Maryland, Clinical Rotator
During this period I was involved in active care of patients with malignant brain tumors.
09/2011
University of Maryland, Maryland, Clinical Rotator, Department of Hematology.
During this period I was involved in active care of patients with multiple myeloma, leukemia and lymphomas.
01/2006 - 06/2010
Parmar Nursing Home, India, Junior Resident
I was primarily involved dealing with emergency care and inpatient services.
01/2005 - 12/2005
Government medical college and Hospital, India, Internship.
Awards

2013 Maryland ACP Mulholland Mohler Associates Meeting, Chief resident 2nd place Award
2006 State Medical Entrance Examination for Post Graduate courses Secured 16th rank.
2003 Silver Medal in discus throw at college Annual Athletic Meet.
2000 State Medical Entrance Examination Secured 12th rank out of more than 5000 candidates that appeared in exam.
1996 100 percentile in AAT, aptitude and academic Performance, Institute of Psychological Measurement

Severe Treatment-Related Lymphopenia in patients with newly Diagnosed rectal cancer. 2017. Jian Campian , Xiaobu Ye, Guneet Sarai, Joseph Herman, Stuart A Grossman, John Hopkins University, Baltimore, MD currently submitted to Cancer Investigation .
Association between Treatment Related Lymphopenia and Survival in Newly Diagnosed Patients with head and neck cancer. Campian Jian, Sarai Guneet, Grossman A Stuart. (2012, July 8). Presented at Frontiers in Basic Immunology, October 2012, NIH , Bethedsa ,Maryland.
High-dose methotrexate with and without rituximab for the treatment of newly diagnosed primary CNS lymphoma: Johns Hopkins Hospital experience. Poster Discussion Session, Central Nervous System Tumors at ASCO 2013. J Clin Oncol 31, 2013 (suppl; abstr 2034) and July 15, 2014 Neurology .org Matthias Holdhoff, Guneet Sarai, Ahmed Abdelaziz, David Bonekamp, Stuart A. Grossman, Xiaobu Ye; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD.
The association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer. General Poster Session, Head and Neck Cancer at ASCO 2013. J Clin Oncol 31, 2013 (suppl; abstr 6068) and published in head and neck cancer April, 2014 and also Cancer research 73 [8 supplement ] 2013 Jian Li Campian, Guneet Sarai, Xiaobu Ye, Shanthi Marur, Stuart A. Grossman; Johns Hopkins Medical Institute, Baltimore, MD; Good Samaritan Hospital, Baltimore, MD; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD; The Johns Hopkins University, School of Medicine, Baltimore, MD.
Use OF Neuroprogenitor Cells (NPC) To Repair the Injured Brain after Rodent Traumatic Brain Injury (TBI). Amanpreet Singh Ph.D., Guneet Sarai., M.D. Kimberly Fernandez R.N., Leo Harris P.A., Jonathan Jagid M.D, Ross M. Bullock, M.D. Ph.D. (2009, September). NEUROTRAUMA 2009, Santa Barbara, California; Miami, CA. Sparing Circulating Lymphocyte populations with Endorectal Brachytherapy.SG Yovino, J Campian , A Wild,SA Grossman, Gsarai , S Geaheart,N Azad,AHacker Prietz,EShin,J Herman 2013, 10/1 International journal of Radiation Oncology vol 87, issue 2
Curious case of Rhino cerebral Aspergillosis in a Diabetic patient, Guneet Sarai, Jenni Yoon ,Aisha Thomas St Cyr , Terina S Chen MD, 2nd place award at ACP , local chapter Maryland .

Cutaneous Mastocytosis Associated with Chronic Myelomonocyte Leukemia, with Symptomatic Response to Imatinib Mesylate". Emily J. Vannorsdall, Jennifer Collins, Ching Chen, Guneet Sarai and Maria R. Baer. Departments of Medicine and Pathology, University of Maryland School of Medicine and University of Maryland Greenebaum Cancer Center, Baltimore, MD Current Oncology Journal.vol20 , issue4 .
An unusual case of idiopathic retroperitoneal fibrosis. Poster presented at: American College of Physicians, ACP, and Maryland Chapter. Baltimore, MD. Sarai Guneet, Holt Peter, Larsen Moira. (2011, February).
A cryptic presentation of T cell lymphoma Poster presented at: American College of Physicians, ACP, and Maryland Chapter. Baltimore, MD. Sarai Guneet, Shahaab Babakoohi ,Sungryong Noh , Medhat Hamed , Adam Berlinger , Marc Shiffman.
Hypomagnesemia as cause of PRES (Posterior reversible Encephalopathy Syndrome) Poster presented at: American College of Physicians, ACP, and Maryland Chapter. Baltimore, MD. Sarai Guneet Ahmet Hoke.
Female Feticide, a curse to society. Sarai Guneet. (2004, July). Poster presented at: Conference on Female foeticide by advisory comittee on PNDT (Prenatal Detection test), India and department of Obstetrics and Gynaecology, Government Medical college and Hospital; Chandigarh, India.

Dr. Hala Mohamed Abdel Halim Assem

Professor in Pediatrics Faculty of Medicine Alexandria University Alexandria, Egypt
Currently, Dr. Hala Mohamed Abdel Halim Assem is Professor of Pediatrics at the Faculty of Medicine, Alexandria University, Alexandria, Egypt since 2003. For 4 years(2011 to 2015) I have been working also as the Professor in Pediatrics at the Faculty of Medicine, Beirut Arab University, Beirut, Lebanon teaching all Pediatrics by the integrated system and with PBL. I am teaching Pediatric Medicine to both undergraduate and postgraduate medical students at the Faculty of Medicine, Alexandria University and in University Hospitals (1985-till now) as well as Nursing students at the Faculty of Health Sciences, BAU (2011, 2012). I attended many workshops about medical education, PBL, and accreditation. I received my Bachelors (1982) and Doctorate (1993) in Pediatrics from the Faculty of Medicine, Alexandria University, Alexandria, Egypt, passed American Qualifying Certificate, USA (ECFMG) examination in 1982 and worked as a fellow at Louisiana State University, Louisiana, USA (LSU) (1988-1990). In addition, I worked as the Head of the department of Clinical Medicine at Faculty of Medicine, Beirut Arab University (2013-2014) and head of pediatric hematology/Oncology and genetics unit, department of pediatrics, Alexandria university (2015-2018). Consultant in Pediatrics, Al- Hayat Clinic, Kuwait (2005-2007), and I worked as an Assistant Professor in Pediatrics (1998-2003), Lecturer in Pediatrics (1993-1998), Assistant Lecturer in Pediatrics (1987-1993), resident in Pediatrics (1982-1985) at Faculty of Medicine, Alexandria University.
General pediatrics, Pediatric Hematology/oncology, diabetes, and pediatric nutrition.
Awards
Alexandria University Scientific Encouragement Award, 2001.
Assem HM, Moghazi K, Yousef M,Shaaban R. Study of bone denisity 25-hydroxy vitamin D and parathyroid hormone in children with sickle cell disease. Accepted for publication 26/2/2018 Alex Journal of Pediatrics.
*Assem HM. Nursing care of infants and children with bronchiolitis. Pe¬diatr Neonatal Nurs Open J. 2015; 2(1): 43-49.
Abd-Elgawad MM, Assem HM, Elbordiny MM. Evaluation of hepatitis B vaccine seroprotection in healthy and polytransfused Egyptian children with B-thalassemia. Egyptian Liver Journal, January 2015; 5 (1) : 1-27.
Moez PS, Farahat N, Hassab H, Assem H. Detection of Hemoglobin F in β Thalassemic Patients by HPLC, Flow cytometry and Electrophoresis: A comparative study. The Egyptian Journal of Hematology 2006; 31 (1): 7-19.
*Soad M Mohamed , Magdi O Abdou , Hala M Assem , Lamia M Soghier. Anticardiolipin antibodies in children with insulin-dependent diabetes mellitus. Metabolism 2002 ,19 :1148-52.
*Ashraf T Soliman , Magdi Omar , Hala M Assem , Rania K El Alaily. Serum leptin concentrations in children with type 1 diabetes mellitus: Relationship to body mass index, insulin dose, and glycemic control. Metabolism 2002, 51:292-6.
Assem HM. Abdel Halim NM. Abdel Megeed, M A. Predictors of microvascular complications in children and adolescents with type 1 diabetes mellitus. Alex Journal of Pediatrics 2002, 16 (2) :345-55.
*Magdy Omar , Mohamed Ibrahim , Hala Assem , Fathi Battah. Teeth and blood lead levels in Egyptian school children:Relationship to health effects. Journal of Applied Toxicology 2001,29:349-52.
Mahmoud Soad, Omar Magdi , Assem Hala, Khalil Ibrahim Saad, Samah Abdel Megeed, M. Ashraf Saad. Subclinical neuropathy in children with IDDM : Peripheral and central nerve functions, Alex Journal of Pediatrics 2001, 15 :319-29.
Mahmoud Soad, Omar Magdi , Assem Hala, Khalil, Ibrahim Saad, Samah Abdel Megeed, M. Ashraf Saad. Subclinical neuropathy in children with IDDM : Autonomic nerve functions. Alex Journal of Pediatrics 2001, 15 :329-34.
Assem HM. , Abdel Halim NM. Antioxidant activity in hematological diseases in children. Alex Journal of Pediatrics 2001, 15 (2):279-82.
Omar M, Elkinany H, Rezk M, Assem H, Shimy N. Biochemical markers of bone formation and resorption in children receiving corticosteroid therapy. Alex Journal of Pediatrics 2000, 14 (2) : 461-7.
Assem HM, Abdel Halim N, Megahed M, Allam S. Parasitic infestation in Egyptian children with diarrhea: Relationship to malabsorption and nutritional status. Alex Journal of Pediatrics 1999, 13 (1):183-8.
*Hassanein el-S A, Assem HM, Rezk MM, el-Maghraby RM. Study of plasma albumin, transferrin and fibronectin in children with mild to moderate protein-energy malnutrition. Journal of Tropical Pediatrics 1998,44 :362-5.
AbdelFattah M, Mowafy E, Assem HM, Hammad M. Study of systemic effects of nebulized salbutamol in acute asthma in children. Alex Journal of Pediatrics 1997, 11 (1): 43-6.
Mahmoud S, Sedrak M, Assem H, Mowafy E, Moftah A. Lipid profile, Lipoprotein-a and apoprotein A1 and b in children with Nephrotic syndrome. Alex Journal of Pediatrics 1996, 10 (1) : 45-50.
Assem Hala M. , Saad M, Abdel Halim NM. Plasma fibronectin, microalbuminuria and electroretinography in IDDM in the young. Alex Journal of Pediatrics 1996, 10 (2): 129-37.
El-Dardiry S, Abdel Halim N, AbulNaga K, Assem H, Sharaf T. Biochemical Changes during recovery phase of hepatitis A and B: Influence of Schistosomiasis in Pediatrics. Alex Journal of Pediatrics 1996, 10: 51-9.
Assem HM, Abdel Fattah M, Mahdy N, Sharaki O. Plasma fibronectin, serum apoproteins, albumin and transferrin concentrations during nutritional repletion in protein energy malnutrition. The Egyptian Journal of Pediatrics 1996, 13(1-2) : 209-24.
El Dardiry SA, AbdelHalim N, Assem HM, Sharaf S, Abo Elazm A. Study of plasma fibronectin, laminin and preprocollagen III in children with viral hepatitis type B and inactive Schistosomiasis. Arab Journal of Laboratory medicine 1996, 22 (2) : 359-70.
Omar M, Rashwan E, Assem HM, AbdelFattah M, Salah N. Polymorphonuclear leukocytes’ chemiluminescence from children with IDDM. Alex Journal of Pediatrics 1995, 9 (2): 161-5.
Mahmoud S, Abdel Aal A, Abdel Fattah M, Assem HM, Fasih N. Lipids profile, and basal insulin levels in obese children. Alex Journal of Pediatrics 1995, 9 (3): 359-63.
Assem HM, ElSebai M, Omar M, Abdel Halim N, Afifi Z. Growth hormone, insulin growth factor-1 and insulin growth factor binding protein-1 in children with insulin-dependent diabetes mellitus. Alex Journal of Pediatrics 1995, 9 (4): 431-7.
Mahmoud S, Assem HM, ElSebai M, Omar M. Study of Lipid profile, Lipoprotein-a in children with insulin-dependent diabetes mellitus. Alex Journal of Pediatrics 1995, 9 (2): 203-9.
Mowafy E, Afify Z, Marzouk S, ElSebai M, Assem HM, ElRaies E. Assessment of proteinuria in Nephrotic children using protein to creatinine ratios in single urine samples. Alex Journal of Pediatrics 1994, 8 (1): 63-7.
Abdel Megeed AS, Assem HM. Clinical findings in infants and children with Down's Syndrome. Bull. Ophthalmol 1994, 87: 989-97.
Mahmoud S, , ElSebai M, Elkinani H, Marzouk S Assem HM. Study of cord serum Lipid pattern in newborn infants and its relationship to clinical data. Alex Journal of Pediatrics 1993, 7 (4): 625-35.
Zeitoun M, Madkour A, Madina E, Sharaf S, Hashem E, Assem H. A study on intestinal protein loss in acute infective diarrhea. Alex Journal of Pediatrics 1987, 1(3): 359-66.
Glutathione and glutathione-dependent enzymes in haematological diseases, Hematologica Journal of Hematology. Abstract book 84, June 1999: 96. (EHA4)

Priyanka Vashisht, MBBS, RhMSUS

Assistant Professor, Division of Rheumatology and Immunology Associate Program Director, Rheumatology fellowship University of Cincinnati Medical Center Omaha
Education and Training
July 2017: RhMSUS, Musculoskeletal ultrasound certification in Rheumatology.
October 2016: ABIM Rheumatology certification completed
July 2014-June 2016: Rheumatology fellowship at University of Nebraska, Omaha, Nebraska.
June 2016: USSONAR certification completion; training for musculoskeletal ultrasound.
August 2012: American Board of Internal Medicine certification completed.
July 2009-June 2012: Internal Medicine residency, Creighton University, Omaha
Aug 2006-May 2008: GP-VTS (General practice residency), LNR Deanery, UK
July 2003-April 2005: Dermatology residency (diploma), Delhi University, India.
Aug 1997-Dec 2002: Medical School, Maulana Azad Medical College, Delhi Univ.

Clinical Experience

August 2016- ongoing: Started position as Assistant Professor Rheumatology at University of Cincinnati Medical Center.
July 2014-June 2016: Rheumatology fellowship at University of Nebraska Medical Center, Omaha, Nebraska.
July 2013-June 2014: Research Trainee appointment at Mayo Clinic, with Dr Timothy Niewold; worked on project on type 1 Interferon levels in Rheumatoid arthritis.
July 2012-June 2013- Assistant Professor Internal Medicine, Creighton University, Omaha. Worked as Primary care physician for a large clinic population as well as did inpatient service rounds on a busy medicine service along with residents and medical students.
July 2009-June 2012: Resident in Internal Medicine, Creighton University, Omaha
Aug 2006-May 2008: Senior House officer and Registrar at Northampton General Hospital and Abbey house surgery, Daventry, United Kingdom, respectively.
July 2003-April 2005: Junior resident in Dermatology, Delhi University, India.
Jan 2002-Dec 2003: Rotating clerkship (Internship) in Medicine, Surgery, Ob-Gyn, Pediatrics, Anesthesia, Orthopedics at Lok Nayak Hospital, Delhi, India.

Honors, Awards & Distinctions

• USSONAR scholarship award: Jan 2016; for participation and completion of the training program for the Ultrasound School of North American Rheumatologists.
• Rheumatology research symposium travel scholarship June 2015
• Congress of Clinical Rheumatology Fellow scholarship award of $1000, May 2015
• Sponsorship and travel grant by the British Association of Dermatologists for presenting my work on skin tuberculosis in the annual meeting in Glasgow July 2005.
• National Merit Scholarship Award by the Directorate of Education in India for outstanding performance in high school: 1996-97.
• Certificate of merit in the 10th National level Science Talent Search Examination 1995 by the “United Council for educational Research and Scientific advancement in learning”.
Original articles:
• Vashisht P, Hearth-Holmes M. Sweet’s syndrome. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-2017 Jan 31. PMID: 28613704
• Vashisht P, Borghoff K, Hearth-Holmes M. Belimumab for the treatment of recalcitrant cutaneous lupus. Lupus. 2016 Jan 1:961203316682097. doi: 1177/0961203316682097. [Epub ahead of print]
• Vashisht P, O’Dell. Not all TNF inhibitors in rheumatoid arthritis are created equal: Important clinical differences. Expert Opin Biol Ther. 2017 Jun 8. PMID: 28594252
• Vashisht P, Harlan S, Mikuls T, Michaud K. Generalizability of patients with Rheumatoid arthritis in Biologic clinical trials. Arthritis Care Res (Hoboken). 2016 Oct;68(10):1478-88. PMID: 26866293
• Muskardin1*, Priyanka Vashisht 2*, et al (* Indicates co-first authors) Baseline serum interferon beta/alpha ratio predicts response to tumor necrosis factor alpha inhibition in rheumatoid arthritis; Ann Rheum Dis. 2016 Oct;75(10):1757-62. PMID(26546586)
• Vashisht P, Casale T. Omalizumab for treatment of allergic rhinitis. Expert Opin Biol Ther. 2013 Jun; 13(6):933-45. PMID(23621175)
• Vashisht P, Sahoo B, Reddy BSN. Cutaneous tuberculosis in children and adolescents: a clinicohistological study. J Eur Acad Dermatol Venereol. 2007 Jan; 21(1):40-7 (Original article) (30 citations). PMID (17207166)
Case reports:
• Akturk HK, Sotello D, Ameri A, Abuzaid AS, Rivas AM, Vashisht P. Toxoplasma Infection in an Immunocompetent Host: Possible Risk of Living with Multiple Cats. Cureus. 2017 Mar 19;9(3):e1103. doi: 10.7759/cureus.1103. PMID: 28435763
• Akturk HK, Vashisht P. How far you can trust c-ANCA. BMJ Case Rep. 2013 Mar 1;2013
• Vashisht P, Akturk K, Krajicek B, Modrykamien A. Painful muscle mass, weight loss and worsening cough. Case report submitted to the journal- Case reports in Pulmonology.
Abstracts:
1. Vashisht P, Danve A et al. Inter-Reader Agreement of a Novel Method of Radiographic Scoring of Rheumatoid Arthritis. 2015 ACR/ARHP Annual Meeting. Abstract Number: 1321
2. Vashisht P, Payne J etal. Antibody Responses to Citrullinated Porphyromonas Gingivalis Peptidylarginine Deiminase: Associations with Disease Risk Factors and Severity in Rheumatoid Arthritis. ACR/ARHP Annual Meeting. Abstract Number: 518
3. Vashisht P, Hearth-Holmes M. Belimumab for the treatment of recalcitrant cutaneous lupus – a pilot project. Abstract for oral presentation at the Rheumatology Dermatology society meeting 2015, San Francisco
4. Vashisht,P Zheng Liu, Yangsheng Yu, Hearth-Holmes, O’Dell, Klassen, Zhixin Zhang, Kaihong Su. Association of anti Epstein-Barr virus (EBV) antibodies with disease parameters in Systemic Lupus Erythematosus. Accepted for presentation at ACR Rheumatology Research symposium, San Diego. 2015
5. Vashisht P, Muskardin TW, Dorschner J, Niewold T. Baseline serum interferon beta/alpha ratio predicts response to tumor necrosis factor alpha inhibition in rheumatoid arthritis; Abstract for presentation in ACR 2014
6. Vashisht P, Sayles H, Mikuls T, Erickson A. A novel, feasible and reliable method of radiographic scoring of rheumatoid arthritis. ACR San Diego in October 2013 Abstract Number: 1968
7. Vashisht P, Harlan S, Mikuls T, Michaud K. Generalizability of patients with Rheumatoid arthritis in Biologic clinical trials. Arthritis Rheum 2011 Oct; 63 (10 Supp): 1 Abstract Number:1200
8. Vashisht P, Sahoo B, Reddy BSN. Clinico-histological study of cutaneous tuberculosis in children and adolescents. British Journal of Dermatology 2005; 53(suppl 1): abstract pg 49.
9. Davies GA, Thornton CA, Moller M, Gopalakrishnan D, Bikhchandani P, Benjamin S, Benton A, Gravenor MB, Hopkin JH. IL-13 Signalling Polymorphisms Predict Asthma and Immune Phenotypes in an Unselected Population. Am J Resp Crit Care Med 2007, 175 (Abstracts Issue): A458.
10. Davies GA, Moller M, Gopalakrishnan D, Bikhchandani P, Benjamin S, Sansbury M, Gravenor MB, Hopkin JH. IL-13 Signalling Polymorphisms Predict Lung Function in an Unselected Population. Am J Resp Crit Care Med 2007, 175 (Abstracts Issue): A832.
11. Davies GA, Moller M, Gopalakrishnan D, Bikhchandani P, Benjamin S, Sansbury M, Gravenor MB, Hopkin JH. IL-13 signalling polymorphisms predict asthma and atopy phenotypes in an unselected population. Thorax 2006; Dec (Abstracts Issue): S124 (ORAL PRESENTATION).
12. Davies GA, Thornton CA, Moller M, Gopalakrishnan D, Bikhchandani P, Benjamin S, Gravenor MB, Benton A, Hopkin JH. Adiposity associates with asthma, IgE and eotaxin levels. Thorax 2006; Dec (Abstracts Issue): S83.
13. Davies GA, Gravenor MB, Gopalakrishnan D, Bikhchandani P, Benjamin S, Benton A, Moller M, Hopkin JH. Adiposity predicts asthma and pulmonary function in a young adult population. Thorax 2006; Dec (Abstracts Issue): P219.
14. Davies GA, Gravenor MB, Gopalakrishnan D, Bikchandani P, Benjamin S, Williams R, Hopkin JM. Body fat predicts asthma and pulmonary function. Proceedings of the American Thoracic Society 2006; 3 (Abstracts Issue): A527.
Book Chapters:
• STAT Pearls: online learning guide for medical students, residents and practitioners. Authored 3 chapters-Sweet syndrome, Discoid lupus and Malar rash; published March 2016
• "Cytokines: Diagnostic and Clinical Applications," (MMCLI8-0082-2014R) has been accepted for publication in the up-and-coming Manual of Molecular and Clinical Laboratory Immunology, 8th edition.
• Vashisht P. Hair Care and Cosmetics. In: Reddy BSN eds. Hair loss-why it occurs and what to do? 2005: 79-96.

Prof. Dr. Alireza Heidari, PhD, DSc

Full Distinguished Professor and Academic Tenure of Chemistry and Director of the BioSpectroscopy Core Research Laboratory Faculty of Chemistry, California South University (CSU), Irvine, California, USA President of American International Standards Institute (AISI) Irvine, California, USA
Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Distinguished Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than four hundred reputed international conferences, seminars, congresses, symposiums, and forums around the world as yet. Also, he possesses many published articles in the Science Citation Index (SCI)/International Scientific Indexing (ISI), PubMed and Scopus Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Indonesia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is an expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than one thousand reputed international awards, prizes, scholarships, and honors. Heretofore, he has multiple editorial duties in many reputed international and peer-reviewed journals, books and publishers. Hitherward, he is a member of more than four hundred reputed international academic–scientific–research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.
• Biophysical Chemistry
• Biomolecular Spectroscopy
• Quantum Chemistry
• Nanochemistry
• Modern Electronic Structure Computations
• Theoretical Chemistry
• Mathematical Chemistry
• Computational Chemistry
• Vibrational Spectroscopy
• Molecular Modelling
• Ab initio & Density Functional Methods
• Molecular Structure
• Biochemistry
• Molecular Simulation
• Pharmaceutical Chemistry
• Medicinal Chemistry
• Oncology
• Synchrotron Radiation
• Synchrocyclotron Radiation
• LASER
• Anti–Cancer Nano Drugs
• Nano Drugs Delivery
• ATR–FTIR Spectroscopy
• Raman Spectroscopy
• Intelligent Molecules
• Molecular Dynamics
• Biosensors
• Biomarkers
• Molecular Diagnostics
• Numerical Chemistry
• Nucleic Acids
• DNA/RNA Monitoring
• DNA/RNA Hypermethylation & Hypomethylation
• Human Cancer Tissues
• Human Cancer Cells
• Tumors
• Cancer Tissues
• Cancer Cells
SCHOLARSHIP AWARDS:
• Sharif University of Technology scholarship for M.Sc. degree studies, Kish Island, Hormozgan, Iran, 2006.
• Islamic Azad University (IAU), North Tehran Branch, scholarship for M.Sc. degree studies, Tehran, Iran, 2006–2008.
• Islamic Azad University (IAU), North Tehran Branch, scholarship for research, Tehran, Iran, 2006–2008.
• Young Researchers Club (YRC) scholarship for M.Sc. degree studies from the Islamic Azad University (IAU), Tehran, Iran, 2006–2008.
• Young Researchers Club (YRC) scholarship for research from the Islamic Azad University (IAU), Tehran, Iran, 2006–2008.
• Islamic Azad University (IAU), Science & Research Campus, scholarship for Ph.D. degree studies, Tehran, Iran, 2009.
• Institute for Advanced Studies (IAS) scholarship for research, Tehran, Iran, 2009–2012.
• California South University (CSU) award of excellence in “Chemical Kinetics and Dynamics”, Irvine, California, USA, 2010.
• California South University (CSU) award of excellence in “Electrochemical Analysis”, Irvine, California, USA, 2012.
• California South University (CSU) award of distinction for Ph.D. in Chemistry with distinction in subject “Advanced Quantum Mechanics”, Irvine, California, USA, 2010.
• California South University (CSU) award of distinction for Ph.D. in Chemistry with distinction in subject “Advanced Research”, Irvine, California, USA, 2010.
• California South University (CSU) scholarship for Ph.D. degree studies from California South University (CSU), Irvine, California, USA, 2009–2012.
• California South University (CSU) scholarship for research, Irvine, California, USA, 2009–2012.
• California South University (CSU) scholarship for postdoctoral research, Irvine, California, USA, 2014.
• Australian Research Council (ARC) scholarship (International Postgraduate Research Scholarship (IPRS)) for research, Melbourne, Victoria, Australia, 2013–2014.
• Australian Research Council (ARC) award (Australian Postgraduate Award (APA)) for research, Melbourne, Victoria, Australia, 2013–2014.
• Monash University scholarship for research (Monash Graduate Scholarship (MGS)), Melbourne, Victoria, Australia, 2013–2014.
MEMBERSHIPS IN PROFESSIONAL SOCIETIES:
National Memberships:
2006 – Present:
An active member of the Iranian Mathematical Society (IMS), The Physics Society of Iran (PSI), The Islamic Azad University Young Researchers Club (YRC), Iranian Association for the Popularization of Sciences (IAPS), Central Committee for Iranian Mathematical House (CCIMH), Iranian Association for Management of Technology (IAMT), Iranian Society of Surface Science & Technology (ISST), Iranian Educational Administration Association (IEAA), Association for Scientific Development of Iran (ASDI), Iranian Curriculum Development Association (ICDA), Iranian Association of Chemical Engineers (IACE), Iranian Society of Acoustics and Vibration (ISAV), Iranian Society for Industry and Academia (ISIA), Council of Iranian Scientific Associations (CISA), Iranian Society of Engineering Education (ISEE), Iranian Project Management Association (IPMA), Iranian Education Research Association (IERA), Iranian Society of Optical and Photonics (ISOP), Iranian Metallurgical Engineers Society (IMES), Iran Society of Biophysical Chemistry (ISBC), Institute for Advanced Studies (IAS), Iranian Higher Education Association (IHEA), Iranian Operations Research Society (IORS), Iranian Nanotechnology Society (INS), Iranian Biotechnology Society (IBS), Iranian Fuzzy Systems Society (IFSS), Iranian Corrosion Association (ICA), Iran Composites Association (ICA), Biochemical Society of Iran (BSI), Iranian Catalysis Association (ICA), Iranian Statistical Society (ISS), Iranian Chemical Society (ICS), Nuclear Society of Iran (NSI), Iran Polymer Society (IPS), and Iran Color Society (ICS).
International Memberships:
2009 – Present:
The American Association for the Advancement of Science (AAAS), American Chemical Society (ACS), American Chemistry Council (ACC), American Society for Biochemistry and Molecular Biology (ASBMB), American Physical Society (APS), American Institute of Physics (AIP), American Mathematical Society (AMS), Mathematical Association of America (MAA), Royal Society of Chemistry (RSC), The Chemical Institute of Canada (CIC), The Canadian Society for Chemistry (CSC), The Royal Australian Chemical Institute (RACI), International Union of Pure and Applied Chemistry (IUPAC), Monash Campus Cluster (MCC), Monash Science Centre for Biospectroscopy, National Computational Infrastructure (NCI), Monash e–Research Centre, Australian Research Council (ARC), ARC Centre of Excellence for Electromaterials Science (ACES), Victorian Life Sciences Computational Initiative (VLSCI), Multi–modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE), Australian Synchrotron, The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Victorian Partnership for Advanced Copmputing (VPAC), National Computational Merit Allocation Scheme (NCMAS), iVEC, National Collaborative Research Infrastructure Strategy (NCRIS), National Health and Medical Research Council (NHMRC), Monash Chemical Society (MCS), Monash Science Society (MSS), Ustinov College, St Catharine’s College, National eResearch Collaboration Tools and Resources (NeCTAR), Monash Ionic Liquids Group, Research Data Storage Infrastructure (RDSI), VicNode, Monash Computational Chemistry Group, and International Neuroinformatics Coordinating Facility (INCF), European Scientific Institute (ESI), Ankara University Institute of Nuclear Sciences, National Institute of Science Communication and Information Resources (New Delhi, India), Indo–American Pharmaceutical Society, American Association of Pharmaceutical Scientists (AAPS), Euro Asia Research and Development Association (EARDA), Institute of Advanced Engineering and Science (IAES), International Academic Institute for Science and Technology (IAIEST), Platform for Young Researchers Welfare Society (PYRWS), Centre For Info Bio Technology (CIBTech), Institute of Research Advances, Association of Global Science Innovations (AGSI), American Institute of Science (AIS), Technical Research Organization India (TROI/TROINDIA), Indian Society for Technical Education (ISTE), Open Association of Research Society USA (OARS), American International Standards Institute (AISI), National Science Library (NSL), Council of Scientific and Industrial Research (New Delhi, India), International Society of Universal Research in Sciences, China National Knowledge Infrastructure (CNKI), International Committee of Medical Journal Editors (ICMJE), International Association of Teachers and Teacher Educators (IATTE), USA, RISHI Educational Society, Research Culture Society, National Institute of Science Communication and Information Resources (NISCAIR) (New Delhi, India), Council of Scientific and Industrial Research (ICSIR) (New Delhi, India), National Science Library (NSL) (New Delhi, India), Committee on Publishing Ethics (COPE), Sanskruti Multidisciplinary Research and Development Training Institute (SMRDTI) (Solapur, Maharashtra, India), Indian Academicians and Researchers Association (IARA), Scholars Academic & Scientific Society (SAS).
HONORS & AWARDS:
• Student researcher of the year at the Islamic Azad University (IAU) for four consecutive years – 2002, 2003, 2004 and 2005, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
• Winner of the 13th National Iranian Student Book Festival Prize for the translation “Mathematics for Chemists (Volumes 1&2)”, Tehran, Iran, 2006.
• Student researcher of the year at the Islamic Azad University (IAU) for three consecutive years – 2006, 2007 and 2008, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
• Winner of the 15th National Iranian Student Book Festival for compiling “Principles of Modern Relativistic Quantum Mechanics”, Tehran, Iran, 2008.
• Winner of the 7th National Iranian Roshd Book Festival for the translation of “Mathematics for Chemists (Volumes 1&2)”, Tehran, Iran, 2008.
• Winner of the Best Poster Presentation Prize at the National Conference for Computing in Chemistry, Arak, Iran, 2008.
• Awarded best thesis prize from the Islamic Azad University (IAU), Tehran, Iran, 2008.
• Ranked top student for six consecutive years – 2002–2008, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran.
• Awarded 1st class honors for my B.Sc. in Pure Chemistry degree with a final overall GPA of 19.08/20 and accepted for an M.Sc. degree program without the mandatory pre–requisite entrance examination requirement by the Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran, 2006.
• Awarded 1st class honors for my M.Sc. in Chemistry (Physical Chemistry) degree with a final overall GPA of 19.08/20 and accepted for Ph.D. studies without a mandatory pre–requisite entrance examination requirement by the Islamic Azad University (IAU), Science & Research Campus, Tehran, Iran, 2009.
• Awarded Honorary Doctorate Degree (Degree Honoris Causa) in Physics (Atomic and Molecular Physics) by the Islamic Azad University (IAU), Tehran, Iran, 2008.
• Winner of best thesis in Iran, Tehran, Iran, 2009.
• Awarded highest GPA for my M.Sc. thesis with a GPA score of 20/20, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran, 2008.
• Winner at the 13th National Iranian Student Thesis Festival, Tehran, Iran, 2009.
• Winner of the 16th National Iranian Student Book Festival for compiling “Principles and Methods of Using Chemical Abstracts”, Tehran, Iran, 2009.
• Winner of the Best Poster Presentation Prize at the 1st Conference on the Application of Nanothechnology in the Petroleum and Petrochemical Industries, Mahshahr, Iran, May 2011.
• Winner of the Best Poster and Best Oral Presentation Prize at the 1st National Student Conference on Nanotechnology, Shahreza, Iran, July 2011.
• Participating at the Carbon Nanotubes workshop during the 1st National Student Conference on Nanotechnology, Shahreza, Iran, July 2011.
• Awarded Doctor of Science (D.Sc.) Diploma in Chemistry by the California South University (CSU), Irvine, California, USA, 2010. Winner of the Best Lecturer Prize in Caspian Higher Education Institute, Qazvin, Iran, 2012.
• Awarded M.Sc. degree offer from Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran, 2006.
• Awarded Ph.D. degree offer from Islamic Azad University (IAU), Science & Research Campus, Tehran, Iran, 2009.
• Awarded Ph.D. degree offer from California South University (CSU), Irvine, California, USA, 2009.
• Awarded “Project Management” Postdoctoral Fellowship Program by School of Chemistry, Faculty of Science, Monash University, Melbourne, Victoria, Australia, 2013.
• Awarded “Modern Molecular Electronic–Structure Computations Theory” and also “Nanochemistry” Postdoctoral fellowship programs by California South University (CSU), Irvine, California, 2014.
[1] A. Heidari, C. Brown, “Study of Composition and Morphology of Cadmium Oxide (CdO) Nanoparticles for Eliminating Cancer Cells”, J Nanomed Res., Volume 2, Issue 5, 20 Pages, 2015.
[2] A. Heidari, C. Brown, “Study of Surface Morphological, Phytochemical and Structural Characteristics of Rhodium (III) Oxide (Rh2O3) Nanoparticles”, International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Volume 1, Issue 1, Pages 15–19, 2015.
[3] A. Heidari, “An Experimental Biospectroscopic Study on Seminal Plasma in Determination of Semen Quality for Evaluation of Male Infertility”, Int J Adv Technol 7: e007, 2016.
[4] A. Heidari, “Extraction and Preconcentration of N–Tolyl–Sulfonyl–Phosphoramid–Saeure–Dichlorid as an Anti–Cancer Drug from Plants: A Pharmacognosy Study”, J Pharmacogn Nat Prod 2: e103, 2016.
[5] A. Heidari, “A Thermodynamic Study on Hydration and Dehydration of DNA and RNA−Amphiphile Complexes”, J Bioeng Biomed Sci S: 006, 2016.
[6] A. Heidari, “Computational Studies on Molecular Structures and Carbonyl and Ketene Groups’ Effects of Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene O=C=CH–N=C=O”, J Appl Computat Math 5: e142, 2016.
[7] A. Heidari, “Study of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds between Peptide Chains and Transition from Helix Structure to Random Coil Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopies”, J Biomol Res Ther 5: e146, 2016.
[8] A. Heidari, “Future Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer Cells”, J Bioanal Biomed 8: e135, 2016.
[9] A. Heidari, “A Bio–Spectroscopic Study of DNA Density and Color Role as Determining Factor for Absorbed Irradiation in Cancer Cells”, Adv Cancer Prev 1: e102, 2016.
[10] A. Heidari, “Manufacturing Process of Solar Cells Using Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles”, J Biotechnol Biomater 6: e125, 2016.
[11] A. Heidari, “A Novel Experimental and Computational Approach to Photobiosimulation of Telomeric DNA/RNA: A Biospectroscopic and Photobiological Study”, J Res Development 4: 144, 2016.
[12] A. Heidari, “Biochemical and Pharmacodynamical Study of Microporous Molecularly Imprinted Polymer Selective for Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin Binding”, Biochem Physiol 5: e146, 2016.
[13] A. Heidari, “Anti–Cancer Effect of UV Irradiation at Presence of Cadmium Oxide (CdO) Nanoparticles on DNA of Cancer Cells: A Photodynamic Therapy Study”, Arch Cancer Res. 4: 1, 2016.
[14] A. Heidari, “Biospectroscopic Study on Multi–Component Reactions (MCRs) in Two A–Type and B–Type Conformations of Nucleic Acids to Determine Ligand Binding Modes, Binding Constant and Stability of Nucleic Acids in Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes as Anti–Cancer Drugs”, Arch Cancer Res. 4: 2, 2016.
[15] A. Heidari, “Simulation of Temperature Distribution of DNA/RNA of Human Cancer Cells Using Time–Dependent Bio–Heat Equation and Nd: YAG Lasers”, Arch Cancer Res. 4: 2, 2016.
[16] A. Heidari, “Quantitative Structure–Activity Relationship (QSAR) Approximation for Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA Using Multiple Linear and Non–Linear Correlation Approach”, Ann Clin Lab Res. 4: 1, 2016.
[17] A. Heidari, “Biomedical Study of Cancer Cells DNA Therapy Using Laser Irradiations at Presence of Intelligent Nanoparticles”, J Biomedical Sci. 5: 2, 2016.
[18] A. Heidari, “Measurement the Amount of Vitamin D2 (Ergocalciferol), Vitamin D3 (Cholecalciferol) and Absorbable Calcium (Ca2+), Iron (II) (Fe2+), Magnesium (Mg2+), Phosphate (PO4–) and Zinc (Zn2+) in Apricot Using High–Performance Liquid Chromatography (HPLC) and Spectroscopic Techniques”, J Biom Biostat 7: 292, 2016.
[19] A. Heidari, “Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+), Neon Dimer (Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cations”, Chem Sci J 7: e112, 2016.
[20] A. Heidari, “Human Toxicity Photodynamic Therapy Studies on DNA/RNA Complexes as a Promising New Sensitizer for the Treatment of Malignant Tumors Using Bio–Spectroscopic Techniques”, J Drug Metab Toxicol 7: e129, 2016.
[21] A. Heidari, “Novel and Stable Modifications of Intelligent Cadmium Oxide (CdO) Nanoparticles as Anti–Cancer Drug in Formation of Nucleic Acids Complexes for Human Cancer Cells’ Treatment”, Biochem Pharmacol (Los Angel) 5: 207, 2016.
[22] A. Heidari, “A Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) as Hydrogen Storage”, Struct Chem Crystallogr Commun 2: 1, 2016.
[23] A. Heidari, “Pharmaceutical and Analytical Chemistry Study of Cadmium Oxide (CdO) Nanoparticles Synthesis Methods and Properties as Anti–Cancer Drug and its Effect on Human Cancer Cells”, Pharm Anal Chem Open Access 2: 113, 2016.
[24] A. Heidari, “A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double–Standard DNA/RNA–Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for Cancer Cells’ Treatment”, Chemo Open Access 5: e129, 2016.
[25] A. Heidari, “Pharmacokinetics and Experimental Therapeutic Study of DNA and Other Biomolecules Using Lasers: Advantages and Applications”, J Pharmacokinet Exp Ther 1: e005, 2016.
[26] A. Heidari, “Determination of Ratio and Stability Constant of DNA/RNA in Human Cancer Cells and Cadmium Oxide (CdO) Nanoparticles Complexes Using Analytical Electrochemical and Spectroscopic Techniques”, Insights Anal Electrochem 2: 1, 2016.
[27] A. Heidari, “Discriminate between Antibacterial and Non–Antibacterial Drugs Artificial Neutral Networks of a Multilayer Perceptron (MLP) Type Using a Set of Topological Descriptors”, J Heavy Met Toxicity Dis. 1: 2, 2016.
[28] A. Heidari, “Combined Theoretical and Computational Study of the Belousov–Zhabotinsky Chaotic Reaction and Curtius Rearrangement for Synthesis of Mechlorethamine, Cisplatin, Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as Anti–Cancer Drugs”, Insights Med Phys. 1: 2, 2016.
[29] A. Heidari, “A Translational Biomedical Approach to Structural Arrangement of Amino Acids’ Complexes: A Combined Theoretical and Computational Study”, Transl Biomed. 7: 2, 2016.
[30] A. Heidari, “Ab Initio and Density Functional Theory (DFT) Studies of Dynamic NMR Shielding Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO) Nanoparticles Complexes in Human Cancer Cells”, J Nanomedine Biotherapeutic Discov 6: e144, 2016.
[31] A. Heidari, “Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars in Insulin Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Study”, J Glycobiol 5: e111, 2016.
[32] A. Heidari, “Synthesis and Study of 5–[(Phenylsulfonyl)Amino]–1,3,4–Thiadiazole–2–Sulfonamide as Potential Anti–Pertussis Drug Using Chromatography and Spectroscopy Techniques”, Transl Med (Sunnyvale) 6: e138, 2016.
[33] A. Heidari, “Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs Separation in the Supercritical Fluid of Ozone (O3) Using Soave–Redlich–Kwong (SRK) and Pang–Robinson (PR) Equations”, Electronic J Biol 12: 4, 2016.
[34] A. Heidari, “An Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes in Nucleic Acids”, Austin J Anal Pharm Chem. 3 (1): 1058, 2016.
[35] A. Heidari, C. Brown, “Phase, Composition and Morphology Study and Analysis of Os–Pd/HfC Nanocomposites”, Nano Res Appl. 2: 1, 2016.
[36] A. Heidari, C. Brown, “Vibrational Spectroscopic Study of Intensities and Shifts of Symmetric Vibration Modes of Ozone Diluted by Cumene”, International Journal of Advanced Chemistry, 4 (1) 5–9, 2016.
[37] A. Heidari, “Study of the Role of Anti–Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues”, Arch Can Res. 4: 2, 2016.
[38] A. Heidari, “Genomics and Proteomics Studies of Zolpidem, Necopidem, Alpidem, Saripidem, Miroprofen, Zolimidine, Olprinone and Abafungin as Anti–Tumor, Peptide Antibiotics, Antiviral and Central Nervous System (CNS) Drugs”, J Data Mining Genomics & Proteomics 7: e125, 2016.
[39] A. Heidari, “Pharmacogenomics and Pharmacoproteomics Studies of Phosphodiesterase–5 (PDE5) Inhibitors and Paclitaxel Albumin–Stabilized Nanoparticles as Sandwiched Anti–Cancer Nano Drugs between Two DNA/RNA Molecules of Human Cancer Cells”, J Pharmacogenomics Pharmacoproteomics 7: e153, 2016.
[40] A. Heidari, “Biotranslational Medical and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–DNA/RNA Straight and Cycle Chain Complexes as Potent Anti–Viral, Anti–Tumor and Anti–Microbial Drugs: A Clinical Approach”, Transl Biomed. 7: 2, 2016.
[41] A. Heidari, “A Comparative Study on Simultaneous Determination and Separation of Adsorbed Cadmium Oxide (CdO) Nanoparticles on DNA/RNA of Human Cancer Cells Using Biospectroscopic Techniques and Dielectrophoresis (DEP) Method”, Arch Can Res. 4: 2, 2016.
[42] A. Heidari, “Cheminformatics and System Chemistry of Cisplatin, Carboplatin, Nedaplatin, Oxaliplatin, Heptaplatin and Lobaplatin as Anti–Cancer Nano Drugs: A Combined Computational and Experimental Study”, J Inform Data Min 1: 3, 2016.
[43] A. Heidari, “Linear and Non–Linear Quantitative Structure–Anti–Cancer–Activity Relationship (QSACAR) Study of Hydrous Ruthenium (IV) Oxide (RuO2) Nanoparticles as Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and Anti–Cancer Nano Drugs”, J Integr Oncol 5: e110, 2016.
[44] A. Heidari, “Synthesis, Characterization and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes Absence of Soluble Polymer as a Protective Agent Using Nucleic Acids Condensation and Solution Reduction Method”, J Nanosci Curr Res 1: e101, 2016.
[45] A. Heidari, “Coplanarity and Collinearity of 4’–Dinonyl–2,2’–Bithiazole in One Domain of Bleomycin and Pingyangmycin to be Responsible for Binding of Cadmium Oxide (CdO) Nanoparticles to DNA/RNA Bidentate Ligands as Anti–Tumor Nano Drug”, Int J Drug Dev & Res 8: 007–008, 2016.
[46] A. Heidari, “A Pharmacovigilance Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for the Prediction of Retention Time of Anti–Cancer Nano Drugs under Synchrotron Radiations”, J Pharmacovigil 4: e161, 2016.
[47] A. Heidari, “Nanotechnology in Preparation of Semipermeable Polymers”, J Adv Chem Eng 6: 157, 2016.
[48] A. Heidari, “A Gastrointestinal Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for Analysis 5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under Synchrotron Radiations”, J Gastrointest Dig Syst 6: e119, 2016.
[49] A. Heidari, “DNA/RNA Fragmentation and Cytolysis in Human Cancer Cells Treated with Diphthamide Nano Particles Derivatives”, Biomedical Data Mining 5: e102, 2016.
[50] A. Heidari, “A Successful Strategy for the Prediction of Solubility in the Construction of Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Using Genetic Function Approximation (GFA) Algorithm”, J Mol Biol Biotechnol 1: 1, 2016.
[51] A. Heidari, “Computational Study on Molecular Structures of C20, C60, C240, C540, C960, C2160 and C3840 Fullerene Nano Molecules under Synchrotron Radiations Using Fuzzy Logic”, J Material Sci Eng 5: 282, 2016.
[52] A. Heidari, “Graph Theoretical Analysis of Zigzag Polyhexamethylene Biguanide, Polyhexamethylene Adipamide, Polyhexamethylene Biguanide Gauze and Polyhexamethylene Biguanide Hydrochloride (PHMB) Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs)”, J Appl Computat Math 5: e143, 2016.
[53] A. Heidari, “The Impact of High Resolution Imaging on Diagnosis”, Int J Clin Med Imaging 3: 1000e101, 2016.
[54] A. Heidari, “A Comparative Study of Conformational Behavior of Isotretinoin (13–Cis Retinoic Acid) and Tretinoin (All–Trans Retinoic Acid (ATRA)) Nano Particles as Anti–Cancer Nano Drugs under Synchrotron Radiations Using Hartree–Fock (HF) and Density Functional Theory (DFT) Methods”, Insights in Biomed 1: 2, 2016.
[55] A. Heidari, “Advances in Logic, Operations and Computational Mathematics”, J Appl Computat Math 5: 5, 2016.
[56] A. Heidari, “Mathematical Equations in Predicting Physical Behavior”, J Appl Computat Math 5: 5, 2016.
[57] A. Heidari, “Chemotherapy a Last Resort for Cancer Treatment”, Chemo Open Access 5: 4, 2016.
[58] A. Heidari, “Separation and Pre–Concentration of Metal Cations–DNA/RNA Chelates Using Molecular Beam Mass Spectrometry with Tunable Vacuum Ultraviolet (VUV) Synchrotron Radiation and Various Analytical Methods”, Mass Spectrom Purif Tech 2: e101, 2016.
[59] A. Heidari, “Yoctosecond Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Studies for Prediction of Solubility of Anti–Cancer Nano Drugs in Aqueous Solutions Using Genetic Function Approximation (GFA) Algorithm”, Insight Pharm Res. 1: 1, 2016.
[60] A. Heidari, “Cancer Risk Prediction and Assessment in Human Cells under Synchrotron Radiations Using Quantitative Structure Activity Relationship (QSAR) and Quantitative Structure Properties Relationship (QSPR) Studies”, Int J Clin Med Imaging 3: 516, 2016.
[61] A. Heidari, “A Novel Approach to Biology”, Electronic J Biol 12: 4, 2016.
[62] A. Heidari, “Innovative Biomedical Equipment’s for Diagnosis and Treatment”, J Bioengineer & Biomedical Sci 6: 2, 2016.
[63] A. Heidari, “Integrating Precision Cancer Medicine into Healthcare, Medicare Reimbursement Changes and the Practice of Oncology: Trends in Oncology Medicine and Practices”, J Oncol Med & Pract 1: 2, 2016.
[64] A. Heidari, “Promoting Convergence in Biomedical and Biomaterials Sciences and Silk Proteins for Biomedical and Biomaterials Applications: An Introduction to Materials in Medicine and Bioengineering Perspectives”, J Bioengineer & Biomedical Sci 6: 3, 2016.
[65] A. Heidari, “X–Ray Fluorescence and X–Ray Diffraction Analysis on Discrete Element Modeling of Nano Powder Metallurgy Processes in Optimal Container
Design”, J Powder Metall Min 6: 1, 2017.
[66] A. Heidari, “Biomolecular Spectroscopy and Dynamics of Nano–Sized Molecules and Clusters as Cross–Linking–Induced Anti–Cancer and Immune–Oncology Nano Drugs Delivery in DNA/RNA of Human Cancer Cells’ Membranes under Synchrotron Radiations: A Payload–Based Perspective”, Arch Chem Res. 1: 2, 2017.
[67] A. Heidari, “Deficiencies in Repair of Double–Standard DNA/RNA–Binding Molecules Identified in Many Types of Solid and Liquid Tumors Oncology in Human Body for Advancing Cancer Immunotherapy Using Computer Simulations and Data Analysis: Number of Mutations in a Synchronous Tumor Varies by Age and Type of Synchronous Cancer”, J Appl Bioinforma Comput Biol, 6: 1, 2017.
[68] A. Heidari, “Electronic Coupling among the Five Nanomolecules Shuts Down Quantum Tunneling in the Presence and Absence of an Applied Magnetic Field for Indication of the Dimer or other Provide Different Influences on the Magnetic Behavior of Single Molecular Magnets (SMMs) as Qubits for Quantum Computing”, Glob J Res Rev. 4: 2, 2017.
[69] A. Heidari, “Polymorphism in Nano–Sized Graphene Ligand–Induced Transformation of Au38–xAgx/xCux(SPh–tBu)24 to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12) Nanomolecules for Synthesis of Au144–xAgx/xCux[(SR)60, (SC4)60, (SC6)60, (SC12)60, (PET)60, (p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60, (At)60, (Uus)60 and (SC6H13)60] Nano Clusters as Anti–Cancer Nano Drugs”, J Nanomater Mol Nanotechnol, 6: 3, 2017.
[70] A. Heidari, “Biomedical Resource Oncology and Data Mining to
Enable Resource Discovery in Medical, Medicinal, Clinical, Pharmaceutical,
Chemical and Translational Research and Their Applications in Cancer Research”,
Int J Biomed Data Min 6: e103, 2017.
[71] A. Heidari, “Study of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing,
Stability, Safety and Efficacy of Olympiadane Nanomolecules as Agent for
Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy,
Hormone Therapy and Targeted Therapy under Synchrotorn Radiation”, J Dev Drugs 6: e154, 2017.
[72] A. Heidari, “A Novel Approach to Future Horizon of Top Seven Biomedical Research Topics to Watch in 2017: Alzheimer's, Ebola, Hypersomnia, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Microbiome/Antibiotic Resistance and Endovascular Stroke”, J Bioengineer & Biomedical Sci 7: e127, 2017.
[73] A. Heidari, “Opinion on Computational Fluid Dynamics (CFD)
Technique”, Fluid Mech Open Acc 4: 157, 2017.
[74] A. Heidari, “Concurrent Diagnosis of Oncology Influence Outcomes in Emergency General Surgery for Colorectal Cancer and Multiple Sclerosis (MS) Treatment Using Magnetic Resonance Imaging (MRI) and Au329(SR)84, Au329–xAgx(SR)84, Au144(SR)60, Au68(SR)36, Au30(SR)18, Au102(SPh)44, Au38(SPh)24, Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24 and Au25(pMBA)18 Nano Clusters”, J Surgery Emerg Med
1: 21, 2017.
[75] A. Heidari, “Developmental Cell Biology in Adult Stem Cells Death and Autophagy to Trigger a Preventive Allergic Reaction to Common Airborne Allergens under Synchrotron Radiation Using Nanotechnology for Therapeutic Goals in Particular Allergy Shots (Immunotherapy)”, Cell Biol (Henderson, NV) 6: 1, 2017.
[76] A. Heidari, “Changing Metal Powder Characteristics for Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins Adjustment in Cancer Metastases Induced by Osteosarcoma, Chondrosarcoma, Carcinoid, Carcinoma, Ewing’s Sarcoma, Fibrosarcoma and Secondary Hematopoietic Solid or Soft Tissue Tumors”, J Powder Metall Min 6: 170, 2017.
[77] A. Heidari, “Nanomedicine–Based Combination Anti–Cancer Therapy between Nucleic Acids and Anti–Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatment of Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti–Cancer Nano Drugs and Nucleic Acids Delivery under Synchrotron Radiation”, Am J Drug Deliv 5: 2, 2017.
[78] A. Heidari, “Clinical Trials of Dendritic Cell Therapies for Cancer Exposing Vulnerabilities in Human Cancer Cells’ Metabolism and Metabolomics: New Discoveries, Unique Features Inform New Therapeutic Opportunities, Biotech's Bumpy Road to the Market and Elucidating the Biochemical Programs that Support Cancer Initiation and Progression”, J Biol Med Science 1: e103, 2017.
[79] A. Heidari, “The Design Graphene–Based Nanosheets as a New Nanomaterial in Anti–Cancer Therapy and Delivery of Chemotherapeutics and Biological Nano Drugs for Liposomal Anti–Cancer Nano Drugs and Gene Delivery”, Br Biomed Bull 5: 305, 2017.
[80] A. Heidari, “Integrative Approach to Biological Networks for Emerging Roles of Proteomics, Genomics and Transcriptomics in the Discovery and Validation of Human Colorectal Cancer Biomarkers from DNA/RNA Sequencing Data under Synchrotron Radiation”, Transcriptomics 5: e117, 2017.
[81] A. Heidari, “Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins and Cell Adhesion Intelligent Nanomolecules Adjustment in Cancer Metastases Using Metalloenzymes and under Synchrotron Radiation”, Lett Health Biol Sci 2 (2): 1–4, 2017.
[82] A. Heidari, “Treatment of Breast Cancer Brain Metastases through a Targeted Nanomolecule Drug Delivery System Based on Dopamine Functionalized Multi–Wall Carbon Nanotubes (MWCNTs) Coated with Nano Graphene Oxide (GO) and Protonated Polyaniline (PANI) in Situ During the Polymerization of Aniline Autogenic Nanoparticles for the Delivery of Anti–Cancer Nano Drugs under Synchrotron Radiation”, Br J Res, 4 (3): 16, 2017.
[83] A. Heidari, “Sedative, Analgesic and Ultrasound–Mediated Gastrointestinal Nano Drugs Delivery for Gastrointestinal Endoscopic Procedure, Nano Drug–Induced Gastrointestinal Disorders and Nano Drug Treatment of Gastric Acidity”, Res Rep Gastroenterol, 1: 1, 2017.
[84] A. Heidari, “Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Orphan Nano Drugs to Treat High Cholesterol and Related Conditions and to Prevent Cardiovascular Disease under Synchrotron Radiation”, J Pharm Sci Emerg Drugs 5: 1, 2017.
[85] A. Heidari, “Non–Linear Compact Proton Synchrotrons to Improve Human Cancer Cells and Tissues Treatments and Diagnostics through Particle Therapy Accelerators with Monochromatic Microbeams”, J Cell Biol Mol Sci 2 (1): 1–5, 2017.
[86] A. Heidari, “Design of Targeted Metal Chelation Therapeutics Nanocapsules as Colloidal Carriers and Blood–Brain Barrier (BBB) Translocation to Targeted Deliver Anti–Cancer Nano Drugs into the Human Brain to Treat Alzheimer’s Disease under Synchrotron Radiation”, J Nanotechnol Material Sci 4 (2): 1–5, 2017.
[87] R. Gobato, A. Heidari, “Calculations Using Quantum Chemistry for Inorganic Molecule Simulation BeLi2SeSi”, Science Journal of Analytical Chemistry, Vol. 5, No. 6, Pages 76–85, 2017.
[88] A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Lung Cancer Translational Anti–Cancer Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Med Oncol. Vol. 1 No. 1: 1, 2017.
[89] A. Heidari, “A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiation”, Am J Ethnomed, Vol. 4 No. 1: 10, 2017.
[90] A. Heidari, “Active Targeted Nanoparticles for Anti–Cancer Nano Drugs Delivery across the Blood–Brain Barrier for Human Brain Cancer Treatment, Multiple Sclerosis (MS) and Alzheimer's Diseases Using Chemical Modifications of Anti–Cancer Nano Drugs or Drug–Nanoparticles through Zika Virus (ZIKV) Nanocarriers under Synchrotron Radiation”, J Med Chem Toxicol, 2 (3): 1–5, 2017.
[91] A. Heidari, “Investigation of Medical, Medicinal, Clinical and Pharmaceutical Applications of Estradiol, Mestranol (Norlutin), Norethindrone (NET), Norethisterone Acetate (NETA), Norethisterone Enanthate (NETE) and Testosterone Nanoparticles as Biological Imaging, Cell Labeling, Anti–Microbial Agents and Anti–Cancer Nano Drugs in Nanomedicines Based Drug Delivery Systems for Anti–Cancer Targeting and Treatment”, Parana Journal of Science and Education (PJSE)–v.3, n.4, (10–19) October 12, 2017.
[92] A. Heidari, “A Comparative Computational and Experimental Study on Different Vibrational Biospectroscopy Methods, Techniques and Applications for Human Cancer Cells in Tumor Tissues Simulation, Modeling, Research, Diagnosis and Treatment”, Open J Anal Bioanal Chem 1 (1): 014–020, 2017.
[93] A. Heidari, “Combination of DNA/RNA Ligands and Linear/Non–Linear Visible–Synchrotron Radiation–Driven N–Doped Ordered Mesoporous Cadmium Oxide (CdO) Nanoparticles Photocatalysts Channels Resulted in an Interesting Synergistic Effect Enhancing Catalytic Anti–Cancer Activity”, Enz Eng 6: 1, 2017.
[94] A. Heidari, “Modern Approaches in Designing Ferritin, Ferritin Light Chain, Transferrin, Beta–2 Transferrin and Bacterioferritin–Based Anti–Cancer Nano Drugs Encapsulating Nanosphere as DNA–Binding Proteins from Starved Cells (DPS)”, Mod Appro Drug Des. 1 (1). MADD.000504. 2017.
[95] A. Heidari, “Potency of Human Interferon β–1a and Human Interferon β–1b in Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy of Encephalomyelitis Disseminate/Multiple Sclerosis (MS) and Hepatitis A, B, C, D, E, F and G Virus Enter and Targets Liver Cells”, J Proteomics Enzymol 6: 1, 2017.
[96] A. Heidari, “Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti–Cancer Nanodrugs Delivery across the Blood–Brain Barrier (BBB) to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiation”, J Pharm Pharmaceutics 4 (2): 1–5, 2017.
[97] A. Heidari, C. Brown, “Combinatorial Therapeutic Approaches to DNA/RNA and Benzylpenicillin (Penicillin G), Fluoxetine Hydrochloride (Prozac and Sarafem), Propofol (Diprivan), Acetylsalicylic Acid (ASA) (Aspirin), Naproxen Sodium (Aleve and Naprosyn) and Dextromethamphetamine Nanocapsules with Surface Conjugated DNA/RNA to Targeted Nano Drugs for Enhanced Anti–Cancer Efficacy and Targeted Cancer Therapy Using Nano Drugs Delivery Systems”, Ann Adv Chem. 1 (2): 061–069, 2017.
[98] A. Heidari, “High–Resolution Simulations of Human Brain Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron Radiation”, J Transl Res. 1 (1): 1–3, 2017.
[99] A. Heidari, “Investigation of Anti–Cancer Nano Drugs’ Effects’ Trend on Human Pancreas Cancer Cells and Tissues Prevention, Diagnosis and Treatment Process under Synchrotron and X–Ray Radiations with the Passage of Time Using Mathematica”, Current Trends Anal Bioanal Chem, 1 (1): 36–41, 2017.
[100] A. Heidari, “Pros and Cons Controversy on Molecular Imaging and Dynamics of Double–Standard DNA/RNA of Human Preserving Stem Cells–Binding Nano Molecules with Androgens/Anabolic Steroids (AAS) or Testosterone Derivatives through Tracking of Helium–4 Nucleus (Alpha Particle) Using Synchrotron Radiation”, Arch Biotechnol Biomed. 1 (1): 067–0100, 2017.
[101] A. Heidari, “Visualizing Metabolic Changes in Probing Human Cancer Cells and Tissues Metabolism Using Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy and Self–Organizing Maps under Synchrotron Radiation”, SOJ Mater Sci Eng 5 (2): 1–6, 2017.
[102] A. Heidari, “Cavity Ring–Down Spectroscopy (CRDS), Circular Dichroism Spectroscopy, Cold Vapour Atomic Fluorescence Spectroscopy and Correlation Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Challenges Cancer Detect Ther 4 (2): e001, 2017.
[103] A. Heidari, “Laser Spectroscopy, Laser–Induced Breakdown Spectroscopy and Laser–Induced Plasma Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Hepatol Gastroenterol, 3 (4): 079–084, 2017.
[104] A. Heidari, “Time–Resolved Spectroscopy and Time–Stretch Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Enliven: Pharmacovigilance and Drug Safety 4 (2): e001, 2017.
[105] A. Heidari, “Overview of the Role of Vitamins in Reducing Negative Effect of Decapeptyl (Triptorelin Acetate or Pamoate Salts) on Prostate Cancer Cells and Tissues in Prostate Cancer Treatment Process through Transformation of Malignant Prostate Tumors into Benign Prostate Tumors under Synchrotron Radiation”, Open J Anal Bioanal Chem 1 (1): 021–026, 2017.
[106] A. Heidari, “Electron Phenomenological Spectroscopy, Electron Paramagnetic Resonance (EPR) Spectroscopy and Electron Spin Resonance (ESR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Austin J Anal Pharm Chem. 4 (3): 1091, 2017.
[107] A. Heidari, “Therapeutic Nanomedicine Different High–Resolution Experimental Images and Computational Simulations for Human Brain Cancer Cells and Tissues Using Nanocarriers Deliver DNA/RNA to Brain Tumors under Synchrotron Radiation with the Passage of Time Using Mathematica and MATLAB”, Madridge J Nano Tech. Sci. 2 (2): 77–83, 2017.
[108] A. Heidari, “A Consensus and Prospective Study on Restoring Cadmium Oxide (CdO) Nanoparticles Sensitivity in Recurrent Ovarian Cancer by Extending the Cadmium Oxide (CdO) Nanoparticles–Free Interval Using Synchrotron Radiation Therapy as Antibody–Drug Conjugate for the Treatment of Limited–Stage Small Cell Diverse Epithelial Cancers”, Cancer Clin Res Rep, 1: 2, e001, 2017.
[109] A. Heidari, “A Novel and Modern Experimental Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White Synchrotron Radiation”, Cancer Sci Res Open Access 4 (2): 1–8, 2017.
[110] A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Breast Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”, J Oral Cancer Res 1 (1): 12–17, 2017.
[111] A. Heidari, “Vibrational Decihertz (dHz), Centihertz (cHz), Millihertz (mHz), Microhertz (μHz), Nanohertz (nHz), Picohertz (pHz), Femtohertz (fHz), Attohertz (aHz), Zeptohertz (zHz) and Yoctohertz (yHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, International Journal of Biomedicine, 7 (4), 335–340, 2017.
[112] A. Heidari, “Force Spectroscopy and Fluorescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, EC Cancer, 2 (5), 239–246, 2017.
[113] A. Heidari, “Photoacoustic Spectroscopy, Photoemission Spectroscopy and Photothermal Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, BAOJ Cancer Res Ther, 3: 3, 045–052, 2017.
[114] A. Heidari, “J–Spectroscopy, Exchange Spectroscopy (EXSY), Nucle¬ar Overhauser Effect Spectroscopy (NOESY) and Total Correlation Spectroscopy (TOCSY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Eng Sci J, 1 (2): 006–013, 2017.
[115] A. Heidari, “Neutron Spin Echo Spectroscopy and Spin Noise Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Biopharm Sci, 1: 103–107, 2017.
[116] A. Heidari, “Vibrational Decahertz (daHz), Hectohertz (hHz), Kilohertz (kHz), Megahertz (MHz), Gigahertz (GHz), Terahertz (THz), Petahertz (PHz), Exahertz (EHz), Zettahertz (ZHz) and Yottahertz (YHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Madridge J Anal Sci Instrum, 2 (1): 41–46, 2017.
[117] A. Heidari, “Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy and Non–Linear Two–Dimensional Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, J Mater Sci Nanotechnol 6 (1): 101, 2018.
[118] A. Heidari, “Fourier Transform Infrared (FTIR) Spectroscopy, Near–Infrared Spectroscopy (NIRS) and Mid–Infrared Spectroscopy (MIRS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Int J Nanotechnol Nanomed, Volume 3, Issue 1, Pages 1–6, 2018.
[119] A. Heidari, “Infrared Photo Dissociation Spectroscopy and Infrared Correlation Table Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Austin Pharmacol Pharm, 3 (1): 1011, 2018.
[120] A. Heidari, “Novel and Transcendental Prevention, Diagnosis and Treatment Strategies for Investigation of Interaction among Human Blood Cancer Cells, Tissues, Tumors and Metastases with Synchrotron Radiation under Anti–Cancer Nano Drugs Delivery Efficacy Using MATLAB Modeling and Simulation”, Madridge J Nov Drug Res, 1 (1): 18–24, 2017.
[121] A. Heidari, “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Open Access J Trans Med Res, 2 (1): 00026–00032, 2018.
[122] M. R. R. Gobato, R. Gobato, A. Heidari, “Planting of Jaboticaba Trees for Landscape Repair of Degraded Area”, Landscape Architecture and Regional Planning, Vol. 3, No. 1, 2018, Pages 1–9, 2018.
[123] A. Heidari, “Fluorescence Spectroscopy, Phosphorescence Spectroscopy and Luminescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, SM J Clin. Med. Imaging, 4 (1): 1018, 2018.
[124] A. Heidari, “Nuclear Inelastic Scattering Spectroscopy (NISS) and Nuclear Inelastic Absorption Spectroscopy (NIAS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Pharm Sci, 2 (1): 1–14, 2018.
[125] A. Heidari, “X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Oncol Res; 2 (1): 1–14, 2018.
[126] A. Heidari, “Correlation Two–Dimensional Nuclear Magnetic Reso¬nance (NMR) (2D–NMR) (COSY) Imaging and Spectrosco¬py Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Can Sci, 1–1–001, 2018.
[127] A. Heidari, “Thermal Spectroscopy, Photothermal Spectroscopy, Thermal Microspectroscopy, Photothermal Microspectroscopy, Thermal Macrospectroscopy and Photothermal Macrospectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, SM J Biometrics Biostat, 3 (1): 1024, 2018.

[128] A. Heidari, “A Modern and Comprehensive Experimental Biospectroscopic Comparative Study on Human Common Cancers’ Cells, Tissues and Tumors before and after Synchrotron Radiation Therapy”, Open Acc J Oncol Med. 1 (1), 2018.

[129] A. Heidari, “Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Endocrinology and Thyroid Cancer Cells and Tissues under Synchrotron Radiation”, J Endocrinol Thyroid Res, 3 (1): 555603, 2018.

[130] A. Heidari, “Nuclear Resonance Vibrational Spectroscopy (NRVS), Nuclear Inelastic Scattering Spectroscopy (NISS), Nuclear Inelastic Absorption Spectroscopy (NIAS) and Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (1e): 1–5, 2018.

[131] A. Heidari, “A Novel and Modern Experimental Approach to Vibrational Circular Dichroism Spectroscopy and Video Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White and Monochromatic Synchrotron Radiation”, Glob J Endocrinol Metab. 1 (3). GJEM. 000514–000519, 2018.

[132] A. Heidari, “Pros and Cons Controversy on Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, EMS Pharma J. 1 (1): 002–008, 2018.

[133] A. Heidari, “A Modern Comparative and Comprehensive Experimental Biospectroscopic Study on Different Types of Infrared Spectroscopy of Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, J Analyt Molecul Tech. 3 (1): 8, 2018.

[134] A. Heidari, “Investigation of Cancer Types Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, European Modern Studies Journal, Vol. 2, No. 1, 13–29, 2018.
[135] A. Heidari, “Saturated Spectroscopy and Unsaturated Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Imaging J Clin Medical Sci. 5 (1): 001–007, 2018.
[136] A. Heidari, “Small–Angle Neutron Scattering (SANS) and Wide–Angle X–Ray Diffraction (WAXD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Int J Bioorg Chem Mol Biol. 6 (2e): 1–6, 2018.
[137] A. Heidari, “Investigation of Bladder Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver, Lung Cancer, Melanoma, Non–Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer and Non–Melanoma Skin Cancer Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Study”, Ther Res Skin Dis 1 (1), 2018.
[138] A. Heidari, “Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy and Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, International Journal of Chemistry Papers, 2 (1): 1–12, 2018.
[139] A. Heidari, “Mössbauer Spectroscopy, Mössbauer Emission Spectroscopy and 57Fe Mössbauer Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Acta Scientific Cancer Biology 2.3: 17–20, 2018.
[140] A. Heidari, “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Organic & Medicinal Chem IJ. 6 (1): 555676, 2018.
[141] A. Heidari, “Correlation Spectroscopy, Exclusive Correlation Spectroscopy and Total Correlation Spectroscopy Comparative Study on Malignant and Benign Human AIDS–Related Cancers Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Int J Bioanal Biomed. 2 (1): 001–007, 2018.
[142] A. Heidari, “Biomedical Instrumentation and Applications of Biospectroscopic Methods and Techniques in Malignant and Benign Human Cancer Cells and Tissues Studies under Synchrotron Radiation and Anti–Cancer Nano Drugs Delivery”, Am J Nanotechnol Nanomed. 1 (1): 001–009, 2018.
[143] A. Heidari, “Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Ann Biomet Biostat. 1 (1): 1001, 2018.
[144] A. Heidari, “Grazing–Incidence Small–Angle Neutron Scattering (GISANS) and Grazing–Incidence X–Ray Diffraction (GIXD) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron Radiation”, Ann Cardiovasc Surg. 1 (2): 1006, 2018.
[145] A. Heidari, “Adsorption Isotherms and Kinetics of Multi–Walled Carbon Nanotubes (MWCNTs), Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) for Eliminating Carcinoma, Sarcoma, Lymphoma, Leukemia, Germ Cell Tumor and Blastoma Cancer Cells and Tissues”, Clin Med Rev Case Rep 5: 201, 2018.
[146] A. Heidari, “Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC), Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Acta Scientific Pharmaceutical Sciences 2.5: 30–35, 2018.
[147] A. Heidari, “Small–Angle X–Ray Scattering (SAXS), Ultra–Small Angle X–Ray Scattering (USAXS), Fluctuation X–Ray Scattering (FXS), Wide–Angle X–Ray Scattering (WAXS), Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS), Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS), Small–Angle Neutron Scattering (SANS), Grazing–Incidence Small–Angle Neutron Scattering (GISANS), X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD), Wide–Angle X–Ray Diffraction (WAXD), Grazing–Incidence X–Ray Diffraction (GIXD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Oncol Res Rev, Volume 1 (1): 1–10, 2018.
[148] A. Heidari, “Pump–Probe Spectroscopy and Transient Grating Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Adv Material Sci Engg, Volume 2, Issue 1, Pages 1–7, 2018.
[149] A. Heidari, “Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS) and Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Insights Pharmacol Pharm Sci 1 (1): 1–8, 2018.
[150] A. Heidari, “Acoustic Spectroscopy, Acoustic Resonance Spectroscopy and Auger Spectroscopy Comparative Study on Anti–Cancer Nano Drugs Delivery in Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Nanosci Technol 5 (1): 1–9, 2018.
[151] A. Heidari, “Niobium, Technetium, Ruthenium, Rhodium, Hafnium, Rhenium, Osmium and Iridium Ions Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Nanomed Nanotechnol, 3 (2): 000138, 2018.
[152] A. Heidari, “Homonuclear Correlation Experiments such as Homonuclear Single–Quantum Correlation Spectroscopy (HSQC), Homonuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Homonuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Austin J Proteomics Bioinform & Genomics. 5 (1): 1024, 2018.
[153] A. Heidari, “Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy and Nuclear Resonance Vibrational Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, J Appl Biotechnol Bioeng. 5 (3): 142‒148, 2018.
[154] A. Heidari, “Time–Dependent Vibrational Spectral Analysis of Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, J Cancer Oncol, 2 (2): 000124, 2018.
[155] A. Heidari, “Palauamine and Olympiadane Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Arc Org Inorg Chem Sci 3 (1), 2018.
[156] R. Gobato, A. Heidari, “Infrared Spectrum and Sites of Action of Sanguinarine by Molecular Mechanics and ab initio Methods”, International Journal of Atmospheric and Oceanic Sciences. Vol. 2, No. 1, pp. 1–9, 2018.
[157] A. Heidari, “Angelic Acid, Diabolic Acids, Draculin and Miraculin Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment Under Synchrotron and Synchrocyclotron Radiations”, Med & Analy Chem Int J, 2 (1): 000111, 2018.
[158] A. Heidari, “Gamma Linolenic Methyl Ester, 5–Heptadeca–5,8,11–Trienyl 1,3,4–Oxadiazole–2–Thiol, Sulphoquinovosyl Diacyl Glycerol, Ruscogenin, Nocturnoside B, Protodioscine B, Parquisoside–B, Leiocarposide, Narangenin, 7–Methoxy Hespertin, Lupeol, Rosemariquinone, Rosmanol and Rosemadiol Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Int J Pharma Anal Acta, 2 (1): 007–014, 2018.
[159] A. Heidari, “Fourier Transform Infrared (FTIR) Spectroscopy, Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy, Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy, Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy, Non–Linear Two–Dimensional Infrared Spectroscopy, Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy, Infrared Photodissociation Spectroscopy, Infrared Correlation Table Spectroscopy, Near–Infrared Spectroscopy (NIRS), Mid–Infrared Spectroscopy (MIRS), Nuclear Resonance Vibrational Spectroscopy, Thermal Infrared Spectroscopy and Photothermal Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (2): 1–14, 2018.
[160] A. Heidari, “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiations”, Chronicle of Medicine and Surgery 2.3: 144–156, 2018.
[161] A. Heidari, “Tetrakis [3, 5–bis (Trifluoromethyl) Phenyl] Borate (BARF)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Medical Research and Clinical Case Reports 2.1: 113–126, 2018.
[162] A. Heidari, “Sydnone, Münchnone, Montréalone, Mogone, Montelukast, Quebecol and Palau’amine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Sur Cas Stud Op Acc J. 1 (3), 2018.
[163] A. Heidari, “Fornacite, Orotic Acid, Rhamnetin, Sodium Ethyl Xanthate (SEX) and Spermine (Spermidine or Polyamine) Nanomolecules Incorporation into the Nanopolymeric Matrix (NPM)”, International Journal of Biochemistry and Biomolecules, Vol. 4: Issue 1, Pages 1–19, 2018.
[164] A. Heidari, R. Gobato, “Putrescine, Cadaverine, Spermine and Spermidine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Parana Journal of Science and Education (PJSE)–v.4, n.5, (1–14) July 1, 2018.
[165] A. Heidari, “Cadaverine (1,5–Pentanediamine or Pentamethylenediamine), Diethyl Azodicarboxylate (DEAD or DEADCAT) and Putrescine (Tetramethylenediamine) Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Hiv and Sexual Health Open Access Open Journal. 1 (1): 4–11, 2018.
[166] A. Heidari, “Improving the Performance of Nano–Endofullerenes in Polyaniline Nanostructure–Based Biosensors by Covering Californium Colloidal Nanoparticles with Multi–Walled Carbon Nanotubes”, Journal of Advances in Nanomaterials, Vol. 3, No. 1, Pages 1–28, 2018.
[167] R. Gobato, A. Heidari, “Molecular Mechanics and Quantum Chemical Study on Sites of Action of Sanguinarine Using Vibrational Spectroscopy Based on Molecular Mechanics and Quantum Chemical Calculations”, Malaysian Journal of Chemistry, Vol. 20 (1), 1–23, 2018.
[168] A. Heidari, “Vibrational Biospectroscopic Studies on Anti–cancer Nanopharmaceuticals (Part I)”, Malaysian Journal of Chemistry, Vol. 20 (1), 33–73, 2018.
[169] A. Heidari, “Vibrational Biospectroscopic Studies on Anti–cancer Nanopharmaceuticals (Part II)”, Malaysian Journal of Chemistry, Vol. 20 (1), 74–117, 2018.
[170] A. Heidari, “Uranocene (U(C8H8)2) and Bis(Cyclooctatetraene)Iron (Fe(C8H8)2 or Fe(COT)2)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Chemistry Reports, Vol. 1, Iss. 2, Pages 1–16, 2018.
[171] A. Heidari, “Biomedical Systematic and Emerging Technological Study on Human Malignant and Benign Cancer Cells and Tissues Biospectroscopic Analysis under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (3): 1–7, 2018.
[172] A. Heidari, “Deep–Level Transient Spectroscopy and X–Ray Photoelectron Spectroscopy (XPS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Res Dev Material Sci. 7(2). RDMS.000659, 2018.
[173] A. Heidari, “C70–Carboxyfullerenes Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (3): 1–7, 2018.
[174] A. Heidari, “The Effect of Temperature on Cadmium Oxide (CdO) Nanoparticles Produced by Synchrotron Radiation in the Human Cancer Cells, Tissues and Tumors”, International Journal of Advanced Chemistry, 6 (2) 140–156, 2018.
[175] A. Heidari, “A Clinical and Molecular Pathology Investigation of Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiations Using Cyclotron versus Synchrotron, Synchrocyclotron and the Large Hadron Collider (LHC) for Delivery of Proton and Helium Ion (Charged Particle) Beams for Oncology Radiotherapy”, European Journal of Advances in Engineering and Technology, 5 (7): 414–426, 2018.
[176] A. Heidari, “Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, J Oncol Res; 1 (1): 1–20, 2018.
[177] A. Heidari, “Use of Molecular Enzymes in the Treatment of Chronic Disorders”, Canc Oncol Open Access J. 1 (1): 12–15, 2018.
[178] A. Heidari, “Vibrational Biospectroscopic Study and Chemical Structure Analysis of Unsaturated Polyamides Nanoparticles as Anti–Cancer Polymeric Nanomedicines Using Synchrotron Radiation”, International Journal of Advanced Chemistry, 6 (2), 167–189, 2018.
[179] A. Heidari, “Adamantane, Irene, Naftazone and Pyridine–Enhanced Precatalyst Preparation Stabilization and Initiation (PEPPSI) Nano Molecules”, Madridge J Nov Drug Res. 2 (1): 61–67, 2018.
[180] A. Heidari, “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Madridge J Nov Drug Res, 2 (1): 68–74, 2018.
[181] A. Heidari, R. Gobato, “A Novel Approach to Reduce Toxicities and to Improve Bioavailabilities of DNA/RNA of Human Cancer Cells–Containing Cocaine (Coke), Lysergide (Lysergic Acid Diethyl Amide or LSD), Δ⁹–Tetrahydrocannabinol (THC) [(–)–trans–Δ⁹–Tetrahydrocannabinol], Theobromine (Xantheose), Caffeine, Aspartame (APM) (NutraSweet) and Zidovudine (ZDV) [Azidothymidine (AZT)] as Anti–Cancer Nano Drugs by Coassembly of Dual Anti–Cancer Nano Drugs to Inhibit DNA/RNA of Human Cancer Cells Drug Resistance”, Parana Journal of Science and Education, v. 4, n. 6, pp. 1–17, 2018.
[182] A. Heidari, R. Gobato, “Ultraviolet Photoelectron Spectroscopy (UPS) and Ultraviolet–Visible (UV–Vis) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Parana Journal of Science and Education, v. 4, n. 6, pp. 18–33, 2018.
[183] R. Gobato, A. Heidari, A. Mitra, “The Creation of C13H20BeLi2SeSi. The Proposal of a Bio–Inorganic Molecule, Using Ab Initio Methods for the Genesis of a Nano Membrane”, Arc Org Inorg Chem Sci 3 (4). AOICS.MS.ID.000167, 2018.
[184] R. Gobato, A. Heidari, A. Mitra, “Using the Quantum Chemistry for Genesis of a Nano Biomembrane with a Combination of the Elements Be, Li, Se, Si, C and H”, ResearchGate, See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/326201181, 2018.
[185] R. Gobato, A. Heidari, “Using the Quantum Chemistry for Genesis of a Nano Biomembrane with a Combination of the Elements Be, Li, Se, Si, C and H”, J Nanomed Res.7 (4): 241‒252, 2018.
[186] A. Heidari, “Bastadins and Bastaranes–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Glob Imaging Insights, Volume 3 (4): 1–7, 2018.
[187] A. Heidari, “Fucitol, Pterodactyladiene, DEAD or DEADCAT (DiEthyl AzoDiCArboxylaTe), Skatole, the NanoPutians, Thebacon, Pikachurin, Tie Fighter, Spermidine and Mirasorvone Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (4): 1–8, 2018.
[188] E. Dadvar, A. Heidari, “A Review on Separation Techniques of Graphene Oxide (GO)/Base on Hybrid Polymer Membranes for Eradication of Dyes and Oil Compounds: Recent Progress in Graphene Oxide (GO)/Base on Polymer Membranes–Related Nanotechnologies”, Clin Med Rev Case Rep 5: 228, 2018.
[189] A. Heidari, R. Gobato, “First–Time Simulation of Deoxyuridine Monophosphate (dUMP) (Deoxyuridylic Acid or Deoxyuridylate) and Vomitoxin (Deoxynivalenol (DON)) ((3α,7α)–3,7,15–Trihydroxy–12,13–Epoxytrichothec–9–En–8–One)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Parana Journal of Science and Education, Vol. 4, No. 6, pp. 46–67, 2018.
[190] A. Heidari, “Buckminsterfullerene (Fullerene), Bullvalene, Dickite and Josiphos Ligands Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Hematology and Thromboembolic Diseases Prevention, Diagnosis and Treatment under Synchrotron and Synchrocyclotron Radiations”, Glob Imaging Insights, Volume 3 (4): 1–7, 2018.
[191] A. Heidari, “Fluctuation X–Ray Scattering (FXS) and Wide–Angle X–Ray Scattering (WAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (4): 1–7, 2018.
[192] A. Heidari, “A Novel Approach to Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC), Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–9, 2018.
[193] A. Heidari, “Terphenyl–Based Reversible Receptor with Rhodamine, Rhodamine–Based Molecular Probe, Rhodamine–Based Using the Spirolactam Ring Opening, Rhodamine B with Ferrocene Substituent, Calix[4]Arene–Based Receptor, Thioether + Aniline–Derived Ligand Framework Linked to a Fluorescein Platform, Mercuryfluor–1 (Flourescent Probe), N,N’–Dibenzyl–1,4,10,13–Tetraraoxa–7,16–Diazacyclooctadecane and Terphenyl–Based Reversible Receptor with Pyrene and Quinoline as the Fluorophores–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Glob Imaging Insights, Volume 3 (5): 1–9, 2018.
[194] A. Heidari, “Small–Angle X–Ray Scattering (SAXS), Ultra–Small Angle X–Ray Scattering (USAXS), Fluctuation X–Ray Scattering (FXS), Wide–Angle X–Ray Scattering (WAXS), Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS), Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS), Small–Angle Neutron Scattering (SANS), Grazing–Incidence Small–Angle Neutron Scattering (GISANS), X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD), Wide–Angle X–Ray Diffraction (WAXD), Grazing– Incidence X–Ray Diffraction (GIXD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–10, 2018.
[195] A. Heidari, “Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS) and Nuclear Resonance Vibrational Spectroscopy (NRVS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–7, 2018.
[196] A. Heidari, “Small–Angle X–Ray Scattering (SAXS) and Ultra–Small Angle X–Ray Scattering (USAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (5): 1–7, 2018.
[197] A. Heidari, “Curious Chloride (CmCl3) and Titanic Chloride (TiCl4)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules for Cancer Treatment and Cellular Therapeutics”, J. Cancer Research and Therapeutic Interventions, Volume 1, Issue 1, Pages 01–10, 2018.
[198] R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Spectroscopy and Dipole Moment of the Molecule C13H20BeLi2SeSi via Quantum Chemistry Using Ab Initio, Hartree–Fock Method in the Base Set CC–pVTZ and 6–311G**(3df, 3pd)”, Arc Org Inorg Chem Sci 3 (5), Pages 402–409, 2018.
[199] A. Heidari, “C60 and C70–Encapsulating Carbon Nanotubes Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations”, Integr Mol Med, Volume 5 (3): 1–8, 2018.
[200] A. Heidari, “Two–Dimensional (2D) 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (6): 1–8, 2018.
[201] A. Heidari, “FT–Raman Spectroscopy, Coherent Anti–Stokes Raman Spectroscopy (CARS) and Raman Optical Activity Spectroscopy (ROAS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018.
[202] A. Heidari, “A Modern and Comprehensive Investigation of Inelastic Electron Tunneling Spectroscopy (IETS) and Scanning Tunneling Spectroscopy on Malignant and Benign Human Cancer Cells, Tissues and Tumors through Optimizing Synchrotron Microbeam Radiotherapy for Human Cancer Treatments and Diagnostics: An Experimental Biospectroscopic Comparative Study”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018.
[203] A. Heidari, “A Hypertension Approach to Thermal Infrared Spectroscopy and Photothermal Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018.
[204] A. Heidari, “Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE), Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018.
[205] A. Heidari, “2–Amino–9–((1S, 3R, 4R)–4–Hydroxy–3–(Hydroxymethyl)–2–Methylenecyclopentyl)–1H–Purin–6(9H)–One, 2–Amino–9–((1R, 3R, 4R)–4–Hydroxy–3–(Hydroxymethyl)–2–Methylenecyclopentyl)–1H–Purin–6(9H)–One, 2–Amino–9–((1R, 3R, 4S)–4–Hydroxy–3–(Hydroxymethyl)–2–Methylenecyclopentyl)–1H–Purin–6(9H)–One and 2–Amino–9–((1S, 3R, 4S)–4–Hydroxy–3–(Hydroxymethyl)–2–Methylenecyclopentyl)–1H–Purin–6(9H)–One–Enhanced Precatalyst Preparation Stabilization and Initiation Nano Molecules”, Glob Imaging Insights, Volume 3 (6): 1–9. 2018.
[206] R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Spectroscopy and Dipole Moment of the Molecule C13H20BeLi2SeSi via Quantum Chemistry Using Ab Initio, Hartree–Fock Method in the Base Set CC–pVTZ and 6–311G**(3df, 3pd)”, American Journal of Quantum Chemistry and Molecular Spectroscopy, Vol. 2, No. 1, pp. 9–17, 2018.
[207] A. Heidari, “Production of Electrochemiluminescence (ECL) Biosensor Using Os–Pd/HfC Nanocomposites for Detecting and Tracking of Human Gastroenterological Cancer Cells, Tissues and Tumors”, Int J Med Nano Res 5: 1, 022–034, 2018.
[208] A. Heidari, “Enhancing the Raman Scattering for Diagnosis and Treatment of Human Cancer Cells, Tissues and Tumors Using Cadmium Oxide (CdO) Nanoparticles”, J Toxicol Risk Assess 4: 1, 012–025, 2018.
[209] A. Heidari, “Human Malignant and Benign Human Cancer Cells and Tissues Biospectroscopic Analysis under Synchrotron Radiation Using Anti–Cancer Nano Drugs Delivery”, Integr Mol Med, Volume 5 (5): 1–13, 2018.
[210] A. Heidari, “Analogous Nano Compounds of the Form M(C8H8)2 Exist for M = (Nd, Tb, Pu, Pa, Np, Th, and Yb)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules”, Integr Mol Med, Volume 5 (5): 1–8, 2018.
[211] A. Heidari, “Hadron Spectroscopy, Baryon Spectroscopy and Meson Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation”, Integr Mol Med, Volume 5 (5): 1–8, 2018.

Obeagu, Emmanuel Ifeanyi

Research Scientist Medical Laboratory Science, Health Services Michael Okpara University of Agriculture Umudike, Nigeria
Emmanuel Ifeanyi Obeagu is one of Medicine's leading celebrities, known for leadership skills and breakthrough research potential. Emmanuel Ifeanyi Obeagu starred in Medicine. Emmanuel Ifeanyi Obeagu is working in Diagnostic Laboratory Unit, Department of University Health Services, Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. He was born in Amede, Eha- Amufu, Enugu State, Nigeria and is pursuing his Ph.D. in Haematology, received his M.Sc in Haematology in Imo State University, Owerri. He attained Bachelor of Medical Laboratory Science in Ebonyi State University, Abakaliki, Nigeria.
Emmanuel Ifeanyi Obeagu received 2 international research awards in 2017 as World Academic Champion in Medicine and Fellow, Directorate of Medicine, IASR, World Academic Champion in Diagnostics and Fellow, Directorate of Diagnostics, IASR. He received 2018 Best Editor award by Annals of Clinical and Laboratory Research. He was included among world 500 most influential public health experts on earth 2017 and included among Global Infectious Diseases Control Experts. He equally received more than 90 International awards and recognition He is a research-oriented person. He has published more than 400 researches and review published papers and invited and reviewed more than 500 papers in reputable international journals and editor and reviewer to more than 140 International Journals. He was promoted to Editor-in-Chief of Journal of Biomedical Research and Review on 4th September 2018. He attended as a delegate, plenary speaker, keynote speaker and organizing committee member of international conferences. He is an eminent scholar and a researcher. He is a prolific writer and has a very high research gate score.
Emmanuel Ifeanyi Obeagu research interests include Haematology and Blood Transfusion, Immunology, and Public Health. He has been enlightening the world with his scientific contributions.
AWARDS/ACHIECEMENTS/ RECOGNITIONS
1. Best Graduating Student, Department of Physical and Health Education, Federal College of Education, Eha-Amufu 2003
2. Champion of World Academic Championship 2017 in Medicine by International Agency for Standards and Ratings 28th Sep., 2017
3. Champion of World Academic Championship 2017 in Diagnostics by International Agency for Standards and Ratings 1st Dec., 2017
4. Included among Global Infectious Diseases Control Experts Feb., 2018-03-23
5. 2018 Award of Certificate of Excellence in Reviewing by Microbiology Research Journal International (Sciencedomain International) March, 2018-03-23
6. 2018 Award of Certificate of Excellence in Reviewing by Annual Research and Review in Biology (Sciencedomain International)
7. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Medical Principles and Clinical Practice (Sciencedomain International) March, 2018-03-30
8. An Organising Committee Member of World Obesity Congress, Osaka, Japan July 23-24, 2018
9. An Organising Committee Member of World Congress on Clinical and Medical Microbiology Dublin, Ireland September 10-11, 2018
10. Included Among 500 Most Influential Public Health Experts on Earth, 2017 by IASR.
11. 2018 Award of Certificate of Excellence in Reviewing by South Asian Journal of Research in Microbiology.
12. 2018 Award of Certificate of Excellence in Reviewing by South Asian Journal of Parasitology.
13. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal Research in Medical and Pharmaceutical Sciences.
14. 2018 Award of Certificate of Excellence in Reviewing by Journal of Complementary and Alternative Medical Research (28/4/2018)
15. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Pathogen Research (28/4/2018).
16. 2017 Award of Excellence in Reviewing by Asian Journal of Medicine and Health (May 2018)
17. 2018 Award of Certificate of Excellence in Reviewing by Journal of Biochemistry Research and Review (May 2018)
18. 2018 Award of Certificate of Excellence in Reviewing by South Asian Research Journal of Natural Products (June 2018).
19. Publons: Merit Score of 2893, 488 verified reviews, 98th percentile of members in the World.
20. Researchgate: RG Score of 35.19, Higher than 92.5% researchgate members in the World, 281 recommendations, 209 citations, 54,352 reads, 174 followers, h-index 5
21. Google Scholar: 220 citations, h-index 6, i 10 index 2
22. 2018 Award of Certificate of Excellence in Reviewing by Journal of Pharmaceutical Research International (28/6/2018)
23. 2018 Award of Certificate of Excellence in Reviewing by Microbiology Research Journal International (29/6/2018)
30. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Tropical Disease and Health (30/6/2018).
31. Among World’s 500 most Influential Experts in Diagnostics for the year 2017 on Earth.
32. 2018 Award of Certificate of Excellence in Reviewing by Journal of Advances in Medicine and Medical Research (6/7/2018).
33. 2018 Award of Certificate of Excellence in Reviewing by International Blood Research and Reviews
34. 2018 Award of Certificate of Excellence in Reviewing by South Asian Journal of Parasitology
35. 2018 Award of Certificate of Excellence in Reviewing by Journal of Pharmaceutical Research International (SDI/GQ/PR/Cert/43495/Emm, 4/8/2018).
36. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Tropical Disease & Health (SDI/HQ/ PR/Cert/43575/Emm, 4/8/2018).
37. 2018 Best Editor Award by Annals of Clinical and Laboratory Research (8/8/2018)
38. 2018 Award of Certificate of Excellence in Reviewing by Asian Hematology Research Journal (SDI/HQ/ PR/Cert/43646/Emm, 9/8/2018).
39. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Biochemistry Research and Review SDI/HQ/ PR/Cert/43724/Emm, 21/8/2018)
40. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Tropical Disease and Health SDI/HQ/ PR/Cert/43962/Emm, 21/8/2018)
41. Review Certificate by Acta Scientific Cancer Biology (ASCB) for through reviewing.
42. An Organising Committee Member of World Heart Congress, May 06-08,2019, Toyko Japan
43. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Medical and Pharmaceutical Case Reports (SDI/HQ/PR/Cert/44044/EMM, Date: 30/8/2018).
44. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Tropical Diseases & Diseases (SDI/HQ/PR/Cert/44019/EMM, Date: 30/8/2018).
45. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Research and Reports in Urology ((SDI/HQ/PR/Cert/43989/EMM, Date: 30/8/2018).
46. Promoted to Editor-in-Chief of Journal of Biomedical Research and Review
47. 2018 Award of Certificate of Excellence in Reviewing by Asian Hematology Research Journal (SDI/HQ/PR/Cert/44275/EMM, Date: 6/9/2018).
48. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Research in Medical and Pharmaceutical Sciences (SDI/HQ/PR/Cert/44133/EMM, Date: 6/9/2018).
49. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Biochemistry Research & Review (SDI/HQ/PR/Cert/44232/EMM, Date: 6/9/2018).
50. 2018 Award of Certificate of Excellence in Reviewing by Journal of Advances in Biology and Biotechnology (SDI/HQ/PR/Cert/44234/EMM, Date: 6/9/2018).
51. 2018 Award of Certificate of Excellence in Reviewing by Journal of Advances in Microbiology (SDI/HQ/PR/Cert/44295/EMM, Date: 6/9/2018).
52. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Research in Animal and Veterinary Sciences (SDI/HQ/PR/Cert/4246/EMM, Date: 13/9/2018).
53. Publons Peer Reviewers Award of top 1% of Reviewers 2018
54. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Pathogen Research (SDI/HQ/PR/Cert/44438/Emm, Date:22/9/2018)
55. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Tropical Disease & Health (SDI/HQ/PR/Cert/44396/Emm, Date: 22/9/2018)
56. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Biochemistry Research & Review (SDI/HQ/PR/Cert/44416/Emm, Date: 22/9/2018)
57. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Biochemistry Research & Review (SDI/HQ/PR/Cert/44417/Emm, Date: 22/9/2018)
58. An Organising Committee Member of 3rd International Heart Conference on March 18-19, 2019 at Las Vegas, USA
59. Certificate of Excellence in Peer- Reviewing awarded by Journal of Basic and Applied Science (Certificate No: Ikp/PR/Cert/6376/EMM, Date: 28/9/2018).
60. Certificate of Excellence in Peer- Reviewing awarded by Asian Journal of Microbiology and Biotechnology (Certificate No: IKP/PR/Cert/6365/EMM Date: 28/9/2018).
61. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Biology (Certificate No: 44641/EMM, Date: 28/9/2018).
62. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Pathogen Research (SDI/GQ/PR/Cert/44703/EMM, Date: 5/10/2018).
63. A member of Conference Committee Member of International Conference of Oncology & Hematology
64. Reviewer and Editor-in-chief in our journal of Education Research and Health Development 9 Date: 19/10/2018)
65. Reviewer and Editor-in-chief in our journal of Journal of Virology, Vaccines, and Immunology (Date: 19/10/2018)
66. 2018 Award of Certificate of Excellence in Reviewing by Microbiology Research Journal International (SDI/GQ/PR/Cert/44932/EMM, Date: 19/10/2018)
67. 2018 Award of Certificate of Excellence in Reviewing by Microbiology Research Journal International (SDI/GQ/PR/Cert/44934/EMM, Date: 19/10/2018)
68. 2018 Award of Certificate of Excellence in Reviewing by Journal of Advances in Medicine and Medical Research (SDI/GQ/PR/Cert/44973/Emm, Date: 19/10/2018)
69. An Organising Committee of Global Conference of Microbiology, Virology and Infectious Diseases, May 13-14, 2019, Rome, Italy
70. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Agricultural Extension, Economics & Sociology (SDI/GQ/PR/Cert/45032/EMM, Date: 25/10/2018)
71. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Research in Zoology (SDI/GQ/PR/Cert/45050/EMM, Date: 25/10/2018)
72. 2018 Award of Certificate of Excellence in Reviewing by Annual Research & Review in Biology (SDI/GQ/PR/Cert/45028/EMM, Date: 25/10/2018)
73. 2018 Award of Certificate of Excellence in Reviewing by Journal of Advances in Medicine and Medical Research (SDI/GQ/PR/Cert/45073/EMM, Date: 25/10/2018)
74. Editor-in-Chief of Journal of Reproductive Biomedicine
75. Editor-in-Chief of Journal of Brain Imaging and Behavior
76. Certificate of Outstanding Reviewer for American Journal of Computer Science and Information Technology
77. 2018 Award of Certificate of Excellence in Reviewing by South Asian Journal of Parasitology (SDI/GQ/PR/Cert/45243/EMM)
78. 2018 Award of Certificate of Excellence in Reviewing by Journal of Advances in Medicine and Medical Research (SDI/GQ/PR/Cert/45171/EMM)
79. 2018 Award of Certificate of Excellence in Reviewing by European Journal of Medicinal Plants (SDI/GQ/PR/Cert/45129/EMM)
80. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Medicine and Health ((SDI/GQ/PR/Cert//45350/EMM, Date: 8/11/2018)
81. 2018 Award of Certificate of Excellence in Reviewing by Journal of Advances in Medical and Pharmaceutical Sciences ((SDI/GQ/PR/Cert/45396/EMM, Date: 8/11/2018)
82. 2018 Award of Certificate of Excellence in Reviewing by International Journal of Biochemistry Research and Review ((SDI/GQ/PR/Cert/45253/EMM, Date: 8/11/2018).
83. 2018 Award of Certificate of Excellence in Reviewing by Annual Research & Review in Biology (SDI/GQ/PR/Cert/45312/EMM, Date: 8/11/2018).
84. Editor-in-Chief of United Journal of Medicine and Health Care (Date: 19/11/2018)
85. 2018 Award of Certificate of Excellence in Reviewing by Chemical Science International Journal (SDI/GQ/PR/Cert/45609/EMM, Date: 23/11/2018).
86. 2018 Award of Certificate of Excellence in Reviewing by Journal of Pharmaceutical Research International (SDI/GQ/PR/Cert/45640/OBE, Date; 22/11/2018).
87. 2018 Award of Certificate of Excellence in Reviewing by Asian Research Journal of Agriculture (SDI/GQ/PR/Cert/45611/EMM, Date: 22/11/2018).
88. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Research in Zoology (SDI/GQ/PR/Cert/45551/EMM, Date: 22/11/2018).
89. 2018 Award of Certificate of Excellence in Reviewing by Microbiology Research Journal International (SDI/GQ/PR/Cert/45571/EMM, Date: 22/11/2018).
90. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Research in Crop Science (SDI/GQ/PR/Cert/45595/EMMA, Date: 22/11/2018).
91. An Organizing Committee Member of World Congress on Immunology and Microbiology(SciTech Immuno-Microbiology 2019) during June 19-20, 2019 at Dubai, UAE.(Date: 29/11/2018).
91. 2018 Award of Certificate of Excellence in Reviewing by Asian Food Science Journal (SDI/GQ/PR/Cert/45711/EMM, Date; 29/11/2018)
92. An Organising Committee Member of 6th International Conference on Cardiology and Cardiovascular Medicine, Dublin, Ireland during June 17-18, 2019.
93. An Organizing Committee Member of Asia Pacific Ophthalmology Congress, Singapore, August 19-20, 2019
94. 2018 Award of Certificate of Excellence in Reviewing by Asian Journal of Chemical Sciences (SDI/GQ/PR/Cert/45819/EMM, Date: 1/12/2018)
95. 2018 Award of Certificate of Excellence in Reviewing by European Journal of Medicinal Plants (SDI/GQ/PR/Cert/45742/OBE, Date: 1/12/2018)
96. 2018 Award of Certificate of Excellence in Reviewing by Journal of Scientific Research and Reports (SDI/GQ/PR/Cert/45563/EMM, Date; 30/11/2018)
97. An Organising Committee Member of 5th World Vaccine and Immunology Congress
June 10-11, 2019 | Bangkok, Thailand (Date: 3/12/2018)
98. Editor-in-Chief of Archives of Blood Transfusion & Disorders.
99. An Editor-in-Chief of United Journal of Physical Medicine & Rehabilitation (Date: 14/12/2018)
100. An Editor in Chief of World Journal of Medicine and Surgery Reports (Date: 15/12/2018).
1.Obeagu, E.I, Eziukwu, K; Ogbodo, O.R; Odo, M.C. and Udochukwu,A.U.(2013). Lipid Profile in Hypertensive Patients Receiving Treatment in Federal Medical Centre Owerri,Nigeria.International Journal of Research and Reviews in Pharmacy and Applied Science.3(4)544-553.
2.Obeagu, E.I; Odo, M.C; Emelike, C.U; and Ogbodo, O.R.(2013). Determination of Levels of Methaemoglobin in Sickle Cell Patients in Abakaliki, Ebonyi State, Nigeria. International Journal of Research and Review in Pharmacy and Applied Science.3(4)554-560.
3.Obeagu, E.I; Ogbodo, O.R; Onyenweaku, F; Emelike, C.U and Udochukwu, A.U.(2013). Frequency Distribution of ABO, Rh Blood Groups and Blood Genotypes Among The Students and Staff of Michael Okpara University of Agriculture , Umudike, Abia State, Nigeria. International Journal of Research and Review in Pharmacy and Applied Science.3(4)561-565.
4.Obeagu, E.I; Uzoije, N.U; Afoma, I; Ogbodo, O.R. and Onyenweaku,F.C. (2013). Malaria, ABO Blood and Haemoglobin Genotypes in Michael Okpara University of Agriculture Umudike,Abia State,Nigeria.International Journal of Advances in Pharmaceutical Sciences.4(5)1110-1113.
5.Obeagu, E.I., Obarezi,T.N., Afoma,I., and Okoro,N.K. (2013). Determination of Methaemoglobin Levels in Malaria Infected Patients in University Health Services Department,Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. World Journal of Pharmaceutical Research 2(6):3172-3177.
6.Obeagu, E.I., Obarezi, T.N., Anaebo, Q.B., Odo, E.O., Ogbu, R.O., and Achigbo,L.U. (2013). Impact of Asymptomatic Malaria: its Implication in Sports Among Students of International Secondary School, Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. World Journal of Pharmaceutical Research 2(6):3178-3187.
7.Obeagu, E.I., Obarezi,T.N., Odo,E.O., Anaebo,Q.B. and Achigbo,L.U.(2013). HIV Screening Status and Prevalence of Malaria Parasite Among Pregnant Women in Ikwuano L.G.A., Abia State, Nigeria.World Journal of Pharmacy and Pharmaceutical Sciences 2(6):4397-4403.
8.Obeagu, E.I., Chikelu, I.M., Obarezi,T.N., Ogbuabor, B.N. and Anaebo,Q.B. (2014). Haematological Effects of Fluted Pumpkin (Telfairia occidentalis) Leaves in Rats. International Journal of Life Sciences Biotechnology and Pharma Research..3(1):172-182.
9.Obeagu, E.I., Obarezi, T.N. and Anaebo, Q.B. (2014). Some Biochemical and Haematological Parameters in Uncomplicated Malaria Infection in Michael Okpara University of Agriculture, Umudike,Abia State, Nigeria. International Journal of Life Sciences Biotechnology and Pharma Research.3(1):183-185.
10.Obeagu, E.I., Obarezi, T.N., Ogbuabor, B.N., Anaebo,Q.B. and Eze,G.C. (2014). Pattern of Total White Blood Cell and Differentijal Count Values in HIV Patients Receiving Treatment in Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria. International Journal of Life Sciences Biotechnology and Pharma Research..3(1):186-189.
11.Obeagu, E.I. (2014). Changes in Some Haematological Parameters in Typhoid Patients Attending University Health Services Department of Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. International Journal of Current Microbiogy and Applied Sciences 3(1):670-674.
12.Obeagu, E.I., Odo,M.C., Anaebo,Q.B. and Emelike,C.U. (2014). Impact of Plasmodium falciparum Malaria and Hookworm Infection on Anaemia Among Pregnant Women of Ikwuano L.G.A., Abia State, Nigeria. International Journal of Current Microbiogy and Applied Sciences 3(1):104-111.
13.Obeagu, E.I., Obarezi,T.N., Eze,O.B.L., and Emelike, C.U. (2014). Haematological Profile of Pregnant Women in Umuahia, Abia State, Nigeria. International Journal of Current Microbiogy and Applied Sciences 3(1):713-718.
14.Eze, O.B.L., Ugwu,O,P.C., Obeagu, E.I. and Ifemeje, J.C. (2014). Antianaemic Potential of Aqueous Leaf Extract of Mucuna Pruriens on Wister Albino Rats. International Journal of Current Microbiogy and Applied Sciences 3(1):707-712.
15.Eze, O.B., Obeagu, E.I., Ugwu, O.P.C., Ifemeje, J.C. (2014). The Effects of Aqueous Leaf Extract of Mucuna Pruriens(agbala) on Some Albino Rats. International Journal of Current Microbiogy and Applied Sciences 3(1):724-729.
16.Obeagu,E.I.,Obarezi,T.N.,Omeh,Y.N.,Okoro,N.K. and Eze,O.B.L.(2014).Assessment of Some Haematological and Biochemical Parameters in HIV Patients Before Receiving Treatment in Abia State,Nigeria.Research Journal of Pharmaceutical,Biological and Chemical Sciences5(2):825-830.
17.Obeagu,E.I.,Omeh,Y.N.,Obarezi,T.N.,Okoro,N.K., and Eze,O.B.L.(2014).Some Haematological and Biochemical Parameters of Chronic Alcoholics in Umuahia,Abia State,Nigeria. Research Journal of Pharmaceutical,Biological and Chemical Sciences 5(2):831-836.
18.Obeagu,E.I.,Omeh,Y.N. and Eze-ifeanyi,G.N.(2014).Some Biochemical and Haematological Effects of Hypertension Among Pregnant Women in Ikwano L.G.A.,Abia State,Nigeria. Research Journal of Pharmaceutical,Biological and Chemical Sciences5(2):837-846.
19.Obeagu,E.I.,Ogbuabor,B.N.,Ikechukwu,O.A. and Chude,C.N.(2014).Haematological Parameters Among Sickle Cell Anaemia Patients in Steady State and Haemoglobin Genotype AA Individuals at Michael Okpara University of Agriculture,Umudike,Abia State,Nigeria. International Journal of Current Microbiogy and Applied Sciences 3(3):1000-1005.
20.Obeagu,E.I.,Mbajiuka,C.S. and Ogbuabor,B.N.(2014).Comparative Analysis of Some Haematological Parameters in Sickle Cell Patients in Steady State and in Crisis State at Michael Okpara University of Agriculture,Umudike,Abia State,Nigeria. International Journal of Current Microbiogy and Applied Sciences 3(3):1046-1050.
21.Mbajiuka,C.S.,Obeagu E.I.,Chude,C.N. and Ihezie,O.E.(2014).Antimicrobial Effects of Chromolaena odorata on Some Human Pathogen . International Journal of Current Microbiogy and Applied Sciences 3(3):1006-1012.
22.Mbajiuka,C.S.,Obeagu,E.I. and Okwendu,G.E.(2014).Antimicrobial Effects of Aloe vera on Some Human Pathogens. International Journal of Current Microbiogy and Applied Sciences 3(3):1022-1028.
23. .Mbajiuka,C.S.,Obeagu,E.I.,Obarezi,T.N.and Mgbemgbe,P.O.(2014).Antimicrobial Effects of Combretum paniculatum(Bush Willow) on Some Pathogenic Organisms. International Journal of Current Microbiogy and Applied Sciences 3(3):1036-1045.
24. Uchegbu ,A.U.,Obeagu, E .I.,Odo, M.C.(2014). The Effect Of Prolonged Administration Of Aqueous Extract Of The Stem Bark Of Khaya Senegalenses On The Liver And Kidney Of Wister Rats. World Journal of Pharmacy and Pharmaceutical Sciences 3(4) :36-51.
25. Ogbuabor, B.N.,Obeagu, E. I., and Aloh,G.S.(2014). Fibrinogen Concentration In Diabetic Patients Attending Clinic At Federal Teaching Hospital Abakaliki(FETHA). World Journal of Pharmacy and Pharmaceutical Sciences 3(4):287-293.
26. Obeagu, E.I.,Aloh ,G.S. and Emelike C.U.(2014). Some Haematological and Biochemical Parameters in Peptic Ulcer Patients in Umudike,Abia State,Nigeria. World Journal of Pharmacy and Pharmaceutical Sciences 3(4):294-302.
27.Obeagu,E.I.,Obarezi,H.C.,Aloh G.S. and Emelike,C.U.(2014).Changes in Some Coagulation Parameters Among Diabetic Patients in Michael Okpara University of Agriculture,Umudike,Abia State,Nigeria. World Journal of Pharmacy and Pharmaceutical Sciences 3(4):52-62.
28.Aloh G.S.,Obeagu,E.I., and Obi,M.A.(2014).The Effects of Insecticide-treated Nets on two Liver Function Parameters of Diabetic Rabbits. World Journal of Pharmacy and Pharmaceutical Sciences 3 (4):217-225.
29. Aloh G.S.,Obeagu,E.I., and Mordi,J.U.(2014).Effects of Gambia albidum Leaf Extracts on Drug-induced Oxidative Stress. World Journal of Pharmacy and Pharmaceutical Sciences 3(4):208-216.
30. Aloh G.S.,Obeagu,E.I., and Ezechukwu,C.M.(2014).Effects of Prolonged Use of Insecticide-treated Nets on Hepatic Function of Albino Rats. World Journal of Pharmacy and Pharmaceutical Sciences 3(4):195-207.
31. Aloh G.S.,Obeagu,E.I., and Arimonu,P.O.(2014).Carbohydrate,Lipid and Protein Profile of Rats Fed on Gambia albidum Endosperm. World Journal of Pharmacy and Pharmaceutical Sciences 3(4) :143-151.
32. Aloh G.S.,Obeagu,E.I., and Madu,C.I.(2014).Wound Healing Potentials of Leaf and Bark Extracts of Delonix regia. World Journal of Pharmacy and Pharmaceutical Sciences 3(4) :133-142.
33. Aloh G.S.,Obeagu,E.I., and Ezenwobi,O.C.(2014).Isolation and Comparism of Fatty Acid Acylglycerol Contents in Local Hybrid Coconuts(Cocos nucifer). World Journal of Pharmacy and Pharmaceutical Sciences 3(4):113-132.
34. Aloh G.S.,Obeagu,E.I., and Amadi,M.S.(2014).The Anti-hypertensive Effects of Mustard Seed Extracts. World Journal of Pharmacy and Pharmaceutical Sciences 3(4):62-74.
35.Aloh,G.S.,Obeagu,E.I. and Okafor,A.H.(2014).Effects of Mustard Seed Oil on Prolong Prtotein-bound Iodine,Globulin and Albumin of Albino Rats.IOSR Journal of Pharmacy and Biological Sciences 9(2):15-17.
36. Aloh,G.S.,Obeagu,E.I. and Onyeonoru,T.C.(2014).Hepatoprotective Effects of Gambia albidum Bark Extract. IOSR Journal of Pharmacy and Biological Sciences 9(2):18-22.
37. Aloh,G.S.,Obeagu,E.I. and Umechukwu,C.E.(2014).The Effects of Casuarine Bark on Lipid Profile and Random Blood Sugar Level in Albino Rats. IOSR Journal of Dental and Medical Sciences 13(4):11-15.
38. Aloh,G.S.,Obeagu,E.I. and Onu,F.U.(2014).Wound Healing Potential of Water and Ethanol Extract of Fresh Leaves and Bark of Gambia albidum in Albino Rats. IOSR Journal of Medical and Dental Sciences 13(4):16-22.
39. Aloh,G.S.,Obeagu,E.I. and Agu,M.O.(2014). Hepatoprotective Potential of Leaf and Bark Extract of Gambia albidum. IOSR Journal of Environmental Science,Toxicology and Food Technology 8(4):25-29.
40. Aloh,G.S.,Obeagu,E.I. and Omeh Y.N.and Imoh,O.(2014).Goitrogenic Effects of Mustard Seed (Bassica junca) Oils. IOSR Journal of Environmental Science,Toxicology and Food Technology 8(4):30-34.
41.Udeozo,I.P.,Eze-Steven,P.E.,Ugwu,C.E.,Obeagu,E.I. and Okenini,S.E.(2014).Phytochemical Compositions of Kola Nitida Bark Extract and its Effect on Liver Markers of Albino Wister Rats Fed with High Fat Diet. World Journal of Pharmacy and Pharmaceutical Sciences 3(4):331-338.
42.Mbajiuka,C.S.,Obeagu,E.I.,Ochei,K.C.,Ifediora,A.C.Okezie,E.and Odo,N.N.(2014).Antimicrobial Actvities of Mucuna pruriens(Agbara) on Some Human Pathogens.IOSR Journal of Pharmacy and Biological Sciences 9(2):9-13.
43.Eze-Steven,P.E.,Udeozo,I.P.,Ugwu,E.C.,Obeagu,E.,Ugwu,O.and Egba,J.J.(2013).Anti-Lipidemic Effects of Desmodium velutinum Water Leaf Extract on Albino Wistar Rats Fed with High Fat Diet.American-Eurasian Journal of Scientific Research 9(2):26-30.
44.Eze-Steven,P.E.,Udeozo,I.P.,Ugwu,E.C.,Obeagu,E.,Okeke,E.C.(2014).Anti-Lipidemic Effects of Kola Pod Extract on Wistar Albino Rats Fed with High Fat Diet.World Applied Sciences Journal 31(9):1614-1617.
45. Eze-Steven,P.E.,Udeozo,I.P.,Obeagu,E.,and Oji,F.(2014).The Effects of Ethanol Extract of Desmodium velutinum Stem on Liver Markers of Albino Rats Fed with High Fat Diet. World Applied Sciences Journal 31(9):1684-1688.
46.Mbajiuka,C.S.,Obeagu,E.I.,Ochei,K.C. and Onyemairo,N.C.(2014).Effect of Ginger and Garlic on the Microbial Load and Shelf-Life of Burukutu.International Journal of Microbiological Research 5(2):117-123.
47. Mbajiuka,C.S.,Obeagu,E.I.,Ochei,K.C. and Nnadi,D.C.(2014).The Antibacterial Activity of Leaf Extracts of Ocimum gratisssimum and Sida acuta. International Journal of Microbiological Research 5(2):124-129.
48.Emelike,C.U.,Obike,C.J.,Nwandikor,U.U.,Ifediora,A.C.,Onyenweaku,F.,Odo,M.C.and Obeagu,E.I.(2014).Pysiochemical Consituents,Phytochemical and Morhporlogical Effects of Oral Administration of Aqueous Extarcts of Hibiscus Sabdariffa on Kidney and Liver of Wister Albino Rats.American Journal of Research Communication 2(7):101-112.
49.. Mbajiuka,C.S.,Obeagu,E.I.,Ochei,K.C. and Iheke, S.O.(2014). Evaluation Of Microbial Contamination Of Tools Used In Hair Dressing Salons In Michael Okpara University Of Agriculture.IOSR Journal of Dental and Medical Sciences 13(7 ver 1):22-27.
50. Obeagu, E.I.,Okoroiwu, I.L.,Ochei, K.C.,Okoro, N.K. and Udenze, C.L.(2014). CD4 Count Of ART and Non-ART HIV Positive Patients Attending Living Word Mission Hospital,Abayi,Aba,Abia State,Nigeria.IOSR Journal of Dental and Medical Sciences 13(7 ver iii):41-46.
51.Okoroiwu,I..L.,Anode,A.,Obeagu,E.I.,Udokwu,E.I. and Amadi,U.(2014).The Effect of Viral Hepatitis on APTT,PT,TT,Fibrinogen and Platelet Among Blood Donors at Fmc,Umuahia.IOSR Journal of Dental and Medical Sciences 13(8 ver v):57-63.
52.Ochei,K.C.,Obeagu,E.I.,Mbajiuka,C.S.and Uzoije,N.U.(2014).Comparative Assessement Of Five Laboratory Techniques In The Diagnosis Of Pulmonary Tuberculosis In Abuja.IOSR Journal of Dental and Medical Sciences 13(9 ver ii):73-78.
53.Ochei,K.C,Obeagu,E.I.,Ugwu,G.U.and George,C.N.(2014).Prevalence of Trichomonas Vaginalis among Pregnant Women Attending Hospital in Irua Specialist Teaching Hospital in Edo State,Nigeria. IOSR Journal of Dental and Medical Sciences 13(9 ver ii):79-82.
54.Okoroiwu,I.L.,Amadi,U.,Obeagu,E.I,Anode,A.and Udokwu,E.I.(2014).The Correlation of Values of CD4 Count,Platelet,PT,APTT,Fibrinogen and Factor VIII Concentrations Among HIV Positive Patients in FMC Owerri. IOSR Journal of Dental and Medical Sciences 13(9 ver ii):94-101.
55.Okoroiwu,I.L.,Udokwu,E.I.,Obeagu,E.I.Amadi,U.and Anode,A.(2014).Comparative Study of CD 8+ T-Cell Count and Leukopoietin Levels in Human Immunodeficiency Virus Infection in Umuahia,Nigeria. IOSR Journal of Dental and Medical Sciences 13(9 ver ii):102-110.
56..Mbajiuka,C.S.,Obeagu,E.I.,Ifediora,A.C.(2014). Fungal Contamination on Non-Cellulosic Instruments in Umuahia,Abia State,Nigeria. IOSR Journal of Dental and Medical Sciences 13(9 ver ii):111-117.
57..Ugwuja,S.E.,Obeagu,E.I.,Ochei,K.C.,Ogbu,R.O.,Agoha,S.C.(2014).Effect of Physical Exercise on Serum Electrolyte. IOSR Journal of Dental and Medical Sciences 13(9 ver ii):118-121.
58..Elemchukwu,Q.,Obeagu,E.I. and Ochei,K.C.(2014).Evaluation of Haematological Parameters Among Pregnant Women Attending Clinic in College of Health Demonstration Clinic,Port Harcourt. IOSR Journal of Dental and Medical Sciences 13(9 ver ii):122-127.
59. Elemchukwu,Q.,Obeagu,E.I. and Ochei,K.C.(2014).The Effect of Storage on Full Blood Count in Different Anticoagulants. Journal of Dental and Medical Sciences 13(9 ver ii):128-131.
60.Udenze,C.L.,Achi,O.K.,Obeagu,E.I. and Elemchukwu,Q.(2014).Prevalence of Bacterial Vaginosis Aong Female Students of Michael Okpara University of Agriculture,Umudike,Abia, State,Nigeria. IOSR Journal of Pharmacy and Biological Sciences 9(5 ver ii):39-52.
61. Elemchukwu,Q.,Obeagu,E.I. and Ochei,K.C.(2014).Prevalence of Anaemia Among Pregnant Women in Braithwaite Memorial Specialist Hospital(BMSH),Port Harcourt. IOSR Journal of Pharmacy and Biological Sciences 9(5 ver ii):59-64
62.. Elemchukwu,Q.,Obeagu,E.I. and Ochei,K.C.(2014).The Prevalence of Human Immunodeficiency Virus,Hepatis B Surface Antigen and Hepatitis C Virus amon Pregnant in Port Harcourt. IOSR Journal of Pharmacy and Biological Sciences 9(5 ver ii):65-72.
63.Ochei,K.C.,Obeagu,E.I., Aniukwu,V.E.and Mbajiuka,C.S.(2014).The Bacteriology of Fried Ready-To-Eat Foods Sold in Enugu Metroolis,Nigeria.IOSR Journal of Environmental Science,Toxicology and Food Technology 8(9 ver i):81-92.
64. Okoroiwu, I. L.,Obeagu, E. I., Elemchukwu, Q.,Ochei ,K. C.(2014). Determination of Ferritin Level and Total Iron Binding Capacity in Pregnancy and Postpartum Subjects in Owerri. IOSR Journal of Dental and Medical Sciences 13(9 Ver. III ):70-73.
65. Okoroiwu, I. L.,Obeagu, E. I., Elemchukwu, Q.,Ochei ,K. C.(2014). Some Hematological Parameters In Malaria Parasitaemia. IOSR Journal of Dental and Medical Sciences 13(9 Ver. III ):74-77.
66. Okoroiwu, I. L., Obeagu, E. I., Elemchukwu, Q.,Ochei ,K. C.(2014). Investigation of Haemostatic Status in the Elderly Male and Female Using Some Parameters; PT, APTT and PC Count: A Case Study in Owerri Metropolis. IOSR Journal of Pharmacy and Biological Sciences 9( 5 Ver. II .) 88-92.
67. Obeagu, E.I., Okoroiwu, I. L., Ochei, K.C., Okoro, N. K., and Udenze, C.L.2014). CD4 Count of ART and Non-ART HIV Positive Patients Attending Living Word Mission Hospital Abayi Aba, Abia State, Nigeria. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 13,( 7 Ver. III): 41-46.
68. Okoroiwu, I.L., Obeagu, E.I., Elemchukwu, Q. and Ochei, K.C.(2014).
The Effect of Storage on Eosinophil Count and Evaluation of Two Major Methods on Eosinophil Count. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) 9( 5 Ver. III) : 37-45.
69. Mbajiuka, C.S.,Obeagu, E.I., Ifediora, A.C. and Ugwu, G. U.(2014).
Isolation And Identification Of Microorganisms Involved In The Spoilage Of Soymilk. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) 9(5 Ver. III ): 29-36.
70. Obeagu, E. I., Okoroiwu, I. L., Okoro, N.K., Agbo,E.C.(2014). Some Haematological And Biochemical Parameters Among ART And Non-ART Hiv Positive Patients In Living Word Mission Hospital, Abayi, Aba, Abia State, Nigeria. European Journal of Biomedical and Pharmaceutical Sciences.1(2): 502-508.
71.Agbo,E.C.,Achi,O.K.,Obeagu,E.I.,Ochei,K.C.and Ogoamaka,A.I.(2014).Incidence of Lower Respiratory Tract Infections Among Elderly Patients in Federal Medical Centre,Umuahia.IOSR Journal of Dental and Medical Sciences.13(11 ver v):85-97.
72.Obeagu,E.I.(2014).Hypoxia and Enzyme Metabolism:A Review.World Engineering and Applied Sciences Journal.5(2):40-43.
73.Mbajiuka,C.S.,Obeagu,E.I.,Nwosu,D.C.and Agbo,C.E.(2014).Microbiological Evaluation of Naira Notes Handled by Fish Sellers in Umuahia Metropolis. World Engineering and Applied Sciences Journal.5(2):44-52.
74.Mbajiuka,C.S.,Obeagu,E.I., Agbo,C.E. and Nwosu,D.C. (2014).Assessment of Microbial Isolates Associated with Contaminated Soil Found Around Slaughter House in Umuahia Metropolis.International Journal of Pharmacy and Medical Sciences.4(2):21-26.
75.Nwosu,D.C.,Nwanjo,H.U.,Opara,A.U.,Obeagu,E.I.,Ugwu,G.U.,Ezeama,M.C.,Okpara,K.E.,Kanu,S.N.,Ojiegbe,G.C.,Onuoha,C.I.,Ajero,C.M.U. and Nwokike,G.I.(2015).Aspects of Sanitation and Intestinal Helminth Infection in Children in Aba,Abia State,Nigeria.European Journal of Biomedical and Pharmaceutical Sciences.2(1):426-433.
76..Nwosu,D.C.,Obeagu,E.I.,Opara,A.U.,Nwanjo,H.U.,Nwachukwu,P.C.,Avoaja,D.A.,Ajero,C.M.U.,Nnorom,R.M.,Ugwu,G.U.,Okpara,K.E.and Kanu,S.N.(2015).Changes in Vitamin A of Children with Protein Energy Malnutrition in a Rural Community of Imo State. European Journal of Biomedical and Pharmaceutical Sciences.2(1):451-460.
77.Aloh,G.S.,Obeagu,E.I.,Okoroiwu,I.L.,Odo,C.E.,Odo,M.C.,Kanu,S.N.,Elemchukwu,Q.,Okpara,K.E.and Ugwu,G.U.(2015).Antioxidant-Mediated Glutathione Levels of Glucose-6-Phosphate Dehydrogenase-Deficient Erythrocytes under-induced Oxidative Stress.European Journal of Pharmaceutical and Medical Research.2(2):64-69.
78.Aloh,G.S.,Obeagu,E.I.,Okoroiwu,I.L.,Odo,C.E.,Odo,M.C.,Kanu,S.N.,Elemchukwu,Q.,Okpara,K.E.and Ugwu,G.U.(2015).Antioxidant-Mediated Glutathione Levels of Sickle Erythrocytes under-induced Oxidative Stress.European Journal of Pharmaceutical and Medical Research.2(2):70-75.
79.Aloh,G.S.,Obeagu,E.I.,Odo,C.E.,Kanu,S.N.,Okpara,K.E.,Egjbon,P.and Obeagu,G.U.(2015).Sugar and Sulphite Levels of Alcoholic and Nonalcoholic Beverages in Nigeria.World Journal of Pharmaceutical Research.4(3):232-239.[Pubmed].
80.Aloh,G.S.,Obeagu,E.I.,Odo,C.E.,Okpara,K.E.,Onyekwere,C.and Obeagu,G.U.(2015).Extraction and Partial Characterisation of Mustard Seed(Brassica spp) Oil. World Journal of Pharmaceutical Research.4(3):177-195.[Pubmed].
81.Nwosu,D.C.,Obeagu,E.I.,Ugwu,G.U.,Ofor,I.B.Okeke,A.,Ochei,K.C.,Kanu,S.N.and Okpara,K.E.(2015).Evaluation of Lipoprotein A and Lipid Tetrad Index Pattern in Diabetic Patients Attending Metabolic Clinic in the Federal Medical Centre,Owerri,Imo State.World Journal of Pharmacy and Pharmaceutical Sciences.4(3):126-140.
82.Nwosu,D.C.,Nwanjo,H.U.,Opara,A.U.,Ofor,I.B.,Obeagu,E.I.,Ugwu,G.U.,Ojiegbe,G.C.,Nnorom,R.M.,Nwokike,G.I.,Okpara,K.E. and Ochei,K.C.(2015).Evaluation of C-Reactive Protein,Selenium and Glycosylated Haemaoglobin Levels in Diabetic Patients Attending Metabolic Clinic in the Federal Medical Centre,Owerri,Imo State. World Journal of Pharmacy and Pharmaceutical Sciences.4(3):141-152.
83.Obeagu,E.I.,Obeagu,G.U.,Okereke,I.F.and Utah,I.C.(2015).The Values of Activated Partial Thromboplsatin Time(APTT) Amomg Positive Patients in FMC,Owerri.International Journal of Current Research and Academic Review.3(4):139-144.
84. Obeagu,E.I.,Obeagu,G.U.,Okereke,I.F. Utah,I.C.and Ochei.K.C.(2015).The Values of Platelet Counts among HIV Positive Patients in FMC,Owerri. International Journal of Current Research and Academic Review.3(4):126-132.
85.Obeagu,E.I.and Obeagu,G.U.(2015).Effects of CD4 Counts on Coagulation Parameters among HIV Positive Patients in Federal Medical Centre,Owerri,Nigeria.International Journal of Current Research in Biosciences and Plant Biology.2(4):45-49.
86. Obeagu,E.I.and Obeagu,G.U.(2015).Fibrinogen Concentrations among HIV Positive Patients in Federal Medical Centre,Owerri,Nigeria.International Journal of Current Research in Biosciences and Plant Biology.2(4):50-53.
87. Obeagu,E.I.and Obeagu,G.U.(2015).The Values of Prothrombin Time among HIV Positive Patients in Federal Medical Centre,Owerri.International Journal of Current Microbiology and Applied Sciences.4(4):911-916.
88. Obeagu,E.I.and Obeagu,G.U.(2015).The Values of CD4 Count among HIV Positive Patients in Federal Medical Centre, Owerri.International Journal of Current Microbiology and Applied Sciences.4(4):906-910.
89..Nwosu,D.C.,Obeagu,E.I.Nwanjo,H.U.,Ogomaka,A.I.,Kanu,S.N.,Okpara,K.E.,Nwachukwu,P.C.,Avoaja,D.A.,Ajero,C.M.U.,Opara,A.U.and Nnorom,R,M.(2015).Female Genital Schistosomiasis(FGS) in S.haematobium Infection;A Review.European Journal of Biomedical and Pharmaceutical Sciences.2(1):434-438.
90..Nwosu,D.C.,Nwanjo,H.U.,Dike,N.J.,Izuka,N.,Obeagu,E.I.,Okpara,K.E.,and Agbo,E.C.(2015).Medical Waste Incineration and the Risk of Cancer;A Review. European Journal of Biomedical and Pharmaceutical Sciences.2(1):472-478.
91..Nwosu,D.C.,Obeagu,E.I.,Amajioyi,O.,Ibebuike,J.E.and Ozims,S.J.(2015).Prevalence of Bacterial and Parasitic Urinary Tract Infections in Female Students of Imo State University.World Journal of Pharmacy and Pharmaceutical Sciences.4(5):152-167.
92.Nwosu,D.C.,Nwanjo,H.U.,Okolie,N.J.C.,Ikeh,K.,Ajero,C.M.U.,Dike,J.,Ojiegbe,G.C.,Oze,G.O.,Obeagu,E.I.,Nnatuanya,I.,Azuonwu,O.,Amajioyi,O.,Ochei,K.C.and Okpara,K.E.(2015).Biochemical Alterations in Adult HIV Patients on Antiretroviral Therapy. World Journal of Pharmacy and Pharmaceutical Sciences.4(3):153-160.
93..Nwosu,D.C.,Nwanjo,H.U.,Okolie,N.J.C.,Opara,A.U.,Obeagu,E.I.,Ugwu,G.U.,Ibebuike,J.E.,Ezeama,M.C.and Okpara,K.E.(2015).Some Biochemical Parameters and Anthroprometric Measurement in Children with Protein Energy Malnutrition in Owerri,Imo State. World Journal of Pharmacy and Pharmaceutical Sciences.4(3):161-168.
94.Aloh,G.S.,Obeagu,E.I.,Odo,C.E.and Nka,J.S.(2015).Estimation of Sugar in Soft Drinks. World Journal of Pharmacy and Pharmaceutical Sciences.4(3):112-125.
95.Nwosu,D.C.,Nwanjo,H.U.,Obiakor,O.R.,Obeagu,E.I.,Ugwu,G.U.,Izuka,N.,Dike-Ndudi,J.,Ojiegbe,G.C.,Onuoha,C.,Ajero,C.M.U,Nwokike,G.I.,and Okpara K.E.(2015).Comparison of the Serum Ferritin Levels of Blood Donors and Non-Blood Donors in Orlu.European Journal of Pharmaceutical and Medical Research.2(2):45-48.[Pubmed]
96.Aloh,G.S.,Obeagu,E.I.,Odo,C.E.,Udezuluigbo,C.N.and Ugwu,G.U.(2015).Hepatoprotective Potentials of Methanol Extracts of Gossweilerodendron balsamarium and Lipid Profile of Albino Rats. European Journal of Pharmaceutical and Medical Research.2(2):124-139.[Pubmed].
97..Aloh,G.S.,Obeagu,E.I.,Odo,C.E.,Kanu,S.N.,Okpara,K.E.,Nwosu,D.C.,Ugwu,G.U.and Ezeumudo,O.C.(2015).Effect of Methanol Extract of Dialium guineense Leaves on Liver Cell Damage and Lipid Profile of Albino Rats. European Journal of Pharmaceutical and Medical Research.2(2):76-94.[Pubmed].
98..Aloh,G.S.,Obeagu,E.I.,Odo,C.E.,Okpara,K.E.,Ogudo,C.O.and Obeagu,G.U.(2015).Effect of Permethrin-Impregnated Bed Nets on the Biosynthetic Functions of the Liver.World Journal of Pharmaceutical Research.4(3):196-204.[Pubmed].
99..Obeagu,E.I.,Aloh,G.S.,Odo,C.E.,Kanu,S.N.,Okpara,K.E.,Odo,M.C.,and Nnamdi,B.O.(2015).The Anti-Epilectic/Anti-Convulsive Effects of Mustard Seed Extracts. World Journal of Pharmaceutical Research.4(3):219-231.
100.Obeagu,E.I.,Aloh,G.S.,Odo,C.E.,Okpara,K.E.,Idenyi,F.A.and Obeagu,G.U.(2015).Electrolyte Profile of Rabbit Fed with Napoleone imperialism Leaf Extract. World Journal of Pharmaceutical Research.4(3):240-251.
101.Obeagu,E.I.,Obeagu,G.U.and Ochei,K.C.(2015).Comparative Study of CD 8+ T-cell Count in Human Immunodeficiency virus Infection in Umuahia, Nigeria.International Journal of Current Research in Biosciences and Plant Biology.2(4):76-82.
102.Obeagu,E.I.,Obeagu,G.U.and Ochei,K.C.(2015).Leukopoiesis Levels in Human Immunodeficiency virus Infection in Umuahia, Nigeria.International Journal of Current Research in Biosciences and Plant Biology.2(4):83-85.
103..Nwosu, D.C., Obeagu,E.I., Nwokike, G.I, Ihekireh,D.I.and Agu,G.C.(2015).Antibacterial Effect of Piper guineense and Aframomum melegueta Extracts on Escherichia coli and Staphylococcus aureus Among Patients Attending Medical Care at Imo State Specialist Hospital Umuguma,Owerri, Imo State, Nigeria. International Journal of Current Research in Biosciences and Plant Biology.2(5):29-32.
104.Obeagu, E.I., Okoroiwu, I.L., Daniel-Igwe,G.and Ijioma,S.N.(2015).Hematology in the Senescence.European Journal of Biomedical and Pharmaceutical Sciences.2(3):97-107.
105.Aloh,G.S.,Obeagu,E.I.,Okoroiwu,I.L.,Odo,C.E.,Odo,M.C.,Kanu,S.N.,Elemchukwu,Q.,Okpara,K.E.and Ugwu,G.U.(2015).Antioxidant-Mediated Amelioration of Drug-Induced Oxidative Stress and Methaemoglobinaemia in G6PD-Deficient and Sickle Erythrocytes. European Journal of Biomedical and Pharmaceutical Sciences.2(1):494-501.
106.Aloh,G.S.,Obeagu,E.I.,Okoroiwu,I.L.,Odo,C.E.,Odo,M.C.,Kanu,S.N.,Elemchukwu,Q.,Okpara,K.E.and Ugwu,G.U.(2015).Antioxidant-Mediated Heinz Bodies Levels of Glucose-6-Phosphate Dehydrogenase-Deficient Erythrocytes Exposed to Acetylphenylhydrazine. European Journal of Biomedical and Pharmaceutical Sciences.2(1):494-501.
107.Obeagu,E.I.,Obeagu,G.U.,Ochei,K.C.,Okereke,F.I.and Utah,I.C.(2015).The Values of Factor VIII Concentrations among HIV Positive Patients in FMC,Owerri.International Jouornal of Current Research and Academic Review.3(4)133-138.
108.Nwosu,D.C.,Nwanjo,H.U.,Obeagu,E.I.,Ibebuike,J.E.,Ezeama,M.C.and Ihekireh,D.I.(2015).Changes in Liver Enzymes and Lipid Profile of Pregnant Women with Malaria in Owerri, Nigeria. International Jouornal of Current Research and Academic Review.3(5):376-383.
109.Nwosu,D.C.,Obeagu,E.I.,Ezeama,M.C.,Agu,G.C.and Amajioyi,O.(2015).Changes in some Biochemical Parameters of HIV Seropositive Patients on Antiretroviral Therapy in Dalhatu Araf Specialist Hospital, Lafia, Nasarawa State. International Journal of Current Research and Academic Review.3(5):395-402.
110.Aloh,G.S.,Obeagu,E.I.,Okoroiwu,I.L.,Odo,C.E.,Odo,.M.C.,Kanu,S.N.,Elemchukwu,Q.,Okpara,K.E.,and Ugwu,G.U.(2015).Antioxidant-Mediated Heinz Bodies Levels of Sickle Erythrocytes under Drug-induced Oxidative Stress.European Journal of Biomedical and Pharmaceutical Sciences.2(1):502-507.
111.Aloh,G.S.,Obeagu,E.I.,Odo,CC.E.,Okpara,K.E.,Ugwu,G.U.and Ononogbu,C.E.(2015).Effects of Methanol Extract of Acioa Barteri on Hepatocellular Damage and Lipid Profile of Albino Rats. European Journal of Biomedical and Pharmaceutical Sciences.2(1):573-588.
112.Aloh,G.S.,Obeagu,E.I.,Odo,C.E.,Obeagu,G.U.,Okpara,K.E.and Kanu,S.N.(2015).Effect of Methanol Extract of Delonix regia on Free Radical Scavengers and Lipid Profile of Wistar Albino Rats.European Journal of Pharmaceutical and Medical Research.2(2):95-123.[Pubmed].
113.Aloh, G.S., Obeagu, E.I., Odo, C.E., Obeagu, G.U., Kanu, S.N., Ugwu, G.U.Ikoro, J.I.(2015).Hepatoprotective and Renal Effects of Methanol Extract of Albuca nigritana bulb in Female Wistar Rats. European Journal of Pharmaceutical and Medical Research.2(2):155-177. [Pubmed].
114.Obeagu, E.I..and Okoroiwu, I.L.(2015).Blood Storage Lesions and other Biochemical Changes Associated with Donor Blood.World Journal of Pharmaceutical Research.4(5):191-199. [Pubmed].
115.Aloh,G.S.,Obeagu,E.I.,Odo,C.E.,Okpara,K.E.,Nwankwo,N.M.and Obeagu,.G.U.(2015).Anti-Diarrhoeal Effects of Napoleonaea imperialism Leaf Extracts. World Journal of Pharmaceutical Research.4(3):205-218. [Pubmed].
116.Nwosu,D.C.,Obeagu,E.I.,Ezeama,M.C.,Ibebuike,J.E.,Agu,G.I.and Uduji, H.I.(2015).Knowledge on Aetiology of Nosocomial Infections among Health Staff Aboh Mbaise General Hospital,Imo State, Nigeria. World Journal of Pharmaceutical Research.4(5):200-208. [Pubmed].
117.Nwosu,D.C.,Obeagu,E.I.,Ozims,S.J.,Ezeama,M.C.and Uduji,H.I.(2015).Prevalence of Urinary Schistosomiasis Infection among Primary School Pupils in Ezza-North Local Government Area of Ebonyi State.International Journal of Current Microbiology and Applied Sciences.4(5):1151-1157.
118..Nwandikor, U.U.and Obeagu, E.I.(2015).Bacteriological Assessment of Different Borehole Drinking Water Sources in Umuahia Metropolis. International Journal of Current Microbiology and Applied Sciences.4(5):1139-1150.
119..Aloh, G.S., Obeagu, E.I.Odo,C.E., Kanu, S.N., Ugwu,G.U.and Mba,O.J.(2015).Effect of Methanol Extract of Napoleonae imperialis on Free Radical Scavengers and Lipid Profile of Wistar Albino Rats.European Journal of Pharmaceutical and Medical Research.2(2):140-154. [Pubmed].
120.Okoroiwu,I.L.and Obeagu,E.I.(2015).Foetal Haemoglobin in Sickle Cell Anaemia in Federal Medical Centre,Owerri,Nigeria.International Journal of Current Research in Biosciences and Plant Biology.2(6);124-126.
121..Aloh,G.S.,Obeagu,E.I.,Odo,C.E.,Okpara,K.E.and Ugwu,G.U.(2015).Effect of Methanol Extract of Gambia albidum Leaves on CCL4-Induced Hepatocellular Damage and Lipid Profile in Albino Rats.European Journal of Biomedical and Pharmaceutical Sciences.2(1):549-572.
122..Nwandikor,U.U.,Obeagu,E.I.and Onyenweaku,F.C.(2015).Bacteriological Assessment of Stream Drinking Water from various Sources in Umuahia Metropolis.World Journal of Pharmceutical Research.4(6):122-137. [Pubmed].
123.Obeagu,E.I.(2015).A Review on Erythropoietin.International Journal of Research in Biological Sciences.2(4):35-47.
124.Aloh,G.S.,Obeagu,E.I.,Odo,C.E.,Okpara,K.E.,Ugwu,G.U.and Abia,K.U.(2015).Anti-Epilectic/Anti-Convulsive Effects of Ocimum basilicum Smoke in Albino Rabbits. European Journal of Biomedical and Pharmaceutical Sciences.2(1):607-621.
125..Nwosu,D.C.,Obeagu,E.I.,Uduji,H.I.,Ezeama,M.C.,Opara,A.U.and Amajioyi,O.(2015).The Socio-Economic Impact of Diabetes Mellitus in Imo State,Nigeria.International Journal of Current Research in Biosciences and Plant Biology.2(5):24-28.
126. .Nwosu,D.C.,Obeagu,E.I.,Ibebuike,J.E.,Ezeama,M.C.and Oze,G.(2015).Effect of Azadirachta Indica A.Juss on Some Biochemical and Haematological Parameters of Wistar Rats. International Journal of Current Research in Biosciences and Plant Biology.2(5):234-238.
127.Obeagu,E.I.,Okoroiwu,I.L.,Ijioma,S.N. and Daniel-Igwe,G.(2015).Vascular Endothelial Growth Factor Receptor-3 in Hypoxia-Induced Vascular Development:A Review. European Journal of Biomedical and Pharmaceutical Sciences.2(3):154-156.
128.Christian,S.C.,Obeagu,E.I.,Jacob,R.B.and Ihua,N.(2015).Effects of Occupational Exposure Hazards on Methaemoglobin Level of Abattoir Workers. International Journal of Current Research in Biosciences and Plant Biology.2(6):54-59.
129.Obeagu,E.I.(2015).Haemolytic Disease of the New Born:A Review.International Journal of Pharmacotherapy.5(1):1-10.
130.Nnodim,J.,Udujih,B.U.,Udujih,H.I.,Nwaokoro,J.C.,Obeagu,E.I.and Aloy-Amadi,O.(2015).Hepcidin and Erythropoietin Level in Sickle Cell Disease.British Journal of Medicine and Medical Research.8(3):261-265.
131.Nnodim,J.,Udujih,B.U.,Edward,U.,Aloy-Amadi,O.,Obeagu,E.I.and Dimeke,C.(2015).Alteration in Uric Acid and C-Reactive Protein in Preeclmpsia Subjects in Owerri.Research Journal of Cell and Molecular Biology.5(1):6-8.
132.Obeagu,E.I.(2015).Erythropoietin(Epo) Level in Sickle Cell Anaemia(HbSS) with Falciparum Malaria Infection in University Health Services,Michael Okpara University of Agriculture,Umudike,Abia State,Nigeria.Paripex-Indian Journal of Research.4(6)259-260.
133.Nwosu,D.C.,Nwanjo,H.U.,Opara,A.U.,Ojiegbe,G.C.,Obeagu,E.I.,Onuoha,C.1, Ajero,C.M.U., Nwokike,G.I.,Okpara,K.E. and Ugwu, G.U.(2015). The Prevalence Of Gastrointestinal Parasites In Children Of School Age In Orodo Mbaitoli L.G.A in 1mo State, Nigeria.European Journal of Biomedical and Pharmaceutical Sciences.2(1):419-425.
134.Nwosu,D.C.,Nwachukwu,P.C.,Avoaja,D.A.,Ajero,C.M.U.,Nwanjo,H.U.,Obeagu,E.I., Nnorom,R.M., Okpara,K.E. and Kanu,S.N.(2015). Index of Potential Contamination For Urinary Schistosomiasis in Afikpo North L.G.A. Ebonyi State, Nigeria. European Journal of Biomedical and Pharmaceutical Sciences.2(1):439-450.
135. Obeagu,E .I.,Okoroiwu,I.L. and Obeagu,G.U.(2015). Molecular mechanism and systemic response of erythropoietin:A Review. International Journal of Advanced Research In Biological Sciences. 2(7): 58–62.
136.Okoroiwu,I.L.,Obeagu, E.I.,Elemchukwu,Q. and Daniel-Igwe,G.(2015). Reticulocyte count in healthy male and female students of imo state university,owerri. International Journal of Advanced Research In Biological Sciences. 2(7): 131–133.
137. Okoroiwu,I.L.,Obeagu,E.I., Daniel-Igwe,G. and Elemchukwu,Q.(2015). Effect of Fever on some Haematological Parameters in Owerri Metropolis. International Journal of Advanced Research In Biological Sciences. 2(7): 134–137.
.138.Okoroiwu,I.L.,Obeagu,E.I.,Elemchukwu,Q.andDaniel-Igwe,G.(2015).Some Haematological Parameters Among Geriatrics in Owerri Metropolis. International Journal of Advanced Research In Biological Sciences. 2(7): 138–141.
139. Obeagu,E.I.,Obeagu,G.U.,Nchuma,B.O.and Amazue,P.O.(2015).A Review on Erythropoietin Receptor(EpoR). International Journal of Advanced Research In Biological Sciences. 2(8): 80-84.
140. Okoroiwu I. L., Obeagu, E. I., Obeagu, G.U. and Adaka ,D.(2015). The Relationship between Platelet Count and Haemoglobin Level. Scholars Academic Journal of Biosciences (SAJB). 3(8):679-68 2. [Pubmed].
141. Obeagu, E.I., Okoroiwu, I.L., Obeagu, G. U., Adaka, D.and Elemchukwu, Q.(2015). Leucocyte Count in Breastfeeding Mothers in Owerri Metropolis. Scholars Academic Journal of Biosciences (SAJB). 3(8): 683-686. [Pubmed].
142.Obeagu,E.I.,Nwovu,A.I.,Ochei,K.C.and Nwachukwu,B.N.(2015).Coagulation System and HIV Infection:A Review.International Journal of Advanced Research in Biological Sciences.2(9):109-134.
143.Obeagu,E.I.,Daniel-Igwe,G.,Obeagu,G.U.,Nwovu,A.I.Nchuma,B.O.(2015).Iron,Ferritin and Total Iron Binding Capacity in Pregnancy and Postpartum.International Journal of Current Research and Review.3(9):158-170.
145.Obeagu,E.I.,Ochei,K.C.,Nwachukwu,B.N.and Nchuma,B.O.(2015).Sickle Cell Anaemia:A Review.Scholar Journal of Applied Medical Science 3(6B):2244-2252. [Pubmed].
146.Obeagu,E.I., Ochei,K.C. and Nwachukwu,B.N.(2015).Methaemoglobinaemia:A Review. Scholar Journal of Applied Medical Science 3(6B):2262-2269. [Pubmed].
147. Obeagu,E.I., Nwachukwu,B.N .and Gloria Daniel-Igwe,G.(2015). Haemostasis and Aging: A Review. International Journal of Current Research in Biosciences and Plant Biology.Volume 2 (10) 68-77.
148.Obeagu,E.I., Ochei,K.C. and Obeagu,G.U.(2015). Leukopoietin and HIV Infection: A Review. International Journal of Current Research in Biosciences and Plant Biology.Volume 2 (10) 78-81.
149.Obeagu,E.I. and Obeagu,G.U.(2015). A Review on Eosinophil Count at Different Conditions. International Journal of Current Research in Medical Sciences. 1 (3): 19–26.
150.Obeagu,E.I. and Obeagu,G.U.(2015).CD8 T Cells in HIV Infection:A Review. International Journal of Current Research in Medical Sciences. 1 (4): 31-38.
151.Nwosu, D.C.,Obeagu, E. I.,Nwanjo, H.U., Ozims, S.J., Uloneme, G.C., Agu, G.C., Nwanna,C.A., Nkwocha, B.C.,Nnorom,R.M.(2015).Studies on Lipid Peroxidative and Antioxidant Activities of Aqueous Leaf Extract of Cymbopogon citratus (Lemon grass) on Paracetamol-induced Hepatoticity in Albino Rats.International Journal of Advanced Multidisciplinary Research . 2(11): 92–96.
152..Nwosu D.C.,Obeagu,E.I.,Nkwocha, B.C., Nwanna, C.A., Nwanjo, H.U., Nwankpa, P., Okpara, A.U., Uloneme, G.C., and Ozims,S.J.(2015). Socio-economic Implications of Diabetes Mellitus in Developing Countries. International Journal of Advanced Multidisciplinary Research . 2(11): 97–101.
153. Nwosu, D.C,Obeagu,E.I., Ikeh, K.O, Nwanjo,H.U., Nwangwu, S.A.. Oluh, C.C.,Okorie, H.,Obioma-Elemba,J.E., Nwankpa,P., Ezenwuba, C. and Ozims, S.J.(2015). Iron Status, Haemoglobin and C-Reactive Protein Levels in Pregnant Women with Malaria Parasitaemia in Owerri. International Journal of Advanced Research in Biological Sciences. 2(11): 260–267.
154. Nwosu, D.C.,Obeagu,E.I., Nkwuocha, B.C., Nwanna, C.A., Nwanjo, H.U.,Amadike, J.N., Ezemma,M.C., Okpomeshine, E.A., Ozims, S.J. and Agu, G.C.(2015). Alterations in superoxide dismutiase, vitamins C and E in HIV infected children in Umuahia, Abia state. International Journal of Advanced Research in Biological Sciences. 2(11): 268–271.
155.Obeagu,E.I.Obeagu,G.U.,Umeh,.A.S. and Okereke,I.F.(2015).Review on Immune Mediated (Type 1 Diabetes Mellitus,Insulin Dependent) Diabetes.InternationalJournal of Innovative and Applied Research.3(11):24-32.
156.Obeagu,E.I.Obeagu,G.U.,Umeh,.A.S. and Okereke,I.F.(2015).Review on Rheumatoid Arthritis. InternationalJournal of Innovative and Applied Research.3(11):33-39.
157.Obeagu,E.I.Obeagu,G.U. and Elemchukwu,Q.(2015).Review on Systemic Lupus Erythematosus (SLE). InternationalJournal of Innovative and Applied Research.3(11):40-45.
158.Emeji, R.,Obeagu, E.I., Idoko, R. and Esanye, B.(2015).Electroyle Concentration in Fuel Pump Attendants within Port Harcourt Metropolis.European Journal of Pharmaceutical
and Medical Research. 2(7):110-114.
159. Ochei, K.C.,Obeagu, E.I., Ugobo, E.E., Mbah, H. and Odo, M.(2015).Perception of Risk of Obesity among Adolescents in Yakurr Local Government, Cross River, Nigeria.European Journal of Biomedical and Pharmaceutical sciences. 2(7): 78-82.
160. Ezeama, M.C.,Obeagu, E.I., Enwereji, E.E., Nwosu, D.C., Nwanjo, H.U., Uduji, H.I. and Ozims,S.J.(2015). challenges of Maternal and Child Health in the Developing World. International Journal of Current Research in Medical and Biological Sciences (IJCRMBS).
161.Ndukwu,M.C., Obeagu, E.I., Enwereji,E.E, Ezeama,E.I., Nwosu,D.C. and Nwanjo, H.U.(2015). Constraints to Non-Compliance to Antiretroviral Drugs Among HIV Sero Positive Patients (A case Study of Ndukwu Hospital,Orlu, Imo State,Nigeria).International Journal of Current Research in Medical and Biological Sciences (IJCRMBS).
162.Okpara A.U.,Obeagu,E.I.,Nkwocha,B.C., Nwanna, C.A., Nwanjo, H.U.,Nwosu, D.C., Ibebuike, J.E. and Nnarom, R.M.(2015). Study on the Variations in CD4+, CD8+ and CD4; CD8 Ratio in HIV-infected Children in Umuahia, Abia State.International Journal of Current Research in Medical and Biological Sciences (IJCRMBS).
163.Nwosu,D.C.,Obeagu,E.I.,Nwanna,C.A.,Nkwocha,B.C.,Ike,K.O.,Nwankpa,P.,Uloneme,G.C.,Elendu,H.N.,Ofodeme,C.N.,Ezenwuba,C.,Oluh,C.C.,Ozims,J.,and Nwanjo, H.U.(2015). Antioxidative Role of Aqueous Leaf Extract of Cymbopogon Citratus (Lemon Grass) on Paracetamol- Induced Hepatoticity in Albino Rats. International Journal of Current Research in Chemistry and Pharmaceutical Sciences. 2(12): 64–70.
164. Obeagu,E.I.,Okoroiwu,I.L.,Daniel-Igwe,Gloria and Elemchukwu,Q.(2015).Comparison of Some Haematological Profiles in Genotype AA, AS and AC Persons Amongst IMO state University students. International Journal of Advanced Multidisciplinary Research. 2(12): 23–28.
165.Obeagu,E.I., Okoroiwu,I.L., Daniel-Igwe,G.,Anaebo, Q.B.N. and ,Ogwuegbu,V. O.(2015). Uric Acid Concentration in Sickle Cell Disease Patients in Owerri Metropolis. International Journal of Advanced Multidisciplinary Research.2(12): 29–32.
166.Nwosu,D.C.,Obeagu,E.l.,Nkwocha,B.C.,Nwanna,C.A.,Nwanjo,H.U.,Amadike,J.N.,Elendu,H.N., Ofoedeme, C.N., Ozims, S.J. and Nwankpa, P.(2016). Change in Lipid Peroxidation Marker (MDA) and Non enzymatic Antioxidants (VIT C & E) in HIV Seropositive Children in an Urban Community of Abia State. Nigeria. J.Bio.Innov .5(1): 24-30.
167. Ifediora,A.C.,Obeagu,E.I.,Anode,A.C. and Okeh, C. C.(2016). Comparison of Bacterial Flora on the Hands of Healthcare Workers and Non-healthcare Workers. J.Bio.Innov5(1): 42-58.

168. Ifediora,A.C.,Obeagu,E.I.,Akahara,I.C.and Eguzouwa, U.P.(2016).Prevalence of Urinary Tract Infection in Diabetic Patients Attending Umuahia Health Care Facilities. J.Bio.Innov5(1): 68-82.
169. Ezimah,A.C.U.,Obeagu,E.I., Ali,J.J., Ezimah,U.A. Ezimah,C.O. , Ugwuishi, C.Chinedum U. Emelike ,C.U.and Ibekailo,S.(2016).Iron Deficiency Anaemia among Adolescent Males in Warri Metropolis, Nigeria. International Journal of Current Research in Medical Sciences. 2(1): 79-82.
170. Odo,M.,Obeagu,E.I., Ochei, K.C., Nkombe, E.,Olusola-Falae, B., Effa, E. and Affirima, B.(2016). Intensified TB Case Finding in PMTCT Settings in Nigeria should be Reconsidered. International Journal of Advanced Research in Biological Sciences. 3(2): 85-92.
171. Olusola-Falae, B., Obeagu,E.I., Odo, M., Ochei, K.C.,Solanke, E. and Idaboh, T.(2016). Impact of Community based Tuberculosis care Interventions on TB Case Detection in Nigeria – What works and what does not? International Journal of Advanced Multidisciplinary Research (IJAMR). 3(2): 30–39
172. Ofor, I. B., Obeagu, E. I., Ochei K.C. and Odo ,M.(2016). Evaluation of Lipids and Protein Profiles in Tuberculosis (TB) Patients on Anti-Tuberculosis Therapy in General Hospital Umuguma, Owerri.International Journal of Current Research in Chemistry and Pharmaceutical Sciences. 3(2): 20-28.
173. Ofor, I. B., Obeagu, E. I., Ochei K.C. and Odo ,M.(2016). Evaluation of Superoxide Dismutase, Glutathione, Vitamins C, E and Trace Element Status in Prostate Cancer Patients in Orlu Teaching Hospital,Imo State. International Journal of Current Research in Chemistry and Pharmaceutical Sciences. 3(2): 29–44.
174. Obeagu, E.I., Ezimah, A.C.U. and Obeagu, G.U.(2016). Erythropoietin in the Anaemias of Pregnancy: A Review. International Journal of Current Research in Chemistry and Pharmaceutical Sciences. 3 3(3): 10-18.
175. Okoroiwu, I.L. Obeagu, E.I., Obeagu, G.U., Chikezie, C.C. and Ezema, G.O. The Prevalence of Selected Autoimmune Diseases.International Journal of Multidisciplinary Research.3.(3):9-14.
176. Ezimah, A. C.U., Obeagu, E. I., Ahmed,H.,Ezimah, U. A. and Ezimah, C. O.(2016). The Prognostic Significance of Neutrophil Polymorph and Band Counts in Under-Five Children with Sepsis in UMTH. International Journal of Advanced Research in Biological Sciences. 3(3): 68-74.
177. Eze, V. U., Obeagu, E.I., Ghali, L., Ezimah ,A.C.U., Ochei ,K.C. Uchegbu-Ibezim, U.A., and Iwegbulam, C.P.(2016). Comparing the Effect of Tocopherol and Inulin on Free Radicals Production in Vitro.World Journal of Pharmaceutical and Medical Research. 2(2): 08-19. [Pubmed].
178. Ezimah, A.C.U.,Obeagu, E.I., Asur, A., Ezimah,U.A. and Ezimah,C. O.(2016). Absolute Platelet Count in Adult Patients with Musculoskeletal Pain:Current Perspectives.International Journal of Current Research in Medical Sciences. 2(2): 30-37.
179. Okoroiwu,I.L.,Obeagu,E.I.,Obeagu,G.U.,Ezema,G.O. and Iwegbulam,C.P.(2016). Some Haematological Variables in Systemic Lupus Erythematosus Patients Imo State Nigeria. International Journal of Current Research in Medical Sciences. 2(3): 8-15.
180.Obeagu,E.I.,Ezimah,A.C.U. and Obeagu,G.U.(2016).Erythropoietin in Hypertension:A Review.Journal of Biological and Chemical Research.33(1):261-278.
181.Ochei,K.C.,Obeagu,E.I.,Ugobo,E.E.,Omo-Emmanuel,U.K. and Odo,M.(2016).Occupational Exposure of Nurses to Harzards in Workplace in Cross River State,Nigeria. Journal of Biological and Chemical Research.33(1B):279-287.
182.Eze,V.U. and Obeagu,E.I.(2016).What are the Arguments that attempts to Show that Embryonic Stem Cell Research is Morally Wrong?Do you agree or disagree with these Arguments. Journal of Biological and Chemical Research.33(1B):288-293.
183.Onyenweaku,F.,Obeagu,E.I.,Ifediora,A.C. and Nwandikor,U.U.(2016).Health Benefits of Probiotics.International Journal of Innovative and Applied Research 4(3):21-30.
184.Okoroiwu,I.L.,Obeagu,E.I. and Obeagu,G.U.(2016).Haematological Variables in Rheumatoid Arthritis Patients in Imo State,Nigeria.International Journal of Advanced Research in Biological Sciences.3(4):91-98.
185.Ezimah,U.A.,Obeagu,E.I.,Ezimah,C.O.,Ezimah,A.and Nto,N.J.(2016).Diarrhoeal Diseases of Acquired Immunodeficiency Syndrome Stimulate more Depletion of Total Antioxidant Status.International Journal of Advanced Multidisciplinary Research 3(4):23-25.
186. Okoroiwu,I.L., Adaka,D.G. and Obeagu,E.I.(2016). Correlation of Values of Haemoglobin and Erythropoietin in Different Trimesters of Pregnancy in Federal Medical Centre Owerri. World Journal of Pharmaceutical and Life Sciences 2(2):26-41.

187.Obeagu,E.I.,Okoroiwu,I.L. and Obeagu,G.U.(2016).Some Haematological Variable in Insulin Dependent Diabetes Mellitus Patients in Imo State,Nigeria. International Journal of Current Research in Chemistry and Pharmaceutical Sciences.3(4): 110-117.
188. Obeagu, E.I., Ochei, K.C., Okeke, E.I. and Anode, A.C.(2016). Assessment of the Level of Haemoglobin and Erythropoietin in Persons Living with HIV in Umuahia.International Journal of Current Research in Medical Sciences. 2(4): 29-33.
189. Obeagu, E.I., Obeagu, G.U.and Ochei, K.C.and Ogbuabor, A.O.(2016). Assessment of the Level of Erythropoietin in Persons Living with HIV in Umuahia. International Journal of Current Research in Medical Sciences. 2(4): 34-37.
190. Ochei K. C.,Obeagu,E.I., Ibegi B. T., Ugobo E. I. and Odo,M.(2016).Prevalence of Hepatitis B and C from Samples Received from the Various Wards in Niger Delta University Teaching Hospital (NDUTH), Okolobiri for Haematological Analyses. Merit Research Journal of Medicine and Medical Sciences . 4(4) pp. 204-209.
191. Obeagu,E.I., Obeagu,G.U., Ezema,G.O. and Eze,V.U.(2016). Evaluation of Erythropoietin and Haematocrit Level in Patients Suffering from Uncomplicated Malaria Infection in Michael Okpara University of Agriculture,Umudike,Abia State,Nigeria. International Journal of Innovative and Applied Research (2016), Volume 4, Issue (4):
192. Obeagu, E. I., Eze,V. U. and Obeagu,G. U.(2016). Serum Erythropoietin and Heamoglobin Concentration in Patients Suffering from Uncomplicated Malaria Infection in Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria. International Journal of Innovative and Applied Research (2016), Volume 4, Issue (4):
193. Obeagu, E.I. (2016).Lipoprotein Implication and Laboratory Estimation.International Journal of Advanced Research in Biological Sciences.3 (6).123-130.
194.Obeagu,E.I. Obeagu,G.U.(2016).Erythrocyte Enumeration,Haemoglobin Concentration and Serum Erythropoietin in Pregnant Women in Federal Medical Centre,Owerri.Journal of Biological and Chemical Research.33(1c):563-573.
195. Ochei,K.C.,Obeagu,E.I.,Odo,M. and Ugobo,E.E.(2016).Laboratory Diagnosis of Mycobacterium tuberculosis in Resource Constraint Setting:Direct Sputum Smear is Comparable with Automated Mycobacterium Growth Indicator Tube( BACTEC MGIT 960).International Journal of Current Microbiology and Applied Sciences 5(6):563-569.
196.Obeagu,E.I.,Okeke,E.I. and Anonde,A.C.(2016).Evaluation of Heamoglobin and Iron Profile Study among Persons Living with HIV in Umuahia,Abia State,Nigeria.International of Currrent Research in Biology and Medicine.1(2):1-5.
197. Obeagu, E.I. Obeagu, G.U., Nwandikor, U. U. and Onyenweaku, F. C.(2016). Determination of Levels of Haematocrit and Erythropoietin in Persons Living with HIV in Umuahia.International Journal of Current Research in Medical Sciences. 2(6): 27-31
198.Obeagu,E.I.,Ibeh,N.C.,Okara,G.C. and Agu C.(2016).Serum Iron Profile Study among Persons Living with HIV in Umuahia,Abia State,Nigeria.World Journal of Biology and Medical Sciences.3(3):11-16.
199.Adaka,D.G.,Okoroiwu,I.L.and Obeagu,E.I.(2016).Correlation of Values of Haematocrit and Erythropoietin in different Trimesters of Pregnancy in Federal Medical Centre,Owerri. World Journal of Biology and Medical Sciences.3 (3):17-26.
200.Ezimah,A.C.U.,Obeagu,E.I.,Nyong,M.I.Ezimah,U.A. and Ezimah,C.O.(2016).Relation between Maternal Haematocrit and Serum Iron Concentration in different stages of Pregancy. World Journal of Biology and Medical Sciences.3 (3):11-16.
201. Obeagu,E.I.(2016).Erythrocyte Enumeration and Serum Erythropoietin in Chronic Kidney Disease Patients: A Study in Federal Medical Centre,Umuahia, Nigeria. International Journal of Advanced Research in Biological Sciences. 3(7): 163-170.
202. Obeagu, E.I., Nwosu,D.C. , Obeagu,G.U. and Emeka-Obi,O.R.(2016).Protein Profile Study among Malnourished Children in Umuahia. International Journal of Current Research in
Medical Sciences. 2(7): 28-31.
203. Obeagu,E.I., Eze,V.U., Alaeboh, E. A. and Ochei,K. C. Determination of Haematocrit Level and Iron Profile Study Among Persons Living With HIV In Umuahia, Abia State, Nigeria.Journal of Bioinnovation.5(4): 464-471.
204. Obeagu, E.I. and Obeagu,G.U.(2016).Correlation of Erythropoietin and Haematocrit Levels in the Anaemias of Chronic Kidney Diseases: A Study in Federal Medical Centre, Umuahia, Nigeria. International Journal of Medicine Research.1 (2): 139-144.
205. Obeagu, E. I., Okoroiwu, I.I. and Ezimah, A.C.U.(2016). Evaluation of serum Erythropoietin Levels in Chronic Kidney Disease Patients in Federal Medical centre, Umuahia, Nigeria.International Journal of Current Research in Biology and Medicine. 1(4): 15-21.
206. Ozims,S.J., Agu,G.C., Amah,H., Izuchukwu,I.F., Nwanjo,H.U.,Nwosu,D.C., Obeagu,E.I., Dike-Ndudi,J., Onu,I., Nnorom,R. and Ibebuike, J.E.(2016). Influence of Socio-economic Factors on Treatment of Tuberculosis Patients in Owerri Municipal.International Journal of Advanced Multidisciplinary Research. (10): 7-20.
207. Izuchukwu,I.F., Ozims,S.J., Agu,G.C., Obeagu,E.I., Onu,I., Amah,H., Nwosu,D.C., Nwanjo,H.U., Edward, Amaka, and Arunsi, M.O. (2016).Knowledge of Preventive Measures and Management of HIV/AIDS Victims among Parents in Umuna Orlu Community of Imo state Nigeria. International Journal of Advanced Research in Biological Sciences.3(10): 55-65.
208. Obeagu, E.I., Oshim, I.O., Ochei, K.C. and Obeagu, G.U.(2016). Iron and blood donation: A Review. International Journal of Current Research in Medical Sciences.2(10): 16-48.
209. Obeagu, E.I., Ochei, K.C. and Oshim, I.O.(2016). Current Concept of Blood Bank Organisation and Planning:A Review.International Journal of Current Research in Biology and Medicine. 1(7): 19-26.
210. Obeagu, E. I., Obeagu, G.U. and Odo, E.O.(2016). A Review on Exercise and Blood Cells. International Journal of Advanced Multidisciplinary Research. 3(11): 70-75.
211. Obeagu, E. I. and Obeagu, G.U.(2016). A Review on Haematological Profile in Menstruating, Pre-menopausal and Menopausal Women. International Journal of Advanced Research in Biological Sciences. 3(11): 92-108.
212. Obeagu,E.I. , Obeagu,G.U. and Nwosu, D.C.(2016). Hepatitis B and Hepatitis C Viral Infection: A Review.International Journal of Current Research in Chemistry and Pharmaceutical Sciences. 3(11): 10-21.
213.Ibeh,N.,Aneke,J.,Okocha,C. and Obeagu,E.(2016). Occupational Exposure to Welders’ Flame could Predispose to Macrocytic Anemia in Welders in Nnewi, South East Nigeria.Journal of Environmental and Occupational Science.5 (3):66-70.
214. Obeagu, E.I.(2016). Correlation of Erythropoietin and Haematocrit in Diabetic Nephropathy Patients in Federal Medical Centre, Umuahia, Nigeria.Journal of Biological and Chemical Research.33 (2):751-759.
215.Obeagu,E.I. and Obeagu,G.U.(2106).Erythropoietin and Kidney Diseases: A Review. Journal of Biological and Chemical Research.33 (2):760-792.
216.Ozims,S.J.,Agu,G.C.,Nwosu,D.C.,Obeagu,E.I.,Amah,H.,Nwanjo,H.U.3,Edward,A. and Izuchukwu,I.F.(2016). The Nature of Institution and the Prevalence of Scabies: a Case Study of Inmates of Portharcourt Prison of Rivers State Nigeria.International Journal of Current Research in Medical Sciences. 2(11): 11-26.
217.Obeagu E.I., Ibeh N.C., Essein U.C., Okafor C.N. and Amachukwu B.O.(2016).Evaluation of Serum Cobalamin Levels in Malnourished Infants in Umuahia.European Journal of Pharmaceutical and Medical Research.4(1), 162-164.[Pubmed]

218 Obeagu E.I., Aneke J., Okafor, C.N., Essein U.C., Ochei K.C. and Obeagu G.U.(2016). Assessment of Serum Iron Status of Malnourished Infants in Umuahia, Abia State, Nigeria. Scholars Journal of Applied Medical Sciences (SJAMS). 4(12C):4384-4387.[Pubmed, DOI: 10.21276/sjams.2016.4.12.39].
219. Ughweroghene, K.O., Ochei ,K.C., Obeagu, E. I. , Odo, M. and Olubunmi ,N.(2017). Evaluation of Laboratory Logistics Management Information System in HIV/AIDS Comprehensive Health Facilities in Bayelsa State, Nigeria. International Journal of Current Research in Medical Sciences. 3(1): 21-38.
220. Onyenweaku, F. C., Amah, H. C., Obeagu, E. I., Nwandikor, U. U. and Onwuasoanya, U. F.(2017). Prevalence of Asymptomatic Bacteriuria and its Antibiotic Susceptibility Pattern in Pregnant Women Attending Private Ante natal Clinics in Umuahia Metropolitan.International Journal of Current Research in Biology and Medicine. 2(2): 13–23.
221. Godswill C Okara,G.C.,Hassan,S. and Obeagu,E.I.(2017). Hepatitis A Virus Infection among Apparently Healthy Nigerian Subjects.ImedJournal-Journal of Biomedical Sciences.6(2):11.
222.Obeagu,E.I.,Ibeh, Nancy C., Nwobodo,H.A.,Ochei,K.C. and Iwegbulam, C.P.(2017).Haematological indices of malaria patients coinfected with HIV in Umuahia. International Journal of Current Research in Medical Sciences. 3(5): 100-104.
223. Obeagu, E.I., Amilo, G. I., Okara, G. C., Ochei, K. C. and Unaeze, B.C.(2017). Evaluation of Impact of HIV on Haematological Indices of Pregnant Women in Umuahia. Merit Research Journal of Medicine and Medical Sciences. 5(5) 214-216.
224. Obeagu, E.I., Onyenweaku, F.C., Nwobodo ,H.A., Ochei, K.C., Ochiabuto, O. M.T.B., Onwuasoanya, U. F., Nwankwo, C.J. and Unaeze, B.C.(2017). Impact of HIV and Hepatitis B Virus Coinfection on Selected Haematological Markers of the Patients in Umuahia, Abia State, Nigeria. Annals of Clinical and Laboratory Research.5 (2):175-178
225. Obeagu,E.I. and Obeagu,G.U.(2017). Hepatitis B Virus and Immunity. Academic Journal of Life Sciences.3 (7): 36-46.

226. Ibebuike J.E., Ojie C.A., Nwokike G.I., Obeagu E.I., Nwosu D.C. ,Nwanjo H.U. , Agu G.C ., Ezenwuba C.O. , Nwagu S.A and Akujuobi A.U.(2017). Factors that influence women’s utilization of primary health care services in Calabar Cros river state, Nigeria. International Journal of Current Research in Chemistry and pharmaceutical sciences. 4(7): 28-33.
227. Ibebuike J.E,, Nwokike G.I,, Nwagu S.A., Ezenwuba C.O., Nwosu D. C., Nwonjo H..U, Obeagu E.I., Ozims S.J., Akujuobi A.U. and Agu G.C.(2017). Adolescent awareness of HIV/AIDS pandemic among secondary school students in Calabar, South-South Nigeria. International Journal of Current Research in Medical Sciences. 3(7): 152-159
228. Obioma, C.F., Jeremiah, Z. A., Okamgba, O. and Obeagu, E.I. (2017). Haemorheologic and Fibrinolytic Activity in HIV Seropositive Subjects at Nnamdi Azikiwe University Teaching Hospital (NAUTH), Nnewi.European Journal of Pharmaceutical and Medical research. 4(8), 159-164

229. Ochiabuto O. M.T.B., Obeagu E.I., Obi C.M., Unaeze B.C., Nwobodo H.A., Obika Chinelo J.1 and Nwosu C.C.(2017). Seroprevalence of Bladder Tumor Antigen in Hospitalized Catheterized Patients and Healthy Individuals of Different Professional Groups in Nnewi.European Journal of Biomedical and Pharmaceutical sciences. 4(8): 50-54.
230. Ochiabuto O. M. T. B., Obeagu E. I., Obi C. M.1, Unaeze B. C., Nwobodo H. A. and
Emmanuel C. B. (2017). Risk Factor for Serocarriage of Ureaplasma Urealyticum among Women of Various Age Range and Profession.World Journal of Pharmaceutical and Medical Research. (7):45-51.
231. Omo-Emmanuel, U.K., Onuzulike, N., Ochei, K. C., Achu, E.T., Obeagu, E. I., Udah, D.C., Omorogbe, E., Ojong, E.O. (2017). HIV and TB co-infection among Patients who used Directly Observed Treatment Short-course centres in Yenagoa, Nigeria. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS). 12(4 Ver. IV ):70-75.

232. Ibebuike, J.E., Ojie, C.A., Nwokike, G.I. , Obeagu, E.I., Nwosu, D.C., Nwanjo, H.U. , Agu, G.C ,Ezenwuba, C.O. , Nwagu, S.A. and Akujuobi, A.U.(2017).Barriers to utilization of maternal health services in southern senatorial district of Cross Rivers state, Nigeria. International Journal of Advanced Multidisciplinary Research. 4(8): 1-9
233. Obeagu,E.I. and Obeagu,G.U. (2017). Occult Hepatitis B infection and immunity. International Journal of Current Research in Medical Sciences. 3(8): 89-100.
234. Obi M. C., Ochiabuto O. M. T. B., Odili F., Onwuasoanya U. F., Ekekwe E. N., Akulue T., Ekwunoh P. O., Chijioke O. U. and Obeagu E. I. (2017). Isolation and Identification of Helicobacter pylori from Cultivated and Commercially Sold Vegetables and Salad from some Selected Towns (Nnewi, and Odekpe) in Anambra State. world Journal of Pharmaceutical and Life Sciences. 3,(7): 55-64

235. Obi M. C., Ochiabuto O. M .T. B., Chukwuma L. N., Onwuasoanya U. F., Ekwunoh P. O., Unaeze B. C. and Obeagu E. I. (2017). Deterimnation of Aflatoxins in Groundnut (Arachis hypogea) Sold in Nnewi Market, Nnewi North L.G.A of Anambra State. World Journal of Pharmaceutical and Life Sciences. 3,(7): 65-68.

236. Unaeze, B.C., Ejike, C. E., Anahalu, I.C. and Obeagu E. I. (2017). Distribution and Antimicrobial Susceptibility of Candida species in different Clinical Samples in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State. European Journal of Biomedical and Pharmaceutical sciences. 4 (9): 171-178.

237. Obeagu, E.I., Amilo, G.I., Obeagu, G.U. and Nnatuanya, I.N.(2017). Human Immunodeficiency Virus infection and cardiovascular Disease. International Journal of Current Research in Medical Sciences. 3(9): 9-44.
238. Obeagu, E.I., Obeagu,G.U., Chijioke,U.O. Ofor, I.B. and Amilo, G.I. (2017). Analysis of Alterations in Selected Haematological Parameters of Ascariasis Patients in Umudike, Abia Stae, Nigeria. Annals of Clinical and Laboratory Research.5 (3):193.
239. Ibebuike J. E., Nwokike I. G., Iquiro A. A., Ibebuike K. E., Nwinyinya O. P., Oti I. P., Obeagu E. I. and Nwosu D. C.(2017). Prevalence of Substance Abuse among Students of Eziach Senior Secondary School Orlu Local Government Area, Imo State. World Journal of Pharmacy and Pharmaceutical Sciences. 6 (10): 1519-1525.
240. Obeagu, E.I., Didia, B.C., Azuonwu, O. and Obeagu, G.U. (2017) .Evaluation of Impact of Congestive Cardiac Failure on Selected Hematological Markers of Patients in Enugu, Nigeria. Interventional Cardiology Journal. 3 (3):68
241. Obeagu, E.I., Obeagu, G.U., Amilo, G.I. and Ekelozie, I.F. (2017). Evaluation of Haematological Parameters in Blount’s Disease in Enugu, Nigeria. Journal of Biotechnology Research.3(9) 72-74.
242. Obeagu EI, Azuonwu O, Didia BC, Obeagu GU.(2017). Evaluation of Impact of Graves Disease on some Selected Haematological Markers among Subjects in Enugu, Nigeria. Open Acc Blood Res Transfus J. 1(4): 555568.
243. Obeagu EI, Didia BC, Obeagu GU, Azuonwu O (2017) Evaluation of Changes in Haematological Profile of Cerebral Malaria Patients in Enugu State, Southeast, Nigeria. Ann Clin Lab Res 5(4): 202.
244. Obeagu EI, Amilo GI, Obeagu GU, Ugwuja SE, Agbo EA.(2017). Evaluation of Impact of Level of Prostate Specific Antigen on Haematological Parameters of Men in Owerri, Nigeria. J Biomed Sci Appl 1 (1):3.
245. Nnatuanya, I.N., Obeagu, E.I., Nnatuanya, C.I.C., Ogar, O.A., Stephen, E.C. and Onah, A . (2017) Evaluation of Alpha One Anti-Trypsin and Haptoglobin in Hypertensive Patients in Elele. Transl Biomed. 8 (4):131
246. Nnatuanya, I.N., Obeagu, E.I., Obeagu, G.U., Nnatuanya, C.I.C. and Chukwudi, E.O. (2017). Evaluation of serum cystatin C levels in fibroid patients in Elele. Int. J. Adv. Res. Biol. Sci. 4(9): 101-103.
247. Ozims S.J., Agu G.C., Amah H.C., Eberendu I.F., Obioma-Elemba J.E., Ihekaire D.E., Akujobi A.U., Obasi C.C., Ibanga I.E., Anokwuru C.O., Nwobodo E.I., Obeagu E.I. and Nwosu D.C.(2017). Effect of aqueous leaf extract of Cymbopogon citrates (Lemongrass- Achara tea) on liver function in paracetamol-induced hepatotoxicity in albino rats. International Journal of Current Research in Chemistry and Pharmaceutical Sciences. 4(11): 43-49.
248. Ozims S.J., Eberendu I.F., Amah H.C., Nwosu D.C., Obeagu E.I., Ibanga I.E., Agu G.C., Uhegbu U., Ihekaire D.E., Amah C.C., Obasi C.C., Agwadike E.O., and Obioma- Elemba J.E.(2017). Prevalence of hypertension among adults aged 30- 69 years who used IMO state specialist hospital, Owerri, Nigeria from 2009-2013. International Journal of Current Research in Medical Sciences. 3(11): 71-82.
249. Obeagu, E.I., and Obeagu, G.U.(2017). Evaluation of Some Haematological Features of Tandem Spinal Stenosis Subjects In a Tertiary Hospital in Enugu, South East, Nigeria. Orthopedics and Rheumatology Open Access Journal. 9(4): 555758..
250. Obeagu, E.I., Obeagu, G.U. and Amilo, G.I.(2017). Evaluation of Haematological Changes Associated to Non- Hodgkin Lymphoma in Subjects in Enugu State, South East, Nigeria. Archives of Blood Transfusion & Disorders.1(2): 000506.
251. Azim's S.J., Eberendu I.F., Obeagu E.I., Ihekaire D.E., Agu G.C., Obioma-Elemba J.E.2, Obasi C.C.1, Uchegbu U.4, Amah H.C.5, Ibanga I.E., Nwosu D.C.5, and Okwara C.(2017). The occurrence of malaria infection in under-five children in Orlu, L.G.A. of Imo state, Nigeria. International Journal of Current Research in Biology and Medicine. 2(11): 72-82.
252. Okamgba, O.C., Nwosu, D.C., Nwobodo, E.I., Agu, G.C., Ozims, S.J., Obeagu, E.I., Ibanga, I.E., Obioma- Elemba, I.E., Ihekaire, D.E., Obasi, C.C., Amah, H.C., Ekendu, M.I. and Ifeanyichukwu, M.O . (2017). Iron Status of Pregnant and Post-Partum Women with Malaria Parasitaemia in Aba Abia State, Nigeria. Ann Clin Lab Res 5(4):206.
253. Obeagu, E.I., Azuonwu , O., Didia, B.C., Obeagu, G.U. and Onyenweaku, F. (2017). Determination of Haematological Changes As¬sociated with Syphilis in Subjects in Umudike, Abia State, Nigeria. Infectious Diseases Diagnosis & Treatment.1(1): -118.

254. Ochei, K.C., Adagbonyin ,E., Obeagu, E.I. and Aminu, B. (2017). Comparative Analysis of Ziehl-Neelsen and Genexpert Techniques for the Diagnosis of Tuberculosis in Human Immuno-Deficiency Virus Positive Patients in Benin City. Ann Clin Lab Res .5(4): 208.
255. Eberendu, I.F., Ozims, S.J., Agu, G.C., Amah, H.C.,, Obasi C.C., Obioma-Elemba, J.E., Ihekaire, D.E., Ibanga, I.E., Amah ,C.C.,Obeagu ,E.I. and Nwosu, D.C.(2017). Impact of human activities on the breeding of mosquitoes of human disease in Owerri metropolis, Imo state. International Journal of Advanced Research in Biological Sciences. 4(12): 98—106
256. Ozims S.J., Agu G.C., Amah H.C., Eberendu I.F., Obioma-Elemba J.E., Ihekaire D.E., Akujobia A.U., Obasi C.C1, Ibanga I.E., Anokwuru C.O., Nwobodo E.I., Obeagu E.I. and Nwosu D.C.(2018). Prevalence of Prostate Enlargement among Males> 50 Years of Age Who were Treated at Abia State University Teaching Hospital, Aba from 2010- 2014. International Journal of Research Studies in Medical and Health Sciences.3(1):1-7.

257. Ekelozie, I. S., Ekejindu, I. M., Ochiabuto, O., Obi, M., Onwuasonya, U. and Obeagu, E. I. (2018). Evaluation of Salmonella Species in Water Sources in Two Local Government Areas of Anambra State. Cohesive Journal Microbiol infectious Disease. 1(1). CJMI.000501.

258. Azim's S.J., Agu G.C., Eberendu I.F., Obioma-Elemba J.E., Amah H.C., Ihekaire D.E., Obasi C.C., Nwosu D.C., Obeagu E.I., Ibanga I.E., Amah C.C.3, and Chidomere M.C.(2018). Patterns of tobacco use among commercial tri-cycle riders in Owerri municipal council, Imo state. International Journal of Advanced Multidisciplinary Research. 5(1): 1-9.
259. Obeagu, E.I. (2018). The role of Hypoxia-inducible factors in Tumourigenesis: A Review. International Journal of Current Research in Biology and Medicine. 3(1): 70-76.
260. Ochei, K.C., Obeagu, E.I., Akpan, E., and Ezeh-Ifeanyi, G.N. and Ekelozie, I.S.(2018). A Review on tuberculosis in Human Immunodeficiency Virus infection. International Journal of Current Research in Medical Sciences. 4(1): 51-80.
261. Nwovu, A.I., Obeagu, E.I., Obeagu, G.U.,, and Nwovu, S.N. (2018). Occurrence of Some Blood Borne Viral Infection and Adherence to Universal Precautions among Laboratory Staff in Federal Teaching Hospital Abakaliki Ebonyi State. Archives of Blood Transfusion and Disorders.1(2):508.

262. Obeagu, E.I. (2018). A Review on Bladder Tumor Antigens. Cancer Therapy and Oncology International Journal. 9 (3):762.

263. Obeagu E.I. and Obeagu, G.U. (2018). A Review on Erythropoietin in Pregnancy.
Journal of Gynecology and Women’s Health.8(3):740.
264. Obeagu, E.I., Ochei, K.C., Obeagu, G.U., Ezeh-Ifeanyi, G.N., Ekelozie, I.S. and Onyenweaku, F.(2018). A Review on Hepatitis and Haemostasis. International Journal Comprehensive Research in Biological Science 5(2): 24-46.
265. Obeagu, E.I., Obeagu ,G.U., Ekelozie, I.S., Ochei, K.C. and Swem, C.A. (2018). Vitamin D and insulin resistance in HIV seropositive individuals in Umudike. Int. J. Curr. Res. Med. Sci. 4(2): 104-108.
266. Obeagu ,E.I. (2018). A Review on insulin and vitamin D in premenopausal and menopausal women. Int. J. Curr. Res. Med. Sci. 4(2): 109-122.
267. Obeagu, E. I. (2018). A Review on Free Radicals and Antioxidants. Int. J. Curr. Res. Med. Sci. 4(2): 123-133.
268. Obeagu, E. I. (2018). A Review on Trace Elements and Petroleum Pollution. International Journal of Current Research in Chemistry and Pharmaceutical Sciences 5(2): 4-12.
269. Obeagu ,E.I, Obeagu, G.U., Ekelozie, I.S., Ochei, K.C. and Swem, C. A. (2018). Comparative study of trace elements level in petroleum attendants exposed to petroleum pollutant in Umuahia. Int. J. Curr. Res. Biol. Med. 3(2): 26-31.
270. Obeagu ,E.I., Obeagu, G.U., Swem, C.A. and Ochei, K.C. (2018). A review on vitamin D and Insulin resistance in HIV infection. Int. J. Curr. Res. Biol. Med. 3(3): 1- 9.
271. Obeagu ,E.I. and Swem, C.A. (2018). A Review on laboratory logistics management information system in HIV commodities supply. Int. J. Adv. Res. Biol. Sci. 5(2): 188-196.
272. Onyenweaku, FC., Obeagu, E.I., Nwandikor, U.U. and Ogwuegbu, V.O. (2018). A Review on Heamolytic Uremic Syndrome. Int. J. Curr. Res. Med. Sci. 4(3): 80- 92.
273. Ogomaka, I.A., Nwachinemere, A.V. and Obeagu, E.I. (2018). Prevalence of Trichomoniasis among Adults in Oru-East L.G.A, Imo State, Nigeria. Archives of Clinical Microbiology 9 (2):79
274. Obeagu, E.I. (2018). A review on Fish Oil for Healthy Living. Int. J. Compr. Res. Biol. Sci. 5(4): 6-13.
275. Obeagu E.I. (2018). A review on palm oil supplemented diet and enzymatic antioxidants in aging. Int. J. Curr. Res. Med. Sci. 4(4): 43-52.
276. Ejike ,B.N. and Obeagu ,E.I. (2018). A review on Fast Foods and Family Lifestyle. Int. J. Curr. Res. Biol. Med. 3(4): 26-30.

277. Ejike, B.N. and Obeagu, E.I. (2018). Consumption of fast foods and their effects on family lifestyle in Aba north L.G.A of Abia state. Int. J. Curr. Res. Med. Sci. 4(4): 34-42.

278. Ifediora, A.C.,Obeagu,E.I.,Akahara,I.C. and Eguzouwa, U.P.(2016). Prevalence Of Urinary Tract Infection In Diabetic Patients Attending Umuahia Health Care Facilities. Journal of Bioinnovation.5(1): 68-82.

279. Obeagu, E,I. and Obeagu, G.U.(2018). An update on Anaemia, Iron, Folic acid and
Vitamin B 12 in Pregnancy and Postpartum. International Journal of Current Research in
Medical Sciences 4(5): 62-70.

280. Obeagu, E.I., Ochei, K.C. and Udunma, O.C. (2018). Trichomonas vaginalis: Complications and Treatment. International Journal of Current Research in Medical Sciences 4(5): 76-89.

281. Obeagu ,E.I. (2018). A Review on Health Benefits of Exercise. International Journal of Current Research in Biology and Medicine 3(5): 83-89.

282. Etim, E.A.,Adebayo,Y.A. and Obeagu, E.I. (2018). Effect of Luffa cylindrica Leaf Extract on Hematological Parameters of Swiss Albino Mice. Medicinal & Aromatic Plants.7(2): 1000318

283. Etim, E.A., Adebayo,Y.A., Adewale, A.A., Ola, M.A., Adjekuko ,O.C and Obeagu, E.I. (2018). Effect of methanolic leaf extract of Ficus thonningii on hematological indices of Swiss albino mice . Journal of Medicinal Plants Studies 2018; 6(4): 22-26.

283. Obeagu, E. I. & Obeagu, G .U. (2018).Use of Umblical Cord Blood in the Management of Leukaemia. Open Access Journal of Oncology and Medicine. 2(3): OAJOM. MS.ID.000138.

284. Obeagu, E. I. & Obeagu, G .U. (2018). Utilization of Antioxidants in the Management of Diabetes Mellitus Patients.1 (1):102

285. Obeagu Emmanuel Ifeanyi, Aloy-Amadi Oluchi Chinwe, Ochei Kingsley Chinedum and Swem Collins Abum. (2018). A Review on Platelets and Coagulation. International Journal of Current Research in Medical Sciences 4(7): 17-24.
286. Obeagu Emmanuel Ifeanyi, Ekelozie Ifeoma Stella, Anyiam Arinze Favour and Onwuzurike Peace Amaka. (2018). Update on Glucose -6- Phosphate Dehydronase Deficiency. International Journal of Current Research in Medical Sciences 4(7): 32-37.

287. Akunueze EU, Ifeanyi OE, Onyemobi EC, Johnson N, Uzoanya EAU (2018) Antioxidants in the Management of Human Immuodeficiency Virus Infection. Journal of HIV & Retrovirus. 4. (2):12

288. Igwe, M.C., Aloh ,G.S. and Obeagu, E.I. (2018). Evaluation of effect of Crude Methanol Tetrapleura Tetraptera (TTE) on Hematological Parameters of Albino Rats. Journal of Hematology &
Thromboembolic Diseases. 6(2): 1000293

289. Igwe, M.C., Obeagu, E.I. (2018). Determination of the Effect of Methanol Extract of Tetrapleura tetraptera Fruit Osmotic Fragility of Erythrocytes, Platelet Aggregation and Phospholipase A2 Activity.Annals of Clinical and Laboratory Research. 6( 3): 250.

290. Obeagu, E.I., Ekelozie, I.S. and Anyiam, A.F.(2018). Antioxidants In The Management of Sickle Cell Anaemia. International Journal of Hematology and Blood Disorders Open Access. 3(2). 1-2

291. Obeagu, E.I. and Obeagu, G.U. (2018). A review on anaemia in pregnancy. Hematology & Transfusion International Journal.6(3). 114.

292. Obeagu, E.I., Okoroiwu, I.L., Nwosu, D.C. and Ochei, K.C. (2018). A Review on blood borne viral infections: Universal precautions. International Journal of Advanced Research in Biological Sciences5(6): 60-66.

293. Obeagu, E.I.( 2018). A Review on Methaemoglobinaemia: From Diagnosis to Treatment.Current Trends in Bimedical Engineering and Biosciences.14(2):884

294. Obeagu, E.I. (2018). A Review on Iron Homeostasis and Anaemia in Pulmonary Tuberculosis.
International Journal of Healthcare and Medical Sciences.4(5): 84-89.

295. Obeagu ,E.I. (2018). A Review on Pregnancy and Haematology. A Review on Pregnancy and Haematology3(5): 26-28.

296. Ogalue, U.M., Ekejindu, I.M., Ochiabuto, O.M.T.B, Obi ,M.C., Obeagu E.I. and Ekelozie, I.S.(2018). Intestinal Parasites, Malaria and Anemia among School Children in Some Flood Affected Areas of Ogbaru Local Government Anambra State, Nigeria 9(2):80.

297. Obeagu ,E.I. and Obeagu, G.U . (2018). A Review on Cystatin C and Fibroid. International Journal of Current Research in Medical Sciences. 4(5): 1-20.

298. Obeagu, E.I. (2018). A Review on Nutritional Anaemia. International Journal of Advanced Multidisciplinary Research. 5(4):11-15.

299. kelozie IS, Obeagu EI, Ochiabuto OMTB, Udunma OC (2018) Hookworm Infestation amongst Primary School Children in Enugu. Annals of Clinical Laboratory Research.6(1): 227.

300. Obeagu Emmanuel Ifeanyi. (2018). A review on palm oil supplemented diet and enzymatic antioxidants in aging. International Journal of Current Research in Medical Sciences. 4(4): 43-52.

301. Okorie, H.M., Obeagu, E.I., Eze, E.N. and Jeremaiah, Z.A. (2018). Assessment of coagulation parameters in malaria infected pregnant women in Imo state Nigeria. International Journal of Current Research in Medical Sciences. 4(9):41-49.

302. Okorie, H.M., Obeagu, E.I., Eze, E.N. and Jeremiah, Z.A. (2018). Assessment of some haematological parameters in malaria infected pregnant women in Imo state Nigeria. International Journal of Current Research in Biology and Medicine. 3(9): 1-14.

303. Obeagu E. I. Okoroiwu I.L. and Azuonwu O. (2018).An update on hypoxic regulation of iron homeostasis and bone marrow environment. International Journal of Current Research in Medical Sciences. 4(10): 42-48.

304. Obeagu, E.I. (2018). An update on micro RNA in sickle cell disease. International Journal of Advanced Research in Biological Sciences 5(10): 157-158.
305. Obeagu E.I., Chijioke, U.O. and Ekelozie I.S. (2018). Hypertension a great threat to human life. International Journal of Advanced Research in Biological Sciences 5(10): 159-161.

306. Obeagu, Emmanuel Ifeanyi. (2018). Sickle Cell Anaemia: Haemolysis and Anemia. International Journal of Current Research in Chemistry and Pharmaceutical Sciences 5(10): 20-21.

307. Ekelozie, I.S., Chijioke, U.O. and Obeagu, E.I. (2018). Evaluation of Candidiasis among pregnant women attending antenatal clinic in University of Benin teaching hospital (Ubth), Benin city, Edo state. International Journal of Current Research in Biology and Medicine 3(11): 15-23.

307. Obeagu, E.I. (2018). Vaso-occlusion and adhesion molecules in sickle cells disease. International Journal of Current Research in Medical Sciences 4(11): 33-35.

308. Ibedu, C. l, Ihetu, C.C., Okoro, O.S. and Obeagu, E.I. (2018). Phytochemical composition and antimicrobial properties of Garcinia kola (Bitter Kola) seed extract. International Journal of Current Research in Chemistry and Pharmaceutical Sciences. 5(11): 8-12.

309. Obeagu, E.I. (2018). Sickle cell anaemia: Historical perspective, Pathophysiology, and Clinical Manifestations. International Journal of Current Research in Chemistry and Pharmaceutical Sciences. 5(11): 13-15.

Juan Carlos Troiano, DVM

Professor at the University of Buenos Aires School of Veterinary Medicine, Buenos Aires Argentina
Troiano, J.C.; Vidal, J.C. ; Gould, E.; Gould, J.-1997 HAEMATOLOGICAL REFERENCE INTERVALS OF THE SOUTH AMERICAN RATTLESNAKE (CROTALUS DURISSUS TERRIFICUS, LAURENTI, 1768) IN CAPTIVITY- Comparative Haematology International, 1:109-112

Troiano, J.C. ; Silva, M.C. -1998 REFERENCE HEMATOLOGIC VALUES IN ARGENTINE TERRESTRIAL TURTLE(CHELONOIDIS CHILENSIS CHILENSIS)
Analecta Veterinaria, 18 (1- 2):47-51.

Troiano, JC; Althaus, RL; Malinskas, G. -1997. PERFIL BIOQUIMICO SANGUINEO DE LAS ESPECIES ARGENTINAS DEL GENERO CAIMAN EN CONDICIONES DE CAUTIVIDAD Revista Española de Herpetología, 11: 31-34.

Troiano, J.C.; Altahus, R. ; Scaglione, M.C. ; Scaglione, L. -1998. OSMOTIC FRAGILITY AND SIZE OF ERYTRHOCYTES IN CAIMAN LATIROSTRIS AND CAIMAN CROCODYLUS JACARE (CROCODYLIA – ALLIGATORIDAE) UNDER CAPTIVE CONDITIONS. Comparative Hematology International, 8: 50-52

Troiano, J.C. ; Vidal, J.C.; Gould, E; Malinskas, Gould, E.; Scaglione, L.M.; Scaglione, M., Heker, J.J. ; Simoncini, C.; Dinapoli, H.A. -1999- HAEMATOLOGICAL AND BLOOD CHEMICAL VALUES FROM BOTHROPS AMMODYTOIDES (OPHIDIA -CROTALIDAE) IN CAPTIVITY.Comparative Haematology International, 9:31-35

de Roodt, A.; Dolab, A.; Hajos, S.E..; Gould,E.; Dinapoli, H.; Troiano, J.C.; Gould, J.; Dokmetjian ,C.; Carfagnini, J.C.; Fernández, T.; Amoroso, M.; Segre, L. ; Vidal,J.C.- 2000.SOME TOXIC AND ENZIMATIC ACTIVITIES OF BOTHROPS AMMODYTOIDES (YARARA ÑATA) VENOM.Toxicon, 38: 49-61.

Troiano, J.C. ; Vidal, J.C. ; Uriarte, E.; Gould, E.; Gould, J.; Heker, J.; Simoncini, C.; Tapia, G. -2000 - OSMOTIC FRAGILITY AND ERYTHROCYTE SIZE IN IGUANA IGUANA (SAURIA -IGUANIDAE) IN CAPTIVITY. Comparative Haematology International, 10: 14-18.

Troiano, J.C.; Vidal, J.C.; Gould, E.; Heker, J.J.; Gould, J.A.; Vogt, A.U.; Simoncini, C.; Amantini, E.; de Roodt, A.R. -2000- HEMATOLOGICAL VALUES IN FOUR BOTHROPIC SPECIES FROM ARGENTINA. The Journal of Venomous Animals and Toxins, 6(2):194-204.

Troiano, J.C.; Gould, E.; Althaus, R.L. ; Malinskas, G.; Gould, J.; Heker, J.; Vidal, J.C. ; Amantini, E.; Simoncini, C. - 2001 -BLOOD BIOCHEMICAL PROFILE OF THE SOUTH AMERICAN RATTLESNAKE (CROTALUS DURISSUS TERRIFICUS) IN CAPTIVITY. The Journal of Venomous Animals and Toxins., 7(2): 183-189

Troiano, J.C., Gould, E., Gould, I. -2006- HEMOLITIC ACTION OF NAJA NAJA ATRA CARDIOTOXIN ON ERYTHROCYTES FROM DIFFERENT ANIMALS.The Journal of Venomous Animals and Toxins, 12(1):44-58

Troiano, J.C., Gould, E., Gould, I. -2008-HEMATOLOGICAL REFERENCE NTERVALS IN ARGENTINE LIZARD TUPINAMBIS MERIANAE (SAURIA – TEIIDAE). Comparative Clinical Pathology, 17:93-97.

Troiano, J.C., Gould, E. – 2011- INTERSPECIFIC DIFFERENCES IN THE HAEMATOLOGICAL REFERENCE INTERVALS IN TUPINAMBIS GENUS FROM ARGENTINA (SAURIA- TEIIDAE) Comparative Clinical Pathology.20( 4): 309-312


Fassac, J.L.; TroianoJ.C. -2011- APPROACH AND SUSTAIN THERAPY OF RESPIRATORY DISORDERS IN THE ARGENTINE TERRESTRIAL TURTLE. Selecciones Veterinarias, Vol. 20 (2): 70-79

Fassac, J.L. ; Troiano J.C. – 2012- REVISIÓN AND ACTUALIZATION TO RADIOLOGIC DIAGNOSTIC IN TERRESTRIAL TURTLES- Selecciones Veterinarias Vol. 20 (1):14 - 25

Troiano J.C. - 2013 -COLECTING BLOOD SAMPLES IN REPTILES
Memories from Intern Conference in Medicine of Wildlife and not convencional Fauna. Vol. 9(1):68-72
Troiano J.C. - 2013 - HEMATOLOGY IN ARTIODACTYLA
Memories from Intern Conference in Medicine of Wildlife and not convencional Fauna. Vol. 9(1):68-72 Vol. 9(2):3-8.

Delgado; A.R., Lorente, J.A.; Troiano, J.C.; Rejf, P.C. (2017)ISOLAMENTO DE CHRYSOSPORIUM SPP. EM DERMATITE EM IGUANA IGUANA. PRIMEIRO RELATO NA ARGENTINA Clínica Veterinaria – 127: 82-85. IN PORTUGUESE

Alain L. Fymat, BA, BS, MA, MS, PhD, PhD

Board Vice Chair, Science Director, and Scientific Committee Chair Society for the Advancement of Science in Africa (SASA) and Founding Chair, President/CEO and Institute Professor International Institute of Medicine & Science California, USA
DR. ALAIN L. FYMAT, Ph.D. is a medical-physical scientist and an educator. He is the current President/CEO and Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was also Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science. He is also Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California. He is a frequent Keynote Speaker and International Organizing Committee Member of several international scientific conferences. He has lectured extensively in the U.S., Europe, Asia, and Africa. He has published ~ 425 scholarly scientific publications and books. He is also Editor-in-Chief, Honorable Editor or Editor of 62 medical/scientific Journals. Dr. Fymat is a Board member of several institutions, a member of the New York Academy of Sciences and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO. His current research interests are focused on nanomedicine, precision/personalized medicine, neurodegenerative diseases (including Alzheimer, Parkinson, epilepsy, dementias) with many open literature contributions in these several areas.
Lie at the interface between medicine and science, particularly molecular/personal/precision medicine, nanomedicine, nanobiotechnology, human genetics/epigenetics/ecogenetics, and neurological disorders (particularly Alzheimer, Parkinson, epilepsy, dementia, etc.).
He has received numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He has lectured extensively in several national and international academic, professional, governmental and industrial venues. He is the Editor-in-Chief, Honorable Editor or Editor of 54 medical/scientific Journals to which he contributes regularly. He is a professional member of the New York Academy of Sciences, an advisor to the American Heart/Stroke Association (Coachella Valley Division) and a reviewer for the prestigious UNESCO Newton Prize.
He has extensively published (~ 425 scholarly publications (including patents, books & monographs, book chapters, refereed articles).

Leonid Nefyodov, PhD, MD

Professor of Biochemistry Department and supervisor of Laboratory of Biochemistry of Biologically Yanka Kupala State University of Grodno Belarus
Leonid Nefyodov – Professor (Biology), Ph.D. [Cand. of Sciences (Biology)], M.D. [Doctor of Sciences (Medicine)], Awarded the Medal of Honor of the European Order of Merit - the EC award for achievements in the field of science, A. Schweitzer Prize Winner, D.h.c., Professor of Biochemistry Department and supervisor of Laboratory of Biochemistry of Biologically Active substances of Yanka Kupala State University of Grodno, Belarus.
Area of researches – biochemical mechanisms of regulatory effects of amino acids, their derivatives, and compositions, the methodology of use of amino acids as universal regulators of metabolism, medicines, components of treatment and prophylactic food, including the development of solutions and specialized mixes of this class of substances. Author of 9 books, 270 reviews and articles and academic publications in journals "Biochemistry", "Biophysics", "Oncology", “Molecular Biology”, "Clinical Surgery", "Chemistry and Pharmacology", "Drugs Exptl. Clin. Res", “European Journal of Cancer” in general and applied biochemistry, biochemistry of amino acids and its derivatives, clinical biochemistry, oncology, and pharmacology.
The organizer and the scientific editor of materials of six international symposiums on biochemistry which are carried out in the Republic of Belarus, Congress of the Belarusian biochem¬ists (2000) and the first (1996, 2001) international "amino acid" congresses of the CIS countries. Current research interests related to mechanisms of realization of antitumor drugs, amino acid pool formation and clinical applications of natural substances and amino acids. The validity of this strategy has been confirmed by the results of the design of novel drugs based on highly purified L-amino acids. Founder and head of the scientific school "Biochemistry of amino acids".
Under him scientific guide more than 20 Ph.D. and MD. The methodology of researches and development Nefyodov's school in the field of creation of new effective medicinal and preventive preparations is based on the operation of regulatory action of the physiological (endogenous) concentration of the free amino acids defining regularities of formation of a metabolic imbalance at various pathological states and diseases.
Fundamental stages on the way of creative formation and development of school of sci¬ences were the results, methodology and strategy of researches presented in Nefyodov's monograph "Taurine: pharmacology, biochemistry and medical application" (1999) and the first international "amino acid" congresses of the CIS countries led to Grodno of organizational con¬gress (1996, 2001), and also development and pro¬duction of the medicines ("Taurine", "Leucine", "Tryptophane", "Takamine").
Biochemical mechanisms of regulatory effects of amino acids, their derivatives, and compositions, the methodology of use of amino acids as universal regulators of metabolism, medicines, components of treatment and prophylactic food, including the development of solutions and specialized mixes of this class of substances
[1] Nefyodov L. Taurine (biochemistry, pharmacology, medical application) Grodno RIPH. - 1999.- 145 p.
[2] Amino Acids And Their Derivatives (chemistry, biochemistry, pharmacology, medicine) /ed. L.Nefyodov // Proc of Internat. Symp; Grodno. – 1996. - 125 p.
[3] Nefyodov LI. et al. Amino acids and their derivatives in tumour tissue from patients with breast cancer treated with Ukrain. Part VI. Drugs Exp Clin Res. 1996;22(3-5):155-7.
[4] Nefyodov LI.et al. Amino acids and their derivatives in blood plasma of patients with breast cancer treated with Ukrain. Part V. Drugs Exp Clin Res. 1996;22(3-5):159-61.
[5] Nefyodov, L.I. Celowo ukierunkowana regulacja rownowagi metabolizmu aminokwasami /L.I.Nefyodov // Proc of XXXIV Zjazd Polskego Towarzystwa Biochemicznego. - Bialystok, 1998. - p. 270.
[6] Biological activity and transport of drugs / ed. L. Nefyodov // Proc of Internat. Symp.; Grodno. – 1999. – 189 p.
[7] VI Ordinary General Assembly Society of Biochemistry of Belarus / ed. L. Nefyodov // Proc of Internat. Symp;. Grodno. – 2000. – 225 p.
[8] Amino acids and their derivatives in biology and medicine / ed. L. Nefyodov // Proc of Internat. Symp;. – Grodno. – 2001. – 124 p.
[9] Nefyodov, L.I. Target - oriented regulation of metabolic equilibrium by amino acids and strategy of their ap-plication as drugs with directional effects /L.I. Nefyodov // XXXVII Zjazd Polskiego towarzystwa biochemicznego, Torun.- 10-14 IX 2001.- p.327
[10] Nefyodov, L.I. The results of biochemical research and development of nitrogen-containing compounds of natural origin: methodology of exploitation of biological properties as universal natural regulators of metabolism and drugs. - http://www.nil.grsu.by/index.php?page=index
[11] Glazev AA, Nefedov LI. Changes in amino acid patterns of blood plasma in tumor patients treated with anti-cancer drug NSC-631570: possible approaches to cancer diagnostics // Biomed Khim. 2008 May-Jun;54(3):289-300
[12] Glazev AA, Nefedov LI. Reduced glutathione interaction with thiophosphoric derivatives of alkaloids of Che-lidonium majus L. in vitro // Biomed Khim. 2009 Jan-Feb;55(1):114-20.
[13] Nefyodov L.I. et al. Determination of level of the added Chelidonium majus L alkaloids in blood of oncologi-cal patients as a high-selective method of diagnosis of a cancer of in vitro. Laboratory diagnostics. Eastern Europe – 2012.-№1. - P.66 - 71.
[14] Nefyodov L.I. et al. Mechanisms of realization of metabolic and specific antitumor activity of new antineoplastic preparation deglutam. Laboratory diagnostics. Eastern Europe – 2012. - No. 2. - P. 36 - 41.
[15] 1. Nefyodov L. Creation Pathogenetic the Determined Compositions of Amino Acids and their Derivatives for Practical Realization of the Regulating Effect of these Substances. J. Blood Disordes & Transfusion. - 2015, V.6, №3 http://www.omicsonline.org/open-ac¬cess/dx.doi.org/10.4172/2155-9864.1000270. php?aid=53369
[16] 2. Nefyodov, L. Metabolic Mechanisms of Specific Antitumor Activity of the Novel Me¬dicinal Preparation Deglutame / L. Nefyodov P. Karavay, N. Karavay // Medical Scienc. Wesley @ Eber Publishing. Weber Medicinal Plant Research, March 2015. - V.1. - №1.-2015.www.weberpub.org/wmpr.htm
[17] Nefyodov L.I. Perspective for the use of regulatory effects of free amino acids in the development of infusion solutions aimed metabolic action / Nefyodov L.I., Karavay P.A., Karavay N.L.//Journal of Molecular Biomarkers & Diagnosis. - 2015. - V.6, №3, p.100-104
[18] Nefyodov L. Creation of Infusion Solutions with Pathogenetically Deterministic Com¬position on the Basis of Regulatory Actions of Free Amino Acids and their Derivatives / Nefyo¬dov L., Karavay P., Karavay N.// J. Res. De-velopment. – 2015, V.3, №1;http://www.omicsonline.com/open-ccess/dx.doi.org/10.4172/jrd.1000122.php?aid=55625
[19] Nefyodov L. Perspective for the Use of Regulatory Effects of Free Amino Acids in the Creation on their Basis of Infusion Solutions / Karavay P., Nefyodov L., Karavay N.// Academia Journal of Scientific Research 2015 V.3, №3:http:// doi:10.15413/ajsr.2015.0139. ISSN2315-7712.
[20] Nefyodov L. Metabolic comfort in oncology and free amino acids: perspectives for the use of their regulatory actions in physiological concentrations / Karavay A., Karavay P., Kaliada T., Nefyodov L. // J. Oncology Res & Exp. 2016.- Med (JOREM_3330973_20160905). ре¬жим доступа http:// www.sciencepublishinggroup.com/j/jorem. DOI:10.15761/IMM.1000245.

Prof. Erich Cosmi, MD, PhD

Director of Prenatal Diagnosis and Fetal Therapy Unit Associate Professor of Obstetrics and Gynecology Department of Woman and Health Child University of Padua School of Medicine Padua, 35128, Italy
Erich Cosmi is one of a leading expert in Maternal-Fetal Medicine with high scientific and clinical expertise in intrauterine growth restriction, fetal anemia, Hydrops in the fetus and Cytomegalovirus infection. Moreover, he contributed to create the new technique called sonovaginography in the diagnosis in deep infiltrating endometriosis. He is skilled in obstetrical surgery and currently is involved in solving the problem with cosmetic surgery in women who underwent esisiorrafy facing dyspareunia and doing abdominoplasty in obese women during Cesarean section.
He received many scientific awards as well as his contributors and actually id the Director of Maternal and Fetal Medicine at Padua University.
He was invited to 120 international conferences, is in the editorial board of 120 Scientific Journals and Editor in Chief of 4 Journals. Erich Cosmi published more than 400 articles and 168 in high ranking Journal. A total citation index is 2732 and H index 29.
Prizes and Awards
2000, “Ugo Tropea” prize for the best communication in Obstetrics
2001, Bastianelli prize at the University of Rome “La Sapienza”.
2002, CNR prize for research in USA, Charlottesville, USA.
2007, Prize “Whos Who in the World",
2007, Prize “International Health Professional”
2008, Prize “Whos Who in Science and engineering”
2009, BestCommunication “International Society of Ultrasound in Obstetrics and Gynecology” Hamburg.
2010, Best Communication “International Society of Ultrasound in Obstetrics and Gynecology” Los Angeles, USA.
Prizes received from his fellows
2010 The Y.W. Loke New Investigator Travel Award abstract “Metabolomic Profiling of Cordonal Blood in Intrauterine Growth Restricted Fetuses”, submitted for presentation at the International Federation of
Placenta Associations 2010 meeting.(Collaborative: Silvia Visentin)
2011Best Abstract italian sociery of perinatal medicine, Firenze in data 29 March - 1 aprile 2011 ed è stata nominata “Miglior Giovane Ricercatore”. (collaborator: Martina Bertin)
2011 The Y.W. Loke New Investigator Travel Award 2011, in recognition of the excellence of the abstract submitted for the EPG/17th IFPA Meeting, 14-17 September 2011, Geilo, Norway. (collaborator: Silvia Visentin)
2011prize “Young Researcher”, congress Controversies in Obstetrics, Gynaecology & Infertility (COGI), Parigi (Francia) 17 al 20 November 2011. (collaborator: Martina Bertin)
2012 Prize Giorgio Pardi Fundation Premio at the FIOG conference 2012, 13-15 April 2012. (collaborator: Martina Bertin)
2014 Italian Society of Maternal Fetal Medicine, November 2014, Milan, Collaborator: Salvatore Gizzo
2014 Italian Society of Maternal Fetal Medicine, November 2014, Milan, Collaborator: Grazia Giunta
1. Cosmi E, Grisan E, Fanos V, Rizzo G, Sivanandam S, Visentin S. Growth Abnormalities of Fetuses and Infants. Biomed Res Int. 2017; 3191308.
2. Correani A, Visentin S, Cosmi E, Ponchia E, D'Aronco S, Simonato M, Vedovelli L, Cogo P, Carnielli VP. The maternal-fetal gradient of free and esterified phytosterols at the time of delivery in humans. Clin Nutr. 2017, 13,
3. Visentin S, Palermo C, Camerin M, Daliento L, Muraru D, Cosmi E, Badano LP. Echocardiographic Techniques of Deformation Imaging in the Evaluation of Maternal Cardiovascular System in Patients with Complicated Pregnancies. Biomed Res Int. 2017; Aug 22. Review.
4. Saia M, Buja A, Cosmi E, Mantoan D, Baldo V. Trend and variability in open and laparoscopic hysterectomies for patients with benign disease: a retrospective cohort study. Ann Ist Super Sanita. 2017; 53(2):135-141.
5. Bellussi F, Cataneo I, Visentin S, Simonazzi G, Lenzi J, Fantini MP, Mimmi S, Cosmi E, Pilu G. Clinical Validation of the INTERGROWTH-21st Standards of Fetal Abdominal Circumference for the Prediction of Small-for-Gestational-Age Neonates in Italy. Fetal Diagn Ther. 2017;42(3):198-203.
6. Visentin S, Londero AP, Camerin M, Grisan E, Cosmi E. A possible new approach in the prediction of late gestational hypertension: The role of the fetal aortic intima-media thickness. Medicine (Baltimore). 2017;96
7. Ghi T, Prefumo F, Fichera A, Lanna M, Periti E, Persico N, Viora E, Rizzo G; Società Italiana di Ecografia Ostetrica e Ginecologica Working Group on Fetal Biometric Charts. Development of customized fetal growth charts in twins. Am J Obstet Gynecol. 2017;216(5)
8. Virdis G, Dessole M, Dessole S, Ambrosini G, Cosmi E, Cherchil PL, Capobianco G. Holt Oram syndrome: a case report and review of the literature. Clin Exp Obstet Gynecol. 2016;43(1):137-9.
9. Tarroni G, Visentin S, Cosmi E, Grisan E. Fully-automated identification and segmentation of aortic lumen from fetal ultrasound images. Conf Proc IEEE Eng Med Biol Soc. 2015; 153-6.
10. TARRONI G, VISENTIN S, COSMI E, GRISAN E. A NOVEL APPROACH TO AORTIC INTIMA-MEDIA THICKNESS QUANTIFICATION FROM FETAL ULTRASOUND IMAGES. PROCEEDINGS - INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGINGVOLUME 2015-JULY, 21 JULY 2015, ARTICLE NUMBER 7164006, PAGES 858-861
11. TARRONI G, VISENTIN S, COSMI E, GRISAN E. A FULLY AUTOMATED APPROACH TO AORTIC DISTENSIBILITY QUANTIFICATION FROM FETAL ULTRASOUND IMAGES. COMPUTING IN CARDIOLOGYVOLUME 42, 16 FEBRUARY 2015, ARTICLE NUMBER 7411014, PAGES 729-732
12. Ghi T, Cariello L, Rizzo L, Ferrazzi E, Periti E, Prefumo F, Stampalija T, Viora E, Verrotti C, Rizzo G; Società Italiana di Ecografia Ostetrica e Ginecologica Working Group on Fetal Biometric Charts. Customized Fetal Growth Charts for Parents' Characteristics, Race, and Parity by Quantile Regression Analysis: A Cross-sectional Multicenter Italian Study. J Ultrasound Med. 2016;35(1)
13. Schiavo AA, Franzin C, Albiero M, Piccoli M, Spiro G, Bertin E, Urbani L, Visentin S, Cosmi E, Fadini GP, De Coppi P, Pozzobon M. Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia. Stem Cell Res Ther. 2015; 31;6:209.
14. Visentin S, Londero AP, Bellamio B, Giunta G, Cosma C, Faggian D, Plebani M, Cosmi E. Fetal Endothelial Remodeling in Late-Onset Gestational Hypertension. Am J Hypertens. 2016 Feb;29(2):273-9.
15. Radu CM, Campello E, Spiezia L, Dhima S, Visentin S, Gavasso S, Woodhams B, Cosmi E, Simioni P. Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women. Scand J Clin Lab Invest. 2015;75(6):487-95.
16. Campello E, Spiezia L, Radu CM, Dhima S, Visentin S, Valle FD, Tormene D, Woodhams B, Cosmi E, Simioni P. Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia. Thromb Res. 2015;136(2):427-31.
17. Roverso M, Berté C, Di Marco V, Lapolla A, Badocco D, Pastore P, Visentin S, Cosmi E. The metallome of the human placenta in gestational diabetes mellitus. Metallomics. 2015 Jul;7(7):1146-54.
18. Noventa M, Ancona E, Quaranta M, Vitagliano A, Cosmi E, D'Antona D, Gizzo S. Intrauterine Morcellator Devices: The Icon of Hysteroscopic Future or Merely a Marketing Image? A Systematic Review Regarding Safety, Efficacy, Advantages, and Contraindications. Reprod Sci. 2015;22(10):1289-96.
19. Gizzo S, Andrisani A, Noventa M, Di Gangi S, Quaranta M, Cosmi E, D'Antona D, Nardelli GB, Ambrosini G. Caesarean section: could different transverse abdominal incision techniques influence postpartum pain and subsequent quality of life? A systematic review. PLoS One. 2015 Feb 3;10(2).
20. Saccardi C, Visentin S, Noventa M, Cosmi E, Litta P, Gizzo S. Uncertainties about laparoscopic myomectomy during pregnancy: A lack of evidence or an inherited misconception? A critical literature review starting from a peculiar case. Minim Invasive Ther Allied Technol. 2015;24(4):189-94.
21. Ottaviano G, Cosmi E, Iacono V, Scarpa B, Staffieri A, Scadding GK. Does the contraceptive pill influence peak nasal inspiratory flow values? Rhinology. 2014;52(4):355-9.
22. Visentin S, Grumolato F, Nardelli GB, Di Camillo B, Grisan E, Cosmi E. Early origins of adult disease: low birth weight and vascular remodeling. Atherosclerosis. 2014;237(2):391-9.
23. Veronese E, Tarroni G, Visentin S, Cosmi E, Linguraru MG, Grisan E. Estimation of prenatal aorta intima-media thickness from ultrasound examination. Phys Med Biol. 2014 Nov 7;59(21):6355-71.
24. Visentin S, Londero AP, Grumolato F, Trevisanuto D, Zanardo V, Ambrosini G, Cosmi E. Timing of delivery and neonatal outcomes for small-for-gestational-age fetuses. J Ultrasound Med. 2014;33(10):1721-8.
25. Gizzo S, Noventa M, Di Gangi S, Saccardi C, Cosmi E, Nardelli GB, Plebani M. Could molecular assessment of calcium metabolism be a useful tool to early screen patients at risk for pre-eclampsia complicated pregnancy? Proposal and rationale. Clin Chem Lab Med. 2015;53(7):975-9.
26. Visentin S, Lapolla A, Londero AP, Cosma C, Dalfrà M, Camerin M, Faggian D, Plebani M, Cosmi E. Adiponectin levels are reduced while markers of systemic inflammation and aortic remodelling are increased in intrauterine growth restricted mother-child couple. Biomed Res Int. 2014;2014:401595.
27. Noventa M, Ancona E, Cosmi E, Saccardi C, Litta P, D'Antona D, Nardelli GB, Gizzo S. Usefulness, methods and rationale of lymph nodes HPV-DNA investigation in estimating risk of early stage cervical cancer recurrence: a systematic literature review. Clin Exp Metastasis. 2014;31(7):853-67.
28. Gizzo S, Noventa M, Bertocco A, Cosmi E, Nardelli GB. Vaginal sampling of amniotic fluid in pPROM: a new technique for early detection of subclinical chorioamnionitis? Pediatr Neonatol. 2015;56(1):70-1
29. Roverso M, Lapolla A, Cosma C, Seraglia R, Galvan E, Visentin S, Cosmi E, Desoye G, Traldi P. Some preliminary matrix-assisted laser desorption/ionization imaging experiments on maternal and fetal sides of human placenta. Eur J Mass Spectrom (Chichester). 2014;20(3):261-9.
30. Bortolus R, Blom F, Filippini F, van Poppel MN, Leoncini E, de Smit DJ, Benetollo PP, Cornel MC, de Walle HE, Mastroiacovo P; Italian and Dutch folic acid trial study groups. Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands. BMC Pregnancy Childbirth. 2014; 13;14:166.
31. Zanardo V, Bertin M, de Luca F, Zaninotto M, Trevisanuto D, Cosmi E. Albuminuria and sodiuria in IUGR children. J Matern Fetal Neonatal Med. 2015;28(3):362-5.
32. Di Gangi S, Bertin M, Noventa M, Cagnin A, Cosmi E, Gizzo S.Obstetric dilemma on the most appropriate management of Creutzfeldt-Jakob disease in pregnancy: seventh case presentation, literature review and new insight. J Matern Fetal Neonatal Med. 2015 Feb;28(3):254-61
33. Andrisani A, Donà G, Ambrosini G, Bonanni G, Bragadin M, Cosmi E, Clari G, Armanini D, Bordin L. Effect of various commercial buffers on sperm viability and capacitation. Syst Biol Reprod Med. 2014;60(4):239-44.
34. Mozzanega B,Gizzo S,Di Gangi S,Cosmi E,Nardelli GB (2014). Ulipristal Acetate: Critical Review About Endometrial and Ovulatory Effects in Emergency Contraception. REPRODUCTIVE SCIENCES (ISSN:1933-7191), 195- 196, 34;
35. Zanardo V, Visentin S, Trevisanuto D, Bertin M, Cavallin F, Cosmi E. Fetal aortic wall thickness: a marker of hypertension inIUGR children? (2013) HYPERTENSION RESEARCH (ISSN: 09169636). 440-43, 36;
36. Visentin S, Macchi V, Grumolato F, Porzionato A, De Caro R, Cosmi E (2013). Expectant management in Type II selective intrauterine growth restriction monochorionic twins and abnormal cord insertion JOURNAL OF PERINATAL MEDICINE (ISSN:1619-3997), 309- 316, 41;
37. Capobianco G,Wenger JM,Marras V,Cosmi E,Ambrosini G,Dessole M,Cherchi PL (2013). Immunohistochemical evaluation of epithelial antigen Ber-Ep4 and CD10: new markers for endometriosis? EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY (ISSN:0392-2936), 254- 256, 34;
38. Cosmi E,Visentin S,Favretto D,Tucci M,Ragazzi E,Viel G,Ferrara SD (2013). Selective Intrauterine Growth Restriction in Monochorionic Twin Pregnancies: Markers of Endothelial Damage and Metabolomic Profile. TWIN RESEARCH AND HUMAN GENETICS (ISSN:1832-4274), 1- 11, 23;
39. Spiezia L,Visentin S,Radu C,Bon M,Woodhams B,Cosmi E,Simioni P (2013). Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia. THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (ISSN:1476-7058) 1252-53, 26;
40. Trevisanuto D,Peruzzetto C,Cavallin F,Vedovato S,Cosmi E,Visentin S,Chiarelli S,Zanardo V (2013). Fetal placental inflammation is associated with poor neonatal growth of preterm infants: a case-control study. THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (ISSN:1476-7058), 1484-90, 26;
41. Visentin S., Grisan E., Zanardo V., Bertin M., Veronese E., Cavallin F., Ambrosini G., Trevisanuto D., E. Cosmi (2013). Developmental programming of cardiovascular risk in intrauterine growth-restricted twin fetuses according to aortic intima thickness JOURNAL OF ULTRASOUND IN MEDICINE (ISSN:0278-4297), 279- 284, 32;
42. Mozzanega B; COSMI E. (2012). Considerazioni su ellaone® ITALIAN JOURNAL OF GYNAECOLOGY & OBSTETRICS (ISSN:1121-8339), 107- 112, 23;
43. Gizzo S, Noventa M, Saccardi C, Paccagnella G, Patrelli TS, Cosmi E, D'Antona D. Twin pregnancy after kidney transplantation: what's on? A case report and review of literature. J Matern Fetal Neonatal Med. 2014 Nov;27(17):1816-9.
44. Capobianco G, Donolo E, Wenger JM, Madonia M, Cosmi E, Antimi L, Dessole M, Cherchi PL. Efficacy and 9 years' follow-up of posterior intravaginal slingplasty for genital prolapse. J Obstet Gynaecol Res. 2014;40(1):219-23.
45. Capobianco G, Wenger JM, Marras V, Cosmi E, Ambrosini G, Dessole M, Cherchi PL. Immunohistochemical evaluation of epithelial antigen Ber-Ep4 and CD10: new markers for endometriosis? Eur J Gynaecol Oncol. 2013;34(3):254-6.
46. Cosmi E, Visentin S, Favretto D, Tucci M, Ragazzi E, Viel G, Ferrara SD. Selective intrauterine growth restriction in monochorionic twin pregnancies: markers of endothelial damage and metabolomic profile. Twin Res Hum Genet. 2013;16(4):816-26.
47. Trevisanuto D, Peruzzetto C, Cavallin F, Vedovato S, Cosmi E, Visentin S, Chiarelli S, Zanardo V. Fetal placental inflammation is associated with poor neonatal growth of preterm infants: a case-control study. J Matern Fetal Neonatal Med. 2013 Oct;26(15):1484-90.
48. Zanardo V, Visentin S, Bertin M, Zaninotto M, Trevisanuto D, Cavallin F, Cosmi E. Aortic wall thickness and amniotic fluid albuminuria in growth-restricted twin fetuses. Twin Res Hum Genet. 2013;16(3):720-6
49. Mozzanega B, Cosmi E, Nardelli GB. Ulipristal acetate in emergency contraception: mechanism of action. Trends Pharmacol Sci. 2013;34(4):195-6.
50. Spiezia L, Visentin S, Radu C, Bon M, Woodhams B, Cosmi E, Simioni P. Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia. J Matern Fetal Neonatal Med. 2013;26(13):1352-4.
51. Zanardo V, Visentin S, Trevisanuto D, Bertin M, Cavallin F, Cosmi E. Fetal aortic wall thickness: a marker of hypertension in IUGR children? Hypertens Res. 2013;36(5):440-3.
52. Visentin S, Grisan E, Zanardo V, Bertin M, Veronese E, Cavallin F, Ambrosini G, Trevisanuto D, Cosmi E.Developmental programming of cardiovascular risk in intrauterine growth-restricted twin fetuses according to aortic intima thickness. J Ultrasound Med. 2013 Feb;32(2):279-84. Erratum in: J Ultrasound Med. 2013;32(3):550.
53. Visentin S, Macchi V, Grumolato F, Porzionato A, De Caro R, Cosmi E. Expectant management in type II selective intrauterine growth restriction and abnormal cord insertion in monochorionic twins. J Perinat Med. 2013;41(3):309-16. doi: 10.1515/jpm-2012-0133.
54. Acanfora L, Rampon M, Filippeschi M, Marchi M, Montisci M, Viel G, Cosmi E. An inflatable ergonomic 3-chamber fundal pressure belt to assist vaginal delivery. Int J Gynaecol Obstet. 2013;120(1):78-81.
55. Ludwig K,Salmaso R,Cosmi E,Iaria L,De Luca A,Margiotti K,Citton V,Manara R,Rugge M (2012). "PENTALOGY OF CANTRELL WITH COMPLETE ECTOPIA CORDIS IN A FETUS WITH ASPLENIA" PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (ISSN:1093-5266), 495- 498, 15(6);
56. Visentin S, Manara R, Milanese L, Da Roit A, Forner G, Salviato E, Citton V, Magno FM, Orzan E, Morando C, Cusinato R, Mengoli C, Palù G, Ermani M, Rinaldi R, Cosmi E, Gussetti N (2012). Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age CLINICAL INFECTIOUS DISEASES (ISSN:1058-4838), 497- 503, 55;
57. Ludwig K, Salmaso R, Cosmi E, Iaria L, De Luca A, Margiotti K, Citton V, Manara R, Rugge M (2012). "PENTALOGY OF CANTRELL WITH COMPLETE ECTOPIA CORDIS IN A FETUS WITH ASPLENIA" PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (ISSN:1093-5266), 495- 498, 15;
58. Ludwig K,Salmaso R,Manara R,Cosmi E,Baldi M,Rugge M (2012). Apert Syndrome with Fused Thalami. FETAL AND PEDIATRIC PATHOLOGY (ISSN:1551-3815), 410- 414, 31(6);
59. Cosmi E,Rampon M,Saccardi C,Zanardo V,Litta P (2012). Middle cerebral artery peak systolic velocity in the diagnosis of fetomaternal hemorrhage. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (ISSN:0020-7292), 128- 130, 117;
60. Saccardi C, Cosmi E, Borghero A, Alberto T, Dessole S, Litta P. (2012). Comparison between transvaginal ultrasound, sonovaginography and magnetic resonance imaging in the diagnosis of posterior deep infiltrating endometriosis. ULTRASOUND IN OBSTETRICS & GYNECOLOGY (ISSN:0960-7692), 464- 469, 40;
61. Patrelli TS, Gizzo S, Cosmi E, Carpano MG, Di Gangi S, Pedrazzi G, Piantelli G, Modena AB. (2012). Maternal hydration therapy improves the quantity of amniotic fluid and the pregnancy outcome in third-trimester isolated oligohydramnios: a controlled randomized institutional trial. JOURNAL OF ULTRASOUND IN MEDICINE (ISSN:0278-4297), 239- 244, 31;
62. Favretto D,Cosmi E,Ragazzi E,Visentin S,Tucci M,Fais P,Cecchetto G,Zanardo V,Viel G,Ferrara SD (2012). Cord blood metabolomic profiling in intrauterine growth restriction. ANALYTICAL AND BIOANALYTICAL CHEMISTRY (ISSN:1618-2642), 1109- 1121, 402;
63. Bertucci V; Boffo M; Mannarini S.; Serena A; Saccardi C; Cosmi E; Andrisani A; Ambrosini G (2012). Assessing the perception of childbirth experience in Italian woman: A contribution to the adaptation of the childbirth perception questionnaire MIDWIFERY (ISSN:0266-6138), 265- 274, 28(2);
64. Lo Vasco VR; Cosmi E; Visentin S; Di Raimo T; Salmaso R; Zanardo V; Trevisanuto D; Businaro R (2011). IL-1ß and IL-23 in amniotic fluids of ultrasound-detected aortic intima/media thickness and growth retardation JOURNAL OF REPRODUCTIVE IMMUNOLOGY (ISSN:0165-0378), 64-67,93;
65. Zanardo V,Gambina I,Begley C,Litta P,Cosmi E,Giustardi A,Trevisanuto D (2011). Psychological distress and early lactation performance in mothers of late preterm infants. EARLY HUMAN DEVELOPMENT (ISSN:0378-3782), 321- 323, 87;
66. Cecconi D. , Lonardoni F.,Favretto D.,Cosmi,E.,Tucci M,Visentin S, Cecchetto, G,Fais P, Viel G, Ferrara SD (2011). Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation. ELECTROPHORESIS (ISSN:0173-0835), 3630- 3637, 32;
67. Cosmi E, Fanelli T, Visentin S, Trevisanuto D, Zanardo V (2011). Consequences in infants that were intrauterine growth restricted. JOURNAL OF PREGNANCY (ISSN:2090-2727), 364- 381,
68. Mozzanega B; Cosmi E (2011). How do levonorgestrel-only emergency contraceptive pills prevent pregnancy? Some considerations. GYNECOLOGICAL ENDOCRINOLOGY (ISSN:0951-3590), 439- 442, 27;
69. Zanardo V; Gambina I; Begley C; Litta P;Cosmi E; Giustardi A; Trevisanuto D. (2011). Psychological distress and early lactation performance in mothers of late preterm infants. EARLY HUMAN DEVELOPMENT (ISSN:0378-3782), 321- 323, 87
70. Zanardo V; Fanelli T; Weiner G; Fanos V; Zaninotto M; Visentin S; Cavallin F; Trevisanuto D;Cosmi E (2011). Intrauterine growth restriction is associated with persistent aortic wall thickening and glomerular proteinuria during infanc KIDNEY INTERNATIONAL (ISSN:0085-2538), 119- 123, 80;
71. Lo Vasco VR; Salmaso R; Zanardo V; Businaro R; Visentin S; Trevisanuto D; Cosmi E (2011). Fetal aorta wall inflammation in ultrasound-detected aortic intima/media thickness and growth retardation. JOURNAL OF REPRODUCTIVE IMMUNOLOGY (ISSN:0165-0378), 103- 107, 91;
72. Litta P; Fantinato S; Calonaci F; Cosmi E.; Filippeschi M; Zerbetto I; Petraglia F; Florio P (2010). A randomized controlled study comparing harmonic versus electrosurgery in laparoscopic myomectomy. FERTILITY AND STERILITY (ISSN:0015-0282), 1882- 1886, 94;
73. Zanardo V, Vedovato S, Cosmi E, Litta P , Cavallin F, Trevisanuto D , Chiarelli S (2010). Exploring the association between chorioamnionitis and respiratory outcome. BJOG (ISSN:1470-0328), 497- 499, 117;
74. Saccardi C., Borghero A., Cosmi E., Conte L., Caserta D., Litta P. (2010). Evaluation of the impact of endmetriotic lesions on patient’s pelvic pain symptoms. JOURNAL OF ENDOMETRIOSIS (ISSN:2035-9969), 155- 163, 2;
75. Zanardo V,Vedovato S,Cosmi E,Litta P,Cavallin F,Trevisanuto D,Chiarelli S (2010). Preterm premature rupture of membranes, chorioamnion inflammatory scores and neonatal respiratory outcome. BJOG (ISSN:1470-0328), 94- 98, 117;
76. Litta P,Sacco G,Tsiroglou D,Cosmi E,Ciavattini A (2010). Is antibiotic prophylaxis necessary in elective laparoscopic surgery for benign gynecologic conditions? GYNECOLOGIC AND OBSTETRIC INVESTIGATION (ISSN:0378-7346), 136-139, 69;
77. Cosmi E,Saccardi C,Litta P,Nardelli GB,Dessole S (2010). Transvaginal ultrasound and sonohysterography for assessment of postpartum residual trophoblastic tissue. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (ISSN:0020-7292), 262- 264, 110;
78. Zanardo V,Svegliado G,Cavallin F,Giustardi A,Cosmi E,Litta P,Trevisanuto D (2010). Elective cesarean delivery: does it have a negative effect on breastfeeding? BIRTH-ISSUES IN PERINATAL CARE (ISSN:0730-7659), 275- 279, 37;
79. Zanardo V; Trevisanuto D; Cosmi E; Chiarelli S. (2010). Chorioamnionitis and cerebral palsy: a meta-analysis. OBSTETRICS AND GYNECOLOGY (ISSN:0029-7844), 1454- 1454, 116 (6);
80. Saccardi C; Ludwig K; Cosmi E; D'Antona D.; Salmaso R; Fassina A (2010). Tracheal agenesis with bifurcating common airway arising from midesophagus. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (ISSN:1093-5266), 252- 254, 13(3);
81. Rossi G; Cosmi E; Trevisanuto D; Cappellari A; Andrisani A; Visentin S; Chiarelli S.; Zanardo V(2010). Umbilical Arterial Necrotic Vasculopathy Associated with Fetal Ascites. FETAL DIAGNOSIS AND THERAPY (ISSN:1015-3837), 110- 112, 27;
82. Zanardo V; Vedovato S; Cosmi E; Litta P; Cavallin F; Trevisanuto D; Chiarelli S.; (2009). Preterm premature rupture of membranes, chorioamnion inflammatory scores and neonatal respiratory outcome. BJOG (ISSN:1470-0328), 94-98,117;
83. Bignardi T., Cosmi E., Saccardi C., Litta P. (2009). Reply JOURNAL OF ULTRASOUND IN MEDICINE (ISSN:0278-4297), 409- 411, 28;
84. Litta P., Altomare A., Giudetti G., Pinzauti S., Giardina I. , Cosmi E., Fantinato S., Conte, L., Battista R., Bertarelli C., Petraglia F., Florio P. (2009). A randomized controlled study comparing harmonic versus electrosurgery in laparoscopic myomectomy [La miomectomia per via laparoscopica: Confronto tra elettrochirurgia e bisturi ad ultrasuoni] GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA (ISSN:0391-9013), 407- 412, 31;
85. Saccardi C., Cocco A., Tregnaghi A., Cosmi E., Baldan N., Ancona E., Litta P. (2009). DEEP PELVIC ENDOMETRIOSIS: FROM DIAGNOSIS TO WELLNESS JOURNAL OF ENDOMETRIOSIS (ISSN:2035-9969), 150- 156,
86. Cosmi E,Saccardi C,Litta P (2009). The sonographic diagnosis of deep endometriosis. JOURNAL OF ULTRASOUND IN MEDICINE (ISSN:0278-4297), 410- 411, 28;
87. Fadda GM,Capobianco G,Balata A,Litta P,Ambrosini G,D'Antona D,Cosmi E,Dessole S (2009). Routine second trimester ultrasound screening for prenatal detection of fetal malformations in Sassari University Hospital, Italy: 23 years of experience in 42,256 pregnancies. EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY (ISSN:0301-2115), 110-114, 144;
88. Salmaso R; Manara R; Fassan M; Severino MS; Visentin S; Macchi V.; Cosmi E (2009). Radiological-Pathological Comparison in a Case of Conjoined Gnatho-Thoracopagus Twins FETAL DIAGNOSIS AND THERAPY (ISSN:1015-3837), 223- 226, 26;
89. Cosmi E; Visentin S; Fanelli T; Mautone AJ; Zanardo V. (2009). Aortic Intima Media Thickness in Fetuses and Children With Intrauterine Growth Restriction OBSTETRICS AND GYNECOLOGY (ISSN:0029-7844), 1109- 1114, 114;
90. Rigon C; Andrisani A; Forzan M; D'Antona D; Bruson A; Cosmi E; Ambrosini G; Tiboni GM; Clementi M. (2009). Association study of AMH and AMHRII polymorphisms with unexplained infertility. FERTILITY AND STERILITY (ISSN:0015-0282), 1244-8, 94;
91. Litta P; Sacco G; Tsiroglou D; Cosmi E.; Ciavattini A (2009). Is antibiotic prophylaxis necessary in elective laparoscopic surgery for benign gynecologic conditions? GYNECOLOGIC AND OBSTETRIC INVESTIGATION (ISSN:0378-7346), 136- 139, 69;
92. Rossi G; Cosmi E.; Trevisanuto D; Cappellari A; Andrisani A; Visentin S; Chiarelli S; Zanardo V (2009). Umbilical Arterial Necrotic Vasculopathy Associated with Fetal Ascites. FETAL DIAGNOSIS AND THERAPY (ISSN:1015-3837), 102- 110, 27;
93. Spiller E; Salvador L; Bogana G; Neri F; Ambrosini G; Cosmi E.; D'Antona D (2008). Body stalk anomaly: management of two dichorionic-diamniotic pregnancies THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (ISSN:1476-7058), 758- 759, 21(10);
94. Ambrosini G,Nanhorngue K,Pascoli I,Cester M,Cosmi E (2008). Mirror syndrome due to coxackie B virus associated to maternal peripartum cardiomyopathy. JOURNAL OF PERINATAL MEDICINE (ISSN:0300-5577), 36;
95. Litta P,Spiller E,Saccardi C,Ambrosini G,Caserta D,Cosmi E (2008). Resectoscope or Versapoint for hysteroscopic metroplasty. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (ISSN:0020-7292), 39-42,101;
96. Litta P,Cosmi E,Saccardi C,Esposito C,Rui R,Ambrosini G (2008). Outpatient operative polypectomy using a 5 mm-hysteroscope without anaesthesia and/or analgesia: advantages and limits. EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY (ISSN:0301-2115), 210-14, 139;
97. Dessole S; Capobianco G; Virdis P; Rubattu G; E. Cosmi; Porcu A; (2007). Hepatic rupture after cesarean section in a patient with HELLP syndrome: a case report and review of the literature ARCHIVES OF GYNECOLOGY AND OBSTETRICS (ISSN:0932-0067), 189- 192, 2;
98. Piazze J; Anceschi M; Cerekja A; Cosmi E.; Meloni P; Alberini A; Pizzulo S; Argento T; Cosmi EV (2007). The combined effect of betamethasone and ritodrine on the middle cerebral artery in low risk third trimester pregnancies. JOURNAL OF PERINATAL MEDICINE (ISSN:0300-5577), 135- 140, 35;
99. Mari G; Hanif F; Kruger M; Cosmi E.; Santolaya-Forgas J; Treadwell MC (2007). Middle cerebral artery peak systolic velocity: a new Doppler parameter in the assessment of growth-restricted fetuses ULTRASOUND IN OBSTETRICS & GYNECOLOGY (ISSN:0960-7692), 306- 310, 29;
100. Baschat AA; Cosmi E.; Bilardo CM; Wolf H; Berg C; Rigano S; Germer U; Moyano D; Turan S; Hartung J; Bhide A; Muller T; Bower S; Nicolaides KH; Thilaganathan B; Gembruch U; Ferrazzi E; Hecher K; Galan HL; Harman CR (2007). Predictors of neonatal outcome in early-onset placental dysfunction. OBSTETRICS AND GYNECOLOGY (ISSN:0029-7844), 253- 261, 109;
101. Zanardo V; Vedovato S; Trevisanuto D; Cosmi E; Suppiej A; Chiarelli S. (2006). Brain damage of extremely low birth weight infants with histopathologic chorioamnionitis. PEDIATRIC RESEARCH (ISSN:0031-3998), 422- 423, 58;
102. Ambrosini G.; Andrisani A; Porcu E; Rebellato E; Revelli R; Caserta D; Cosmi E; Marci R; Moscarini M (2006). Oocytes cryopreservation: state of art. REPRODUCTIVE TOXICOLOGY (ISSN:0890-6238), 250- 262, 22;
103. Capobianco G; Cherchi Pl; Ambrosini G; Cosmi E.; Andrisani A; Dessole S (2006). Alobar holoprosencephaly, mobile proboscis and trisomy 13 in a fetus with maternal gestational diabetes mellitus: a 2D ultrasound diagnosis and review of the literature ARCHIVES OF GYNECOLOGY AND OBSTETRICS (ISSN:0932-0067), 264- 266, 18;
104. Zanardo V; Vedovato S; Trevisanuto D; Suppiej A; Cosmi E.; Fais GF; Chiarelli S. (2006). Histological chorioamnionitis and neonatal leukemoid reaction in low-birth-weight infants. HUMAN PATHOLOGY (ISSN:0046-8177), 87- 91, 37;
105. Cosmi E,Ambrosini G,D'Antona D,Saccardi C,Mari G (2005). Doppler, cardiotocography, and biophysical profile changes in growth-restricted fetuses. OBSTETRICS AND GYNECOLOGY (ISSN:0029-7844), 1240- 1245, 106;
106. Litta P,Cosmi E,Sacco G,Saccardi C,Ciavattini A,Ambrosini G (2005). Hysteroscopic permanent tubal sterilization using a nitinol-dacron intratubal device without anaesthesia in the outpatient setting: procedure feasibility and effectiveness. HUMAN REPRODUCTION (ISSN:0268-1161), 3419-22,20;
107. Cosmi E; Piazze JJ; Ruozi A; Anceschi M; La Torre R; Andrisani A; Litta P; Nardelli G.B.; Ambrosini G. (2005). Structural-tridimensional study of yolk sac in pregnancies complicated by diabetes JOURNAL OF PERINATAL MEDICINE (ISSN:0300-5577), 132- 136, 33;
108. Litta P.S.; Cosmi E.; Nardelli G.B. (2005). Laparoscopic myomectomy following GnRH therapy INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (ISSN:0020-7292), 63- 64, 88;
109. Cosmi E.; Litta P; Andrisani A; Di Lenardo L; Fadda Gm; Ambrosini G. (2005). Non-invasive diagnosis by Doppler ultrasonography of fetal anemia due to massive fetomaternal hemorrhage in a case of twin-twin transfusion syndrome treated with serial amnioreduction ULTRASOUND IN OBSTETRICS & GYNECOLOGY (ISSN:0960-7692), 415- 416, 25;
110. Cosmi E.; Dessole S; Uras L; Capobianco G; D'antona D; Andrisani A; Litta P; Ambrosini G.(2005). Middle cerebral artery peak systolic and ductus venosus velocity waveforms in the hydropic fetus JOURNAL OF ULTRASOUND IN MEDICINE (ISSN:0278-4297), 209- 213, 24;
111. Trevisanuto D; Doglioni N; Ferrarese P; Vedovato S; Cosmi E.; Zanardo V. (2005). Neonatal pneumothorax: comparison between neonatal transfers and inborn infants. 2005;33(5):449-54 JOURNAL OF PERINATAL MEDICINE (ISSN:0300-5577), 449- 454, 33;
112. Gloria-Bottini F; Bottini N; Cosmi E.; Cosmi Ev; Bottini E. (2005). The effect of gender and ACP1 genetic polymorphism on the correlation between birth weight and placental weight.(2005). PLACENTA (ISSN:0143-4004), 846- 848, 26;
113. Mari G; Abuhamad Az; Cosmi E.; Segata M; Altaye M; Akiyama M. (2005). Middle cerebral artery peak systolic velocity: technique and variability JOURNAL OF ULTRASOUND IN MEDICINE (ISSN:0278-4297), 425- 430, 24;
114. Dessole S; Capobianco G; Cosmi E. (2005). Reply CORRESPONDENCE AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (ISSN:0002-9378), 898- 898, 193;
115. Gloria-Bottini E; Cosmi E; Nicotra M; Cosmi EV; Bottini E (2005). Is delayed childbearing changing gene frequencies in Western populations? HUMAN BIOLOGY (ISSN:0018-7143), 433- 441, 77;
116. Ruozi-Berretta A; Piazze JJ; Cosmi E.; Cerekja A; Kashami A; Anceschi MM (2004). Computerized cardiotocography parameters in pregnant women affected by pregestational diabetes mellitus JOURNAL OF PERINATAL MEDICINE (ISSN:0300-5577), 426- 429, 32;
117. Dessole S,Cosmi E,Balata A,Uras L,Caserta D,Capobianco G,Ambrosini G (2004). Accidental fetal lacerations during cesarean delivery: experience in an Italian level III university hospital. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (ISSN:0002-9378), 1673-77,191;
118. Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi Pl; Marci R; Cosmi E. (2004). Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women MENOPAUSE (ISSN:1072-3714), 49- 56, 11;
119. Bottini N; Magrini A; Cosmi E.; Gloria-Bottini F; Saccucci P; Di Iorio R; Bergamaschi A; Bottini E (2004). Genetics of signal transduction and the effect of maternal smoking on sex ratio of offspring AMERICAN JOURNAL OF HUMAN BIOLOGY (ISSN:1042-0533), 588- 592, 16;
120. Anceschi Mm; Ruozi-Berretta A; Piazze JJ; Cosmi E.; Cerekja A; Meloni P; Cosmi EV (2004). Computerized cardiotocography in the management of intrauterine growth restriction associated with Doppler velocimetry alterations INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (ISSN:0020-7292), 365- 370, 86;
121. Bottini N; Gloria-Bottini F; Magrini A; Stefanini L; Cosmi E.; Bergamaschi A; Cosmi EV; Bottini E (2004). Maternal cigarette smoking, metabolic enzyme polymorphism, and developmental events in the early stages of extrauterine life, HUMAN BIOLOGY (ISSN:0018-7143), 289- 297, 76;
122. La Torre R; Cosmi E.; Anceschi M; Piazze J; Piga MD; Cosmi E. (2003). Preliminary report on a new and noninvasive method for the assessment of fetal lung maturity, JOURNAL OF PERINATAL MEDICINE (ISSN:0300-5577), 431- 434, 31;
123. Dessole S,Farina M,Rubattu G,Cosmi E,Ambrosini G,Nardelli GB (2003). Sonovaginography is a new technique for assessing rectovaginal endometriosis. FERTILITY AND STERILITY (ISSN:0015-0282), 1023- 1027, 79;
124. Dessole S.; Farina M.; Rubattu G.; Cosmi E.; Ambrosini G.; Nardelli G.B. (2003). Side effects and complications of sonoisterosalpingography FERTILITY AND STERILITY (ISSN:0015-0282), 620- 624, 80;
125. Gloria-Bottini F.; La Torre; Lucarini N.; Cosmi E. (2003). Evidence of Association of the Ratio Birth Weight/Placental Weight M. with Genetic Factors Located in the Short Arm of Chromosome 1. PLACENTA (ISSN:0143-4004), 571- 573, 24;
126. Cosmi E; Ambrosini G.; D'antona D; Capobianco G; Uras L; Dessole S (2003). Middle cerebral artery peak systolic velocity and Ductus venosus in the assessment of fetal hydrops ULTRASOUND IN OBSTETRICS & GYNECOLOGY (ISSN:0960-7692), 159- 159, 22;
127. Borgiani P; Nicotra M; Amante A; Lucarini N; Cosmi E.; Bottini E (2003). Intrauterine development and MNSs blood groups in repeated spontaneous abortion INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (ISSN:0020-7292), 207- 211, 81;
128. Cosmi EV; Anceschi MM; Cosmi E.; Piazze JJ; La Torre R (2003). Ultrasonographic patterns of fetal breathing movements in normal pregnancy INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (ISSN:0020-7292), 285- 290, 80;
129. Anceschi MM; Piazze JJ; Ruozi-Berretta A; Cosmi E.; Cerekja A; Maranghi L; Cosmi EV (2003). Validity of short term variation (STV) in detection of fetal acidemia JOURNAL OF PERINATAL MEDICINE (ISSN:0300-5577), 231- 236, 31;
130. Cosmi E.; Mari G.; Chiaie LD.; Bahadosigh R.; Abuhamad A.; Ambrosini G.; Nardelli G.B.; Capobianco G.; Rubattu G.; Dessole S. (2002). Management of fetal parvovirus infection by MCA-PSV Doppler ultrasonography: a multicenter study. FETAL DIAGNOSIS AND THERAPY (ISSN:1015-3837), 98- 99, 17;
131. Cosmi E.; Mari G; Delle Chiaie L; Detti L; Akiyama M; Murphy J; Stefos T; Ferguson J ; Hunter D; Hsu CD; Abuhamad A; Bahado-Singh R (2002). Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection, AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (ISSN:0002-9378), 1290- 1293, 187;
132. Detti L; Mari G; Akiyama M; Cosmi E.; Moise KJ Jr; Stefor T; Conaway M; Deter R (2002). Longitudinal assessment of the middle cerebral artery peak systolic velocity in healthy fetuses and in fetuses at risk for anemia, AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (ISSN:0002-9378), 937- 939, 187;
133. Stefos T; Plachouras N; Mari G; Cosmi E.; Lolis D (2002). A case of partial mole and atypical type I triploidy associated with severe HELLP syndrome at 18 weeks' gestation ULTRASOUND IN OBSTETRICS & GYNECOLOGY (ISSN:0960-7692), 403- 404, 20;
134. Nigro G; La Torre R; Sali E; Auteri M; Mazzocco M; Maranghi L; Cosmi E. (2002). Intraventricular haemorrhage in a fetus with cerebral cytomegalovirus infection PRENATAL DIAGNOSIS (ISSN:0197-3851), 558- 561, 22;
135. Stefos T; Cosmi E.; Detti L; Mari G (2002). Correction of fetal anemia on the middle cerebral artery peak systolic velocity, OBSTETRICS AND GYNECOLOGY (ISSN:0029-7844), 211- 215, 99;
136. Liang RI; Prapas N; Detti L; Cosmi E.; Copel JA; Mari G (2002). Assessment of blood flow velocity waveforms of the pulmonary circulation by multigate spectral Doppler scanning and traditional pulsed Doppler ultrasonography JOURNAL OF ULTRASOUND IN MEDICINE (ISSN:0278-4297), 31- 37, 31;
137. Minozzi M; Costabile L; Cosmi E.; Donadio F; De Filippis E; Cosmi E. (2001). Beneficial effects of low doses of ethinyl-estradiol on the lipid profile in postmenopausal women, CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN:0390-6663), 81- 82, 28;
138. Nigro G; Mazzocco M; Aragona C; D'emilio C; Cosmi E. (2000). Hyperimmunoglobulin therapy for cytomegalovirus-associated infertility: Case reports FERTILITY AND STERILITY (ISSN:0015-0282), 830- 831, 74;
139. Cosmi E.; Mazzocco M; La Torre R; Ligi P; Sali E; Nigro G (2000). Therapy or prevention of fetal infection by cytomegalovirus with immunoglobulin infusion in pregnant women with primary infection ACTA BIO-MEDICA DE L'ATENEO PARMENSE (ISSN:0392-4203), 547- 551, 71;
140. Gergely A; Kovanci E; Senturk L; Cosmi E; Vigue L; Huszar G. (1999). Morphometric assessment of mature and diminished-maturity human spermatozoa: sperm regions that reflect differences in maturity, HUMAN REPRODUCTION (ISSN:0268-1161), 2007- 2014, 14;

Anil Tombak, MD

Associate Professor Department of Internal Medicine – Hematology Mersin University Medical Faculty Mersin, Turkey
Associate Doctor Anil Tombak, M.D. was born on April 25, 1976. He was graduated from Gazi Anatolian High School at 1994 and then graduated from Çukurova University Medical Faculty at 2000. After that, he was trained at Mersin University Medical Faculty Internal Medicine Department, and after Internal Medicine specialization, became a fellow of Hematology at the same University. He became a hematologist in 2013 and still working at Mersin University Medical Faculty, Department of Internal Medicine – Hematology, Mersin, Turkey. Associate Doctor Anil Tombak is married and has two children.
Awards
International
1. Clinical Research First Prize, International Eurasian Hematology Congress, 2013-06-19, Antalya, Turkey.
National
1. Turkish Society of Gastroenterology, 2007-06-19, Antalya, Turkey.
2. Turkish Society of Hematology, 2010-09-19, Antalya, Turkey.
3. Turkish Society of Hematology, 2013-06-19, Antalya, Turkey.
4. Turkish Society of Apheresis, 2013-06-19, Kıbrıs, Turkey.
5. Geriatric Hematology Young Investigator Award, Geriatric Hematology Society, 2014-06-19, Ankara, Turkey.
6. Jury, HOD, 2015-09-24, Kıbrıs, Turkey.
Memberships in Scientific Organizations
1. Hematological Oncology Association, Member No: 100, Turkey, 2016-03-07-Continue.
2. Turkish hematology association, Member No: 766, Turkey, 2007-06-07-Continue.
Certification
1. Certificate of Good Clinical Practice, Minister of Health, 01, 2016-06-19.
2. Course on Use of Experimental Animals, Mersin University, 000042, 2014-07-04
International - SCI/SCI-Expanded category
2017
25. Yavasoglu, I.; Sargin, G.; Yilmaz, F.; Altındag, S.; Akgun, G.; Tombak, A.; Toka, B.; Dal, S.; Ozbas, H. Cholesterol Levels in Patients with Chronic Lymphocytic Leukemia. ELSEVIER BV, 2017, 0-0. http://dx.doi.org/10.1016/j.jnma.2016.11.006
24. Tombak, A.; Uçar, M.; Akdeniz, A.; Yilmaz, A.; Kaleagası, H.; Sungur, M.; Tiftik, E. Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases. SPRINGER NATURE , 2017, 33 , 97-105. http://dx.doi.org/10.1007/s12288-016-0661-3
2016
23. Karakaya, B.; Tombak, A.; Serin, M.; Tiftik, N. Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients. INFORMA UK LIMITED, 2016, 21 , 295-299. http://dx.doi.org/10.1080/10245332.2015.1125079 Publications_003.pdf
22. Tombak, A.; Uçar, M.; Akdeniz, A.; Tiftik, E.; Gören şahin, D.; Akay, O.; Yıldırım, M.; Nevruz, O.; Kış, C. The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study. TURKISH JOURNAL OF HAEMATOLOGY , 2016, 33 , 273-280. http://dx.doi.org/10.4274/tjh.2015.0203 Publications_002.pdf
21. Salim, O.; Toptas, T.; Avsar, E.; Yucel, O.; Ozturk, E.; Ferhanoglu, B.; Geduk, A.; Mehtap, O.; Tombak, A. Azacitidine versus decitabine in patients with refractory anemia with excess blast—Results of multicenter study. ELSEVIER BV, 2016, 45 , 82-89.
http://dx.doi.org/10.1016/j.leukres.2016.04.003 Publications_004.pdf
2015
20. Tombak, A.; Ay, O.; Erdal, M.; Sungur, M.; Ucar, M.; Akdeniz, A.; Tiftik, E. MicroRNA Expression Analysis in Patients with Primary Myelofibrosis, Polycythemia vera and Essential Thrombocythemia. SPRINGER SCIENCE + BUSINESS MEDIA, 2015, 31 , 416-425.
http://dx.doi.org/10.1007/s12288-014-0492-z
19. Tombak, A. Circulating MicroRNAs in Newly Diagnosed Acute and Chronic Leukemias. AKADEMI DOKTORLAR YAYINEVI, 2015, 25 , 75-80. http://dx.doi.org/10.4999/uhod.15765
18. Hacioglu, S.; Bilen, Y.; Eser, A.; Sivgin, S.; Gurkan, E.; Yildirim, R.; Aydogdu, I.; Dogu, M.; Yilmaz, M. Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy. WILEYBLACKWELL, 2015, 172-179. http://dx.doi.org/10.1002/hon.2177
17. Tombak, A.; Aygün, S.; Serinsöz, E.; Tiftik, E. Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine. KOREAN ASSOCIATION OF INTERNAL MEDICINE , 2015, 30 , 739-741.
http://dx.doi.org/10.3904/kjim.2015.30.5.739
16. Tombak, A.; Boztepe, B.; Tiftik, N.; Comert, M.; Salim, O.; Aydin, K.; Gurkan, E.; Yucel, O.; Saydam, G. Seasonal Association of Immune Thrombocytopenia in Adults. AVES PUBLISHING CO. , 2015, 1-5. http://dx.doi.org/10.5152/balkanmedj.2015.151223
2014
15. Turgutalp, K.; Ozhan, O.; Akbay, E.; Tombak, A.; Tiftik, N.; Ozcan, T.; Yilmaz, S.; Helvaci, I.; Kiykim, A. Mean Platelet Volume and Related Factors in Patients at Different Stages of Diabetic Nephropathy: A Preliminary Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 , 190-195. https://dx.doi.org/10.1177/1076029612456734
14. Tombak, A.; Tiftik, N.; Dogu, M.; Sari, I.; Akay, M.; Karagulle, M.; Kaya, E.; Korkmaz, S.; Sencan, M. The Clinical Characteristics and Therapeutic Outcomes of Elderly Patients with Chronic Lymphocytic Leukemia: A Retrospective Multicenter Study. BLOOD, 2014, 124 , 0-0.
13. Hacioglu, S.; Bilen, Y.; Eser, A.; Sivgin, S.; Gurkan, E.; Yildirim, R.; Aydogdu, I.; Dogu, M.; Yilmaz, M. HAIRY CELL LEUKEMIA: MULTICENTER RETROSPECTIVE ANALYSIS IN TURKEY. HAEMATOLOGICA, 2014, 99 , 694-694.
12. Korkmaz, S.; Dal, M.; Berber, I.; Sahin, D.; Dogu, M.; Ayyildiz, O.; Nizam, I.; Albayrak, M.; Esen, R. Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study. WILEY-BLACKWELL, 2014, 15 , 729-735. http://dx.doi.org/10.1111/ggi.12341
11. Avsar, E.; Salim, O.; Toptas, T.; Deveci, B.; Kurtoglu, E.; Tombak, A.; Tiftik, E.; Undar, L. Comparison of DNA Methyltransferase Inhibitors in Patients with Myelodysplastic Syndrome. BLOOD, 2014, 124 , 0-0.
10. Hacioglu, S.; Bilen, Y.; Eser, A.; Sivgin, S.; Gurkan, E.; Yildirim, R.; Aydogdu, I.; Dogu, M.; Yilmaz, M. Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy. WILEYBLACKWELL, 2014, 1-10. http://dx.doi.org/10.1002/hon.2177
2013
9. Yavasoglu, I.; Pektas, G.; Yilmaz, F.; Akguen, G.; Tombak, A.; Toka, B.; Dal, S.; Ozbas, H.; Cetin, G. Cholesterol Levels In Patients With Newly Diagnosed Chronic Lymphocytic Leukemia: A retrospective Multicenter Study. BLOOD, 2013, 122 , 0-0.
8. Korkmaz, S.; Keklik, M.; Sivgin, S.; Yildirim, R.; Tombak, A.; Kaya, M.; Acik, D.; Esen, R.; Hacioglu, S. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study. TRANSFUSION AND APHERESIS SCIENCE , 2013, 48 , 353-358. https://dx.doi.org/10.1016/j.transci.2013.04.016
7. Turgutalp, K.; Kiykim, A.; Tabakan, F.; Tombak, A.; Tiftik, N.; Ozhan, O. Secondary Amiloidosis and Familial Mediterranean Fever Mimicking Recurrent Abdominal Sickling Crisis in a Patient with Sickle Cell Anemia. TURKISH JOURNAL OF RHEUMATOLOGY , 2013, 28 , 218-219. https://dx.doi.org/10.5606/tjr.2013.3570
2011
6. Horasan, E.; Ersoz, G.; Tombak, A.; Tiftik, N.; Kaya, A. Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients. MEDICAL SCIENCE MONITOR, 2011, 17 , CR304-CR309.
2010
5. Sezgin, O.; Altintas, E.; Ucbilek, E.; Tombak, A. Percutaneous Liver Biopsies: Safety and Efficacy. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30 ,1287-1291. https://dx.doi.org/10.5336/medsci.2009-13508
4. Sezgin, O.; Altintas, E.; Tombak, A.; Ucbilek, E. Fasciola hepatica-induced acute pancreatitis: Report of two cases and review of the literature. TURKISH JOURNAL OF GASTROENTEROLOGY , 2010, 21 , 183-187. https://dx.doi.org/10.4318/tjg.2010.0081
2009
3. Sezgin, O.; Altintas, E.; Polat, A.; Tombak, A. Ultrasonographic features of a large B-cell lymphoma of the gallbladder. TURKISH JOURNAL OF GASTROENTEROLOGY , 2009, 20 , 239-240. https://dx.doi.org/10.4318/tjg.2009.0019
2007
2. Sezgin, O.; Altintas, E.; Uecbilek, E.; Tombak, A.; Tellioglu, B. Low efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: In an observational study in a turkish population. HELICOBACTER, 2007, 12 , 518-522. https://dx.doi.org/10.1111/j.1523-5378.2007.00535.x
1. Sezgin, O.; Altintas, E.; Tombak, A. Effects of seasonal variations on acute upper gastrointestinal bleeding and its etiology. TURKISH JOURNAL OF GASTROENTEROLOGY , 2007, 18 , 172-176.
International - Covered by Other International Indexes
2016
1. şahin, F.; Akay, O.; Mesut, A.; Dal, M.; Ertop, 􀁒.; Ilhan, O.; Karakuş, V.; özcan, M.; özkocaman, V. Pesg PNH diagnosis, follow-up and treatment guidelines. AMERICAN JOURNAL OF BLOOD RESEARCH, 2016, 6 , 19-27. Publications_005.pdf
National - Covered by ULAKBIM
2013
2. Tombak, A.; Tekin, Tiftik, E. Cardiac Tamponade: An Unusual Presentation of Multiple Myeloma: Case Report. TURKIYE KLINIKLERI JOURNAL OF CASE REPORTS, 2013, 21 , 167-170.
2010
1. Altıntaş, E.; Tombak, .; Tellioğlu, B. The causes, diagnosis and treatment of severe jaundice. AKADEMIK GASTROENTEROLOJI DERGISI, 2010, 9 , 02-07.
National - Other
2014
3. Tombak, A.; Tabakan, F.; Eskandari, H.; Tiftik, E. Chronic Lymphocytic Leukemia With Meningeal Infiltration By Monoclonal T Lymphocytes. CAUSAPEDIA, 2014, 3 , 926-926.
2. Turgutalp, K.; Karabulut, U.; Tombak, A.; Koseci, T.; Ozgur, A.; Kiykim, A. Thrombocytopenia Associated with Portal Vein Thrombosis as a Presenting Sign of Adult Nephrotic Syndrome: A Case Report. TURKISH NEPHROLOGY DIALYSIS TRANSPLANTATION , 2014, 23 , 70-72. http://dx.doi.org/10.5262/tndt.2014.1001.15
2008
1. Sezgin, O.; Altıntaş , E.; Tombak, A.; Karabacak, T. A jejunal non-hodgkin’s lymphoma: Initial presentation of celiac disease. AKADEMIK GASTROENTEROLOJI DERGISI, 2008, 7 , 46-50.
Books
International - Chaper(s) in Book (Translated)
1. Tombak, A. Case-Based Hematology, ISBN: 9786053971207, Akademisyen Kitabevi, Number of print: 1, Total Printing Number: 500, 197 Page, Turkish, İstanbul, Turkey, 2012.
2. Tombak, A. The Best 500 Qoestions and Answers, ISBN: 1493287, Nobel, Number of print: 2015, Total Printing Number: 100, 450 Page, Turkish, Mersin, Turkey, 2015.

Alexander Birbrair, PhD

Professor Department of Pathology Federal University of Minas Gerais Belo Horizonte, MG, Brazil
EDUCATION
(2016 – present) Professor, Department of Pathology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
(2014 – 2016) Posdoc, Albert Einstein College of Medicine, Bronx, NY, USA, Field of Study: Stem cell biology, Advisor: Paul S. Frenette, MD.
(2010 – 2014) Ph.D., Neuroscience Program, Wake Forest School of Medicine, Winston-Salem, NC, USA, Field of Study: Stem cell biology, Advisor: Osvaldo Delbono, Ph.D., MD.
(2009 – 2010) Research Scholar, Wake Forest School of Medicine, Winston-Salem, NC, USA, Field of Study: Muscle biology, Advisor: Osvaldo Delbono, Ph.D, MD.
(2005 - 2009) B.S., Biomedical Science, Universidade Estadual de Santa Cruz, UESC, Ilheus, Brazil, Field of Study: Genetics of microorganisms, Advisors: Rachel Passos Rezende, Ph.D. and Joao Carlos Teixeira Dias, Ph.D.
HONORS AND AWARDS
2017. Won the prestigious Instituto Serrapilheira Grant 2017-Call
2017. Elected Affiliated Member of the Brazilian Academy of Sciences
2015. Recipient of Gordon A. Melson Outstanding Doctoral Student Award for 2015
2014. Winner of 3-minute thesis (3MT) oral competition (2014 Fourteenth Annual Wake Forest University Graduate Student & Postdoc Research Day)
2014. Editor's choice in Journal of Gerontology Biological Sciences Volume 69 Issue 12 December 2014 for the manuscript “Human Slow Troponin T (TNNT1) Pre-mRNA Alternative Splicing is An Indicator of Skeletal Muscle Response to Resistance Exercise in Older Adults.” by Zhang T, Choi SJ, Wang ZM, Birbrair A, Messi ML, Jin J-P, Marsh AP, Nicklas B, and Delbono O.
2013. Awarded with the Glenn/AFAR Scholarship for Research in the Biology of Aging
2012. Wake Forest University Graduate and Postdoctoral Students Research Day (Troponin T nuclear localization and its role in skeletal muscle aging) (12th annual competition) (First place) (Co-author)
2008. “Metagenome of soil contaminated with petroleum.” Scholarship from : Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB), Brazil.
2006. “Best poster (Genetic diversity between isolates of Chromobacterium violaceum) presented in the area of biological sciences during the XII Seminário de Iniciação Científica da Universidade Estadual de Santa Cruz – UESC, Ilhéus – Bahia.”
(1) Paiva AE, Lousado L, Guerra DAP, Azevedo PO, Sena IFG, Andreotti JP, Santos GSP, Gonçalves R, Mintz A, Birbrair A. (2018) Pericytes in the Premetastatic Niche. Cancer Res. 78(11):2779-2786. PMID: 29789421.
(2) Azevedo PO, Paiva AE, Santos GSP, Lousado L, Andreotti JP, Sena IFG, Tagliati CA, Mintz A, Birbrair A. (2018) Cross-talk between lung cancer and bones results in neutrophils that promote tumor progression. Cancer Metastasis Rev. In press. PMID: 30203108.
(3) de Alvarenga EC, Silva WN, Vasconcellos R, Paredes-Gamero EJ, Mintz A, Birbrair A. (2018) Promyelocytic leukemia protein in mesenchymal stem cells is essential for leukemia progression. Ann Hematol. 97(10):1749-1755. PMID: 30069705.
(4) Guerra DAP, Paiva AE, Sena IFG, Azevedo PO, Silva WN, Mintz A, Birbrair A. (2018) Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome. Angiogenesis. In press. PMID: 29761249.
(5) Silva WN, Leonel C, Prazeres PHDM, Sena IFG, Guerra DAP, Heller D, Diniz IMA, Fortuna V, Mintz A, Birbrair A. (2018) Role of Schwann cells in cutaneous wound healing. Wound Repair Regen. In press. PMID: 30098299.
(6) Sena IFG, Paiva AE, Prazeres PHDM, Azevedo PO, Lousado L, Bhutia SK, Salmina AB, Mintz A, Birbrair A. (2018) Glioblastoma-activated pericytes support tumor growth via immunosuppression. Cancer Med. 7(4):1232-1239. PMID: 29479841.
(7) Henriques F, Lopes M, Franco F, Knobl P, Santos K, Bueno L, Correa V, Bedard A, Guilherme A, Birbrair A, Peres S, Farmer S, Batista ML Jr. (2018) Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival During Cancer Cachexia Syndrome. Scientific Reports. In press.
(8) Birbrair A. (2018) Pericyte Biology: Development, Homeostasis and Disease. Adv Exp Med Biol. In press.
(9) Santos GSP, Magno LAV, Romano-Silva MA, Mintz A, Birbrair A. (2018) Pericytes plasticity in the brain. Neuroscience Bulletin. In press.
(10) Prazeres PHDM, Turquetti AOM, Azevedo PO, Barreto RSN, Miglino MA, Mintz A, Delbono O, Birbrair A. (2018) Perivascular cell αv integrins as a target to treat skeletal muscle fibrosis. Int J Biochem Cell Biol. In press. PMID: 29627438.
(11) Andreotti JP, Paiva AE, Prazeres PHDM, Guerra DAP, Silva WN, Vaz RS, Mintz A, Birbrair A. (2018) The role of natural killer cells in the uterine microenvironment during pregnancy. Cell Mol Immunol. In press. PMID: 29572543.
(12) Andreotti JP, Prazeres PHDM, Magno LAV, Romano-Silva MA, Mintz A, Birbrair A. (2018) Neurogenesis in the postnatal cerebellum after injury. Int J Dev Neurosci. In press. PMID: 29555564.
(13) Silva WN, Prazeres PHDM, Paiva AE, Lousado L, Turquetti AOM, Barreto RSN, de Alvarenga EC, Miglino MA, Gonçalves R, Mintz A, Birbrair A. (2018) Macrophage-derived GPNMB accelerates skin healing. Exp Dermatol. In press. PMID: 29505115.
(14) Costa MA, Paiva AE, Andreotti JP, Cardoso MV, Cardoso CD, Mintz A, Birbrair A. (2018) Pericytes constrict blood vessels after myocardial ischemia. J Mol Cell Cardiol. In press. PMID: 29371134.
(15) Andreotti JP, Lousado L, Magno LAV, Birbrair A. (2017) Hypothalamic Neurons Take Center Stage in the Neural Stem Cell Niche. Cell Stem Cell. 21(3):293-294. PMID: 28886362.
(16) Guerra DAP, Paiva AE, Sena IFG, Azevedo PO, Batista ML Jr, Mintz A, Birbrair A. (2017) Adipocytes role in the bone marrow niche. Cytometry A. In press. PMID: 29236351.
(17) Azevedo PO, Sena IFG, Andreotti JP, Carvalho-Tavares J, Alves-Filho JC, Cunha TM, Cunha FQ, Mintz A, Birbrair A. (2017) Pericytes modulate myelination in the central nervous system. J Cell Physiol. In press. PMID: 29215724.
(18) Birbrair A. (2017) Stem Cell Microenvironments and Beyond. Adv Exp Med Biol. 1041:1-3. PMID: 29204825.
(19) Santos GSP, Prazeres PHDM, Mintz A, Birbrair A. (2017) Role of pericytes in the retina. Eye (Lond). In press. PMID: 29125148.
(20) Prazeres PHDM, Almeida VM, Lousado L, Andreotti JP, Paiva AE, Santos GSP, Azevedo PO, Souto L, Almeida GG, Filev R, Mintz A, Gonçalves R, Birbrair A. (2017)
Macrophages Generate Pericytes in the Developing Brain. Cell Mol Neurobiol. 38(4):777-782. PMID: 28894964.
(21) Sena IFG, Prazeres PHDM, Santos GSP, Borges IT, Azevedo PO, Andreotti JP, Almeida VM, Paiva AE, Guerra DAP, Lousado L, Souto L, Mintz A, Birbrair A. (2017) LepR+ cells dispute hegemony with Gli1+ cells in bone marrow fibrosis. Cell Cycle. In press. PMID: 28976809.
(22) Paiva AE, Lousado L, Almeida VM, Andreotti JP, Santos GSP, Azevedo PO, Sena IFG, Prazeres PHDM, Borges IT, Azevedo V, Mintz A, Birbrair A. (2017) Endothelial cells as precursors for osteoblasts in the metastatic prostate cancer bone. Neoplasia. 19(11):928-931. PMID: 28957694.
(23) Lousado L, Prazeres PHDM, Andreotti JP, Paiva AE, Azevedo PO, Santos GSP, Filev R, Mintz A, Birbrair A. (2017) Schwann cell precursors as a source for adrenal gland chromaffin cells. Cell Death and Disease. 8(10):e3072. PMID: 28981120.
(24) Almeida VM, Paiva AE, Sena IFG, Mintz A, Magno LAV, Birbrair A. (2017) Pericytes make spinal cord breathless after injury. Neuroscientist. In press. PMID: 29283016.
(25) Azevedo PO, Lousado L, Paiva AE, Andreotti JP, Santos GSP, Sena IFG, Prazeres PHDM, Filev R, Mintz A, Birbrair A. (2017) Endothelial cells maintain neural stem cells quiescent in their niche. Neuroscience. 363:62-65. PMID: 28893649.
(26) Coatti GC, Frangini M, Valadares MC, Gomes JP, Lima NO, Cavaçana N, Assoni AF, Pelatti MV, Birbrair A, de Lima ACP, Singer JM, Rocha FMM, Da Silva GL, Mantovani MS, Macedo-Souza LI, Ferrari MFR, Zatz M. (2017) Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient. Stem Cell Reviews and Reports. 13:686-698. PMID: 28710685.
(27) Sena IFG, Prazeres PHDM, Santos GSP, Borges IT, Azevedo PO, Andreotti JP, Almeida VM, Paiva AE, Guerra DAP, Lousado L, Souto L, Mintz A, Birbrair A. (2017) Identity of Gli1+ cells in the bone marrow. Exp Hematol. 54:12-16. PMID: 28690072.
(28) Borges I, Sena I, Azevedo P, Andreotti J, Almeida V, Paiva A, Santos G, Guerra D, Prazeres P, Mesquita LL, Silva LSB, Leonel C, Mintz A, Birbrair A. (2017) Lung as a Niche for Hematopoietic Progenitors. Stem Cell Reviews and Reports. 13: 567-574. PMID: 28669077.
(29) Birbrair A, Borges IDT, Gilson Sena IF, Almeida GG, da Silva Meirelles L, Gonçalves R, Mintz A, Delbono O. (2017) How Plastic Are Pericytes? Stem Cells Dev. 26(14):1013-1019. PMID: 28490256.
(30) Dias Moura Prazeres PH, Sena IFG, Borges IDT, de Azevedo PO, Andreotti JP, de Paiva AE, de Almeida VM, de Paula Guerra DA, Pinheiro Dos Santos GS, Mintz A, Delbono
O, Birbrair A. (2017) Pericytes are heterogeneous in their origin within the same tissue. Dev Biol. 427(1):6-11. PMID: 28479340.
(31) Pereira LX, Viana CTR, Orellano LAA, Almeida SA, Vasconcelos AC, Goes AM, Birbrair A, Andrade SP, Campos PP. (2017) Synthetic matrix of polyether-polyurethane as a biological platform for pancreatic regeneration. Life Sciences. 176:67-74. PMID: 28336399.
(32) Asada N, Kunisaki Y, Pierce H, Wang Z, Fernandez NF, Birbrair A, Ma'ayan A, Frenette PS. (2017) Differential cytokine contributions of perivascular haematopoietic stem cell niches. Nature Cell Biology. 19(3):214-223. PMID: 28218906.
(33) Birbrair A, Sattiraju A, Zhu D, Zulato G, Batista I, Nguyen VT, Messi ML, Solingapuram Sai KK, Marini FC, Delbono O, Mintz A. (2017) Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas. Stem Cells Translational Medicine. 6(2):471-481. PMID: 28191774.
(34) Birbrair A. (2016) Learn new languages to get ahead. Nature Biotechnology. 34:1073-1074. PMID: 27727214.
(35) Birbrair A and Frenette PS. (2016). Niche heterogeneity in the bone marrow. Annals of the New York Academy of Sciences. 1370(1):82-96. PMID: 27015419.
(36) Zhang T, Pereyra AS, Wang ZM, Birbrair A, Reisz JA, Files DC, Purcell L, Feng X, Messi ML, Feng H, Chalovich J, Jin JP, Furdui C, Delbono O. (2016) Calpain inhibition rescues troponin T3 fragmentation, increases Cav1.1 , and enhances skeletal muscle force in aging sedentary mice. Aging Cell. 15(3):488-98. PMID: 26892246.
(37) Khan JA, Mendelson A, Kunisaki Y, Birbrair A, Kou Y, Arnal A, Pinho S, Ciero P, Nakahara F, Ma’ayan A, Bergman A, Merad M and Frenette PS. (2015) Identification of a portal vessel-associated fetal liver hematopoietic stem cell niche. Science. 351:176-180. PMID: 26634440.
(38) Birbrair A and Delbono O. (2015). Pericytes are Essential for Skeletal Muscle Formation. Stem Cell Reviews and Reports. 11(4):547-8. PMID: 25896402.
(39) Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A and Delbono O. (2015). Pericytes at the intersection between tissue regeneration and pathology. Clinical Science. 128(2): 81–93. PMID: 25236972.
(40) Zhang T, Birbrair A, Wang ZM, Messi ML, Marsh AP, Leng I, Nicklas BJ, Delbono O. (2015). Improved knee extensor strength with resistance training associates with muscle specific miRNAs in older adults. Exp Gerontol. 62:7-13. PMID: 25560803.
(41) Birbrair A, Zhang T, Files DC, Mannava S, Smith T, Wang ZM, Messi ML, Mintz A, Delbono O. (2014). Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Res Ther. 5(6):122. PMID: 25376879.
(42) Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A and Delbono O. (2014). Pericytes: Multitasking Cells in the Regeneration of Injured, Diseased, and Aged Skeletal Muscle. Frontiers in Aging Neuroscience. 6:245. PMID: 25278877.
(43) Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A and Delbono O. (2014). Type-2 Pericytes Participate in Normal and Tumoral Angiogenesis. Am J Physiol Cell Physiol. 307 (1): C25-C38. PMID: 24788248
(44) Zhang T, Choi SJ, Wang ZM, Birbrair A, Messi ML, Jin J-P, Marsh AP, Nicklas B, and Delbono O. (2014). Human Slow Troponin T (TNNT1) Pre-mRNA Alternative Splicing is An Indicator of Skeletal Muscle Response to Resistance Exercise in Older Adults. J Gerontol A Biol Sci Med Sci. 69(12):1437-47. PMID: 24368775.
(45) Birbrair A, T Zhang, ZM Wang, ML Messi, A Mintz and O Delbono. (2013). Type-1 Pericytes Participate in Fibrous Tissue Deposition in Aged Skeletal Muscle. Am J Physiol Cell Physiol. 305 (11): C1098-C1113. PMID: 24067916.
(46) Birbrair A, T Zhang, ZM Wang, ML Messi, GN Enikolopov, A Mintz and O Delbono. (2013). Role of Pericytes in Skeletal Muscle Regeneration and Fat Accumulation. Stem Cells Dev. 22 (16): 2298-314. PMID: 23517218.
(47) Zhang, T, Birbrair, A, and Delbono, O. (2013). Nonmyofilament-Associated Troponin T3 Nuclear and Nucleolar Localization Sequence and Leucine Zipper Domain Mediate Muscle Cell Apoptosis. Cytoskeleton (Hoboken). 70(3):134-47. PMID: 23378072.
(48) Birbrair A, T Zhang, ZM Wang, ML Messi, GN Enikolopov, A Mintz and O Delbono. (2013). Skeletal muscle neural progenitor cells exhibit properties of NG2-glia. Exp Cell Res 319:45–63. PMID: 22999866.
(49) Birbrair A, T Zhang, ZM Wang, ML Messi, GN Enikolopov, A Mintz and O Delbono. (2013). Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res 10:67-84. PMID: 23128780.
(50) Zhang T, Birbrair A, ZM Wang, J Taylor, ML Messi and O Delbono. (2013). Troponin T nuclear localization and its role in aging skeletal muscle. Age (Dordr). 35(2):353-70. PMID: 22189912.
(51) Birbrair A, ZM Wang, ML Messi, GN Enikolopov and O Delbono. (2011). Nestin-GFP transgene reveals neural precursor cells in adult skeletal muscle. PLoS One 6:e16816. PMID: 21304812.
BOOKS
Birbrair A. (2017). Stem Cell Microenvironments and Beyond. 1. ed. Springer Nature. Print ISBN: 978-3-319-69193-0. DOI: https://doi.org/10.1007/978-3-319-69194-7
Birbrair A. (2018). Pericyte Biology – Novel Concepts. 1. ed. Springer Nature. ISBN: 978-3-030-02601-1. In press

Maher Salamoon, MD

Lecturer Department of Medical Oncology Al-Bairouni University Cancer Center Damascus, Syria
Maher Salamoon obtained his MD from the Faculty of Medicine from Damascus University School of Medicine (Syria) in 1998 then a Master degree in Medical Oncology and Hemato-Oncology from the Nuclear Medicine Centre, Damascus University in 2003, then a Post-doctoral study in Medical Oncology and Molecular Biology from Curie Institution in Paris (France). He did subspecialty in Non-Hodgkin Lymphoma and bone marrow transplant from Lyon-Sud University Hospital in Lyon (France) in 2006. He is the Head of Breast Cancer Department at Al Bairouni University Hospital 2008-2011, Damascus (Syria) and Head of Department of Soft Tissue Sarcoma at the same hospital (2011-2013). At present, he is the Team Leader of translational research at al Bairouni University Hospital and the Institute of biotechnology. He contributed more than 10 papers on translational research in several international oncology and hematology conference and 7 of them are in peer review, with more than 50 national and international publications. He was a speaker in several international and national meetings and reviewed more than 200 papers for international reputable journals.
Cell Culture
Cancer Biology
Health Education and Promotion
Oncology
Clinical Oncology
Lymphoma
Hematology
1- Treatment of peripheral T-cell Lymphoma (PTCL) with an intensive protocol ACEP plus Ifosfamide showed an important progression free survival and overall survival rates. Journal of medical oncology, April 2013, 30:554.
2- High-dose Methotrexate, high-dose Cytarabine and Temozolomide for the treatment of Primary Central Nervous System Lymphoma (PCNSL),journal of medical oncology, August 2013, 30:690.
3-Phenotyping Of Cancer Stem Cells From Primary Breast Cancers: A Model For Evaluating The Response To Anti-Tumor Drugs M.I. Salamoon 1 M. Al Jamali 2 L. Youcef 2 I. Kasem 3 M. Bachour 1 1 Medical Oncology, Al Bairouni University Hospital, Damascus... Ann Oncol (2012) 23 (suppl 9): ix67-ix72 doi:10.1093/annonc/mds390.
4- Is It Possible To Tailor Breast Cancer Treatment By Using Breast Cancer Stem Cells As A Cell Model? Ann Oncol (2013) 24 (suppl 3): iii44 doi:10.1093/annonc/mdt086.6
5- metastatic breast cancer: getting the facts from peripheral blood. Annals of Oncology (2014) 25 (suppl_1): i21-i22. 10.1093/annonc/mdu069
6- Serum Caspase-3 and Caspase-7 as Predictive Factors of Response in Locally Advanced and Metastatic Breast Carcinoma , Hayma Hammoud, Jumana Saleh, Marroan Bachour, Maher Salamoon, Journal of Cancer TherapyVol.5 No.6(2014), Paper ID 46246DOI:10.4236/jct.2014.56067
7- Battah, Basem , salamoon M et al. “Serum CK18 as a Predictive Factor of Response to Chemotherapy in Locally Advanced and Metastatic Breast Cancer.” (2014).
8- Maher Salamoon. New Trends for the Treatment of Follicular Lymphoma in
Relapse: The Role of Type II Anti CD20. Sci J Blood Disord. 2017; 1(1): 1001.
9- Salamoon M (2018) BCL6/BCL2 and MYC Alterations Drawing the Gray Zone between Diffuse Large B-cell Lymphoma and Double, Triple Hit Lymphoma. J Mol Genet Med 12: 336. doi:10.4172/1747-0862.1000336
10- new insight into the treatment of follicular lymphoma: the role of Obinituzumab. Journal of hematology and oncology forecast. Salamoon M. New Insight for the Treatment of Follicular Lymphoma in Relapse: The Role of Obinutuzumab. J Hematol Oncol Forecast. 2018; 1(1):1002.
11- treatment of gray zone lymphoma, Jacobs journal of hematology issue 1, volume 1
12- her-2/ neu status in Syrian women with breast carcinoma : a Syrian cohort study of more than 10000 cases. Salamoon M*, Assad L, Ahmad F, Kenj M and Bachour M. Her-2/neu Status in Syrian Women with Breast Carcinoma: A SyrianCohort Study of more than 10000 Cases. Madridge J Can Stu Res. 2018; 2(1): 59-63. doi: 10.18689/MJCSR-1000109
13- A giant fibrovascular polype regurgitating out side the mouth upon coughing. Mustafa A, Khani RA, Salamoon M (2017) A Giant Fibrovascular Polyp Regurgitating Outside the Mouth upon Coughing. J Clin Epigenet. Vol.3 No.4:48
14- Targeting EGFR T790M in Advanced Adenocarcinoma of the Lung. Salamoon M. Targeting EGFR T790M in Advanced Adenocarcinoma of the Lung. Clin Oncol. 2018; 3: 1427.

Chapter book:
1-B-cell lymphoma treatment : present and future , Lambert academic publishing, code: 978-613-7-37849-6 will be on Amazon by feb.2019 (4 chapters)
2-Temozolomide: uses and adverse events: published by nova scientific publisher , new yourk will be available on Amazon by march.2019 (7 chapters)
3- 6 chapters in the book of: Cyclophosphamide: Clinical Pharmacology, Uses and Potential Adverse Effects.
Published by nova publishers, new York 2015
Chapter 1: Alkylating Agents
(Obeida Khalife, Muhammad Muhammad, Mazen Kenj and Maher Salamoon, Department of Medical Oncology; Kenj Cytogenetic Lab, and Department of Hematology, Al Bairouni University Cancer Center, Damascus, Syria)
Chapter 2: Cyclophosphamide in Hematological Malignancies
(Saurabh Chhabra, Rishi Agarwal, Zartash Gul and Muneer H. Abidi, Medical University of South Carolina, Charleston SC, USA and others)
Chapter 3: Treatment of Peripheral T-Cell Lymphoma with an Intensive Protocol ACEP (Adriamycin, Cyclophosfamide, Etoposide and Prednisolone) and Ifosfamide Showing a Good Overall Survival Rate at 7 Years
(Maher Salamoon, Marouane Bachour, Taisir Hussein and Mazen Kenj, Al Bairouni University Hospital, Department of Hematology and Medical Oncology; Tishreen Hospital, Department of Pathology, and Mazen Kenj Laboratory, Molecularbiology Section, Damascus, Syria)
Chapter 4: Improving Cancer Micro-Environment in Breast Cancer with Bone Metastasis through Chemopriming with High-Dose Cyclophosphamide and Mesenchymal Stem Cells Mobilization
(Mazen Kenj and Maher Salamoon, Kenj Lab, and Department of Medical Oncology, Al Bairouni University Cancer Center, Damascus, Syria)
Chapter 5: Oral Cyclophosphamide in Combination with Aromatase Inhibitors Can Control Bone Pain in Breast Cancer with Painful Bone Metastasis
(Maher Salamoon, Al Bairouni University Cancer Center, Damascus, Syria)
Chapter 6: High-Dose Cyclophosphamide can Replace Ifosfamide in Metastatic Soft Tissue Sarcoma in Case of Ifosfamide Shortage
(Maher Salamoon, Al Bairouni University Cancer Center, Damascus, Syria)
Chapter 7: Cyclophosphamide–Induced Hemorrhagic Cystitis
(Muhammad Muhammad, Obeida Khalife, Mazen Kenj and Maher Salamoon, Department of Medical Oncology, Al Bairouni University Cancer Center, and Kenj Cytogenetic Lab, Damascus, Syria)
Join as a Editor